UNAIDS REPORT ON THE GLOBAL AIDS EPIDEMIC | 2010

Copyright © 2010 Joint United Nations Programme on HIV/AIDS (UNAIDS) All rights reserved The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of UNAIDS concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. UNAIDS does not warrant that the information published in this publication is complete and correct and shall not be liable for any damages incurred as a result of its use. WHO Library Cataloguing-in-Publication Data Global report: UNAIDS report on the global AIDS epidemic 2010. “UNAIDS/10.11E | JC1958E” 1.Acquired immunodeficiency syndrome − epidemiology. 2.Acquired immunodeficiency syndrome − prevention and control. 3.HIV infections − epidemiology. 4.HIV infections − prevention and control. I.UNAIDS. ISBN 978-92-9173-871-7 (NLM classification: WC 503.4)

GLOBAL REPORT UNAIDS REPORT ON THE GLOBAL AIDS EPIDEMIC | 2010

UNAIDS VISION

ZERO NEW HIV INFECTIONS. ZERO DISCRIMINATION. ZERO AIDS-RELATED DEATHS.

TABLE OF CONTENTS

04 06 16 62 94 120 144 164 178

FOREWORD CHAPTER 1 INTRODUCTION CHAPTER 2 EPIDEMIC UPDATE CHAPTER 3 HIV PREVENTION CHAPTER 4 HIV TREATMENT CHAPTER 5 HUMAN RIGHTS AND GENDER CHAPTER 6 HIV INVESTMENTS REFERENCES ANNEX 1 HIV AND AIDS ESTIMATES AND DATA, 2009 AND 2001 ANNEX 2 COUNTRY PROGRESS INDICATORS AND DATA, 2004 TO 2010

208

FOREWORD

Ebube Sylvia Taylor at the 2010 United Nations Millennium Development Goals Summit

“No child should be born with HIV; no child should be an orphan because of HIV; no child should die due to lack of access to treatment,” urged Ebube Sylvia Taylor, an eleven year old born free of HIV, to world leaders gathered in New York to share progress made towards achieving the Millennium Development Goals by 2015. We have halted and begun to reverse the epidemic. Fewer people are becoming infected with HIV and fewer people are dying from AIDS. We must be proud of these successes and the potential of our shared future— breakthroughs in a prevention revolution are at hand with a new microbicide gel holding promise for a generation of women who will be able to initiate usage and take control of their ability to stop HIV. Political breakthroughs will be achieved as more countries abolish discriminatory practices led by voices of a new law commission, and Treatment 2.0—a breakthrough that could save an additional 10 million lives. However we are not yet in a position to say “mission accomplished”. Growth in investment for the AIDS response has flattened for the first time in 2009. Demand is outstripping supply. Stigma, discrimination, and bad laws continue to place roadblocks for people living with HIV and people on the margins. To fulfill Ebube’s hope, we must break the trajectory of the AIDS epidemic by redoubling our efforts to ensure countries meet their goals towards universal access to HIV prevention, treatment, care and support. We must leverage the growing integration of AIDS with maternal and child health and all of our Millennium Development Goals. We know that there are solutions. We know that there is political and societal will to bring change. The real challenge is following through. This new fourth decade of the epidemic should be one of moving towards efficient, focused and scaled-up programmes to accelerate progress for Results. Results. Results.

Michel Sidibé UNAIDS Executive Director Under Secretary-General of the United Nations

CHAPTER 1 6 Chapter 1: Introduction | 2010 GLOBAL REPORT .

the number of new infections has fallen by 19%.3 million people living with HIV after nearly 30 years into a very complex epidemic. along with extensive input from civil society and other sources. the world has turned the corner—it has halted and begun to reverse the spread of HIV (Millennium Development Goal 6. the gains are real but still fragile. HIV prevention is working.2 million have access—translating into fewer AIDS-related deaths. Since 1999. The evidence supporting increased investment in the HIV response has never been clearer or more compelling. help people in accessing information and services to reduce their risk of HIV infection.and middle-income countries who need treatment today. care. New data from 182 countries. The question remains how quickly the response can chart a new course towards UNAIDS’ vision of zero discrimination. Chapter 1: Introduction | 2010 GLOBAL REPORT 7 . good investments are more important than ever. treatment. For the estimated 33. At a time of financial constraint. and support that will extend and improve the lives of people living with HIV. Treatment is working. Future progress will depend heavily on the joint efforts of everyone involved in the HIV response. 5. Increasing evidence definitively demonstrates that investments in the HIV response can lead to clear reductions in discrimination and stigma. globally. care and support. the year in which it is thought that the epidemic peaked. care and support. treatment.1 INTRODUCTION On the cusp of the fourth decade of the AIDS epidemic.A). and deliver the treatment. and zero AIDS-related deaths through universal access to effective HIV prevention. zero new HIV infections. clearly show that steady progress is being made towards achieving universal access to HIV prevention. Of the estimated 15 million people living with HIV in low.

The biggest epidemics in sub-Saharan Africa—Ethiopia. South Africa.2 million people received HIV antiretroviral therapy for the first time—an increase in the number of people receiving treatment of 30% in a single year. since 2004. more than five million people in low. the new platform could reduce the number of people newly infected with HIV by up to one million annually if countries provide antiretroviral therapy to all people in need. the number of people receiving therapy has grown 13-fold. 8 Chapter 1: Introduction | 2010 GLOBAL REPORT . and Zimbabwe—have either stabilized or are showing signs of decline. These figures demonstrate that positive behaviour change can alter the course of the epidemic—while stigma and discrimination. Treatment 2. the effects are often profound. Modelling suggests that.and middle-income countries. Howevever. HIV prevention works—new HIV infections are declining in many countries most affected by the epidemic In 33 countries. Expanding access to treatment has contributed to a 19% decline in deaths among people living with HIV between 2004 and 2009. a new approach to simplify the way HIV treatment is currently provided and to scale up access to life-saving medicines.CHAPTER 1 | INTRODUCTION » More than 5 million people are now receiving HIV treatment In 2009 alone. and improve the quality of life for people living with HIV and their families. This is just the beginning: 10 million people living with HIV who are eligible for treatment under the new WHO guidelines are still in need. Zambia. following revised WHO treatment guidelines. make treatment regimens simpler and smarter. 1. HIV incidence has fallen by more than 25% between 2001 and 2009. several regions and countries do not fit the overall trend. Overall. In seven countries. Using a combination of efforts.0. reduce the burden on health systems. Nigeria. this new approach could bring down treatment costs. five of them in Eastern Europe and Central Asia. lack of access to services and bad laws can make epidemics worse. Efforts are now underway for Treatment 2. Of these countries 22 are in sub-Saharan Africa.0 could avert an additional 10 million deaths by 2025. compared with current treatment approaches. In both cases. In addition. HIV incidence increased by more than 25% between 2001 and 2009.

What will it take to achieve virtual elimination of mother-to-child transmission of HIV? An assessment of current progress and future needs. Figure 1. incidence reduced by 50%. Young people’s knowledge about HIV is increasing but needs to grow further. the room for continued improvement on this success is great. Sex Trans Infect (Suppl) 2010. an estimated 370 000 children [220 000–520 000] contracted HIV during the perinatal and breastfeeding period. Stover J. incidence reduced by 50%.1 The virtual elimination of mother-to-child transmission of HIV is possible Estimated New HIV infections among children 0-14: Different scenarios for 25 countries Source: Mahy M. and eliminate unmet need for family planning 90% of women reached with services matching WHO guidelines. Kiragu K. HIV prevalence has fallen by more than 25% as these young people have adopted safer sexual practices. restrict breastfeeding to 12 months Chapter 1: Introduction | 2010 GLOBAL REPORT 9 . Virtual elimination of mother-to-child transmission of HIV is possible In 2009. eliminate unmet need for family planning. Similar to treatment access. et al.1 Among young people in 15 of the most severely affected countries. 500000 450000 400000 350000 300000 250000 200000 150000 100000 50000 0 2009 2010 2011 2012 2013 2014 2015 No ARV prophylaxis for PMTCT Constant 2009 coverage of ARV prophylaxis 90% of women reached with services matching WHO guidelines 90% of women reached with services matching WHO guidelines. down from 500 000 [320 000– 670 000] in 2001.

More than 80 countries across the world have laws against same-sex behaviour.1).Although this is a significant reduction.3). 10m % In 2009. Treatment 2. and the free travel of people living with HIV is restricted in 51 countries. which achieved almost 90% coverage of treatment to prevent mother-to-child transmission of HIV. countries and regions of the world. and increasing external aid in a global environment of constrained resources.and middleincome countries. however. Protecting women and girls from HIV means protecting against genderbased violence and promoting economic independence from older men. many countries will fail to achieve Millennium Development Goal 6: halting and reversing the spread of HIV (Figure 1. At the same time. access to services to halt mother-to-child transmission needs to be scaled up. with 92% of countries reporting that they have programmes in place to reduce HIV-related stigma and discrimination. transmission to infants has been drastically reduced. Domestic expenditure is the largest source of HIV financing globally today. accounting for 52% of resources for the HIV response in low. 10 Chapter 1: Introduction | 2010 GLOBAL REPORT . Human rights are increasingly a part of national strategies Human rights are no longer considered peripheral to the AIDS response. A fragile progress Despite extensive progress against a number of indicators on the global scale. treatment. increasing the efficient use of funds for HIV and other related health and development programmes. >50 Slightly more than half of all people living with HIV are women and girls. Today. In subSaharan Africa. care and support. Financing the response is a shared responsibility Increasingly.0 could avert an additional 10 million deaths by 2025. the vast majority of countries (89%) explicitly acknowledge or address human rights in their national AIDS strategies. In the 10 most severely affected countries. Improving financing for the global response will require ongoing efforts to mobilize domestic resources among countries that appear to be under-investing in the HIV response. however. countries with heavy HIV burdens are assuming their responsibilities to resource the response to the degree that their means permit. more women than men are living with HIV. UNAIDS called for the virtual elimination of mother-to-child transmission of HIV by 2015 (Figure 1. and young women aged 15–24 years are as much as eight times more likely than men to be HIV positive. Women and girls need support Slightly more than half of all people living with HIV are women and girls. this is a realistic aim and can be achieved with significantly increased action to implement proven strategies to eliminate HIV transmission to young people.2 and Figure 1. criminalization of people living with HIV still presents significant challenges to the AIDS response. In many communities. Such laws are not only discriminatory and unjust—they also drive HIV underground and inhibit efforts to expand access to life-saving HIV prevention. But in South Africa. territories and areas. HIV continues to weigh heavily on maternal and child mortality in some countries.

0 6.Figure 1.0 4.3 Young people and sexual risk People aged 15–25 years who had sex before age 15 years and who had multiple partners in the past 12 months. 1999–2003 and 2004–2009. Source: DHS and UN Population Statistics.0 12.2 Millennium Development Goal 6 indicators Population-adjusted averages for indicators for Millennium Development Goal target 6. % 2. 1 % 10 20 30 40 50 60 70 80 90 100 Orphan School Attendance (n=19) Non-Orphan School Attendance (n=16) Knowledge Males 15–24 years old (n=17) Knowledge Females 15–24 years old (n=17) Condom Use Males (n=23) Condom Use Females (n=23) 1999-2003 2004-2009 Figure 1.A (halt and begin to reverse the spread of HIV/AIDS).0 16.0 8.0 14. Source: DHS and UN Population Statistics.0 1999–2003 Sex before 15 2004–2009 1999–2003 2004–2009 Males Females Multiple partners in last 12 months Chapter 1: Introduction | 2010 GLOBAL REPORT 11 .0 10.

however. A new vision Fulfilling the UNAIDS vision of zero new infections will require a hard look at the societal structures. treatment and care services to people in need. importantly. Building social coalitions to reduce vulnerability to HIV infection supports individuals and strengthens communities. Many people still lack ready access to condoms and lubrication. according to WHO guidelines issued in early 2010. but are not yet receiving it. Strengthened programming using the latest knowledge and best practices to deliver effective prevention. or at risk. and financing this expansion in access to HIV therapy will require a continued and expanded global commitment to providing high quality HIV care for all. often lack the tools they need to practice HIV risk-reduction strategies. and unequal resource pathways all affect—and often slow—the HIV response. discrimination against marginalized people. Reaching the two thirds of people who need treatment. Six countries have achieved greater than 80% condom use at last higher-risk sex among males. The vision of eliminating the toll that HIV imposes on human life can be made real using the knowledge and resources available today. gender inequity. UNAIDS’ vision of zero discrimination. and people who inject drugs also lack sufficient access to sterile needles.” Young people still lack knowledge and. Knowledge of the epidemic and how to prevent HIV infection has increased among young people aged 15–24 years—people frequently at the highest risk for infection. In a world that has had to learn to live with an evolving and seemingly unstoppable epidemic over the course of three decades. beliefs and value systems that present obstacles to effective HIV prevention efforts. Investing in health care and social support systems. 12 Chapter 1: Introduction | 2010 GLOBAL REPORT . programme administrators and implementers must make a sustained and dedicated effort to use the best social and scientific knowledge available. inequity in health and the education system. Planners. is highly effective. Poverty. zero new infections and zero AIDS-related deaths poses a challenge. Safeguarding the health of mothers and infants and optimizing infant feeding provides a strong basis for the growth of new generations. But it is not a hopeless challenge. “MANY PEOPLE STILL LACK READY ACCESS TO CONDOMS AND LUBRICATION.Having more than 5 million people receiving treatment is a major public health achievement—but still represents only 35% of the people who need HIV therapy now. working to eliminate violence against women and girls and promote gender equality and working to end stigma and discrimination against people living with HIV and members of other marginalized groups help to provide social environments that are effective against the spread of HIV and promote more general mental and physical well-being. And in providing HIV-specific services with an awareness of other health and social issues and forging appropriate linkages. the response to HIV can make an important contribution to global health. AND PEOPLE WHO INJECT DRUGS ALSO LACK SUFFICIENT ACCESS TO STERILE NEEDLES. and two countries have achieved this high level of condom use among females (see the HIV prevention scorecard).

1 Figure 1.and middle-income countries by geographical region in 2009 based on 2010 WHO guidelines: Millennium Development Goal target 6. The regional figure for North America is not shown because of lack of data. % 10 20 30 40 50 60 sub-Saharan Africa Latin America Caribbean East. by 2010. South and South-east Asia Europe and Central Asia North Africa and the Middle East Chapter 1: Introduction | 2010 GLOBAL REPORT 13 .B (achieve. Source: WHO Towards Universal Access 2010.4 Treatment coverage in low. universal access to treatment for HIV/AIDS for all those who need it).and middle-income countries Population-adjusted averages for treatment coverage in low.

The Millennium Development Goals are intertwined. Stopping infections. Goal 6 will probably not be achieved. The successes and continuing challenges described in this report should serve as catalysts for continued action. Without achieving substantive progress towards the HIV-specific Goal 6. without integration and significant progress towards most other Goals being made. few other Goals are likely to be reached. likewise. ■ 14 Chapter 1: Introduction | 2010 GLOBAL REPORT . saving lives and improving the quality of life of people living with HIV have always been at the heart of the global AIDS response.

and (5) investment. Readers seeking more detailed data can find a comprehensive tabulation of all available data on each of the indicators used for the international monitoring of national responses to HIV in the annexes. care. (4) human rights and gender equality. (3) treatment. treatment.1 AIDS SCORECARDS For the first time. failures and obstacles in achieving universal access to HIV prevention. care and support. show the top national values for key indicators at the end of each chapter. and support. Five scorecards for (1) HIV incidence (2) prevention. Chapter 1: Introduction | 2010 GLOBAL REPORT 15 . They provide a snapshot of achievements. UNAIDS is publishing scorecards to provide a quick overview of the progress made by United Nations Member States in the global AIDS response.

This trend reflects a combination of factors.3 million–2. Figure 2. the year in which annual new infections peaked (Figure 2.2).CHAPTER 2 | EPIDEMIC UPDATE EPIDEMIC UPDATE » THE OVERALL GROWTH OF THE GLOBAL AIDS EPIDEMIC APPEARS TO HAVE STABILIZED. This is nearly one fifth (19%) fewer than the 3.0 1. including the impact of HIV prevention efforts and the natural course of HIV epidemics.2 million [1.2 million [3.1 Number of people newly infected with HIV 4.0 3.5 MILLIONS 3.4 million] people newly infected in 1999. an estimated 1.0 ‘90 ‘91 ‘92 ‘93 ‘94 ‘95 ‘96 ‘97 ‘98 ‘99 ‘00 ‘01 ‘02 ‘03 ‘04 ‘05 ‘06 ‘07 ‘08 ‘09 16 Chapter 2: Epidemic update | 2010 GLOBAL REPORT .9 million–2.6 million–2. New HIV infections are declining In 2009. ALTHOUGH THE NUMBER OF NEW INFECTIONS HAS BEEN FALLING.0 million–3.0 million] people became infected in 2009. THE ANNUAL NUMBER OF NEW HIV INFECTIONS HAS BEEN STEADILY DECLINING SINCE THE LATE 1990S AND THERE ARE FEWER AIDS-RELATED DEATHS DUE TO THE SIGNIFICANT SCALE UP OF ANTIRETROVIRAL THERAPY OVER THE PAST FEW YEARS. LEVELS OF NEW INFECTIONS OVERALL ARE STILL HIGH. AND WITH SIGNIFICANT REDUCTIONS IN MORTALITY THE NUMBER OF PEOPLE LIVING WITH HIV WORLDWIDE HAS INCREASED.6 million [2.8 million] people who became newly infected with HIV.0 0. and more than one fifth (21%) fewer than the estimated 3.1 million [2.0 2. there were an estimated 2.5 0.1). In subSaharan Africa. 2.8 million [1.5 2.4 million] people in sub-Saharan Africa newly infected with HIV in 2001. considerably lower than the estimated 2.9 million–3. 22 of these countries are in sub-Saharan Africa.5 million] in 1997. the HIV incidence has fallen by more than 25% between 2001 and 2009 (Figure. In 33 countries.5 1. where the majority of new HIV infections continue to occur.

China and the Russian Federation. Young people leading a revolution in HIV prevention A recent analysis among young people provides further evidence of decreasing incidence and safer sexual behaviour (Table 2.Figure 2. high rates of HIV transmission continue to occur in networks of people who inject drugs and their sexual partners. In Eastern Europe and Central Asia. and 3 countries for which peer-reviewed publications with incidence trends were available.2 Changes in the incidence rate of HIV infection. for the majority of epidemic curves for a given country. selected countries Source: UNAIDS. 2001 to 2009. such as Brazil. there were at least four time points between 2001 and 2009 for which prevalence data were available for concentrated epidemics and at least three data points in the same period for generalized epidemics. estimates of HIV incidence have been produced through modeling The map includes 60 countries for which reliable estimates of new HIV infections over time were available from the 2010 round of country-specific estimation using the EPP/Spectrum tools. data were representative of the country. prevalence data were available up to at least 2007. The EPP/Spectrum methods estimate HIV incidence trends from HIV prevalence over time combined with the changing level of antiretroviral therapy. 2 Increasing >25% Stable Decreasing >25% Not included in analysis In the absence of a reliable diagnostic test that can directly measure the level of new HIV infections in a population. For some countries with complex epidemics including multiple populations groups with different risk behaviours as well as major geographic differences. the HIV incidence increased by more than 25% between 2001 and 2009.1). Seven countries showed a statistically significant decline of 25% or more in HIV prevalence (the percentage of people living with HIV) by 2008 among young pregnant women attending antenatal clinics. In Western. and Eastern Europe. this type of assessment is highly complex and it could not be concluded in the 2010 estimation round. Chapter 2: Epidemic update | 2010 GLOBAL REPORT 17 . The criteria for including countries in this analysis were as follows. In seven countries. Central Asia. Note about Figures: Dotted lines in figures represent ranges. evidence is increasing of a resurgence of HIV in several highincome countries among men who have sex with men. Several regions and countries do not fit the overall trend. and the EPP/Spectrum–derived incidence trend was not in conflict with modelled incidence trends derived from age-specific prevalence in national survey results. solid lines represent the best estimate. Central. the EPP/Spectrum–derived incidence trend was not in conflict with the trend in case reports of new HIV diagnoses. However. EPP files were available and trends in EPP were not derived from workbook prevalence estimates. UNAIDS will continue to work with countries and partners to improve the quality of available information and modeling methodologies to include HIV incidence data for additional countries in future reports. the rates of annual new HIV infections have been stable for at least the past five years. and North America. EPP did not produce an artificial increase in HIV prevalence in recent years due to scarcity of prevalence data points.

2008 2002. 2007 2002.1 HIV prevalence and behaviour Trends in HIV prevalence and behaviour among young people in countries most severely affected by HIV Source: UNAIDS.Table 2. 2007 2004.2004. 2007 Increasing Trends Decreasing Trends No Evidence of Change 18 Chapter 2: Epidemic update | 2010 GLOBAL REPORT . Prevalence data were available from antenatal care surveillance PERIOD Prevalence trend among antenatal care attendees National HIV prevalence surveys conducted Trend in HIV prevalence from national surveys Percentage who have had sex by age 15 Percentage who have had sex with more than one partner in past year F M Proportion who have had more than one partner not using condoms during last sex F M URBAN RURAL YEARS F M F M Angola Bahamas Belize Botswana Burundi Cameroon Central African Republic Chad Congo Côte d’Ivoire Djibouti Ethiopia Gabon Guyana Haiti Kenya Lesotho Malawi Mozambique Namibia Nigeria Rwanda South Africa Suriname Swaziland Togo Uganda United Republic of Tanzania Zambia Zimbabwe NOTES: 2004–2007 2000–2008 NA 2001–2006 2000–2007 NA ID ID NA 2000–2008 ID 2001–2005 ID NA 2000–2007 2000–2005 2003–2007 1999–2007 2001–2007 2002–2008 2003–2008 2002–2007 2000–2007 NA 2002–2008 2004–2007 2003–2008 2002–2006 2002–2006 2000–2006 NA=Not Available 2003. 2007 2003.2005. 2006 ID=Insufficient Data M=Male F=Female Declining trend is statistically significant 2002. 2007 2002.

The estimated 260 000 [150 000–360 000] children who died from AIDS-related illnesses in 2009 were 19% fewer than the estimated 320 000 [210 000–430 000] who died in 2004. AIDS-related deaths are decreasing The number of annual AIDS-related deaths worldwide is steadily decreasing from the peak of 2.1 million] in 2009 (Figure 2. it is also a result of decreasing incidence starting in the late 1990s. deaths among children younger than 15 years of age are also declining. AIDS-related mortality began to decline in sub-Saharan Africa and the Caribbean in 2005. This trend reflects the steady expansion of services to prevent transmission of HIV to infants and an increase (albeit slow) in access to treatment for children. Globally. to people living with HIV. where an estimated 320 000 (or 20%) fewer people died of AIDS-related causes in 2009 than in 2004. The decline reflects the increased availability of antiretroviral therapy. 2 19 % Estimated decrease in AIDS-related deaths globally among children from 2004 to 2009. but there is no indication yet of decline.9 million–2. the number of deaths has stabilized. New infections among children decreasing As access to services for preventing the mother-to-child transmission of HIV has increased.and low-income countries. and Zimbabwe—showed a significant decline in HIV prevalence among young women or men in national surveys. Sexual behaviour changed in most countries. the total number of children being born with HIV has decreased.8 million [1. Chapter 2: Epidemic update | 2010 GLOBAL REPORT 19 .5). In eight countries with significant declines in HIV prevalence. particularly in middle.3 million] in 2004 to an estimated 1.3).1 million [1.6 million–2. the sexual behaviour of either men or women also changed significantly. An estimated 370 000 [230 000–510 000] children were newly infected with HIV in 2009 (a drop of 24% from five years earlier). South Africa. The effects of antiretroviral therapy are especially evident in sub-Saharan Africa. Different patterns have emerged in other regions.Five countries—Botswana. as well as care and support. In Asia and Central and South America. when antiretroviral therapy began to be dramatically expanded (Figure 2. Deaths continue to increase in Eastern Europe. deaths due to AIDS began to decline soon after antiretroviral therapy was introduced in 1996. In North America and Western and Central Europe. United Republic of Tanzania. Zambia.

7– 4.5 [0.5 million [20.3] 0.6 –2.1–0.1 [<0.1 [0.2 [0.1– 0.2–1.1] 24 000 [20 000 –27 000] 8300 [6300 –11 000] 2001 SOUTH AND SOUTH-EAST ASIA 2009 4.2 million] 270 000 [240 000 –320 000] 380 000 [350 000– 430 000] 0.6 million] 1.4 – 0.7 million] 1.1 million [3.5 [0.4 million] 5.2] 1400 [<1000–2400] <1000 [<500 –1100] 2001 CENTRAL AND SOUTH AMERICA 2009 1.Table 2.3] 0.8 million [3.2 Regional HIV and AIDS statistics.2–0.5] 58 000 [43 000–70 000] 53 000 [44 000–65 000] 2001 20 Chapter 2: Epidemic update | 2010 GLOBAL REPORT .0 [4.3–0.3] 0.2 million [1.3 million [18.3–0.6 million] 3. Adults and children living with HIV Adults and children newly infected with HIV % Adult prevalence (15–49 years) AIDS-related deaths among adults and children SUB-SAHARAN AFRICA 2009 22.5 million] 1.9–24.7–5.1] <0.1] 1.0 –1.2–1. 2001 and 2009 Regional figures on adults and children newly infected and living with HIV and AIDS-related deaths Source: UNAIDS.1–1.4 million [1.1] 36 000 [25 000–50 000] 15 000 [9400 –28 000] 2001 OCEANIA 2009 57 000 [50 000–64 000] 29 000 [23 000–35 000] 4500 [3400–6000] 4700 [3800–5600] 0.4 – 0.6 million] 2001 MIDDLE EAST AND NORTH AFRICA 2009 460 000 [400 000–530 000] 180 000 [150 000–210 000] 75 000 [61 000–92 000] 36 000 [32 000– 42 000] 0.2 million] 20.9–21.1 million [1.6– 6.0 million] 2.2 – 0.0 million] 350 000 [250 000– 480 000] 82 000 [48 000 –140 000] 64 000 [47 000 – 88 000] 0.3 [0.1– <0.3 [0.3 million] 92 000 [70 000–120 000] 99 000 [85 000–120 000] 0.6] 0.3 million [1.1 [0.8 million [1.1– 0.4 million [1.9–2.2] 5.2 [0.4] 260 000 [230 000 –300 000] 230 000 [210 000–280 000] 2001 EAST ASIA 2009 770 000 [560 000–1.5–4.9 [5.4 [0.

2 [0.2– 0.0–1.7] 0.1–30.6–2.6 million] 760 000 [670 000– 890 000] 130 000 [110 000–160 000] 240 000 [210 000–300 000] 0.7– 0.8 million] 3.3 million] 28.4 million] 70 000 [44 000 –130 000] 66 000 [54 000– 81 000] 0.2 [0.3 –1.4 [0.2] 12 000 [8500 –15 000] 19 000 [16 000–23 000] 2001 EASTERN EUROPE AND CENTRAL ASIA 2009 1.3–2.2–2.8 million [1.2] 8500 [6800 –19 000] 7300 [5700 –11 000] 2001 NORTH AMERICA 2009 1.5] 76 000 [60 000–95 000] 18 000 [14 000 –23 000] 2001 WESTERN AND CENTRAL EUROPE 2009 820 000 [720 000–910 000] 630 000 [570 000–700 000] 31 000 [23 000 – 40 000] 31 000 [27 000 – 35 000] 0.5 million [1.4 – 0.9] 0.7– 0.4 million [1.8 million [1.1 [1.5] 26 000 [22 000 – 44 000] 30 000 [26 000 – 35 000] 2001 TOTAL 2009 33.8] 1.2 million [960 000–1.9–3.2 Adults and children living with HIV Adults and children newly infected with HIV % Adult prevalence (15–49 years) AIDS-related deaths among adults and children CARIBBEAN 2009 240 000 [220 000–270 000] 240 000 [210 000– 270 000] 17 000 [13 000 –21 000] 20 000 [17 000 – 23 000] 1.9–1.7– 0.6–2.1] 1.1 million [2.8] 0.8 [0.4 million] 0.2] 0.4 – 0.4 [0.8 [0.4 –35.6 million [2.0 [0.8 [0.2– 0.3 million] 2.0 million] 2001 Chapter 2: Epidemic update | 2010 GLOBAL REPORT 21 .4 – 0.5 [0.0 million] 1.6 million [27.3 million [31.1 million] 1.

3 Annual AIDS-related deaths by region. Sub-Saharan Africa 2. 1990-2009 Source: UNAIDS.5 350 MILLIONS THOUSANDS 300 250 200 150 0.5 100 50 Asia 1.0 500 450 400 1.Figure 2.0 ‘90 ‘92 ‘94 ‘96 ‘98 ‘00 ‘02 ‘04 ‘06 ‘08 ‘90 ‘92 ‘94 ‘96 ‘98 ‘00 ‘02 ‘04 ‘06 ‘08 Eastern Europe + Central Asia 100 25 Caribbean 80 20 THOUSANDS 60 THOUSANDS ‘90 ‘92 ‘94 ‘96 ‘98 ‘00 ‘02 ‘04 ‘06 ‘08 15 40 10 20 5 ‘90 ‘92 ‘94 ‘96 ‘98 ‘00 ‘02 ‘04 ‘06 ‘08 Central + South America 80 125 North America + Western and Central Europe 100 60 THOUSANDS THOUSANDS 75 40 50 20 25 ‘90 ‘92 ‘94 ‘96 ‘98 ‘00 ‘02 ‘04 ‘06 ‘08 ‘90 ‘92 ‘94 ‘96 ‘98 ‘00 ‘02 ‘04 ‘06 ‘08 22 Chapter 2: Epidemic update | 2010 GLOBAL REPORT .

8 million] published in AIDS epidemic update: November 2009.8 million] in 1999—a 27% increase (Figure 2.8 million [30.7 million–3.3 million] people living with HIV at the end of 2009 compared with 26. This report revises the estimate of the number of people living with HIV in 2008 of 33. at slightly less than 52% of the global total (Figure 2.5 million [1. The estimated number of children living with HIV increased to 2. This report includes Mexico in North America and categorizes the rest of Latin America as Central and South America.4 million [31.4 Global prevalence of HIV.5% .5% – <1% 1% – <5% 5% – <15% >15% – 28% Chapter 2: Epidemic update | 2010 GLOBAL REPORT 23 .4 million–35.3 million [31.5). This report presents trend analysis based on the new definition of these regions.2).4 million] in 2009 (Figure 2.6).Trends in the number of people living with HIV UNAIDS estimates that there were 33. including data from population-based surveys such as in Mozambique.1% . The proportion of women living with HIV has remained stable. 2009 Source: UNAIDS.6 million–27. 2 Figure 2.7 million]. No data < .1 million–35. AIDS epidemic update: November 2009 included Mexico in Latin America. this decrease is offset by the reduction in AIDS-related deaths due to the significant scale up of antiretroviral therapy over the past few years (Table 2.2 million [24. Although the annual number of new HIV infections has been steadily declining since the late 1990s.3). which is within the uncertainty range of the previous estimate.4 and Figure 2.9 million–34. to 32.1% – <. This revision is based on additional data becoming available for many countries.

1990 to 2009 Source: UNAIDS.0 3.5 0.5 Global HIV trends.5 1.0 ‘90 ‘91 ‘92 ‘93 ‘94 ‘95 ‘96 ‘97 ‘98 ‘99 ‘00 ‘01 ‘02 ‘03 ‘04 ‘05 ‘06 ‘07 ‘08 ‘09 Adult and child deaths due to AIDS 2.5 2.0 1.0 0.0 0.0 MILLIONS 1.0 ‘90 ‘91 ‘92 ‘93 ‘94 ‘95 ‘96 ‘97 ‘98 ‘99 ‘00 ‘01 ‘02 ‘03 ‘04 ‘05 ‘06 ‘07 ‘08 ‘09 Number of orphans due to AIDS 20 16 MILLIONS 12 8 4 0 ‘90 ‘91 ‘92 ‘93 ‘94 ‘95 ‘96 ‘97 ‘98 ‘99 ‘00 ‘01 ‘02 ‘03 ‘04 ‘05 ‘06 ‘07 ‘08 ‘09 24 Chapter 2: Epidemic update | 2010 GLOBAL REPORT .5 0.5 MILLIONS 3. Number of people living with HIV 40 35 MILLIONS 30 25 20 15 10 5 0 ‘90 ‘91 ‘92 ‘93 ‘94 ‘95 ‘96 ‘97 ‘98 ‘99 ‘00 ‘01 ‘02 ‘03 ‘04 ‘05 ‘06 ‘07 ‘08 ‘09 Number of children living with HIV 4.5 2.0 2.5 1.Figure 2.

5 million [20.5 million] people who died of HIVrelated illnesses in sub-Saharan Africa in 2009 comprised 72% of the global total of 1.0 million] deaths attributable to the epidemic. 2 Figure 2.3 million [1. the total number of people living with HIV continues to rise. South Africa. Although the rate of new HIV infections has decreased. and Zimbabwe—have either stabilized or are showing signs of decline. The largest epidemics in sub-Saharan Africa—Ethiopia. Zambia.9 million–24. Sub-Saharan Africa has more women than men living with HIV. The estimated 1. 68% of the global total.6 Trends in women living with HIV Proportion of people 15 years and older living with HIV who are women. 70 Sub-Saharan Africa 60 Caribbean 50 Global Eastern Europe and Central Asia Central and South America Asia Western and Central Europe and North America 40 30 20 10 % ‘90 ‘91 ‘92 ‘93 ‘94 ‘95 ‘96 ‘97 ‘98 ‘99 ‘00 ‘01 ‘02 ‘03 ‘04 ‘05 ‘06 ‘07 ‘08 ‘09 Chapter 2: Epidemic update | 2010 GLOBAL REPORT 25 .6 million–2. Source: UNAIDS.2 million]. 1990–2009.Sub-Saharan Africa still bears an inordinate share of the global HIV burden. In 2009.8 million [1.1 million–1. that number reached 22. Nigeria.

2001 and 2009 Source: UNAIDS.5 million] 1.5 million] 1.6 million] 2001 Figure 2.4 million [1.1–1. Source: UNAIDS.1–2.9–24.6–2.8 million [1.3 million [1.9–21.4 –3. 1990 to 2009.2 million] 20.0 million] 2. No data < 1% 1% – <5% 5% – <10% 10% – <20% 20% – 28% 26 Chapter 2: Epidemic update | 2010 GLOBAL REPORT .3 million [1.4 million] 2.2 million [1.3 AIDS statistics for sub-Saharan Africa.7 HIV prevalence in sub-Saharan Africa HIV prevalence among adults aged 15–49 years old in sub-Saharan Africa.1 million] 1.SUB-SAHARAN AFRICA Table 2.7 million] 1.8 million [1.9–2.5 million [20.2–1.3 million [18. People living with HIV People newly infected with HIV Children living with HIV AIDS-related deaths SUB-SAHARAN AFRICA 2009 22.

8 HIV trends in sub-Saharan Africa Source: UNAIDS.5 2.5 3.5 1.0 1.0 MILLIONS 2.0 1. 2 Number of people living with HIV 25 20 MILLIONS 15 10 5 0 ‘90 ‘91 ‘92 ‘93 ‘94 ‘95 ‘96 ‘97 ‘98 ‘99 ‘00 ‘01 ‘02 ‘03 ‘04 ‘05 ‘06 ‘07 ‘08 ‘09 Number of people newly infected with HIV 3.5 1.0 1.0 .0 2.5 0 ‘90 ‘91 ‘92 ‘93 ‘94 ‘95 ‘96 ‘97 ‘98 ‘99 ‘00 ‘01 ‘02 ‘03 ‘04 ‘05 ‘06 ‘07 ‘08 ‘09 Number of children living with HIV 3.0 .5 0 ‘90 ‘91 ‘92 ‘93 ‘94 ‘95 ‘96 ‘97 ‘98 ‘99 ‘00 ‘01 ‘02 ‘03 ‘04 ‘05 ‘06 ‘07 ‘08 ‘09 Adult and child deaths due to AIDS 2.5 0 ‘90 ‘91 ‘92 ‘93 ‘94 ‘95 ‘96 ‘97 ‘98 ‘99 ‘00 ‘01 ‘02 ‘03 ‘04 ‘05 ‘06 ‘07 ‘08 ‘09 MILLIONS Chapter 2: Epidemic update | 2010 GLOBAL REPORT 27 .5 1.Figure 2.5 MILLIONS 2.0 .

5.5% and 7. South Africa’s epidemic remains the largest in the world. An estimated 11. The prevalence of HIV is highest in Cameroon at 5.4 million–5.2 and Figure 2. The HIV incidence slowed in the United Republic of Tanzania to about 3. and there is evidence of declines in incidence in several countries in sub-Saharan Africa.2). Central African Republic 4.5% in 2003–2005 to 2. nearly one third (31%) more than the 8.8% in 2008.0% since 2001. The HIV prevalence in Rwanda has been about 3. with the adult HIV prevalence estimated at 2% or under in 12 countries in 2009 (Benin.6 million [5. With an estimated 5. At an estimated 25.2 million– 9.SUB-SAHARAN AFRICA Sub-Saharan Africa still bears an inordinate share of the global HIV burden The epidemics in sub-Saharan Africa vary considerably. In Zimbabwe. Democratic Republic of the Congo.3 million [10.8 million] people living with HIV in 2009. Swaziland.2% [4. South Africa. with southern Africa1 still the most severely affected (Table 2. About 40% of all adult women with HIV live in southern Africa. Other epidemics in southern Africa have also levelled off at very high levels.3% [4.8% in 2005 to 0. Between 2001 and 2009.4 per 1000 person-years between 2004 and 2008 (5).9%–27.6% [3. and among women 15–24 years old it dropped from 5. Ghana.2% in 2005–2008 (4). Mauritania. Liberia. Niger. Côte d’Ivoire 3. 31% of new HIV infections in the same year occurred in these 10 countries. HIV incidence falling in 22 countries in sub-Saharan Africa The HIV incidence (number of people newly infected with HIV) appears to have peaked in the mid-1990s. The national HIV prevalence in Kenya fell from about 14% in the mid-1990s to 5% in 2006 (6). The HIV prevalence in Uganda has stabilized at between 6. With an estimated 5.2%]. 34% of people living with HIV in 2009 resided in the 10 countries in southern Africa. The epidemics in East Africa have declined since 2000 but are stabilizing in many countries.1%–3. while condom use with nonregular partners has remained high since the late 1990s (1. the incidence of HIV infection declined by more than 25% in an estimated 22 countries.6 million [8.3%–4. Gambia.2%].6 million people living with HIV in 2009. Senegal.9 million] people were living with HIV in southern Africa in 2009. and Zimbabwe.7% [4.9%]. The annual HIV incidence among 18-yearolds declined sharply from 1.2%–5.2%–6.1 million] people living with HIV in the region a decade earlier.0%] in 2009. 28 Chapter 2: Epidemic update | 2010 GLOBAL REPORT . Botswana. Globally.0% since 2005. Swaziland has the highest adult HIV prevalence in the world.8%]. South Africa’s epidemic remains the largest in the world.8).9%–5.6m 1 Angola.6 million–11.9% [24. Mali. Malawi.4% [3. New indications show a slowing of HIV incidence amid some signs of a shift towards safer sex among young people (3). Burkina Faso. Lesotho. Zambia. and Sierra Leone). Gabon 5. and Nigeria 3. Namibia. the main behavioural change appears to have been a reduction in the proportion of men with casual partners. as did 34% of all AIDS-related deaths. Guinea.0%]. The HIV prevalence in West and Central Africa remains comparatively low. Mozambique.

There were 32% fewer children newly infected—an estimated 130 000 [90 000–160 000] versus 190 000 [140 000–230 000]—and 26% fewer AIDS-related deaths among children—90 000 [61 000–110 000] versus 120 000 [88 000–150 000]—in 2009 compared with 2004. systems. Botswana could avert a further estimated 130 000 deaths through 2016 (11). down from 4600 in 1999 (information from NACA). South Africa is one of the few countries in the world where child and maternal mortality has risen since the 1990s (8). compared with only 2% seven years earlier (9).9% in 2009. Most people receiving antiretroviral therapy in sub-Saharan Africa start treatment late (13). At the end of 2009.9 % 2 At an estimated 25. AIDS-related mortality decreasing The scaling up of treatment is profoundly affecting sub-Saharan Africa. Chapter 2: Epidemic update | 2010 GLOBAL REPORT 29 .Slight declines in prevalence have been detected in household surveys in Mali and Niger and among antenatal clinic attendees in Benin. Côte d’Ivoire. In Botswana. Antiretroviral therapy and other types of treatment have expanded since the early 2000s. The extensive provision of antiretroviral therapy has averted an estimated 50 000 adult deaths and. systems are strengthened to monitor the health status of people living with HIV. Swaziland has the highest adult HIV prevalence in the world. 25. AIDS-related mortality is likely to further reduce. 37% of adults and children eligible for antiretroviral therapy were receiving it in the region overall (41% in Eastern and Southern Africa and 25% in Western and Central Africa). AIDS is the largest cause of maternal mortality in South Africa and also accounts for 35% of deaths in children younger than five years (3). and staff required to properly monitor treatment retention and loss are becoming increasingly inadequate as programmes are scaled up. which limits the overall impact of HIV treatment programmes. but the number of AIDS-related deaths remains high. provision of antiretroviral therapy was linked to a 10% drop in the adult death rate between 2004 and 2008 (12). where antiretroviral therapy coverage exceeds 90%. and access to treatment is provided at the appropriate time. AIDS-related deaths decreased by 18% in southern Africa—an estimated 610 000 [530 000–700 000] people died from AIDS-related illnesses in southern Africa in 2009. compared with 740 000 [670 000–820 000] five years earlier. Reducing new HIV infections among children There has been pronounced progress in reducing the incidence and impact of HIV among children younger than 15 years in southern Africa. As HIV testing expands. and Togo (7). AIDS-related deaths in Kenya fell by 29% between 2002 and 2007 (6). Burkina Faso. The infrastructure. In rural Malawi. if this is sustained. About 890 children became newly infected with HIV in Botswana in 2007. the estimated annual number of AIDS-related deaths declined by half (from 18 000 [15 000– 22 000] in 2002 to 9100 [2400–19 000] in 2009). while the estimated number of children newly orphaned by AIDS fell by 40% (10).

As mainly heterosexual epidemics evolve. 35%–62% in Lesotho (19) and an estimated 44% in Kenya (20). 21). and the use of contaminated drug-injecting equipment by two or more people on the same occasion are significant factors in the HIV epidemics of several countries with generalized epidemics. Prevention strategies. however. In Malawi. one third of men who have sex with men were married or cohabiting with a woman (26). 30 Chapter 2: Epidemic update | 2010 GLOBAL REPORT . 14% in Kenya and 10% in Uganda are linked to sex work (HIV infection among sex workers. as were two thirds of those surveyed in the Nigerian state of Enugu (27). Paid sex remains an important factor in many of the HIV epidemics in Western. Having unprotected sex with multiple partners remains the greatest risk factor for HIV in this region.SUB-SAHARAN AFRICA Addressing sexual behaviour to prevent the sexual transmission of HIV The vast majority of people newly infected with HIV in sub-Saharan Africa are infected during unprotected heterosexual intercourse (including paid sex) and onward transmission of HIV to newborns and breastfed babies. compared with more than half (50%–65%) in Swaziland (18). Central and Eastern Africa. It is estimated that almost one third (32%) of new HIV infections in Ghana. for example (14). Together. Large proportions of people living with HIV are in long-term relationships—62% in Kenya and 78% in Malawi. Urban data in Zambia suggest that 60% of the people newly infected through heterosexual transmission are infected within marriage or cohabitation (17). for example. Couples testing and other prevention services for serodiscordant couples receive inadequate support (20). as elsewhere in the world. four fifths (82%) of the surveyed men who have sex with men said that they also have sex with women (25). those modes of transmission are believed to account for about 33% of new HIV infections in Kenya and almost 40% in Ghana. Increasing evidence indicates that unprotected paid sex. However. ranging between 36% and 85% (16). the numbers of discordant couples (only one person is infected with HIV) increase and HIV transmission within long-term relationships increases (15). the majority of men who have sex with men also have sex with women. Available evidence suggests that in sub-Saharan Africa. Up to 20% of new HIV infections in Senegal (23) and 15% of those in Kenya (20) and Rwanda (24) could be linked to unprotected sex between men. sex between men.9) (22). Results from recent studies in sub-Saharan Africa indicate the existence of groups of men who have sex with men and high levels of HIV infection among them (Figure 2. In Senegal. or their other sex partners) (20. their clients. often do not adequately address the patterns of HIV transmission. Research in 12 countries in eastern and southern Africa shows that prevalence of discordant couples is high. comparatively little funding is channelled into prevention services for populations at higher risk (20).

Mauritius. injecting drug use remains a minor factor in most of the epidemics in the region. (32). (34). Available research shows high HIV prevalence among people who inject drugs: 36% among those tested in Nairobi (Kenya) (36). (28). Overall. and the United Republic of Tanzania. In 2007. South Africa Injecting drug use appearing in sub-Saharan Africa Injecting drug use is a relatively recent phenomenon in sub-Saharan Africa that features in some of the region’s epidemics. Kenya Mombasa. Nigeria Federal Ministry of Health (29).8% of people newly infected with HIV in 2006 (20). including in Kenya. ■ Chapter 2: Epidemic update | 2010 GLOBAL REPORT 31 . (33). Uniquely in sub-Saharan Africa. South Africa Durban. South Africa Soweto. and an estimated 12% in South Africa (38). Sander et al. Lane et al. 2 % 10 20 30 40 50 Botswana Kilifi. (31). Nigeria five urban areas of Senegal Cape Town. In Kenya. injecting drug use is the main driver of the comparatively small HIV epidemic in Mauritius (35). Source: Baral et al. 10% of people who inject drugs surveyed in the Kano region of Nigeria tested HIV-positive (29). Kenya Malawi Namibia Lagos. 2009 or latest available year. (30).Figure 2. for example.9 HIV among men who have sex with men in sub-Saharan Africa HIV prevalence (%) among male adults 15–49 years old who have sex with men in seven countries in sub-Saharan Africa. 26% in Zanzibar (37). Sander et al. South Africa Pretoria. and Wade et al. South Africa. however. it accounted for an estimated 3. Parry et al.

1% . 1990 to 2009.5% 1. 2001 and 2009 Source: UNAIDS.5% .5% – 2.10 HIV prevalence in Asia HIV prevalence among adults aged 15–49 years old in Asia.6 million] 360 000 160 000 [300 000– 430 000] [110 000– 210 000] 450 000 [410 000–500 000] 100 000 [69 000–140 000] 300 000 [260 000–340 000] 250 000 [220 000–300 000] 2001 Figure 2.2 million [3.9 million [4. Source: UNAIDS.5–5.5% – <1% 1% – <1.1% – <. People living with HIV People newly infected with HIV Children living with HIV AIDS-related deaths ASIA 2009 4.ASIA Table 2.5% 32 Chapter 2: Epidemic update | 2010 GLOBAL REPORT . No data < .5 million] 4.4 AIDS statistics for Asia.8– 4.

11 HIV trends in Asia Source: UNAIDS. 2 Number of people living with HIV 6 5 MILLIONS 4 3 2 1 0 ‘90 ‘91 ‘92 ‘93 ‘94 ‘95 ‘96 ‘97 ‘98 ‘99 ‘00 ‘01 ‘02 ‘03 ‘04 ‘05 ‘06 ‘07 ‘08 ‘09 Number of people newly infected with HIV 700 600 THOUSANDS 500 400 300 200 100 0 ‘90 ‘91 ‘92 ‘93 ‘94 ‘95 ‘96 ‘97 ‘98 ‘99 ‘00 ‘01 ‘02 ‘03 ‘04 ‘05 ‘06 ‘07 ‘08 ‘09 Number of children living with HIV 250 THOUSANDS 200 150 100 50 0 ‘90 ‘91 ‘92 ‘93 ‘94 ‘95 ‘96 ‘97 ‘98 ‘99 ‘00 ‘01 ‘02 ‘03 ‘04 ‘05 ‘06 ‘07 ‘08 ‘09 Adult and child deaths due to AIDS 400 THOUSANDS 300 200 100 0 ‘90 ‘91 ‘92 ‘93 ‘94 ‘95 ‘96 ‘97 ‘98 ‘99 ‘00 ‘01 ‘02 ‘03 ‘04 ‘05 ‘06 ‘07 ‘08 ‘09 Chapter 2: Epidemic update | 2010 GLOBAL REPORT 33 .Figure 2.

8%–1.9 million [4.2% [0. national epidemics are concentrated in a relatively small number of provinces. The Indian state of Karnataka has shown evidence that intensive HIV prevention efforts among female sex workers can be highly effective. and HIV infection levels in Indonesia’s Papua province are 15 times higher than the national average (41).4 and Figure 2.3% [0. 20% lower than the 450 000 [410 000–500 000] in 2001. But the HIV prevalence is increasing in such low-prevalence countries as Bangladesh. In some countries such as Viet Nam. In southern India.6%] in 2001. In most of them. A four-year prevention programme in 18 of the state’s 27 districts almost halved HIV prevalence among young antenatal clinic attendees (from 1.” Asian epidemic largely stable In Asia. Incidence increased by 25% in Bangladesh and Philippines between 2001 and 2009 even as the countries continue to have relatively low epidemic levels. an estimated 4. the epidemics appear stable. and its epidemic appears to be stable overall.5% [0.11). and the Philippines. Incidence fell by more than 25% in India.5 million] people were living with HIV in 2009.1% (39). Nepal. Further. but the common use of contaminated injecting equipment by two or more people on the same occasion is the main mode of HIV transmission in the country’s north-eastern states (42).4%– 0. No country in the region has a generalized epidemic. Epidemic patterns vary—between and within countries The overall trends in this region hide important variation in the epidemics. Sex work—central to the region’s epidemics Paid sex features centrally in the region’s HIV epidemics. the people who inject drugs in some countries are also buying or selling sex. sex workers and their clients. Asia’s epidemics remain concentrated largely among people who inject drugs. Almost one in five (18%) surveyed female sex workers in Myanmar tested HIV-positive in the mid-2000s.ASIA “HIV PREVALENCE IS INCREASING IN LOWPREVALENCE COUNTRIES SUCH AS PAKISTAN.8%–1.8%) (44). In many countries in the region. WHERE DRUG INJECTING IS THE MAIN MODE OF HIV TRANSMISSION. Most national HIV epidemics appear to have stabilized. The adult HIV prevalence was 1. Pakistan (where drug injecting is the main mode of HIV transmission).8%] in 2009.4%] in 2009. and men who have sex with men. and the HIV incidence had slowed to 0. down from 1. five provinces account for just over half (53%) of the people living with HIV (40). Incidence patterns can vary considerably in large countries such as India. About 90% of people newly infected with HIV in India are believed to have acquired it during unprotected sex. and Thailand between 2001 and 2009. condom use during commercial sex is infrequent. about the same as five years earlier (Table 2.4% to 0. up to 15% of female sex workers were living with HIV (43). 34 Chapter 2: Epidemic update | 2010 GLOBAL REPORT . both between and within countries.5 million–5. In China. The epidemic remained stable in Malaysia and Sri Lanka during this time period. Thailand is the only country in this region in which the prevalence is close to 1%. New HIV infections—mixed progress There were 360 000 [300 000–430 000] people newly infected with HIV in 2009. In Cambodia. A resurgent epidemic in the late 1990s (when up to 60 000 people were becoming newly infected annually) has since receded. the adult HIV prevalence declined to 0.

the risk of living with HIV appears to be much higher for men who only have sex with men (56. In Asia. The epidemic among men who have sex with men in Thailand had been largely ignored until a study uncovered 17% prevalence in Bangkok in 2005. from 18 000 [11 000–25 000] to 15 000 [9000–22 000]. 6% in the Laotian capital of Vientiane (51). and 9% in rural parts of Tamil Nadu state in India (53). including in Shandong (56) and Jiangsu provinces (57) and in the city of Beijing (58). Surveys have also found rising HIV prevalence in China among men who have sex with men. and Viet Nam also have large numbers of people who inject drugs.Injecting drug use—fuelling new epidemics It is estimated that as many as 4.5 million people in Asia inject drugs. more than half of whom live in China (38). In China. In Asia overall. HIV is spreading more widely. an estimated 7%–13% of the people who inject drugs are living with HIV (40). There were an estimated 300 000 [260 000–340 000] AIDS-related deaths in 2009 compared with 250 000 [220 000–300 000] in 2001. up to 38% of the people who inject drugs have tested HIV-positive. An estimated 22 000 [15 000–31 000] children aged 0–14 years became infected in 2009—a 15% decrease on the 1999 estimate of 26 000 [18 000–38 000]. from 140 000 [92 000–190 000] in 2005 to 160 000 [110 000 –210 000] in 2009. between 7% and 18% in parts of southern India (52). In Viet Nam. and an annual HIV incidence of 5. But decreasing HIV incidence and slowly widening access to services that prevent mother-to-child transmission of HIV have led to a steep drop in the number of children becoming newly infected. although the prevalence is considerably higher in some countries. 5% nationally in Indonesia (41). AIDS-related mortality stable The number of deaths has stabilized in Asia. Although studies in Asia suggest that a significant proportion of men who have sex with men also have sex with women (51). on average. between 32% and 58% of people who inject drugs are living with HIV in various provinces (47–49). Pakistan. but there are no indications of a decline.46).5% was recorded in 2008 (55). an estimated 16% of the people who inject drugs are living with HIV.45. women account for a growing proportion of HIV infections: from 21% in 1990 to 35% in 2009. AIDS-related deaths in this age group have declined by 15% since 2004. India.59). ■ Chapter 2: Epidemic update | 2010 GLOBAL REPORT 35 2 . Men who have sex with men—marginalized but not marginal to the growth of the epidemic High HIV prevalence among men who have sex with men has been reported in several countries: 29% in Myanmar (50). As the epidemics mature in Asia. Subsequent studies in 2005 and 2007 found that the infection levels had risen to 28% and 31% (54). especially to the female partners of people who inject drugs and the clients of sex workers and their other sex partners. In studies in Myanmar. this is estimated to be 30%– 50% in Thailand and more than half in parts of Indonesia (41. New HIV infections among children The estimated number of children younger than 15 years living with HIV has increased marginally.

1% .3–1.4 million [1. No data < .EASTERN EUROPE AND CENTRAL ASIA Table 2.5% – <1% 1% – <2% 2% – 5% 36 Chapter 2: Epidemic update | 2010 GLOBAL REPORT . 1990 to 2009.6 million] 760 000 [670 000–890 000] 130 000 [110 000 –160 000] 240 000 [210 000–300 000] 18 000 [8600–29 000] 4000 [2000– 6100] 76 000 [60 000–95 000] 18 000 [14 000–23 000] 2001 Figure 2. Source: UNAIDS.1% – <.5 AIDS statistics for Eastern Europe and Central Asia.5% . 2001 and 2009 Source: UNAIDS.12 HIV prevalence in Eastern Europe and Central Asia HIV prevalence among adults aged 15–49 years old in Eastern Europe and Central Asia. People living with HIV People newly infected with HIV Children living with HIV AIDS-related deaths EASTERN EUROPE + CENTRAL ASIA 2009 1.

5 0 ‘90 ‘91 ‘92 ‘93 ‘94 ‘95 ‘96 ‘97 ‘98 ‘99 ‘00 ‘01 ‘02 ‘03 ‘04 ‘05 ‘06 ‘07 ‘08 ‘09 MILLIONS Number of people newly infected with HIV 350 300 THOUSANDS 250 200 150 100 50 0 ‘90 ‘91 ‘92 ‘93 ‘94 ‘95 ‘96 ‘97 ‘98 ‘99 ‘00 ‘01 ‘02 ‘03 ‘04 ‘05 ‘06 ‘07 ‘08 ‘09 Number of children living with HIV 30 25 THOUSANDS 20 15 10 5 0 ‘90 ‘91 ‘92 ‘93 ‘94 ‘95 ‘96 ‘97 ‘98 ‘99 ‘00 ‘01 ‘02 ‘03 ‘04 ‘05 ‘06 ‘07 ‘08 ‘09 Adult and child deaths due to AIDS 100 THOUSANDS 75 50 25 0 ‘90 ‘91 ‘92 ‘93 ‘94 ‘95 ‘96 ‘97 ‘98 ‘99 ‘00 ‘01 ‘02 ‘03 ‘04 ‘05 ‘06 ‘07 ‘08 ‘09 Chapter 2: Epidemic update | 2010 GLOBAL REPORT 37 . 2 Number of people living with HIV 2.0 .Figure 2.13 HIV trends in Eastern Europe and Central Asia Source: UNAIDS.5 1.0 1.

0%–1. Newly reported HIV cases have increased in several of the countries in Central Asia. By 2009. the adult HIV prevalence in Ukraine is higher than in any other country in all of Europe and Central Asia (60). which together account for almost 90% of newly reported HIV diagnoses. In the Russian Federation. A rapid rise in HIV infections among people who inject drugs at the turn of the century caused the epidemic in this region to surge. sex workers. for example. High HIV prevalence has also been found in prison populations. compared with between 39% and 50% in Ukraine (60). Annual HIV diagnoses in Ukraine have more than doubled since 2001.13). The interplay between sex work and injecting drug use is accelerating the spread of HIV in the region. Because most people who inject drugs are sexually active. sexual transmission of HIV has increased in older epidemics such as that in Ukraine. compared with 41% in 2004 The number of people living with HIV in Eastern Europe and Central Asia has almost tripled since 2000. their sexual partners and. the proportion of women living with HIV is also growing. and the high HIV infection levels found among sex workers in Ukraine (14% to 31% in various studies) (60) are almost certainly due to the overlap of paid sex with injecting drug use.6 million] in 2009 compared with 760 000 [670 000–890 000] in 2001 (Table 2. Overall. to a much lesser extent. the number of people living with HIV has almost tripled since 2000 and reached an estimated total of 1.4 million [1. but at a slower pace than in the late 1990s.7 million people (most of whom are men) who inject drugs in the region are living with HIV (38).3%]. which has the largest epidemic in Central Asia (61). the Russian Federation and Ukraine. At 1.3 million–1. making these more challenging to manage (65). including Uzbekistan. The HIV epidemic in the Russian Federation also continues to grow. the HIV prevalence is 1% or higher in two countries in this region. Surveys among people who inject drugs in 2007 found HIV prevalence as high as 88% (in the city of Kryvyi Rih) (62). 38 Chapter 2: Epidemic update | 2010 GLOBAL REPORT . drug use and sex between men linked The HIV epidemics in Eastern Europe and Central Asia are concentrated mainly among people who inject drugs. Concentrated epidemics—sex work. men who have sex with men.EASTERN EUROPE AND CENTRAL ASIA 200 % The largest regional increase in HIV prevalence In Eastern Europe and Central Asia.5 and Figure 2. an estimated 45% of the people living with HIV in Ukraine were women. At least 30% of sex workers in the Russian Federation. have injected drugs (64). An estimated one quarter of the 3.8 million people who inject drugs are believed to be living with HIV (38). As the epidemic spreads from (predominantly male) people who inject drugs to their sexual partners. especially among incarcerated people who inject drugs (63).1% [1. more than one third (37%) of the country’s estimated 1. An estimated 10 000 prisoners are living with HIV in Ukraine (60).

and 37% in 1999. the HIV prevalence among men who have sex with men has ranged from zero in Belarus. In small surveys. while an additional 50% were probably infected by partners who inject drugs (61.66). AIDS-related mortality AIDS-related deaths continue to rise in the region. An estimated 35% of women living with HIV probably acquired HIV through injecting drug use.” 2 Chapter 2: Epidemic update | 2010 GLOBAL REPORT 39 . There were an estimated 76 000 [60 000–95 000] AIDS-related deaths in 2009 compared with 18 000 [14 000–23 000] in 2001. Lithuania and parts of Central Asia to 5% in Georgia (69). a four-fold increase during this period. THE PROPORTION OF WOMEN LIVING WITH HIV IS ALSO GROWING. Unprotected sex between men is responsible for a small share of new infections in the region—less than 1% of people newly diagnosed with HIV infection for whom the route of transmission was identified (67). 6% in the Russian Federation (70) and between 4% (in Kyiv) and 23% (in Odessa) in Ukraine (60). official data may underplay the actual extent of infection in this highly stigmatized population (68). Nevertheless. ■ “AS THE EPIDEMIC SPREADS FROM PREDOMINANTLY MALE POPULATIONS WHO INJECT DRUGS TO THEIR SEXUAL PARTNERS. Different people using the same contaminated injecting equipment within a short time frame remains a core driver of these epidemics.

1990 to 2009.CARIBBEAN Table 2.6 AIDS statistics for the Caribbean.5% . People living with HIV People newly infected with HIV Children living with HIV AIDS-related deaths CARIBBEAN 2009 240 000 [220 000–270 000] 240 000 [210 000–270 000] 17 000 [13 000–21 000] 20 000 [17 000–23 000] 17 000 [8500–26 000] 18 000 [9100–27 000] 12 000 [8500–15 000] 19 000 [16 000–23 000] 2001 Figure 2.1% . No data < . Source: UNAIDS. 2001 and 2009 Source: UNAIDS.5% – <1% 1% – <2% 2% – 5% 40 Chapter 2: Epidemic update | 2010 GLOBAL REPORT .1% – <.14 HIV prevalence in the Caribbean HIV prevalence among adults aged 15–49 years old in the Caribbean.

15 HIV trends in the Caribbean Source: UNAIDS. 2 Number of people living with HIV 300 250 THOUSANDS 200 150 100 50 0 ‘90 ‘91 ‘92 ‘93 ‘94 ‘95 ‘96 ‘97 ‘98 ‘99 ‘00 ‘01 ‘02 ‘03 ‘04 ‘05 ‘06 ‘07 ‘08 ‘09 Number of people newly infected with HIV 175 150 THOUSANDS 125 100 75 50 25 0 ‘90 ‘91 ‘92 ‘93 ‘94 ‘95 ‘96 ‘97 ‘98 ‘99 ‘00 ‘01 ‘02 ‘03 ‘04 ‘05 ‘06 ‘07 ‘08 ‘09 Number of children living with HIV 30 25 THOUSANDS 20 15 10 5 0 ‘90 ‘91 ‘92 ‘93 ‘94 ‘95 ‘96 ‘97 ‘98 ‘99 ‘00 ‘01 ‘02 ‘03 ‘04 ‘05 ‘06 ‘07 ‘08 ‘09 Adult and child deaths due to AIDS 25 THOUSANDS 20 15 10 5 0 ‘90 ‘91 ‘92 ‘93 ‘94 ‘95 ‘96 ‘97 ‘98 ‘99 ‘00 ‘01 ‘02 ‘03 ‘04 ‘05 ‘06 ‘07 ‘08 ‘09 Chapter 2: Epidemic update | 2010 GLOBAL REPORT 41 .Figure 2.

The Caribbean remains the only region.13).08%–0. which is higher than in other all regions outside sub-Saharan Africa (Table 2. Most countries in the region have focused their HIV prevention efforts on paid sex.76). In the neighbouring Dominican Republic. Unprotected sex between men and women—especially paid sex—is believed to be the main mode of HIV transmission in this region (73. 12% of pregnant women using antenatal facilities in one of Haiti’s cities have tested HIV-positive. New HIV infections slightly declining New infections have slightly declined between 2001 and 2009. HIV infection levels also vary considerably. In 2009.74).0% [0. and 27% in Guyana (78).1% [1.2%–5. 0.9%–1. where women and girls outnumber men and boys among people living with HIV. with HIV prevalence among communities near sugar plantations (the bateyes) about four times higher than the national average (72).CARIBBEAN High HIV prevalence but fewer people living with HIV The HIV prevalence among adults in the Caribbean is about 1. about 3000 less than the 20 000 [17 000–23 000] in 2001. An estimated 17 000 [13 000–21 000] people became newly infected with HIV in 2009. besides sub-Saharan Africa. Meanwhile.1%]. with a 3.1 % 42 Chapter 2: Epidemic update | 2010 GLOBAL REPORT . compared with less than 1% in the west of the country (71).1% [0.13%]) contrasts.4%] adult HIV prevalence in the Bahamas (64). including 4% in the Dominican Republic (72. 9% in Jamaica (77). for example. The exceptionally low HIV prevalence in Cuba (0. Estimated HIV prevalence in Cuba. the number of people living with HIV in the Caribbean is relatively small—240 000 [220 000–270 000] in 2009—and has varied little since the late 1990s. High infection levels have been found among female sex workers. The burden of HIV varies considerably between and within countries.5 and Figure 2. an estimated 53% of people with HIV were female. However. which is exceptionally low.

One in five men who have sex with men surveyed in Trinidad and Tobago were living with HIV. In Jamaica. unsafe injecting drug use contributes significantly to the spread of HIV. contaminated injecting equipment accounted for about 40% of males becoming newly infected in 2006 and for 27% among females (82). and one in four said they regularly also had sex with women (69). In Puerto Rico.Unsafe sex between men is a significant but largely hidden facet of the epidemics in this region. In Bermuda and Puerto Rico. Evidence indicates increasing HIV infections among men who have sex with men in Cuba (80) and the Dominican Republic (81).” 2 Chapter 2: Epidemic update | 2010 GLOBAL REPORT 43 . BESIDES SUB-SAHARAN AFRICA. for example. ■ “THE CARIBBEAN REMAINS THE ONLY REGION. An estimated 12 000 [8500–15 000] people lost their lives due to AIDS in 2009 compared with 19 000 [16 000–23 000] deaths in 2001. WHERE WOMEN AND GIRLS OUTNUMBER MEN AND BOYS AMONG PEOPLE LIVING WITH HIV. AIDS-related mortality declining AIDS-related deaths are falling in the Caribbean. a study found an HIV prevalence of 32% among men who have sex with men (73). where several countries still criminalize sexual relations between men (79).

No data < .4 million [1. 2001 and 2009 Source: UNAIDS.5% – <1% 1% – <2% 2% – 5% 44 Chapter 2: Epidemic update | 2010 GLOBAL REPORT . 1990 to 2009.1% – <.0–1.6 million] 1.CENTRAL AND SOUTH AMERICA Table 2.16 HIV prevalence in Central and South America HIV prevalence among adults aged 15–49 years old in Central and South America.2–1. Source: UNAIDS.1% . People living with HIV People newly infected with HIV Children living with HIV AIDS-related deaths CENTRAL AND SOUTH AMERICA 2009 1.7 AIDS statistics for Central and South America.1 million [1.5% .3 million] 92 000 [70 000–120 000] 99 000 [85 000–120 000] 36 000 [25 000 –50 000] 30 000 [20 000–42 000] 58 000 [43 000–70 000] 53 000 [44 000–65 000] 2001 Figure 2.

0 .Figure 2.5 0 ‘90 ‘91 ‘92 ‘93 ‘94 ‘95 ‘96 ‘97 ‘98 ‘99 ‘00 ‘01 ‘02 ‘03 ‘04 ‘05 ‘06 ‘07 ‘08 ‘09 MILLIONS Number of people newly infected with HIV 140 120 THOUSANDS 100 80 60 40 20 0 ‘90 ‘91 ‘92 ‘93 ‘94 ‘95 ‘96 ‘97 ‘98 ‘99 ‘00 ‘01 ‘02 ‘03 ‘04 ‘05 ‘06 ‘07 ‘08 ‘09 Number of children living with HIV 60 50 THOUSANDS 40 30 20 10 0 ‘90 ‘91 ‘92 ‘93 ‘94 ‘95 ‘96 ‘97 ‘98 ‘99 ‘00 ‘01 ‘02 ‘03 ‘04 ‘05 ‘06 ‘07 ‘08 ‘09 Adult and child deaths due to AIDS 80 THOUSANDS 60 40 20 0 ‘90 ‘91 ‘92 ‘93 ‘94 ‘95 ‘96 ‘97 ‘98 ‘99 ‘00 ‘01 ‘02 ‘03 ‘04 ‘05 ‘06 ‘07 ‘08 ‘09 Chapter 2: Epidemic update | 2010 GLOBAL REPORT 45 .5 1.0 1. 2 Number of people living with HIV 2.17 HIV trends in Central and South America Source: UNAIDS.

Concentrated epidemics—primarily among men who have sex with men Most of the HIV epidemics in this region are concentrated in and around networks of men who have sex with men. Surveys conducted in groups of urban men who have sex with men have found HIV prevalence of at least 10% in 12 of 14 countries (69). 1/3 Social stigma. High rates of HIV infection have been found in networks of men who have sex with men.6 million] in 2009 from 1. more than one in five men who said that they had sex with other men reported having had sex with at least one woman in the previous six months (84). Proportion of the population living with HIV in Central and South America that live in Brazil. Several countries. Injecting drug use has been the other main route of HIV transmission in this region. especially in Central America and in the Andes. It has been estimated that as many as 2 million people in Central and South America inject drugs and that more than one quarter of these might be living with HIV (38).1% (84) among men who have sex with men. continue to have fewer programmes that address the key role of unsafe sex between men in their HIV epidemics (64). In five Central American countries.0 million–1. however. including in Costa Rica (83). The total number of people living with HIV continues to grow to an estimated 1.CENTRAL AND SOUTH AMERICA Stable epidemic—but HIV prevalence rises with high access to antiretroviral therapy The HIV epidemics in South and Central America have changed little in recent years (Table 2.6 and Figure 2.4 million [1.3 million] in 2001) due largely to the availability of antiretroviral therapy. 46 Chapter 2: Epidemic update | 2010 GLOBAL REPORT . In Central America.2 million–1. Peru. About one third of all people living with HIV in Central and South America live in populous Brazil. Stopping HIV among sex workers—investments are reaping dividends Most countries have focused attention on preventing HIV transmission during paid sex. the annual HIV incidence was 5. The adult HIV prevalence in Brazil has remained well under 1% for at least the past decade. has kept many of these epidemics among men who have sex with men hidden and unacknowledged. Fear of being stigmatized can compel many men who have sex with men to also have sexual relationships with women. High condom use rates and low HIV prevalence have been reported among female sex workers in Santiago. and there are indications that these efforts are paying off. Chile (86).5% has been found among men who have sex with men who attended public health clinics in Lima. These rates were higher than those observed among the men who have sex with men in Europe and North America (85). for example. especially in the southern cone of South America.14). where early and ongoing HIV prevention and treatment efforts have contained the epidemic. while an incidence of 3. El Salvador (87) and Guatemala (88).1 million [1.

This trend is occurring despite the comparatively low coverage of services for preventing the transmission of HIV to infants. heterosexual HIV transmission is increasing in the older epidemics in South America.and middle-income countries (9). 54% [39%–83%] of the pregnant women living with HIV in the region were receiving antiretroviral drugs to prevent transmission to their newborns. At the end of 2009. ■ 2 “THE NUMBER OF CHILDREN LIVING WITH HIV REMAINS SMALL IN CENTRAL AND SOUTH AMERICA AND APPEARS TO BE DECLINING. mainly between men and women (90). remains small in Central and South America (around 4000 children newly infected in 2009) and appears to be declining. an estimated four of five new HIV diagnoses in the mid-2000s were attributed to unprotected sexual intercourse. Close to 6% of male inmates tested at a São Paulo (Brazil) penitentiary. however. When injecting drug use receded as a mode of transmission in Argentina’s HIV epidemic. Meanwhile. prisoners and detainees also have a high HIV prevalence. for example. only slightly higher than the global coverage of 53% [40%–79%] in low. HIV among children The number of children (younger than 15 years of age) living with HIV.” Chapter 2: Epidemic update | 2010 GLOBAL REPORT 47 . Almost half (43%) of the new HIV infections in Peru are now attributed to heterosexual transmission (91).As in other regions with many people who inject drugs. although most of those infections are believed to occur during paid and other forms of higher-risk sex. for example. were living with HIV (89). Such evidence has prompted some countries to move towards introducing HIV prevention services in prisons.

5% – 1% 1% – 1.8 AIDS statistics for North America and Western and Central Europe. Source: UNAIDS.3 million [2.0– 2.5% .8 million [1.1% .5% 1. No data < .NORTH AMERICA AND WESTERN AND CENTRAL EUROPE Table 2.6– 2.7 million] 1. 2001 and 2009 Source: UNAIDS.1% – <. 1990 to 2009. People living with HIV People newly infected with HIV Children living with HIV AIDS-related deaths NORTH AMERICA AND WESTERN AND CENTRAL EUROPE 2009 2.5% – 2% 48 Chapter 2: Epidemic update | 2010 GLOBAL REPORT .18 HIV prevalence in North America and Western and Central Europe HIV prevalence among adults aged 15-49 years old in North America and Western and Central Europe.0 million] 100 000 [73 000–150 000] 97 000 [82 000–110 000] 6000 [3500– 8000] 7400 [4500– 10 000] 35 000 [29 000–56 000] 37 000 [32 000–44 000] 2001 Figure 2.

2 Number of people living with HIV 3.5 0 ‘90 ‘91 ‘92 ‘93 ‘94 ‘95 ‘96 ‘97 ‘98 ‘99 ‘00 ‘01 ‘02 ‘03 ‘04 ‘05 ‘06 ‘07 ‘08 ‘09 Adult and child deaths due to AIDS 150 THOUSANDS 125 100 75 50 25 0 ‘90 ‘91 ‘92 ‘93 ‘94 ‘95 ‘96 ‘97 ‘98 ‘99 ‘00 ‘01 ‘02 ‘03 ‘04 ‘05 ‘06 ‘07 ‘08 ‘09 Chapter 2: Epidemic update | 2010 GLOBAL REPORT 49 .Figure 2.5 MILLIONS 2.19 HIV trends in North America and Western and Central Europe Source: UNAIDS.0 2.5 1.0 1.0 .

The HIV epidemics are disproportionately concentrated in racial and ethnic minorities in some countries.93).0 million–2. for example. women comprised about 26% of the people living with HIV in North America and 29% of those in Western and Central Europe.18). Data from 23 European countries show that the annual number of HIV diagnoses among men who have sex with men rose by 86% between 2000 and 2006 (95). African-Americans constitute 12% of the population but accounted for 45% of the people newly infected with HIV in 2006 (98). Figure 2. new HIV infections attributed to unprotected sex between men increased by more than 50% from 1991–1993 to 2003–2006 (98). Increases in higher-risk sexual behaviour are associated with this trend. Resurging epidemics among men who have sex with men There is strong evidence of resurgent HIV epidemics among men who have sex with men in North America and in Western Europe (94). and the United States of America (97).5 times and African-American females 19 times more likely to acquire HIV compared with their Caucasian counterparts (103).7 million] in 2009—30% more than in 2001 (Table 2. and surveys in Denmark and Amsterdam (the Netherlands) have reported similar findings (101. men who have sex with men account for more than half the men newly diagnosed with HIV.3 million [2. for example.6% of the country’s population (92. The 3160 new HIV diagnoses among men who have sex with men in 2007 in the United Kingdom were the most ever reported up to that point (96). Spain. for example. 3160 50 Chapter 2: Epidemic update | 2010 GLOBAL REPORT . the Netherlands. Germany. African-American males are 6. National surveillance data also show significant increases in new HIV diagnoses between 2000 and 2005 among men who have sex with men in Canada. In the United States of America. yet they represent only 1.NORTH AMERICA AND WESTERN AND CENTRAL EUROPE AIDS is not over in the higher-income countries The total number of people living with HIV in North America and Western and Central Europe continues to grow and reached an estimated 2. In France. although injecting drug use and unprotected paid sex also feature (especially in Mexico and parts of southern Europe). In the United States of America. Researchers in Catalonia (Spain). have reported that one third (32%) of men who have sex with men had recently had unprotected anal sex with a casual partner (100). Unprotected sex between men continues to dominate patterns of HIV transmission in North America and Western and Central Europe.8. the most ever reported up to that point. Similar trends have been reported in Canada (99). In 2009. This epidemic pattern means that men outnumber women among people living with HIV. Number of new HIV diagnoses among men who have sex with men in 2007 in the UK.102).

the Caribbean. for example. one third as many as in 1984–1986. within a few years. In a large study among pregnant women in Tijuana. The epidemic is also declining among people who inject drugs in North America. aboriginal people comprised 3. Chapter 2: Epidemic update | 2010 GLOBAL REPORT 51 . ■ 2 19x Increase in likelihood that African-American females will aquire HIV. There are also flashpoints along the border between Mexico and the United States of America where intersecting networks of drug use and paid sex appear to be driving the spread of HIV.In Canada in the mid-2000s. These localized epidemics have considerable potential for growth. In the Netherlands (67) and Switzerland (98). the HIV prevalence was 1%. in the United States. a majority of the surveyed people who inject drugs (72% in one survey) were living with HIV (38). for example. but many of these people were infected abroad (mostly in sub-Saharan Africa. about 44% of the people newly infected with HIV in 2007 had acquired HIV abroad. Rates of new infections among people who inject drugs have been falling overall—largely due to harm-reduction services. Overall in Europe. and among those who used drugs it was 6% (106). respectively) were attributable to injecting drug use. Two thirds (66%) of the people newly infected inject drugs (99). mainly in sub-Saharan Africa (96). almost one in five (17%) people newly diagnosed with HIV in 2007 were from countries with generalized epidemics (107). Fewer than 10 000 people who inject drugs contracted HIV in 2006 in the United States of America. compared to their Caucasian counterparts.8% of the population but accounted for 8% of the cumulative people living with HIV and 13% of the people newly infected annually. Immigrants living with HIV have become a growing feature of the epidemics in several countries in Europe. In the United Kingdom. and Asia). Hardly any people newly infected with HIV were detected there a decade ago. for example. Multiple use by different people of contaminated drug-injecting equipment can still dramatically accelerate an HIV epidemic. HIV infections due to ‘social’ drug using— several people using the same contaminated injecting equipment—have almost been eliminated: at most 5% of new infections (in 2008 and 2007. Studies have found an HIV prevalence of 12% among female sex workers who inject drugs in Ciudad Juarez and Tijuana (104) and 3% among other people who inject drugs (105) in Tijuana. Heterosexual transmission accounts for about half of the people newly infected with HIV in Central Europe (67). as Estonia has discovered.

5% – 3% 52 Chapter 2: Epidemic update | 2010 GLOBAL REPORT . People living with HIV People newly infected with HIV Children living with HIV AIDS-related deaths MIDDLE EAST AND NORTH AFRICA 2009 460 000 [400 000–530 000] 180 000 [150 000–200 000] 75 000 [61 000–92 000] 36 000 [32 000– 42 000] 21 000 [13 000–28 000] 7100 [3800–13 000] 23 000 [20 000 –27 000] 8300 [6300–11 000] 2001 Figure 2. 2001 and 2009 Source: UNAIDS.20 HIV prevalence in Middle East and North Africa HIV prevalence among adults aged 15–49 years old in Middle East and North Africa.1% – <. Source: UNAIDS.5% 1.9 AIDS statistics for the Middle East and North Africa. No data < .MIDDLE EAST AND NORTH AFRICA Table 2.1% .5% – <1% 1% – <1.5% . 1990 to 2009.

21 HIV trends in the Middle East and North Africa Source: UNAIDS. 2 Number of people living with HIV 600 500 THOUSANDS 400 300 200 100 0 ‘90 ‘91 ‘92 ‘93 ‘94 ‘95 ‘96 ‘97 ‘98 ‘99 ‘00 ‘01 ‘02 ‘03 ‘04 ‘05 ‘06 ‘07 ‘08 ‘09 Number of people newly infected with HIV 100 THOUSANDS 80 60 40 20 0 ‘90 ‘91 ‘92 ‘93 ‘94 ‘95 ‘96 ‘97 ‘98 ‘99 ‘00 ‘01 ‘02 ‘03 ‘04 ‘05 ‘06 ‘07 ‘08 ‘09 Number of children living with HIV 30 25 THOUSANDS 20 15 10 5 0 ‘90 ‘91 ‘92 ‘93 ‘94 ‘95 ‘96 ‘97 ‘98 ‘99 ‘00 ‘01 ‘02 ‘03 ‘04 ‘05 ‘06 ‘07 ‘08 ‘09 Adult and child deaths due to AIDS 30 25 THOUSANDS 20 15 10 5 0 ‘90 ‘91 ‘92 ‘93 ‘94 ‘95 ‘96 ‘97 ‘98 ‘99 ‘00 ‘01 ‘02 ‘03 ‘04 ‘05 ‘06 ‘07 ‘08 ‘09 Chapter 2: Epidemic update | 2010 GLOBAL REPORT 53 .Figure 2.

Morocco. Egypt. and pregnant women using antenatal services have a HIV prevalence of more than 1%. and Tunisia.20). new HIV infections. The available evidence points to increases in HIV prevalence. The HIV prevalence is low—with the exceptions of Djibouti and southern Sudan. and its HIV epidemic is centred mainly within this population group. where HIV is spreading in the general population. Lebanon. new HIV infections and AIDS-related deaths An estimated 460 000 [400 000–530 000] people were living with HIV in the Middle East and North Africa at the end of 2009. Oman. There were 75 000 [61 000–92 000] people newly infected in 2009.111). The extremely high prevalence of hepatitis C virus (80%) found among detained people who inject drugs in Tehran (109) indicates considerable potential for the spread of HIV among and beyond people who inject drugs. Reliable data on the epidemics in the Middle East and North Africa remain in short supply. It has been estimated that close to half (45%) of the Iranian prison population is incarcerated for drug-related offences (110. and AIDS-related deaths. 80 % 54 Chapter 2: Epidemic update | 2010 GLOBAL REPORT . the Libyan Arab Jamahiriya.MIDDLE EAST AND NORTH AFRICA Increasing HIV prevalence. An estimated 14% of people who inject drugs countrywide were living with HIV in 2007 (108). creating difficulty in tracking recent trends with confidence. the Syrian Arab Republic. more than twice the number (36 000 [32 000–42 000]) in 2001. Prevalence of hepatitis C virus among detained people who inject drugs in Tehran. up from 180 000 [150 000–200 000] in 2001 (Table 2. The number of people newly infected has also increased over the last decade. The Islamic Republic of Iran is believed to have the largest number of people who inject drugs in the region. AIDS-related deaths have nearly tripled: from 8300 [6300–11 000] in 2001 to 23 000 [20 000–27 000] at the end of 2009. Exposure to contaminated drug-injecting equipment features in the epidemics of Algeria.9 and Figure 2.

Sex work networks exist but have low HIV prevalence The available evidence suggests that HIV transmission is still limited in paid sex networks. HIV services for men who have sex with men tend to be limited (112). many men who have sex with men also have sex with women (114). When surveyed in 2006. In surveys in Sudan. There are not enough data to determine the extent to which HIV is being transmitted to sex workers’ male clients and other sex partners and to their respective partners. As in other regions. 8%–9% of men who have sex with men were living with HIV (70).Men who have sex with men disproportionately affected Sex between men is heavily stigmatized in this region and is a punishable offence in many countries. Morocco and Yemen (112).” 2 Chapter 2: Epidemic update | 2010 GLOBAL REPORT 55 . compared with an estimated 2%–4% in Algeria. about 1% of female sex workers in Egypt were living with HIV (113). compared with 6% in Egypt (113). ■ “SEX BETWEEN MEN IS HEAVILY STIGMATIZED IN THE MIDDLE EAST AND NORTH AFRICA AND IS A PUNISHABLE OFFENCE IN MANY COUNTRIES. Evidence indicates that men who have sex with men bear a disproportionate share of the HIV burden in at least some countries.

2001 and 2009 Source: UNAIDS. No data < . Source: UNAIDS.5% 1. People living with HIV People newly infected with HIV Children living with HIV AIDS-related deaths OCEANIA 2009 57 000 [50 000–64 000] 28 000 [23 000– 35 000] 4500 [3400–6000] 4700 [3800– 5600] 3100 [1500– 4800] <1000 [<500 –1600] 1400 [900–2400] <1000 [<500–1000] 2001 Figure 2.10 AIDS statistics for Oceania.22 HIV prevalence in Oceania HIV prevalence among adults aged 15–49 years old in Oceania.OCEANIA Table 2.5% – <1% 1% – <1. 1990 to 2009.1% .5% – 2% 56 Chapter 2: Epidemic update | 2010 GLOBAL REPORT .1% – .5% .

23 HIV trends in Oceania Source: UNAIDS.Figure 2.5 1.0 .0 1.5 THOUSANDS 2.5 0 ‘90 ‘91 ‘92 ‘93 ‘94 ‘95 ‘96 ‘97 ‘98 ‘99 ‘00 ‘01 ‘02 ‘03 ‘04 ‘05 ‘06 ‘07 ‘08 ‘09 Chapter 2: Epidemic update | 2010 GLOBAL REPORT 57 . 2 Number of people living with HIV 80 THOUSANDS 60 40 20 0 ‘90 ‘91 ‘92 ‘93 ‘94 ‘95 ‘96 ‘97 ‘98 ‘99 ‘00 ‘01 ‘02 ‘03 ‘04 ‘05 ‘06 ‘07 ‘08 ‘09 Number of people newly infected with HIV 8 THOUSANDS 6 4 2 0 ‘90 ‘91 ‘92 ‘93 ‘94 ‘95 ‘96 ‘97 ‘98 ‘99 ‘00 ‘01 ‘02 ‘03 ‘04 ‘05 ‘06 ‘07 ‘08 ‘09 Number of children living with HIV 5 THOUSANDS 4 3 2 1 0 ‘90 ‘91 ‘92 ‘93 ‘94 ‘95 ‘96 ‘97 ‘98 ‘99 ‘00 ‘01 ‘02 ‘03 ‘04 ‘05 ‘06 ‘07 ‘08 ‘09 Adult and child deaths due to AIDS 2.

The trend may point to increased higher-risk sexual behaviour in this population group (116. “THE HIV EPIDEMIC IN PAPUA NEW GUINEA IS THE LARGEST AND THE ONLY GENERALIZED ONE IN OCEANIA. and military personnel (118). 161 58 Chapter 2: Epidemic update | 2010 GLOBAL REPORT . from 17 in 2005 to 178 in 2009.0%]. The estimates were calculated using data from antenatal clinics in all parts of Papua New Guinea that offer HIV testing to pregnant women as part of routine care.10 and Figure 2. with about 34 000 [30 000–39 000] people living with HIV. whereas unprotected sex between men predominates in the epidemics of the smaller Pacific countries and in those of Australia and New Zealand (115).9% [0. Recent analysis of available data across the country shows that the epidemic is starting to level off. transport workers. also resulting in more information available for the estimation process.117). Sexual transmission promotes HIV epidemics The HIV epidemics in Oceania are mainly driven by sexual transmission. However. new HIV diagnoses have increased among men who have sex with men in Australia and New Zealand in the past decade. A lack of survey data creates difficulty in determining the role of commercial sex work in Papua New Guinea’s epidemic. the number of people newly infected with HIV has begun to decline from 4700 [3800–5600] in 2001 to 4500 [3400–6000] in 2009.8%–1. but paid sex appears to be commonplace among mobile populations. The national adult HIV prevalence in 2009 was estimated at 0. As in many other high-income countries with older HIV epidemics.” From 2005 to 2009. Programmes that aim to prevent mother-tochild transmission of HIV substantially increased the number of sites providing testing services to women during recent years. Unprotected heterosexual intercourse is the main mode of transmission in Papua New Guinea. including migrant workers. increase in number of testing sites with programmes that aim to prevent mother-to-child transmission of HIV. but the number of people living with HIV in this region nearly doubled between 2001 and 2009—from 28 000 [23 000–35 000] to 57 000 [50 000–64 000] (Table 2.22). The HIV epidemic in Papua New Guinea is the largest and the only generalized one in this region.OCEANIA HIV epidemic begins to stabilize The HIV epidemic in Oceania is small.

HIV infection among Aboriginal and Torres Strait Islander people was attributed to injecting drug use in 22% of cases over the past five years (117). of cumulative HIV case reports (115). However. Children newly infected—Papua New Guinea has most of the burden Mother-to-child transmission of HIV is a significant factor only in Papua New Guinea’s epidemic. people who inject drugs comprise 12% and 6%.Injecting drug use—a small but significant factor Injecting drug use is a minor factor in the epidemics in this region. But in parts of Australia. ■ 2 Chapter 2: Epidemic update | 2010 GLOBAL REPORT 59 . it features prominently in the HIV epidemic among aboriginal people. where nearly 10% of all people newly diagnosed with HIV to date acquired it during perinatal exposure (115). respectively. in French Polynesia and Melanesia (excluding Papua New Guinea).

2001 to 2009. selected countries Increasing >25% Stable Decreasing >25% Not included in analysis 60 Chapter 2: Epidemic update | 2010 GLOBAL REPORT .SCORECARD: INCIDENCE Changes in the incidence rate of HIV infection.

EPP files were available and trends in EPP were not derived from workbook prevalence estimates. estimates of HIV incidence have been produced through modeling The map includes 60 countries for which reliable estimates of new HIV infections over time were available from the 2010 round of country-specific estimation using the EPP/Spectrum tools. such as Brazil. and the EPP/Spectrum–derived incidence trend was not in conflict with modelled incidence trends derived from age-specific prevalence in national survey results. EPP did not produce an artificial increase in HIV prevalence in recent years due to scarcity of prevalence data points. Chapter 2: Epidemic update | 2010 GLOBAL REPORT 61 . the EPP/Spectrum–derived incidence trend was not in conflict with the trend in case reports of new HIV diagnoses. prevalence data were available up to at least 2007. UNAIDS will continue to work with countries and partners to improve the quality of available information and modeling methodologies to include HIV incidence data for additional countries in future reports.Increasing >25% Armenia Bangladesh Georgia Kazakhstan Kyrgyzstan Philippines Tajikistan Stable Angola Argentina Belarus Benin Cameroon Democratic Republic of the Congo Djibouti France Germany Ghana Haiti Kenya Lesotho Lithuania Malaysia Niger Nigeria Panama Republic of Moldova Senegal Sri Lanka Uganda United States of America Decreasing >25% Belize Botswana Burkina Faso Cambodia Central African Republic Congo Côte d’Ivoire Dominican Republic Eritrea Ethiopia Gabon Guinea Guinea-Bissau India Jamaica Latvia Malawi Mali Mozambique Myanmar Namibia Nepal Papua New Guinea Rwanda Sierra Leone South Africa Suriname Swaziland Thailand Togo United Republic of Tanzania Zambia Zimbabwe 2 In the absence of a reliable diagnostic test that can directly measure the level of new HIV infections in a population. there were at least four time points between 2001 and 2009 for which prevalence data were available for concentrated epidemics and at least three data points in the same period for generalized epidemics. and 3 countries for which peer-reviewed publications with incidence trends were available. data were representative of the country. The EPP/Spectrum methods estimate HIV incidence trends from HIV prevalence over time combined with the changing level of antiretroviral therapy. China and the Russian Federation. for the majority of epidemic curves for a given country. this type of assessment is highly complex and it could not be concluded in the 2010 estimation round. The criteria for including countries in this analysis were as follows. For some countries with complex epidemics including multiple populations groups with different risk behaviours as well as major geographic differences.

CHAPTER 3 62 Chapter 3: HIV prevention | 2010 GLOBAL REPORT .

the decline exceeded 25% in 33 countries. ■ HIV prevention investments are about 22% of all spending in 106 low. 370 000 [230 000–510 000] children were infected with HIV through mother-to-child transmission. ■ Globally. Condom distribution increased by 10 million between 2008 and 2009. comprehensive and correct knowledge about HIV among both young men and young women has increased slightly since 2008—but at only 34%. including 22 countries in sub-Saharan Africa. rapid expansion of delivery of effective advances in preventing mother-to-child transmission is being held back by inadequate access to antenatal and postnatal services. ■ Recent promising results of a tenofovir-based gel have raised hopes that an additional effective female-initiated prevention option may soon become viable.3 HIV PREVENTION KEY FINDINGS ■ The global incidence of HIV infection declined by 19% between 1999 (the year of peak incidence) and 2009. with 25. ■ Trend analysis shows a general decline in the percentage of people who have had more than one sexual partner in the past year in sub-Saharan Africa.8 million female condoms provided through international and nongovernmental funding sources in 2009. ■ Condom availability in places of need is increasing significantly. This is a drop of 24% from five years earlier. However. Chapter 3: HIV prevention | 2010 GLOBAL REPORT 63 . ■ In 2009. the number of young people with this comprehensive knowledge is barely one third of the UNGASS target of 95%.and middle-income countries.

The incidence of HIV infection declined by 19% between 1999 and 2009 globally. Behaviour change is the most important factor accounting for these encouraging declines in new HIV infections in many countries. Among young people. And HIV incidence remained stable in 23 countries between 2001 and 2009. the decline exceeded 25% in 33 countries. during the same period the incidence increased by more than 25% in seven countries. But while parts of the world experienced significant and encouraging decreases in HIV incidence between 2001 and 2009.and middle-income countries. one notable challenge to strengthening the effects of the response to the epidemic has been the reluctance of planners and implementers to focus prevention efforts where they produce maximum impact. areas experiencing 64 Chapter 3: HIV prevention | 2010 GLOBAL REPORT . Too often. including five in Eastern Europe and Central Asia. Even with existing resources. 370 000 [230 000–510 000] children were infected with HIV through mother-to-child transmission (down from 500 000 [320 000–680 000] in 2001). further rapid expansion in delivering advances in preventing motherto-child transmission is being held back by inadequate access to antenatal and postnatal services. In Eastern Europe and Central Asia. delayed sexual debut. Focusing HIV-prevention investments appropriately HIV prevention investments are about 22% of all spending in 106 low. including 22 countries in sub-Saharan Africa. Eleven countries reported levels of 75% or greater among either men or women for condom use at last higher-risk sex. Although this is an important achievement for the health of both mothers and infants.CHAPTER 3 | HIV PREVENTION » New HIV infections are declining globally Dedicated efforts to promote and support combination HIV prevention are producing clear and impressive results. Major successes in HIV prevention have been achieved in concentrated epidemic countries that have devoted substantial programming efforts and funds to prevention among people at higher risk of exposure to HIV. noteworthy drops in HIV incidence have been associated with a significant positive trend (for either or both sexes) in important behaviour indicators. and reductions in multiple partnerships (1). prevention responses still do not focus on these key populations. however. including increased condom use. Correct and consistent condom use has been found to be greater than 90% effective in preventing transmission of HIV and other sexually transmitted infections. In 2009. HIV prevention investments do not always follow epidemic patterns.

sex workers and their clients. 0. yet prevention spending often ignores this reality. For example in Asia.7% in Burkina Faso. even in countries with generalized epidemics. In Namibia. from slightly more than 10% in 2007 to about 5% in 2009. improvements across key knowledge and behaviour indicators—including comprehensive knowledge. engagement in higher-risk sex. investment focused on young people often does not achieve an appropriate balance between the need for continued investment in HIV prevention among all young people and the need to pay particular attention to the special needs of young people at higher risk from drug use. between one quarter and one third of new HIV infections occur among people who inject drugs. the proportion of HIV prevention expenditure devoted to programmes for sex workers and their clients. such as people who inject drugs. The proportions of Kenya’s and Mozambique’s total AIDS spending directed to HIV prevention among these key populations are 0.35% and 0. the incidence of HIV infection is markedly reduced (1). or unprotected sex between men. yet the percentage of new infections in these population groups is 30%. 89% of HIV-prevention investments in these regions are not focused on people at higher risk. Similarly. an estimated 370 000 children were infected with HIV through mother-to-child transmission (down from 500 000 in 2001). men who have sex with men.24% in Ghana. and sex workers and their clients (3). and men who have sex with men. Spending directed specifically to support these populations in their response to HIV is only one hundredth of their respective share of the national epidemic (4). and almost all is from international sources. 28% and 43%. age of sexual debut. Combination HIV prevention efforts are bearing results Where key behavioural indicators related to the risk of HIV infection—condom use. sex before age 15 years (early sexual debut) and multiple partnerships—all have positive trends.4% in Côte d’Ivoire and 0. For example. respectively (2). Evidence that combination HIV prevention efforts that address the most pressing HIV risks have decisively changed the course of the epidemic continues to accumulate. sex work. A notable proportion of new infections are found among these population groups. 90% of resources for young people are spent on low-risk youth. who represent just 5% of the people becoming infected with HIV (5).3 primarily concentrated epidemics. men who have sex with men and people who inject drugs is only 1. In both Kenya and Mozambique. .25% respectively. Chapter 3: HIV prevention | 2010 GLOBAL REPORT 65 370K In 2009. and condom use among both males and females aged 15–24 years—were associated with declines in HIV prevalence among young people.

Males 15–24 years 100 90 80 70 60 50 40 30 20 10 % 2000 2003 2005 2009 Young people never having had sex (15-19 years) Condom use at last sex with a non-marital. among respondents who had >1 partner in the last year Proportion of respondents who had had sex before age 15 Proportion of respondents that had >1 partner in past year Young people never having had sex (15-24 years) Never married respondents who had sex in the last 12 months who used a condom with their last sexual partner Females 15–24 years 100 90 80 70 60 50 40 30 20 10 % 2000 2003 2005 2009 Young people never having had sex (15-19 years) Condom use at last sex with a non-marital. noncohabiting sexual partner Condom use at last sex.Figure 3. noncohabiting sexual partner Condom use at last sex. among respondents who had >1 partner in the last year Proportion of respondents who had had sex before age 15 Proportion of respondents that had >1 partner in past year Young people never having had sex (15-24 years) Never married respondents who had sex in the last 12 months who used a condom with their last sexual partner 66 Chapter 3: HIV prevention | 2010 GLOBAL REPORT .1 HIV prevention in Zambia. 2000-2009 Source: Zambia Sexual Behavior Survey.

non-cohabiting sexual partner Condom use at last sex among respondents who had >1 partner in the last year Proportion of respondents that had >1 partner in past year Chapter 3: HIV prevention | 2010 GLOBAL REPORT 67 . non-cohabiting sexual partner Condom use at last sex among respondents who had >1 partner in the last year Proportion of respondents that had >1 partner in past year Females 25–49 years 100 90 80 70 60 50 40 30 20 10 % 2000 2003 2005 2009 Condom use at last sex with a non-marital.Males 25–49 years 100 90 80 70 60 50 40 30 20 10 % 3 2000 2003 2005 2009 Condom use at last sex with a non-marital.

the number of young people with this comprehensive knowledge is only slightly greater than one third of the UNGASS target of 95%. when condom use increases and multiple partnerships do also. In Uganda. and to a lesser extent. men older than 25 years are increasingly 68 Chapter 3: HIV prevention | 2010 GLOBAL REPORT . The country has successfully increased both the age of sexual debut and abstinence among young people (6). Congo. Behaviour change and increased comprehensive correct knowledge reduces HIV incidence and prevalence in most countries with high HIV prevalence Globally. United Republic of Tanzania and Zambia). Cameroon. Young people ages 15–24 years old showed gradually improving knowledge about HIV in these 25 countries but still fall short of the global targets for comprehensive knowledge set in 2001. or vice versa—the effects of changes in reducing incidence are less easy to identify clearly. But when different types of behaviour change vary—for example. Malawi. and multiple relationships Understanding the varieties and patterns of sexual relationships is a necessary element in implementing effective prevention programmes. Togo.2). Guinea-Bissau. Trend analysis shows a general decline in the percentage of people who had more than one partner in the past year in sub-Saharan Africa. all routes to reducing the risk of sexual exposure to HIV must be pursued simultaneously (Figure 3. such as Botswana. changing. the proportion of men and women 15–24 years old with more than one partner in the past year who used a condom at last sex has also markedly declined. The number of both young and older adults who have multiple partners has also declined. a minority of males and females report having had sex with more than one partner in the last year.1 Ten countries have achieved comprehensive correct knowledge levels above 60% for either men or women 15–24 years old (Figure 3. Nigeria. Although fewer young men and women in Zambia are sexually active and fewer have had more than one partner in the past 12 months. For maximum effect. Between 2001 and 2009. with some exceptions. Congo. condom use within this population has decreased rather than increased. HIV incidence declined by more than 25% between 2001 and 2009. Cote d’Ivoire.1 Limited data (nine of 41 countries) are available from Western and Central Europe. However. In Zambia. Burundi. Complex. the Middle East and North Africa (eight of 20 countries). overall HIV incidence in Namibia decreased by more than 25%. South Africa. Kenya. Chad. In most countries. SubSaharan Africa is the region with the most complete data on comprehensive knowledge of HIV. Less than half of young people living in 15 of the 25 countries with the highest HIV prevalence can correctly answer five basic questions about HIV and its transmission (these include Botswana. largely due to the Demographic and Health Surveys that have been undertaken in 85 countries. Similar trends were also recorded in Zimbabwe.1). with major support from the United States Government together with participating countries and other funders. South Africa and Uganda. Opportunities to improve HIV prevention knowledge and behaviour still abound. comprehensive and correct knowledge about HIV among both young men and young women has increased slightly since 2003—but at only 34%. Central African Republic.

% 10 20 30 40 50 60 70 80 90 100 3 Sweden Saint Lucia Tuvalu Namibia Cape Verde Norway Liberia Belarus Eritrea Chile Males Females Figure 3. Source: Country Progress Reports 2010.3 Multiple sexual partners in the past year. 40 % H I G H E R R I S K S E X ( I N D I C AT O R 16 ) 15-24 M 25-49 M 15-49 M 15-24 F 25-49 F 35 30 25 20 15 15-49 F 10 5 0 ‘89 ‘90 ‘91 ‘92 ‘93 ‘94 ‘95 ‘96 ‘97 ‘98 ‘99 YEAR ‘00 ‘01 ‘02 ‘03 ‘04 ‘05 ‘06 ‘07 ‘08 ‘09 Chapter 3: HIV prevention | 2010 GLOBAL REPORT 69 . Uganda Percentage of the population (ages 15–49 years old) that have had multiple sex partners in the past year in Uganda.Figure 3. 1989–2006.2 Young people’s knowledge of HIV Countries with comprehensive correct knowledge of HIV exceeding 60% among people 15–24 years old. Source: Demographic and Health Surveys and other population-based behavioural survey data. by sex and age group.

Reports of condom use by sex workers at last sex with a client are encouraging. most reported between 51% and 80% using a condom at last higher-risk sex. In contrast. with another 13 countries reporting condom use levels from 80% to 90%. Rwanda. Myanmar and Thailand and men in Timor-Leste reported lower than 25% condom use at last higher-risk sex. In 59 of the 93 countries reporting these data—including 18 of the 25 countries with the highest prevalence of HIV—less than 25% of men reported sex with more than one partner in the last 12 months. A substantially larger number—84 countries—reported that less than 25% of women had sex with more than one partner in the past 12 months. while the number of women reporting sex with more than one partner has remained fairly stable (Figure 3. 70 Chapter 3: HIV prevention | 2010 GLOBAL REPORT Level of condom use in risky sex by men and women reported by 11 countries 75 % . Trend data from Demographic and Health Surveys show that condom use is increasing in sub-Saharan Africa.3). 14 countries report condom use rates of 20% or less at last sex for those with more than one partner in the past year among either males or females. 32 reported 60% or greater condom use at last sex among the men who have had sex with more than one partner in the past 12 months versus 20 of 80 reporting countries among women. including less than 60% in 17 countries. On average. Of the 83 countries for which data are available. Greater condom promotion efforts are needed to increase the levels of usage of this technology for protection against HIV by sex workers and their clients. 26 reported that 90% or more of sex workers report having used a condom with their last client. Uganda and the United Republic of Tanzania. 47 countries— more than half of those reporting—report rates of condom use by sex workers with their last client below 80%. The other countries in Asia showed higher rates of condom use at last higher-risk sex or did not report on this indicator. the proportion of men who reported having had sex with more than one partner in the past year was 16 percentage points higher than among women. In Asia. two countries reported that 26% to 50% of women did so. Ethiopia. Condom availability and condom uptake is improving Eleven countries reported levels of 75% or greater among either men or women for condom use at last higher-risk sex—these countries include Botswana. The availability of female condoms in places of need is significantly increasing. Of the countries reporting this indicator in Eastern Europe and Central Asia. Ten countries reported that 26% to 50% of men had more than one partner in the past year. Botswana reported that at least 80% of men used a condom at last higher-risk sex.reporting multiple partners. including the high-prevalence countries of the Democratic Republic of the Congo. women in Cambodia. Malawi. Of 86 countries providing data. Country progress reports show that the median percentage of condom use at last sex for males with more than one partner in the past 12 months is 48% versus 38% for women. At the same time. no countries reported this level of condom use for women. India and South Africa.

4). UNGASS Country Progress Reports 2010. Data from multiple sources. Ukraine has had the most severe HIV epidemic among people who inject drugs in Eastern Europe and Central Asia. sentinel surveys and programmes serving people who inject drugs all indicate that HIV transmission among people who inject drugs in Ukraine appears to be significantly decreasing. Recent Initiators Young IDUs (15-24) IDU Coverage of harm reduction sites (right axis) Coverage of harm reduction sites (15-24) (right axis) 70 60 50 PERCENT 30000 25000 20000 PEOPLE 40 15000 30 10000 20 10 0 2004 2006 2007 2008 2009 5000 0 Chapter 3: HIV prevention | 2010 GLOBAL REPORT 71 .Ukraine—significant strides in protecting people who use drugs from HIV infection For many years. Journal of HIV/AIDS Surveillance and Epidemiology. from behavioural surveillance. However. O Varetska. Although the HIV epidemic among people who inject drugs in Ukraine has stabilized. In 2009. they remain at high risk of acquiring HIV. Behavioural surveillance in Ukraine shows that people who inject drugs are increasingly adapting key HIV risk-reduction measures. C Chhea. HIV infections among people who started injecting drugs in only the past two years (and are thus more likely to represent incident infections rather than ones acquired much earlier) decreased from a peak of 30% in 2004 to 11% in 2008 (14).4 Harm reduction programmes and HIV prevalence in Ukraine Association between harm reduction programmes and HIV prevalence in Ukraine. four years of comprehensive. The percentage of people who inject drugs who report using sterile injecting equipment at last injection rose from 80% in 2006 to 86% in 2008. T Saliuk. 2004–2009. 3 Figure 3. Sources: M Mahy. sustained funding for and implementation of evidence-based harm reduction programming have helped reduce the HIV incidence among people who inject drugs in Ukraine. whether by sharing contaminated equipment or through the sexual transmission of HIV from people who inject drugs to their partners (Figure 3. R Lyerla (2010). about 4600 people who inject drugs were accessing opioid substitution therapy at any time (15). A proxy measure for HIV incidence among populations at increased risk to HIV Vol 2(1):8.

1). has increased. treatment and care for people who inject drugs: A systematic review of global. of these. Source: Mathers BM. Mattick R. HIV prevention. Globally. Between 2008 and 2009 alone. Degenhardt L. regional and national coverage. nearly 20%.5 million] are living with HIV (12)(Table 3.0 million–21. as opposed to 10.2 million] people inject drugs worldwide. including harm-reduction programmes assisting people who use drugs. an estimated 3 million [500 000–5. Although both men and women who inject drugs experience a significant burden of HIV disease.375:1014-28. 2010 Global estimates of the availability of sterile injecting equipment per person who uses drugs per year. 2010. Wiessing L.5 Availability of sterile injecting equipment. et al. the median coverage of HIV prevention services was 32%. Ali H. The Lancet 2010. however.8 million condoms provided through international and nongovernmental funding sources in 2009. >0-20 needles-syringes per IDU per year 20-50 needles-syringes per IDU per year 50-100 needles-syringes per IDU per year >100 needles-syringes per IDU per year NSP present but coverage data not available NSP absent No reports of IDU No data available with 25. Global distribution of female condoms. condom distribution increased by 10 million.Figure 3. still lags far behind that of male condoms. Access to HIV prevention services. Hickman M.9 million [11. HIV prevention efforts focused on people who inject drugs An estimated 15. but not at the required scale.7 million condoms financed through these sources in 2006. infection with other 72 Chapter 3: HIV prevention | 2010 GLOBAL REPORT .

Among countries reporting to UNGASS in 2010. Figure 3. Suriname. Myanmar. Making injecting safer for people who use drugs by providing sterile equipment is relatively easy and inexpensive and can significantly reduce levels of HIV transmission. (12). and more than 200 high. especially not having unprotected penetrative sex.6). In Central and South America. all three reporting countries had levels below 80%. where the HIV epidemics are primarily driven by injecting drug use. According to WHO. Ukraine and Uzbekistan) reported in 2009 that more than 80% of people who inject drugs used sterile injecting equipment at last injection. Guyana. In Oceania. the Russian Federation. In addition to the survey data on the extent to which sterile needles were used at the most recent injection. 10 countries report exceeding 80% usage of sterile equipment and nine below. Data from 78 countries show that condom use by men who have sex with men was less than 50% in 24 countries. 100–200 medium. five of nine countries (Belarus. Cambodia. UNODC and UNAIDS target-setting guidelines (16). In Eastern Europe and Central Asia. Australia reports more than 80% using a sterile needle at last injection (other countries not reporting). the Republic of Moldova. In North America and Europe. 60% to 80% in 28 countries and more than 80% in only seven countries: Andorra.7 gives the median and range of the proportion of reported condom use at last sex by men who have sex with men by geographical region. is effective in protecting individuals and the larger communities of men who have sex with men from HIV and other sexually transmitted infections.1 Countries in which HIV infections among people who inject drugs represent 20% or more of the total number of people living with HIV Source: Mathers et al. In the other regions. Panama.bloodborne viruses and also potentially life-threatening conditions such as tuberculosis. between 50% to 60% in 16 countries. Safer sex behaviour. Azerbaijan Canada China Estonia Georgia Indonesia Iran (Islamic Republic of) Italy Kazakhstan Kyrgyzstan Malaysia New Zealand Pakistan Russian Federation Spain Tajikistan Ukraine United States of America Uzbekistan 3 Chapter 3: HIV prevention | 2010 GLOBAL REPORT 73 . A man knowing his HIV-positive status can protect his health by receiving appropriate treatment early and also be encouraged through Table 3. Studies indicate that women who inject drugs are more likely to face violence and greater levels of stigma and are more likely to die earlier (13). Eight of 12 countries reporting in South and South-East Asia report rates of sterile needle usage at last injection exceeding 80%. Figure 3. the availability of fewer than 100 syringes per person who injects drugs per year is considered low. Argentina reports more than 80% using a sterile needle at last injection (most other countries do not report on this indicator).5 illustrates that the number of sterile needles made available per estimated person who injects drugs is very low. a global median of 42% of men who have sex with men reported receiving an HIV test and the result in the past 12 months. and Uzbekistan. women who inject drugs face even greater risks. In the Middle East and North Africa. Half of the 50 countries that report data about the use of safe injection equipment estimate that 80% or more of the people who inject drugs used a sterile needle at last injection. Men who have sex with men—a key population still needing support Access to HIV prevention programmes and services for men who have sex with men has increased somewhat in the past two years but remains inadequate overall (Figure 3. a large majority of countries did not report on this indicator.

El Salvador. Some regions report testing rates considerably above the median. only in two areas (sexually transmitted infection testing and circumcision) did a majority of respondents (only 51% in both cases) report that the services were easily accessible. stigma. condom programming and sexually transmitted infection and HIV testing services) explicitly addresses individuals with great vulnerability to HIV infection in six high-prevalence states: sex workers. In India. showed that. people who inject drugs. 17 countries report rates of less than 60%. Recent results from an Avahan study of sex workers in Karnataka. A man who tests HIV-negative can be supported to continue to avoid being infected. men who have sex with men. Guyana.counselling and support to lessen the risk of transmitting the virus to his future partners. HIV prevalence trends among recent initiates into sex work provide insight into the trajectory of the HIV epidemic and are a proxy measure of HIV incidence. Of the 17 services assessed (including sexually transmitted infection and HIV testing and counselling. 80 % A recent survey by the Global Forum on MSM and HIV assessed the availability of and access to testing and prevention services for sexually transmitted infections and HIV among men who have sex with men in eight regions (18). Guyana. has demonstrated significant results among sex workers (19). the HIV prevalence in this population declined from 20% to 16% and condom use at last client sex increased from 66% to 84% (20). Respondents also noted the many barriers to their access to services. 74 Chapter 3: HIV prevention | 2010 GLOBAL REPORT . Commercial and transactional sex HIV prevention programmes among sex workers have achieved major progress both in increasing condom use in sex work and in reducing associated HIV infections. In countries with concentrated epidemics. criminalization of same-sex acts. empowerment. policy barriers. HIV prevalence also declined among sex workers who have been working for more than two years. and Paraguay reported that more than 80% of men who have sex with men have had an HIV test and know the results in the past 12 months. Considerable room remains. and men at higher risk along key trucking routes. El Salvador. data indicate that 90% or more of sex workers report condom use with their last client. including homophobia.8 illustrates the case of sex workers in Cambodia: HIV prevalence among those engaged in sex work for less than one year declined steadily from 2002 to 2006. free condoms. but prevalence remains considerably higher than for those more recently engaged in sex work. in south India. such as in Central and South America. Figure 3. and mass-media campaigns to reduce HIV and to reduce homophobia). A further 17 countries report condom use by sex workers at 80% to 90%. however. mental health services. from the time the programme was first implemented. the Avahan programme. In 27 of 87 countries. underway since 2003. to improve the availability and use of condoms among sex workers and their clients. HIV treatment. and Paraguay reported that more than 80% of men who have sex with men have had an HIV test and know the results in the past 12 months. circumcision. tracking a decline in estimated incidence. where Argentina. The combined prevention approach of Avahan (community outreach. Argentina. In contrast. and insensitivity or lack of awareness among health care providers.

2008 and 2010.6 HIV prevention programmes for selected populations Median coverage of HIV prevention programmes for selected population groups.7 Condom use by men who have sex with men Percentage (median and range) of men who have sex with men who used a condom at last sex by geographical region. Source: Country Progress Reports 2010 Median Medians were not calculated where number of countries was 5 or less MEDIAN % % 10 20 30 40 50 60 70 80 90 100 Caribbean (n=6) East Asia (n=3) EECA (n=7) Central and South America (n=13) MENA (n=3) North America (n=2) Oceania (n=3) West and Central Europe (n=20) South and South-East Asia (n=12) sub-Saharan Africa (n=9) Total (n=78) Chapter 3: HIV prevention | 2010 GLOBAL REPORT 75 .Figure 3. 43 countries in 2010) IDU (19 countries in 2008. 29 countries in 2010) 2008 2010 Figure 3. Source: Country Progress Reports 2010. 54 countries in 2010) MSM (37 countries in 2008. 2010. 3 % 10 20 30 40 50 60 Sex workers (60 countries in 2008.

a key driver of the epidemic in several countries. has found that structural activities can be feasible and cost-effective. and can contribute to more sustainable HIV prevention when integrated into a package of prevention activities. Another approach is the IMAGE Programme in South Africa. often reinforced by intergenerational sex. and gangs (26). Age-disparate partnerships. including sex workers. The programme has scaled up to reach more than 12 000 women in South Africa. One example of social change that could directly reduce the number of new HIV infections is reducing the violence faced by people who inject drugs. and self-reported sexual activity declined notably among beneficiaries of both types of cash transfers. Cash transfers are emerging as a potential intervention to mitigate certain social or economic drivers of HIV vulnerability. in which young women are in relationships with men at least five years older. Similarly. as they may engage in transactional sex to procure food for themselves and their children. Building on this association. further weakens women’s negotiating power. Pathfinder International. whose visibility makes them vulnerable to arrest and to violence from police. Early marriage. Malawi. Moving beyond the availability of sterile needles and syringes and treatment programmes to reduce HIV for people who inject drugs—changes in the social. The positive effects of both school participation and HIV programmes in schools on HIV-related risks have been well established (22). structural approaches that strengthen solidarity and collective action `can play a critical role in enhancing resilience to HIV among marginalized groups. and its local implementing nongovernmental organization partner in Kolhapur are implementing a structural intervention that provides supported peer-led outreach. a study in Uganda that investigated the relationship between food insecurity and transactional sex showed the negative effects of food insecurity on control over condom use and the risk of staying in abusive relationships (28). In Zomba. These associations remained even when controlling for other markers of socioeconomic status. both conditional and unconditional cash transfers for adolescent girls resulted in increased school attendance among beneficiaries (24). crisis response services and community mobilization to street-based sex workers. and to engage in unprotected sex with clients (29). pregnancy. for example.9). In addition. recent modelling has estimated the number of HIV infections that could be averted if police violence against people who inject drugs was eliminated (Figure 3. Gender inequality. economic and policy environment can also have a marked effect. particularly sexual risk-taking among women. Avahan. According to the evidence. observed changes in self-reported sexual `account for less than half of the programme’s effects on HIV. conducted in Botswana and Swaziland. 70% increased odds of engaging in unprotected sex and reporting lack of sexual control and 50% increased odds of intergenerational sex (27). Food insecurity is widespread globally (more than 1 billion people are undernourished) and forces people to use various types of coping behaviour. an association has been observed between police violence against people who inject drugs and specific types of higher-risk behaviour such as using preloaded syringes. A study from Nigeria reported that 35% of female sex workers said that poverty and lack of means to obtain food caused them to join the sex trade. some of which increase the likelihood of engaging in unprotected sex. Several recent studies provide evidence of the effectiveness of cash transfers in educational retention and HIV prevention. the India AIDS Initiative funded by the Bill & Melinda Gates Foundation (19). a key partner of Avahan. clients. The programme was evaluated as a randomized trial and found positive effects on household economic well-being and women’s empowerment. with the rest due to a change in the risk profile of the girls’ sexual partners (25). For example.Structural approaches to HIV prevention Tackling the social and economic drivers of HIV risk and vulnerability can significantly influence the epidemic if these approaches are implemented systematically. showed that food insecurity was associated with inconsistent condom use with a “non-primary” partner: women reporting food insufficiency in the previous 12 months had 80% increased odds of selling sex for money or resources. These results suggest that structural interventions such as cash transfers might be a promising tactic for overcoming age-disparate sex. and reduced HIV risk behaviour among young women participants. which combines microfinance for women with gender training and community mobilization. Schooling for girls has the potential to reduce HIV risk. 76 Chapter 3: HIV prevention | 2010 GLOBAL REPORT . A study. are also associated with elevated risk of HIV infection (23). a 50% reduction in intimate partner violence.

C Chhea. 1998–2007. 3 100 90 80 70 PERCENT 60 50 40 30 20 10 0 ‘98 ‘99 ‘00 ‘01 ‘02 YEAR ‘03 ‘04 ‘05 ‘06 ‘07 Percent of sex workers reporting condom use at last sex HIV prevalence among women working less than 2 years at brothel HIV prevalence among women working less than 1 year at brothel Figure 3. Source: M Mahy. O Varetska. Journal of HIV/AIDS Surveillance and Epidemiology.000 Odessa Elimination of police beatings Makeevka Kiev Chapter 3: HIV prevention | 2010 GLOBAL REPORT 77 . R Lyerla (2010).8 Condom use and HIV prevalence among sex workers in Cambodia Percentage of sex workers using condoms and HIV prevalence among brothel-based sex workers in Cambodia by length of time involved in sex work.9 Averting HIV infection by eliminating police beatings of people who inject drugs. Ukraine HIV infections that could be averted by eliminating police beatings of people who inject drugs in three cities in Ukraine Source: Strathdee et al 2010 HIV INFECTIONS AVERTED BY STRUCTURAL CHANGES 0 200 400 600 800 1. A proxy measure for HIV incidence among populations at increased risk to HIV Vol 2(1):8.Figure 3. T Saliuk.

2 Countries with the largest number of pregnant women living with HIV in 2009: Angola. from 500 000 [320 000–680 000] in 2001 to 370 000 [230 000–510 000] children infected with HIV in 2009. South Africa and Swaziland have achieved more than 80% coverage of antiretroviral prophylaxis to prevent mother-to-child transmission. Rwanda. Several countries have advanced efforts to prevent the mother-to-child transmission of HIV. more than one quarter of women living with HIV do not desire their current pregnancy or would like to delay their next pregnancy by two years. Chad. on the path towards the UNAIDS goal of virtually eliminating the mother-to-child transmission of HIV by 2015. The proportion of pregnant women in low. United Republic of Tanzania. Significant strides in preventing mother-to-child transmission Preventing mother-to-child transmission of HIV has been a fundamental advance in the AIDS response for the past decade. Infection rates among children born to mothers living with HIV have dropped significantly in recent years.10.and middle-income countries received antiretroviral medication to prevent the mother-to-child transmission of HIV in 2009. In West and Central Africa. newborn and child health care would produce better outcomes for babies and their mothers.12). Monotherapies are also prone to building antiretroviral resistance in the virus. In East and Southern Africa. Ghana. Lesotho. with the Democratic Republic of the Congo next. According to the 2010 WHO 78 Chapter 3: HIV prevention | 2010 GLOBAL REPORT . Cote d’Ivoire. Mozambique. Figure 3. but still a low figure. which may limit future therapeutic options when treatment is needed. contributing 7% of the gap (Figure 3. Strengthening family planning services and the delivery of maternal.and middle-income countries who received an HIV test reached 26%. 68% [53%–95%] of pregnant women living with HIV received antiretroviral medication to prevent mother-to-child transmission in 2009 (up substantially from 15% in 2005). Democratic Republic of the Congo. Namibia. Coverage for services for preventing mother-to-child transmission has lagged behind antenatal care access (Figure 3. Uganda. The gap in reaching the target of 80% coverage of antiretroviral prophylaxis for preventing mother-to-child transmission is becoming more concentrated in a handful of countries. coverage lags at 23% [16%–44%] (30). Swaziland. Worldwide. 53% [40%–79%] of women in low. Burundi. Sub-Saharan Africa as a whole achieved 54% [40%–84%] coverage. Nigeria.11). Burkina Faso. up from 21% in 2008 and 7% in 2005 (31)—progress. Kenya. Cameroon. Zambia. Zimbabwe. Nigeria alone now contributes to 32% of the gap. Namibia. India. Ethiopia. Combination regimens which include different types of antiretroviral drugs are more efficacious than monotherapies. Seven other countries in sub-Saharan Africa have coverage levels of 50% to 80%. Sudan. however. In addition. In the 25 countries with the greatest number of pregnant women living with HIV. versus 45% [37%–57%] in 2008 and 15% in 2005 (31). with 14 countries comprising more than 80% of the global gap. Botswana. South Africa. Botswana. The efficacy of antiretroviral drugs in preventing mother-to-child transmission of HIV varies with the type of regimen used and the duration over which it is given. women living with HIV continue to have a high unmet need for family planning: in some countries. Malawi.2 the percentage receiving HIV testing and counselling varied greatly—from more than 95% in South Africa and Zambia to 9% in the Democratic Republic of the Congo and 6% in Chad (31).

About 15% of all mothers received ongoing antiretroviral therapy based on eligibility criteria for treatment. all women eligible for treatment under WHO guidelines should receive an appropriate combination therapy for their own health. Figure 3. while 54% received a combination regimen to avoid mother-to-child transmission of HIV. Antiretroviral prophylaxis is also recommended during breastfeeding in settings where breastfeeding is judged to be the safest infant feeding option. In addition. Source: WHO Towards Universal Access 2010. In the 59 low. Chapter 3: HIV prevention | 2010 GLOBAL REPORT 79 .10 Gaps in antiretroviral therapy to prevent mother-to-child transmission Global gap in providing antiretroviral therapy to 80% of mothers to prevent mother-to-child transmission in lowand middle-income countries. 3 Nigeria DR Congo Uganda Ethiopia Cameroon India Malawi Chad Zimbabwe Sudan Burundi Angola Mozambique Tanzania Other 32% 7% 6% 5% 5% 6% 3% 3% 3% 3% 3% 3% 3% 2% 16% treatment guidelines it is recommended that pregnant women living with HIV and their exposed infants receive combination therapy rather than single-dose Nevirapine.11 shows the distribution of regimens given for the prevention of mother-to-child transmission in 2009 for the 25 countries with the greatest number of HIV positive pregnant women.Figure 3. Of those countries 10 have moved from using single-dose Nevirapine to providing more efficacious combination regimens.and middle-income countries that provided disaggregated data for their prevention of mother-to-child regimens around 30% of pregnant women received singledose Nevirapine.

in India. Zimbabwe and Malawi over two thirds of women who were provided with antiretrovial drugs for the prevention of mother-to-child transmission were still offered single dose Nevirapine. which emphasize increasing knowledge and behaviour change. 80 Chapter 3: HIV prevention | 2010 GLOBAL REPORT .Figure 3. New tools to expanding effective HIV prevention The goals and targets set at the United Nations General Assembly Special Session on HIV/AIDS (UNGASS) in 2001. In these countries there is an urgent need to update the regimens in line with the global standards. major advances in HIV prevention tools and methods have been integrated progressively into increasingly effective HIV prevention programmes. Since 2001. continue to be the mainstay of HIV prevention efforts. Ethiopia. the Democratic Republic of Congo.11 Distribution of prophylactic regimens for the prevention of mother-to-child transmission Source: Country Progress Reports 2010 % India Ethiopia Democratic Republic of the Congo Zimbabwe Malawi Uganda Namibia United Republic of Tanzania Mozambique Zambia Swaziland Cameroon Kenya South Africa Rwanda Ghana Sudan Nigeria Botswana Côte d'Ivoire Angola Burkina Faso Burundi Chad Lesotho 10 20 30 40 50 60 70 80 90 100 Single-dose Nevirapine only Prophylactic regimens using a combination of three antiretroviral drugs Other/Uncategorized Prophylactic regimens using a combination of two antiretroviral drugs Antiretroviral drugs for HIV-infected pregnant women eligible for treatment However.

2010 Source: WHO and UN Statistics Division PMTCT coverage. ANC coverage and number of HIV+ pregnant women (bubble size) 100 2 3 80 14 P M T C T Coverage 60 10 11 16 15 40 6 12 9 4 20 8 13 5 1 7 3 0 0 20 40 A N C Coverage (1 visit) 60 80 100 1 Angola 2 Botswana 3 Burundi 4 Cameroon 5 Chad 6 Côte d’Ivoire 7 D. Male circumcision Three clinical trials have demonstrated that adult male circumcision significantly reduces the likelihood of uninfected men acquiring HIV from an HIV-infected female sex partner. UNAIDS and WHO have recommended that male circumcision be scaled up in areas of high HIV prevalence and low rates of male circumcision.R.2). and the potential expansion of the prophylactic use of antiretroviral drugs before exposure to HIV.Figure 3. On the horizon is the potential of expanded efforts to reap the prevention benefits of access to antiretroviral therapy. A review of nine country experiences of scaling up adult male circumcision in Southern and Eastern Africa shows significant roll-out in the Nyanza province of Kenya and considerable experience gained in other areas (Table 3. Congo 8 Ethiopia 9 Ghana 10 Kenya 11 Lesotho 12 Mozambique 13 Nigeria 14 South Africa 15 Uganda 16 Zambia Among these are efforts to prevent mother-to-child transmission and to promote male circumcision.12 Preventing mother-to-child transmission Coverage of antenatal care services and services for preventing mother-to-child transmission among women living with HIV in high-prevalence countries. topical uses of antiretroviral drugs in microbicides. Chapter 3: HIV prevention | 2010 GLOBAL REPORT 81 .

Source: Meeting reports and presentations. Clearinghouse on Male Circumcision for HIV Prevention.2 Scaling up male circumcision Recent roll-out of the scaling up of adult male circumcision in nine countries. Durham. 2010. Number circumcised Time period Number of sites established BOTSWANA 6 180 April 2009 – March 2010 35 KENYA 91 300 (90 000 in Nyanza alone) 2009 – June 2010 NAMIBIA 350 September 2009 – June 2010 3 RWANDA 542 October 2009 – April 2010 9 SWAZILAND 10 000 2008 – June 2010 UGANDA 5 340 October 2008 – March 2010 UNITED REPUBLIC OF TANZANIA 4 700 September 2009 – May 2010 3 ZAMBIA 9 906 10 000 9 179 6 070 January – June 2010 2009 2007 – 2008 May 2009 – April 2010 56 ZIMBABWE 5 82 Chapter 3: HIV prevention | 2010 GLOBAL REPORT . NC.Table 3.

■ “RECENT PROMISING RESULTS OF A TENOFOVIR-BASED GEL HAVE RAISED HOPES THAT AN ADDITIONAL FEMALEINITIATED PREVENTION OPTION MAY SOON BECOME VIABLE. A concerted focus on bridging the gap between HIV treatment need and HIV treatment access will maximize the potential of antiretroviral therapy to contribute to secondary individual. determining the requirements for the approval by national drug regulatory authorities of this new indication for tenofovir. Moving forward. based on these data. ■ effective referral systems across HIV. treatment. determining the frequency of HIV testing needed to ensure the safe use of the microbicide gel. This commitment was underpinned by successful country experiences in accelerating access to HIV treatment. and in the beneficial results from reduced viral load at both the individual and population levels in reducing the onward transmission of HIV. dignity and prevention”. for example in the prevention of mother-to-child transmission. This is especially true when prevention and treatment interact in synergy. family and population-level HIV prevention benefits. Treatment is not a “magic bullet” to bring HIV epidemics to a halt (35). in post-exposure prophylaxis. Trials are also underway to examine their role in pre-exposure prophylaxis. and accelerating studies to expand knowledge of whether the product is safe and effective for women younger than 18 years of age and pregnant women. The action agenda to build stronger prevention and treatment responses in tandem requires: ■ non-stigmatizing health services. and making a safe and effective tenofovir gel available to women who want it will require: rapidly moving to additional trials to confirm results.” 3 THE HIV TREATMENT AND PREVENTION CONTINUUM When the United Nations General Assembly Special Session on HIV/AIDS was held in 2001. tuberculosis. conducting the operations research needed to determine how to deliver and sustain product supplies within combination prevention programmes. and sexually transmitted infection behaviour and social support services. care and support. but antiretroviral therapy as an element of combination HIV prevention programmes seems likely to have potentially significant secondary benefits beyond prevention programmes that do not include increased treatment access. Antiretroviral therapy is now better seen as having several crucial roles in the AIDS response. Member States unanimously supported goals towards universal access to HIV prevention. access to antiretroviral therapy in low.and middle-income countries was in its infancy. and ■ social and behavioural change communication around risk and treatment. By 2006. This landmark proofof-concept study by the Centre for the AIDS Programme of Research in South Africa (CAPRISA) (34) found that the microbicide gel studied reduced HIV infection by 39% and herpes simplex virus-2 infection by 51% and that the gel was both safe and acceptable when used once in the 12 hours before sex and once in the 12 hours after sex by women aged 18–40 years. Chapter 3: HIV prevention | 2010 GLOBAL REPORT 83 .Microbicides Recent promising results of a tenofovir-based gel have raised hopes that an additional female-initiated prevention option may soon become viable. These secondary benefits will be realized where antiretroviral therapy reaches everyone in need of treatment and where people living with HIV are able to shape HIV prevention programming in a framework of “positive health. ■ increased investment in the capacities of people living with HIV and key affected communities to organize and empower themselves.

84 Chapter 3: HIV prevention | 2010 GLOBAL REPORT .

National programmes should ensure that investments are given priority according to epidemic patterns to reach the populations most in need. ■ HIV prevention programmes must include a combination of behavioural. Behaviour change and condom promotion efforts must work in tandem. ■ Investments in HIV prevention programmes are insufficient and should increase.3 ACTION ITEMS ■ HIV prevention programmes must be scaled up rapidly to deflect the upward trajectory of the epidemic. and structural responses. sex workers and their clients. ■ New HIV prevention methods such as male circumcision must be scaled up in countries with generalized epidemics. Current advances in stopping new infections among children must be accelerated by integrating services in antenatal care settings. ■ HIV prevention programmes should reach men who have sex with men. ■ The virtual elimination of mother-to-child transmission of HIV is possible. and people who inject drugs. transgender people. Chapter 3: HIV prevention | 2010 GLOBAL REPORT 85 . and these activities should operate in synergy. ■ The results from the CAPRISA microbicide gel trial hold promise for a womaninitiated and controlled HIV prevention option. biomedical. The international community must fully support the next steps to confirm the trial results at the earliest.

SCORECARD: HIV PREVENTION Male Female No Data Available Knowledge 25 50 75 % Higher risk sex 25 50 75 % Condom use 25 50 75 % Condom use by sex workers 25 50 75 % SUB-SAHARAN AFRICA Angola Benin Botswana Burkina Faso Burundi Cameroon Cape Verde Central African Republic Chad Comoros Congo Côte d’Ivoire Democratic Republic of Congo Equatorial Guinea Eritrea Ethiopia Gabon Gambia Ghana Guinea Guinea-Bissau Kenya Lesotho Liberia Madagascar Malawi Mali Mauritania Mauritius Mozambique Namibia Niger 86 Chapter 3: HIV prevention | 2010 GLOBAL REPORT .

Knowledge 25 50 75 % Higher risk sex 25 50 75 % Condom use 25 50 75 % Condom use by sex workers 25 50 75 % SUB-SAHARAN AFRICA Continued Nigeria Rwanda 3 Sao Tome and Principe Senegal Seychelles Sierra Leone South Africa Swaziland Togo Uganda United Republic of Tanzania Zambia Zimbabwe EAST ASIA China Democratic People’s Republic of Korea Japan Mongolia Republic of Korea OCEANIA Australia Fiji Kiribati Marshall Islands Micronesia. Federated States Of Nauru New Zealand Palau Papua New Guinea Samoa Solomon Islands Tonga Chapter 3: HIV prevention | 2010 GLOBAL REPORT 87 .

SCORECARD: HIV PREVENTION Male Female No Data Available Knowledge 25 50 75 % Higher risk sex 25 50 75 % Condom use 25 50 75 % Condom use by sex workers 25 50 75 % OCEANIA Continued Tuvalu Vanuatu SOUTH AND SOUTH-EAST ASIA Afghanistan Bangladesh Bhutan Brunei Darussalam Cambodia India Indonesia Lao People’s Democratic Republic Malaysia Maldives Myanmar Nepal Pakistan Philippines Singapore Sri Lanka Thailand Timor-Leste Viet Nam EASTERN EUROPE AND CENTRAL ASIA Armenia Azerbaijan Belarus Georgia Kazakhstan Kyrgyzstan Moldova Russian Federation Tajikistan 88 Chapter 3: HIV prevention | 2010 GLOBAL REPORT .

Knowledge 25 50 75 % Higher risk sex 25 50 75 % Condom use 25 50 75 % Condom use by sex workers 25 50 75 % EASTERN Turkmenistan EUROPE AND CENTRAL ASIA Ukraine Continued Uzbekistan 3 WESTERN AND CENTRAL EUROPE Albania Andorra Austria Belgium Bosnia and Herzegovina Bulgaria Croatia Cyprus Czech Republic Denmark Estonia Finland France Germany Greece Hungary Iceland Ireland Israel Italy Latvia Liechtenstein Lithuania Luxembourg Malta Monaco Montenegro Netherlands Chapter 3: HIV prevention | 2010 GLOBAL REPORT 89 .

SCORECARD: HIV PREVENTION Male Female No Data Available Knowledge 25 50 75 % Higher risk sex 25 50 75 % Condom use 25 50 75 % Condom use by sex workers 25 50 75 % WESTERN AND CENTRAL EUROPE Continued Norway Poland Portugal Romania San Marino Serbia Slovakia Slovenia Spain Sweden Switzerland The Former Yugoslav Republic of Macedonia Turkey United Kingdom of Great Britain and Northern Ireland NORTH AMERICA Canada Mexico United States of America MIDDLE EAST AND NORTH AFRICA Algeria Bahrain Djibouti Egypt Iran. Islamic Republic Of Iraq Jordan Kuwait Lebanon Libyan Arab Jamahiriya Morocco Oman Qatar 90 Chapter 3: HIV prevention | 2010 GLOBAL REPORT .

Knowledge 25 50 75 % Higher risk sex 25 50 75 % Condom use 25 50 75 % Condom use by sex workers 25 50 75 % MIDDLE EAST AND NORTH AFRICA Continued Saudi Arabia Somalia Sudan 3 Syrian Arab Republic Tunisia United Arab Emirates Yemen CARIBBEAN Antigua and Barbuda Bahamas Barbados Cuba Dominica Dominican Republic Grenada Haiti Jamaica Saint Kitts and Nevis Saint Lucia Saint Vincent and the Grenadines Trinidad and Tobago CENTRAL AND SOUTH AMERICA Argentina Belize Bolivia Brazil Chile Colombia Costa Rica Ecuador El Salvador Guatemala Chapter 3: HIV prevention | 2010 GLOBAL REPORT 91 .

SCORECARD: HIV PREVENTION Male Female No Data Available Knowledge 25 50 75 % Higher risk sex 25 50 75 % Condom use 25 50 75 % Condom use by sex workers 25 50 75 % CENTRAL AND SOUTH AMERICA Continued Guyana Honduras Nicaragua Panama Paraguay Peru Suriname Uruguay Venezuela 92 Chapter 3: HIV prevention | 2010 GLOBAL REPORT .

3 Chapter 3: HIV prevention | 2010 GLOBAL REPORT 93 .

CHAPTER 4 94 Chapter 4: HIV treatment | 2010 GLOBAL REPORT .

HIV TREATMENT 4 KEY FINDINGS ■ An additional 1. Progress in scaling up TB services for people living with HIV is also very slow. ■ About 50% of pregnant women testing HIV positive were assessed for their eligibility to receive antiretroviral therapy for their own health.4 million lifeyears have been gained by providing antiretroviral therapy since 1996.2 million people received antiretroviral therapy in 2009. the percentage of people with TB who received an HIV test in 2009 remained low. 36% (about 5. a 30% increase over 2008. ■ Children and marginalized populations (such as people who inject drugs) are less likely to receive antiretroviral therapy than the population at large. ■ While steady progress is being made in scaling up access to HIV services for people with tuberculosis (TB). ■ Children orphaned by AIDS were nearly as likely to attend school as other children.and middleincome countries to 5.and middle-income countries were receiving antiretroviral therapy. bringing the total number of people receiving treatment in low. Chapter 4: HIV treatment | 2010 GLOBAL REPORT 95 . About 14.2 million) of the 15 million people in need in low. ■ At the end of 2009. ■ The availability of palliative and home-based care services for people living with HIV remains uneven. at 26%. ■ Fewer people are dying from AIDS-related causes.2 million.

Antiretroviral therapy coverage for children is lower than that for adults. an estimated 5. In sub-Saharan Africa. and 19% [15%-21%] in Eastern Europe and Central Asia were accessing such treatment. Similarly 42% [35%–47%] in Central and South America. especially given the considerable challenges that accompanied the flattening of global funding for HIV programmes in lowand middle-income countries. and the average number of people receiving antiretroviral therapy per health facility rose from 260 in 2008 to 274 in 2009. These new criteria increased the total number of people medically eligible for antiretroviral therapy by roughly 50%—from 10 million to 15 million in 2009. progress toward universal access goals remained mixed.2 million people. 96 Chapter 4: HIV treatment | 2010 GLOBAL REPORT . care and support services were a significant achievement in 2009. As of December 2009. over the number receiving such treatment 12 months earlier. at a CD4 count of <350 cells/mm3. was the rate of increase in access in 2009 significantly lower. nearly 37% [34%–40%] of people eligible for treatment were able to access life-saving medicines in 2009. Only in Central and South America (6%). The number of health facilities delivering antiretroviral therapy increased by 36% in 2009. limited data show low coverage for key populations at higher risk. WHO issued revised treatment guidelines (2) recommending earlier initiation of antiretroviral therapy. 48% [42%–55%] in the Caribbean. according to data submitted by 99 countries. Coverage needs to be more equitable. a low percentage of pregnant women were assessed for their eligibility and received antiretroviral therapy for their own health.2 million people in low. However. Asia (29%) and the Caribbean (30%). More people are receiving antiretroviral therapy in all regions of the world than at any previous time in the epidemic. and support than in others. care.and middleincome countries were receiving antiretroviral therapy (1). where antiretroviral therapy coverage was already high. sub-Saharan Africa (33%).CHAPTER 4 | HIV TREATMENT » More people received antiretroviral therapy in all regions in 2009 Advances toward universal access to treatment. This represented an increase of 1. 51% [40%–60%] in Oceania. or 30%. with substantially greater gains in some settings and on certain aspects of treatment. In 2010. The increase in the number of people receiving antiretroviral therapy in 2009 was virtually even across Eastern Europe (34%).

Rwanda achieved 88% coverage among adults. Cambodia. Indonesia and Ukraine reported less than 20% of eligible adults were receiving antiretroviral therapy (Table 4. South Africa. Eleven countries (Cameroon. Viet Nam and Zimbabwe) had coverage of less than 40%. from 275 000 to 354 000. Botswana 83%. Ghana. KEY ELEMENTS OF WHO’S 2010 REVISION OF ANTIRETROVIRAL TREATMENT THERAPY GUIDELINES Start antiretroviral therapy earlier: Begin antiretroviral therapy when the CD4 cell count is less than 350 cells/mm3. and Namibia 76%. Guyana. Ukraine. Chapter 4: HIV treatment | 2010 GLOBAL REPORT 97 .Half or more of all adults eligible for treatment (CD4 <350 cells/mm3) were receiving antiretroviral therapy in 29 of the 109 low. Croatia. India.1).and middle-income countries with the largest number of people living with HIV. Indonesia. Antiretroviral therapy coverage for children is lower than that for adults The number of children younger than 15 years receiving antiretroviral therapy increased by about 80 000 (or 29%) in 2009. However. Improve management of coinfections between HIV and TB or hepatitis B: Start antiretroviral therapy in all people living with HIV who have active TB and chronic active hepatitis B disease irrespective of CD4 cell count. Romania and Rwanda —achieved antiretroviral therapy coverage of 80% or more. Mozambique.and middle-income countries for which data are available by December 2009. United Republic of Tanzania. Côte d’Ivoire. Eight countries— Botswana. 37 4 % People in sub-Saharan Africa eligible for treatment who were able to access life-saving medicines in 2009. Cuba. Namibia. Use less toxic and more patient-friendly options: Reduce the risk of adverse events and improve adherence by using less toxic drugs and fixed-dose antiretroviral therapy combinations. Of the 19 of the 25 low. Promote strategic use of laboratory monitoring: Use laboratory monitoring such as CD4 and viral load counts to improve the efficiency and quality of HIV treatment and care.

Table 4.e 12% 8% 24% 14% 25% 23% 23% 40% 34% 37% 21% 50% 50% 48% 32% 23% 14% 46% 45% 44% 29% 21% 16% 34% 72% 75% 72% 51% 35% 24% 64% 65% 62% 43% 30% 27% 32% 23% 29% 14% 10% 22% 17% 21% 10% 7% 17% 54% 2% 41% 1% 73% 36% 35% 56% 49% Thailand Uganda Ukraine United Republic of Tanzania Viet Nam Zambia Zimbabwe 36% 30% 17% 18% 61% 43% 9% 32% 33% 68% 34% 49% 38% 8% 29% 25% 62% 32% 77% 48% 10% 35% 44% 76% 37% 75% 62% 15% 49% 44% >95% 52% 61% 54% 13% 43% 35% 84% 47% 95% 72% 17% 55% 55% >95% 57% 12% 69% 11% 54% 26% 23% a Point estimates published for countries with generalized epidemics only. The ranges in coverage estimates are based on plausibility bounds in the denominator: that is. Children d Adult Coverage 2010 Guidelines (CD4 350) C Low High Point Estimate Low High Adult Coverage 2006 Guidelines (CD4 200) C Point Estimate Low High Point Estimate a Botswana Brazil b 90% 76% 65% >95% >95% 20% 74% 30% 23% 38% 24% 59% 48% 59% 39% 51% 26% 19% 60% 94% 4% >95% 33% >95% 34% >95% 65% 50% 83% 77% 50% >95% 89% 34% 38% 32% 20% 65% 29% 27% 30% 55% 54% 54% 35% 25% 23% 37% >95% >95% >95% 65% >95% 54% 67% 49% 32% 94% 46% 45% 58% 81% 86% 81% 59% 41% 42% 63% Cameroon b China Côte d’Ivoire b 11% 8% 21% 30% 27% 19% 46% 40% 31% b 15% 10% 9% 14% 29% 26% 15% 52% 44% 38% 22% 72% Democratic Republic of the Congo Ethiopia b Ghana India b Indonesia Kenya Lesotho Malawi Mozambique Nigeria Russian Federation b South Africa Sudan b. c The coverage estimates are based on the estimated unrounded numbers of adults receiving antiretroviral therapy and the estimated unrounded need for antiretroviral therapy (based on UNAIDS/WHO methods). Estimates of the number of people needing antiretroviral therapy are currently being reviewed and will be adjusted.1 Treatment coverage for adults and children. e Data for antiretroviral therapy coverage for adults in Sudan are not available for 2009. The estimates are standardized for comparability according to UNAIDS/WHO methods. 2009 based on 2006 and 2010 WHO guidelines. based on ongoing data collection and analysis. as appropriate. The ranges in coverage estimates are based on plausibility bounds in the denominator: that is. low and high estimates of need. low and high estimates of need. 2009 (2006 and 2010 WHO guidelines) Coverage of antiretroviral therapy among adults and children in 25 countries with the most people living with HIV. Source: Country Progress Reports 2010 and UNAIDS estimates. d The coverage estimates are based on the estimated unrounded numbers of children receiving antiretroviral therapy and the estimated unrounded need for antiretroviral therapy (based on UNAIDS/WHO methods). b 98 Chapter 4: HIV treatment | 2010 GLOBAL REPORT .

with particularly large differences in countries such as Cameroon (30% adults versus 11% children). Access to antiretroviral therapy eludes marginalized populations Few data are available about access to antiretroviral therapy by sex workers. at just 26%. only four of the 12 countries collect such data. the total number of women enrolled in treatment roughly doubled. from more than 18 000 to more than 37 000. Most countries do not collect such data. two of the 12 countries (South Africa and Botswana) report greater antiretroviral therapy coverage for children than for adults. according to country reports to UNAIDS (6). Only 15% of pregnant women living with HIV whose HIV status is detected while accessing maternal and child health services were also provided antiretroviral therapy for their own health at the same time. Central and South America and other regions report that negative attitudes on the part of health care workers often deter people at high risk of HIV infection from seeking treatment services (4). only Botswana reported antiretroviral therapy coverage of children of greater than 80% (Table 4. Very few pregnant women living with HIV receive antiretroviral therapy for their own health Access to services for preventing mother-child-transmission of HIV increased between 2008 and 2009. . Many prison systems limit access to antiretroviral therapy.1). Mozambique (32% versus 12%) and Uganda (43% versus 18%). in Eastern Europe and Central Asia. An estimated 90% of the world’s children living with HIV reside in sub-Saharan Africa. compared with 37% coverage of adults). a major effort to provide antiretroviral therapy in maternal and child health settings increased the number of women beginning therapy from 259 in 2007 to 1844 in 2009. Further obstacles to antiretroviral therapy access include laws in a number of countries with sizeable populations of people born outside national borders that limit antiretroviral therapy access to citizens (5). By contrast. but still few pregnant women living with HIV are screened for their own health. Among the 25 countries with the greatest number of people living with HIV. In Swaziland. Chapter 4: HIV treatment | 2010 GLOBAL REPORT 99 15 4 % 15% of pregnant women living with HIV whose HIV status is detected while accessing maternal and child health services were also provided antiretroviral therapy for their own health at the same time. In the 12 high-prevalence countries that reported on antiretroviral therapy access for pregnant women in both 2007 and 2009. Antiretroviral therapy coverage of children in the region is slightly below the global average.children continued to have less access to antiretroviral therapy than adults (28% coverage of children. Many countries in Asia. A number of countries report sharply lower antiretroviral therapy coverage for children than for adults. In six countries. The proportion of pregnant women who tested positive for HIV and were assessed for their eligibility to receive antiretroviral therapy for their own health increased from 34% to 51%. men who have sex with men and people who inject drugs. Adult coverage is higher in 12 of the 14 highburden countries for which coverage estimates for both adults and children are available. antiretroviral therapy coverage of children is less than half that of adults. For example.

the 48-month retention rate is between 60% and 70%. and Viet Nam all report retaining at least 80% of people in treatment for at least one year. fragmented rather than integrated and holistic services delivery. 14 countries treat 5% or fewer of all such individuals (7). Brazil and Cameroon report that 90% or more remain on treatment 12 months after initiation. care and support In many countries. One likely reason for lower treatment retention rates is initiating treatment at a late stage of HIV illness and the premature death of the treatment recipient. report survival rather than retention. 26 REPORT THAT AT LEAST 95% OF PEOPLE ARE STILL RECEIVING TREATMENT ONE YEAR AFTER INITIATING ANTIRETROVIRAL THERAPY. or erroneously record transfers to different treatment sites as loss to follow-up. centralized programmes. whereas in Botswana it exceeds 80%.” .1). Lesotho. Of the 25 countries with the highest number of people living with HIV. Of the countries for which data are available. Thailand.Of the 21 countries that have data on antiretroviral therapy coverage for people living with HIV who inject drugs. Ukraine. Long-term retention in treatment is critical for health outcomes. however. Ghana. Better understanding of the factors that depress longer-term retention is needed. and weak community treatment literacy. data suggest that 70% of the people initiating treatment are still recorded as “in treatment” after 24 months. including health worker shortages. which must care for two of three people living with HIV but have only 3% of the world’s health care providers (8). Retention rates may not always be directly comparable. dropping to about 55% after 48 months (Figure 4. Sudan reports a 12-month retention rate of 56% and Chad only 47%. In Malawi. as some countries may report data from tertiary hospitals only. Possible factors limiting treatment retention include constraints within health and community systems such as overly centralized treatment programmes that limit geographical accessibility. through ongoing efforts to initiate HIV treatment earlier. but many people are lost to followup during the first year. Botswana. This is especially true for health systems in sub-Saharan Africa. 26 report that at least 95% of people are still receiving treatment one year after initiating antiretroviral therapy. and new strategies are needed to increase retention in antiretroviral therapy programmes. Loss to follow-up in antiretroviral therapy programmes tends to increase over time. Kenya. at least in part. In only nine countries does treatment reach more than 10% of people living with HIV who inject drugs. In Burundi and the Central African Republic. which has rapidly scaled up antiretroviral therapy in recent years. health worker shortages. Challenges associated with health-system capacity are not limited to 100 Chapter 4: HIV treatment | 2010 GLOBAL REPORT “NEW DATA PROVIDE STRONG EVIDENCE THAT HIGH ANTIRETROVIRAL THERAPY RETENTION RATES ARE ACHIEVABLE. OF THE COUNTRIES FOR WHICH DATA ARE AVAILABLE. Health systems challenged by and benefit from HIV treatment. India. Evidence shows that retention rates need to be improved. overburdened health systems are struggling valiantly to address the challenges posed by HIV. Uganda. and weak procurement and supply systems. Treatment retention is possible and can be achieved New data provide strong evidence that high antiretroviral therapy retention rates are achievable. drug stock-outs.

toxicity. other forms of task-shifting in clinical settings. Current roll-out models are hospital. 0–48 months. A randomized controlled trial that has assessed the effectiveness of task-shifting for antiretroviral therapy delivery in urban clinics of Johannesburg and Cape Town found that nurse-managed antiretroviral therapy was not inferior to doctor-managed antiretroviral therapy: both treatment arms had similar outcomes of viral suppression. adherence. in Rwanda. or delegating tasks performed by physicians to staff with lower-level qualifications. nurses accurately determined eligibility for antiretroviral therapy for more than Chapter 4: HIV treatment | 2010 GLOBAL REPORT 101 . Countries in Asia. 100 Botswana Burundi % KNOWN TO BE ON ART 90 Central African Republic 80 4 Malawi Uganda 70 60 50 0 12 24 MONTHS 36 48 sub-Saharan Africa. Similarly. is an effective strategy for addressing shortages of human resources for health in HIV treatment and care.and physician-intensive.1 Adult retention in antiretroviral therapy in selected countries. and institutional twinning arrangements between local clinics and institutions in high-income countries. however. In response. including lay and community workers.Figure 4. A recent review (9) has shown that taskshifting. These include increasing the use of civil society partners to manage health care facilities. Shortages of human resources for health have severely hampered the rolling out of antiretroviral therapy in sub-Saharan Africa. and death (10). many countries have implemented innovative strategies to expand the capacity of health systems to address HIV and other challenges. 2009 Source: WHO Towards Universal Access 2010. the Middle East and North Africa report that an inadequate supply of health care workers skilled in delivering antiretroviral therapy impedes treatment scale-up. South Africa is using a nurse-driven model to decentralize antiretroviral therapy provision and expedite treatment scale-up.

MAKING THE MOST OF THE TRIPS AGREEMENT The World Trade Organization Declaration on the TRIPS Agreement and Public Health (the Doha Declaration) emphasizes that the TRIPS Agreement does not and should not prevent states from taking measures to protect public health and reaffirms their right to use. The Medicines Patent Pool aims to increase access to treatment by promoting price reductions of existing antiretroviral drugs. the provisions of the TRIPS Agreement that provide flexibility for public health purposes. However. some middle. Thailand and.INNOVATION AND FLEXIBILITY FOR INCREASING ACCESS TO ANTIRETROVIRAL MEDICINES THE MEDICINES PATENT POOL The Medicines Patent Pool was set up in July 2008 by the global health financing mechanism UNITAID. in recent years fewer countries have taken advantage of such opportunities. or adherence rates (12). to the full. a study (14) examined concordance between the decisions of doctors and nurses to initiate antiretroviral therapy and found 95% agreement on initiating therapy. people seen by mid-level health workers (with 2. including that national authorities are free to determine the grounds on which compulsory licences are granted to allow the purchase and use of otherwise protected products.5 years of training) were almost 30% more likely to have CD4 counts done six months after antiretroviral therapy was initiated than those seen by doctors and were 44% less likely to be lost to follow-up. The Doha Declaration also clarifies some of the flexibility contained in the TRIPS Agreement. CD4 counts done at 12 months. 99% of the people examined (11).and low-income countries are entering bilateral and regional trade agreements with high-income countries that impose intellectual property protection that is stricter than necessary under the TRIPS Agreement and that may limit their rights to promote access to affordable HIV medicines and other pharmaceutical products in their countries. stimulating the production of newer first. in particular to promote access to medicines for all.and low-income countries such as Brazil. There were no significant differences in mortality. A study from Malawi found that the training of lay workers as pharmacy assistants reduced prescribing errors by 25% by unburdening the system (13). The United States National Institutes of Health recently announced that they will be sharing patents with the Medicines Patent Pool. This is the first time that a patent holder has shared intellectual property on antiretroviral medicines with the newly established Medicines Patent Pool. Ecuador have used the flexibility available to them under the TRIPS Agreement and Doha Declaration to make HIV medicines more affordable. 102 Chapter 4: HIV treatment | 2010 GLOBAL REPORT .and second-line drugs and increasing the number of generic producers of these medicines. In Mozambique. correcting the misconception that some form of emergency is required for issuing a compulsory licence. In the Democratic Republic of the Congo. more recently. Although a number of middle. to increase access to newer antiretroviral medicines by creating a pool of patents and intelligence on antiretroviral drug production.

everyone with TB who is living with HIV should receive antiretroviral therapy. a treatment that can greatly reduce a person’s risk of developing TB disease. improved laboratory capacity and strengthened systems for commodity procurement and supply management—are enhancing the availability and quality of care services for everyone. In addition. integrating new members into health care teams. only 79 000 (0. Under newly released WHO guidelines. 75% of those who were positive received co-trimoxazole and 37% received antiretroviral therapy. The main challenges to implementation include adequate and sustainable training. In an effort to avoid stock-outs. Systemic deficiencies in commodity procurement and supply management undermine treatment efforts in many countries. international organizations. Of 94 countries. Yemen and several countries in Central and South America cite drug supply interruptions as notable barriers to access to antiretroviral therapy (6). regardless of their CD4 count. 450 000 were found to be HIV positive. In sub-Saharan Africa. donors. The Islamic Republic of Iran. which unites the national government. infrastructure improvements financed by HIV funding—including refurbished clinics.3). scaling up antiretroviral therapy provision presents not only challenges but also opportunities and benefits that extend well beyond HIV.2%) people living with HIV received isoniazid preventive therapy. IN 2009. Of the people tested. Multiple research studies show that antiretroviral therapy Chapter 4: HIV treatment | 2010 GLOBAL REPORT 103 4 “TUBERCULOSIS (TB) IS A LEADING CAUSE OF DEATH AMONG PEOPLE LIVING WITH HIV. and compliance with regulations. support and pay for staff in new roles. However. In 2009. Rwanda has moved to convene a Coordinated Procurement and Distribution System.6 million people with TB (26% of the total) were tested for HIV. Widening the provision of antiretroviral therapy reduces the incidence of TB and AIDS mortality. the HIV prevalence among people with TB is as high as 80% in some countries. Across health systems. In hyper-endemic settings in which people living with HIV have accounted for the bulk of hospital patients in recent years. regardless of HIV serostatus. up from 22% in 2008 and 4% in 2003. 1. the scaling up of therapy is freeing up health system capacity to address other health priorities and is reducing absenteeism and deaths among health care workers living with HIV. Reducing the burden of HIV among people with tuberculosis Tuberculosis (TB) is a leading cause of death among people living with HIV. there were an estimated 380 000 deaths from TB among people living with HIV. 38% responding to surveys report at least one drug stock-out in 2009 (1).” .Task-shifting offers high-quality. which accounts for 78% of people with HIVrelated TB (1).2 and Figure 4. Two of the 21 countries with the highest burden of HIV-related TB provide treatment for both diseases for over half the people who need it (Figure 4. THERE WERE AN ESTIMATED 380 000 DEATHS FROM TB AMONG PEOPLE LIVING WITH HIV. Tunisia. Task-shifting should be considered for careful implementation where shortages of human resources for health threaten roll-out programmes. and other countrylevel partners in a common effort to ensure an uninterrupted supply of HIV drugs and other commodities (1). cost-effective care to more people than a physician-centred model. In 2009.

2009 Coverage services aimed to reduce the burden of TB per 1000 people living with HIV globally. WHO Towards Universal Access 2010 and WHO Global TB Control Report 2010. Source: UNAIDS estimates.2 Coverage of TB services among people living with HIV.Figure 4. Eligible for ART (441) Know HIV status (333) On ART (158) Incident TB in people living with HIV (33) Screened for TB (50) TB ART (5) IPT (2) Outer square equals 1000 HIV incident cases 104 Chapter 4: HIV treatment | 2010 GLOBAL REPORT .

Source: WHO Global TB Control Report 2010.3 Coverage of HIV services among people with TB. 2009.Figure 4. 2009 Coverage of services aimed to reduce the burden of HIV per 1000 people with TB globally. Diagnosed and registered to TB programme (656) Offered HIV test (174) HIV-positive incident TB cases (117) HIV positive TB patients on ART (15) HIV positive TB patients on co-trimoxazole (20) Outer square equals 1000 TB incident cases 4 Chapter 4: HIV treatment | 2010 GLOBAL REPORT 105 .

make treatment regimens simpler and smarter.4) In addition.0 could avert an additional 10 million deaths by 2025. 5.0 Treatment 2. and out-of-pocket expenses. Provide access to point of care diagnostics: Monitoring treatment requires complex equipment and specialized laboratory technicians. better pill” that will be less toxic. Today. it could reduce treatment costs. Combined with dose optimization and improved sequencing of first and second line regimens this will simplify treatment protocols and improve efficacy. 5 million of the 15 million people in need are accessing these life-saving medicines. (Figure 4. and facilitating a more effective continuum of care. Using a combination of efforts. thereby reducing redundancy and complexity.0 is a new approach to simplifying the way HIV treatment is currently provided and to scale up access to life-saving medicines. Such a simplified treatment platform will defray costs and increase people’s access to treatment. Optimize drug regimes: UNAIDS calls for the development of new pharmaceutical compounds that will lead to a “smarter. reduce the burden on health systems and improve the quality of life for people living with HIV and their families. Taskshifting and strengthening procurement and supply systems will be important elements of this change. 106 Chapter 4: HIV treatment | 2010 GLOBAL REPORT . Modelling suggests that.0 requires progress across five areas. Optimizing HIV treatment will also result in other health benefits.including first and second line regimens – potential gains are highest in reducing the non-drug-related costs of providing treatment. 1. the new approach could also reduce the number of people newly infected with HIV by up to 1 million annually if countries provide antiretroviral therapy to everyone who needs it. such as hospitalization. These costs are currently twice the cost of the drugs themselves. compared with current treatment approaches. following the 2010 WHO treatment guidelines. Reduce costs: Despite drastic reductions in drug pricing over the past decade. 2. adherence support and monitoring will reduce the burden on health systems. Treatment 2. monitoring treatment. including much lower rates of TB and malaria among people living with HIV. 4. Simplifying diagnostic tools in order to provide viral load and CD4 cell counts at the point of care could help to reduce the burden on health systems. longer-acting and easier to use. 3. Adapt delivery systems: Simpler diagnostics and treatment regimes will also allow for further decentralizing and integrating service delivery systems. Greater involvement of community based organizations in treatment maintenance. Strengthening the demand and uptake for testing and treatment will both improve treatment coverage and help to reduce costs for extensive outreach.TREATMENT 2. Achieving the full benefits of Treatment 2. Mobilize communities: Treatment access and adherence can be improved by involving the community in managing treatment programmes. the costs of antiretroviral therapy programmes continue to rise. While drugs must continue to be made more affordable.

4 million life-years have been gained due to the provision of antiretroviral therapy (Table 4.Figure 4. mean that this decline probably reflects a true reduction in TB infections due to antiretroviral therapy.5) indicate a decline in the number of TB cases reported nationwide that has coincided with rapid antiretroviral therapy roll-out since 2002–2003. The data also suggest initial mortality declines by 2007 in the Western Cape and KwaZulu-Natal. including case detection and reporting.6). Effect of antiretroviral therapy on mortality The expansion of antiretroviral therapy has yielded remarkable health dividends in countries in which an HIV diagnosis was regarded as a death sentence only a decade ago.4 Five pillars of Treatment 2. worldwide. Data from Botswana (Figure 4.0 Strengthen delivery systems Reduce costs can reduce the incidence of TB among people living with HIV. More than 1. about 14.2 million life-years are estimated to have been gained in Brazil between 1996 and 2009. the roll-out of antiretroviral therapy. Estimates suggest that.0 Optimize drug regimes Mobilize communities Provide point of care diagnostics 4 TREATMENT 2. Improvements in Botswana’s national TB programme over this same period.2). In South Africa’s North West Province. Emerging evidence shows associations between rolling out treatment and reduced population mortality in high-prevalence settings. Chapter 4: HIV treatment | 2010 GLOBAL REPORT 107 . The preliminary findings of a study on death registration undertaken by the Medical Research Council of South Africa provide supporting evidence of continued declines in mortality. coincides and appears to be associated with a decline in mortality in most affected age groups (Figure 4. one of the earliest and most aggressive efforts to improve access.

1997–2007.000 100 10.000 25.000 200 20.Figure 4.000 On ART 15-24 25-34 35-44 45-54 65+ 12000 35. Source: Ministry of Health. Northwest Province. South Africa Number of people ever receiving antiretroviral therapy and annual number of deaths by age group.000 50. 40.000 2000 5.000 10000 30.000 30.000 600 80.000 D E AT H S 8000 20. South Africa.000 300 40. South Africa.000 0 0 ‘90 ‘91 ‘92 ‘93 ‘94 ‘95 ‘96 ‘97 ‘98 ‘99 ‘00 ‘01 ‘02 ‘03 ‘04 ‘05 ‘06 ‘07 Figure 4. 1990–2007. Northwest Province.000 0 ‘97 ‘98 ‘99 ‘00 ‘01 ‘02 ‘03 ‘04 ‘05 ‘06 ‘07 0 108 Chapter 4: HIV treatment | 2010 GLOBAL REPORT . ART 700 TB 100. Source: Ministry of Health.000 500 70.6 Antiretroviral therapy and mortality.000 INCIDENCE/100.000 6000 15. Botswana.000 400 60.000 4000 10.000 90.5 Antiretroviral therapy and TB incidence in Botswana Reported incidence of TB and number of people receiving antiretroviral therapy in Botswana.

volunteers rather than governments provide the bulk of needed psychosocial. Because of a lack of clarity about what comprises comprehensive care and support. While 73% of governments responding agree with the statement that the majority of people in need have access to palliative care and treatment of common HIV-related infections.which has had a long-standing policy of universal therapy coverage. In Kenya. socioeconomic. inadequate political will and insufficient resourcing are significant challenges in increasing access to high-quality care and support services. Through support provided by the HIV Collaborative Fund. about 30 community-based organizations headed by people living with HIV provide treatment literacy and adherence support services. delivering. For example. whose contribution to the HIV response often goes unrecognized and unsupported—meet most care and support responsibilities. Home-based care. current national HIV policies or strategies may not address many central aspects of care and support. including 87% of the target age group 15–49 years. More often than not. At present. only 57% of civil society respondents agree that that statement is true (Figure 4. more than 970 000 people are now enrolled in antiretroviral therapy and more than 700 000 life-years have already been gained. however. Ukraine and Viet Nam. Also in Kenya. the Lao People’s Democratic Republic has made concerted efforts to mobilize people living with HIV to support antiretroviral therapy initiatives. Kenya and Nigeria have both enrolled more than 300 000 in treatment. and legal care services and support. Tuberculosis and Malaria issued its first guide on strengthening community systems in the context of Global Fund programming. including people enrolled and people waiting for treatment. socioeconomic. ongoing monitoring of more than 14 000 people by AIDS Care China indicates that individuals receiving such community-based services are more likely to adhere to treatment regimens and are better equipped to manage drug toxicity. care and support”. the Global Fund to Fight AIDS. and evaluating initiatives to improve health outcomes. the court hearing the lawsuit stayed enforcement of the legislation. home-based care. The 4% who tested positive were given a three-month supply of co-trimoxazole and were referred to treatment (18). finding that people living with HIV would suffer irreparable damage as a result of the law. Only 44% of governments (and 35% of civil society responses) report that most people in need have access to home-based care services (Figure 4. The guide aims to encourage new funding channels to increase the capacity of communities to participate in designing. Access to these comprehensive services is far from complete. and HIV prevention education. physical. Families and communities—particularly women. physical. and providing care and support to children orphaned because of AIDS. In May 2010. At the same time. the AIDS Law Project and the East African Treatment Access Movement filed a legal challenge in 2008 requesting suspension of a national law prohibiting the importation or manufacture of affordable generic antiretroviral drugs. and legal care and support. resulting in earlier diagnosis of HIV infection and increased survival rates (4).7). Most countries (162 of 171) report they have “a policy or strategy to promote comprehensive HIV treatment. monitoring. relatively few funding channels exist to build the capacity of grassroots community groups. In China.8). As Uganda notes in its 2010 country report (6). 4 Chapter 4: HIV treatment | 2010 GLOBAL REPORT 109 . and many antiretroviral therapy programmes have yet to integrate community workers into their operations. which includes the care of people who are home-bound or bedridden. These include the need for psychosocial. a mass campaign to mobilize the population for HIV testing and referral led to the testing of more than 47 000 residents in seven days. distribution of basic supplies. have a range of care and support needs in addition to antiretroviral therapy. The availability of palliative and home-based care services remains uneven People living with HIV. In South Africa. In April 2010. are essential elements of care and support programmes. Community groups mostly undertake these efforts with little financial or technical support. Later roll-out of antiretroviral therapy and/or low coverage mean that significant gains in life-years have yet to be documented in some of the concentrated epidemic countries such as Indonesia. in the Lurambi area in the west of the country. palliative care. these families and communities COMMUNITIES LEAD IN EXPANDING HIV TREATMENT Community leadership helps drive the expansion of antiretroviral therapy worldwide. leading to about 320 000 life-years gained in each country.

Congo [430 000 .300 000] 2 400 000 [2 100 000 .Table 4.3 600 000] 30 265 25% 29% 23% 26 000 India 320 074 27% 23% 233 000 Indonesia 15 442 21% 30% 14% 13 000 Kenya 336 980 50% 55% 46% 326 000 Lesotho 61 736 50% 54% 45% 48 000 Malawi 198 846 48% 54% 44% 161 000 Mozambique 170 198 32% 35% 29% 139 000 Nigeria 302 973 23% 25% 21% 316 000 110 Chapter 4: HIV treatment | 2010 GLOBAL REPORT .560 000] 34 967 20% 15% 42 000 Ethiopia 176 632 65% 52% 160 000 Ghana 260 000 [230 000 . WHO Towards Universal Access Report 2010 and WHO Global TB Control Report 2010.1 000 000] 450 000 [390 000 .670 000] 740 000 [540 000 .1 000 000] 1 400 000 [1 200 000 .510 000] 76 228 30% 34% 27% 97 000 China 12 762 38% 19% 84 000 Côte d’Ivoire 72 011 29% 32% 26% 80 000 D.810 000] 50% 89% 1 215 000 Cameroon 610 000 [540 000 . 2009 Number of people receiving antiretroviral therapy in December 2009 Antiretroviral therapy coverage (2010 WHO guidelines) Point Estimate Low High Life years among adults gained due to ART between 1996 and 2009 Botswana 320 000 [300 000 .460 000] 1 500 000 [1 300 000 .2 800 000] 310 000 [200 000 .350 000] 145 190 83% >95% 77% 271 000 Brazil [460 000 .1 600 000] 290 000 [260 000 .R. Source: UNAIDS estimates.310 000] 920 000 [830 000 .1 500 000] 3 300 000 [2 900 000 . Number of people living with HIV.2 Adult life-years gained by antiretroviral therapy Adult life years gained due to antiretroviral therapy in 25 countries with the highest number of persons living with HIV.

5 900 000] 260 000 [210 000 .1 300 000] 350 000 [300 000 .1 300 000] 75 900 23% 16% 65 000 4 South Africa 971 556 36% 37% 35% 707 000 Sudan 3 825 0% 0% 3 000 Thailand 216 118 61% 77% 49% 389 000 Uganda 200 413 43% 48% 38% 293 000 Ukraine 15 871 9% 10% 8% 16 000 United Republic of Tanzania 199 413 32% 35% 29% 150 000 Viet Nam 37 995 33% 44% 25% 27 000 Zambia 283 863 68% 76% 62% 270 000 Zimbabwe 218 589 34% 37% 32% 172 000 Chapter 4: HIV treatment | 2010 GLOBAL REPORT 111 .660 000] 1 200 000 [1 100 000 . 2009 Number of people receiving antiretroviral therapy in December 2009 Antiretroviral therapy coverage (2010 WHO guidelines) Point Estimate Low High Life years among adults gained due to ART between 1996 and 2009 Russian Federation 980 000 [840 000 .330 000] 530 000 [420 000 .1 500 000] 280 000 [220 000 .410 000] 1 400 000 [1 300 000 .Number of people living with HIV.1 100 000] 1 200 000 [1 100 000 .1 200 000] 5 600 000 [5 400 000 .350 000] 980 000 [890 000 .

and Botswana and Swaziland (12%).4 million–17. Availability of palliative care Assessment by governments as to whether most people in need have access to palliative care. Source: Country Progress Reports 2010.6 million [12. ■ Figure 4. with Nigeria alone counting 2. Among the most remarkable contributions to the global response to HIV are the systems and networks. Uganda. both formal and informal. Lesotho (13%).8 Access to home-based care Assessment by governments as to whether most people in need have access to home-based care. training and support to provide these critical responses (Figure 4. United Republic of Tanzania.1 million] in 2005 to 16. Almost 90% live in sub-Saharan Africa. Source: Country Progress Reports 2010. are still not accessing any external care and support. South Africa. Indeed. Missing 2 Not applicable 19 Not applicable 4 Missing 2 No 40 Yes 76 No 74 Yes 125 112 Chapter 4: HIV treatment | 2010 GLOBAL REPORT . Nigeria. that have been established to support children orphaned by the epidemic (Figure 4. it has further increased from 14.10). No decline in the number of children orphaned by AIDS Despite the modest decline in HIV adult prevalence worldwide and increasing access to treatment.6 million [14. however.4 million–18.9). Most households caring for children affected by HIV.5 million orphans due to HIV. and Zimbabwe—is more than 9 million. The number of orphans due to AIDS living in six countries—Kenya. More than 10% of all children aged 0–17 years have lost one or two parents due to HIV in Zimbabwe (16%). The narrowing of the difference in school attendance between orphans and nonorphans is one main achievement of this response. the total number of children aged 0–17 years who have lost their parents due to HIV has not yet declined.often struggle to access adequate resources.8 million] in 2009.7 Figure 4.

Sept 2009. -40 -20 Zambia Uganda Ethiopia WORSE BETTER % 20 40 60 Per cent of children whose births are registered Proportion of households with orphans and vulnerable children (OVC) that receive free basic external support in caring for the children Proportion of OVC that have three.Figure 4. Nigeria. Kenya. locally defined basic needs met compared to non-OVC Proportion of OVC receiving appropriate psychosocial support Proportion of OVC receiving normal meals compared to non-OVC Healthcare access for OVC compared to non-OVC School attendance of OVC compared to non-OVC Chapter 4: HIV treatment | 2010 GLOBAL REPORT 113 . 2005 to 2010. Source: Compensation for Contributions: report on interviews with volunteer caregivers in six countries.9 Types of care and support work performed by volunteers Types of care and support work for people living with HIV performed by 1366 volunteer caregivers interviewed in Cameroon. 2005 to 2010 Changes in the coverage of support services for orphans and vulnerable children in three countries with high HIV prevalence. % 20 40 60 80 100 Home visit ART monitoring Hospital visit Advocacy Training carers Caring for orphans Orphans school follow-up Finding school bursaries for orphans Distributing supplies from NGOs and government Redressing land grabbing and widow’s inheritance Working for referral organisations 4 Figure 4. Malawi. Source: World Vision. Hairu Commission and Community Agency for Social Enquiry. South Africa and Uganda.10 Trends in support for orphans and vulnerable children.

114

Chapter 4: HIV treatment | 2010 GLOBAL REPORT

ACTION ITEMS

■ HIV treatment must be scaled up to keep pace with increasing demand. ■ HIV testing and counselling must be expanded, as most people get to know
their status very late and access treatment later, which reduces the effectiveness of treatment programmes.

4

■ An integrated HIV and TB programme is essential to meet the challenges
posed by the dual epidemics.

■ Maternal and child health services must be strengthened so that all pregnant
women living with HIV can access comprehensive services for preventing maternal and child mortality and infants from becoming newly infected and for providing antiretroviral therapy for mothers.

■ Children’s access to antiretroviral therapy must improve. This will require
maternal and child health and antiretroviral therapy centres to work closely. In addition, better diagnostic tools and antiretroviral therapy formulations for children continue to be needed.

■ Current approaches to treatment have not been optimal for the 15 million
people in need. Treatment 2.0—a radically simplified treatment platform— holds promise to simplify treatment and provide all people needing it with a better pill less likely to lead to resistance, simpler diagnostics and monitoring, easier HIV testing, and more community empowerment. All stakeholders should unite to make this a reality.

■ Social support for orphans must continue, and recent success in rolling out
programmes of support such as cash transfers, food support, and education bursaries must be expanded and sustained.

■ Investments in treatment have brought results for AIDS-related mortality and
reducing the number of people newly infected with HIV. These investments must be continued and sustained over the long term.

Chapter 4: HIV treatment | 2010 GLOBAL REPORT

115

SCORECARD: HIV TREATMENT

Data not available

ART Coverage (adults)
25 50 75 %

ART Coverage (children) ART Coverage (IDU)
25 50 75 25 50 75 % %

TB-ART Coverage
25 50 75 %

ART Survival
25 50 75 %

SUB-SAHARAN AFRICA

Angola Benin Botswana Burkina Faso Burundi Cameroon Cape Verde

Central African Republic Chad Comoros Congo Côte d’Ivoire Democratic Republic of Congo Equatorial Guinea Eritrea Ethiopia Gabon Gambia Ghana Guinea Guinea-Bissau Kenya Lesotho Liberia Madagascar Malawi Mali Mauritania Mauritius Mozambique Namibia Niger Nigeria Rwanda Sao Tome and Principe Senegal Seychelles Sierra Leone South Africa Swaziland Togo Uganda United Republic of Tanzania Zambia Zimbabwe

EAST ASIA

China Japan Mongolia Republic of Korea

Democratic People’s Republic of Korea

116

Chapter 4: HIV treatment | 2010 GLOBAL REPORT

ART Coverage (adults)
25 50 75 %

ART Coverage (children) ART Coverage (IDU)
25 50 75 25 50 75 % %

TB-ART Coverage
25 50 75 %

ART Survival
25 50 75 %

OCEANIA

Australia Fiji Kiribati Marshall Islands

Micronesia, Federated States Of Nauru New Zealand Palau Papua New Guinea Samoa Solomon Islands Tonga Tuvalu Vanuatu

4

SOUTH AND SOUTH-EAST ASIA

Afghanistan Bangladesh Bhutan

Brunei Darussalam Cambodia India Indonesia Lao People’s Democratic Republic Malaysia Maldives Myanmar Nepal Pakistan Philippines Singapore Sri Lanka Thailand Timor-Leste Viet Nam

EASTERN EUROPE AND CENTRAL ASIA

Armenia Azerbaijan Belarus Georgia Kazakhstan Kyrgyzstan Moldova

Russian Federation Tajikistan Turkmenistan Ukraine Uzbekistan

Chapter 4: HIV treatment | 2010 GLOBAL REPORT

117

SCORECARD: HIV TREATMENT

Data not available

ART Coverage (adults)
25 50 75 %

ART Coverage (children) ART Coverage (IDU)
25 50 75 25 50 75 % %

TB-ART Coverage
25 50 75 %

ART Survival
25 50 75 %

WESTERN AND CENTRAL EUROPE

Albania Andorra Austria Belgium

Bosnia and Herzegovina Bulgaria Croatia Cyprus Czech Republic Denmark Estonia Finland France Germany Greece Hungary Iceland Ireland Israel Italy Latvia Liechtenstein Lithuania Luxembourg Malta Monaco Montenegro Netherlands Norway Poland Portugal Romania San Marino Serbia Slovakia Slovenia Spain Sweden Switzerland The Former Yugoslav Republic of Macedonia Turkey United Kingdom of Great Britain and Northern Ireland

NORTH AMERICA

Canada Mexico

United States of America

MIDDLE EAST AND NORTH AFRICA

Algeria Bahrain Djibouti

118

Chapter 4: HIV treatment | 2010 GLOBAL REPORT

ART Coverage (adults)
25 50 75 %

ART Coverage (children) ART Coverage (IDU)
25 50 75 25 50 75 % %

TB-ART Coverage
25 50 75 %

ART Survival
25 50 75 %

MIDDLE EAST Egypt AND NORTH Iran, Islamic Republic of Iraq AFRICA Continued Jordan
Kuwait Lebanon Libyan Arab Jamahiriya Morocco Oman Qatar Saudi Arabia Somalia Sudan Syrian Arab Republic Tunisia United Arab Emirates Yemen

4

CARIBBEAN Antigua & Barbuda
Bahamas Barbados Cuba Dominica Dominican Republic Grenada Haiti Jamaica Saint Kitts and Nevis Saint Lucia Saint Vincent and the Grenadines Trinidad and Tobago

CENTRAL AND SOUTH AMERICA

Argentina Belize Bolivia Brazil Chile Colombia Costa Rica Ecuador El Salvador Guatemala Guyana Honduras Nicaragua Panama Paraguay Peru Suriname Uruguay Venezuela

Chapter 4: HIV treatment | 2010 GLOBAL REPORT

119

CHAPTER 5

80% of all women in the world living with HIV live in this region. Fewer than half of countries report having a specific budget for HIV-related programmes addressing women and girls. care and support services require a sharper focus on women and girls. and violence against transgender people. discrimination. Laws protecting such people exist in many countries. ■ Despite evidence that beneficial behaviour change can be achieved. increase their risk of HIV infection and also for their male and female partners. but there are not enough data to show whether they are actively or widely enforced. and men who have sex with men. Chapter 5: Human rights and gender equality | 2010 GLOBAL REPORT 121 . ■ Punitive laws that affect people living with HIV. GENDER EQUALITY ■ The vulnerability of women and girls to HIV remains particularly high in subSaharan Africa. ■ Stigma. remain widespread. ■ Efforts to promote universal access to HIV prevention. few HIV programmes engage men and boys. treatment. or other people at higher risk of exposure.HUMAN RIGHTS AND GENDER EQUALITY 5 KEY FINDINGS HUMAN RIGHTS ■ Failing to address the human rights of key populations at higher risk of exposure to HIV facilitates the growth of the epidemic and enhances its socially damaging effects.

and support services in recent years but some key populations at higher risk such as sex workers. Significant advances have been made in expanding HIV prevention. A rights-based approach to HIV requires: realization and protection of the rights people need to avoid exposure to HIV. care. Further. and empowerment of key populations through encouraging social participation. In 2008–2009. know your rights/legal literacy. and programmes supporting the human rights of women and 122 Chapter 5: Human rights and gender equality | 2010 GLOBAL REPORT . reports of programmes to address stigma and discrimination have doubled in less than five years (92% in 2010 against 46% in 2006). This improvement indicates increased acknowledgement of the importance of working to eliminate stigmatization of. are often not proportional to the degree to which they are affected by the epidemic. They do not confirm whether efforts are implemented at sufficient scale and of a quality to make real and sustained improvements to the lives of people living with HIV and other members of key populations at higher risk of exposure. protections comprise legal approaches that implement international human rights commitments as well as efforts to address harmful social and gender norms that put women. enabling and protecting people living with HIV so that they can live and thrive with dignity. and children at increased risk of HIV infection and increase its impact. these reports refer only to the existence of such programmes. attention to the most marginalized within societies. promoting inclusion and raising rights-awareness. people who inject drugs. treatment. men. provision of legal services. the UNAIDS Secretariat commissioned the International HIV/AIDS Alliance to review the national AIDS planning documents of 56 countries to ascertain whether they included programmes to increase access to justice and reduce stigma and discrimination (e.CHAPTER 5 | HUMAN RIGHTS AND GENDER EQUALITY » Human rights and gender equality are critical to effective responses to HIV In the context of HIV. from nongovernmental sources that have consistently reported on the National Composite Policy Index (NCPI) since 2006. However. Resources directed towards the needs of these populations. and human rights training for service providers. and men who have sex with men. including support for them to claim and exercise their rights. people living with HIV.g. law reform. and discrimination against. 91% of governments reported that they address stigma and discrimination as cross cutting issues in their national strategies. Stigma and discrimination In 2010. remain often underserved.

Middle East and North Africa.1 Countries with laws or regulations that create obstacles Percentage of countries in which nongovernmental sources report laws or regulations that create obstacles to effective HIV prevention. 2008. and North America. East Asia. and support for population groups at higher risk and other vulnerable population groups. Oceania.Figure 5. care. Source: Country Progress Reports 2006. 2010. treatment. 5 2006 2008 2010 Overall % 20 40 60 80 100 South and Central America (19) Eastern Europe and Central Asia (11) South and South-East Asia (18) Sub-Saharan Africa (29) Western and Central Europe (8) The following regions are not displayed due to insufficient countries: Caribbean. Chapter 5: Human rights and gender equality | 2010 GLOBAL REPORT 123 .

Nepal. 36% physically harassed and 20% physically assaulted. Results from the People Living with HIV Stigma Index illustrate the need to increase efforts to reduce stigma and discrimination as part of national HIV responses. refusal of care by health care workers. Further. The Index. In Paraguay. treatment. for example. Rwanda. 17% reported having been denied health care (5). An extensive survey by the nongovernmental organization representatives of the UNAIDS Programme Coordinating Board in 2010 showed that people living with HIV and key populations at higher risk continue to experience high levels of HIV-related stigma and discrimination. 65% experienced loss of job or income and 88% were denied access to family planning services due to their HIV status (4). Other experiences in at least one third of the sample included loss of employment. 11% were physically harassed and 9% physically assaulted (3). more than 30% of people living with HIV said they had been subject to verbal abuse. Paraguay. and prisoners (2). Myanmar. currently being rolled out in more than 70 countries and with preliminary results from 10 now available (Bangladesh. 124 Chapter 5: Human rights and gender equality | 2010 GLOBAL REPORT . and blameworthy. This study (to be published in 2010) found that. people who use drugs. Malaysia. UNAIDS. Tuberculosis and Malaria examined whether human rights programmes were included in the Global Fund’s HIV portfolio for Rounds 6 and 7. guilty. United Kingdom—including a separate component for Scotland—and Zambia). 9% had been physically harassed. and the Global Fund to Fight AIDS. Several examples from the UNGASS narrative reports (7) also show that stigma and discrimination continue to hinder effective HIV responses. In China. Dominican Republic. suicidal. fewer than 50% of countries costed or budgeted such programmes. This 2009-2010 study found that one third of the key human-rights programmes identified by Country Coordinating Mechanisms as being necessary for an effective HIV response were not implemented. although about 90% of country activity plans included stigma and discrimination reduction programmes. Fiji. China. transgender people. and care services to key population groups and to providing treatment and care for people living with HIV (8). High percentages of respondents in all countries reported internalized stigma: feeling ashamed. the review indicated that countries rarely included a comprehensive package of programmes to reduce stigma and discrimination in their national strategies (1). In Rwanda. provides rich evidence of the multi-layered ways in which stigma and discrimination manifest in the lives of people living with HIV. The same study also found that less than one quarter of planned programmes explicitly engaged men who have sex with men. and Pakistan include stigma and discrimination as barriers to providing prevention. Narrative reports from Cambodia. 12% were excluded from social gatherings. social or vocational exclusion. and 12% denied health care (2).girls). Slightly less than half of respondents experienced negative attitudes or exclusion from family members. In the United Kingdom. sex workers. The United Nations Development Programme. more than 50% were verbally insulted. and/ or involuntary disclosure (6). 14% refused employment.

National networks of people living with HIV lead the implementation of the Index. For example. the shadow report submitted under UNGASS reporting on Honduras described several murders and a climate of impunity for perpetrators of violations of human rights that seriously undermines the HIV response (12). which comprises a series of questions on each country’s legal and policy landscape in relation to HIV. For example. in Central and South America. International Community of Women Living with HIV. Meaningfully involving people living with and vulnerable to HIV in national HIV responses is a part of realizing human rights. People Living with HIV Stigma Index The People Living with HIV Stigma Index is an innovative way to measure HIV-related stigma and discrimination experienced by people living with HIV. Chapter 5: Human rights and gender equality | 2010 GLOBAL REPORT 125 . Country progress reports for 2010 from Lesotho. Most questions are answered yes/no. they may provide a realistic picture of national and community efforts to eliminate stigma and discrimination. The answers are not independently verified but provide a snapshot of how different organizations view the various national AIDS policies and their implementation. service providers may treat people who inject drugs as “delinquents” (8).Several countries reported that stigma and discrimination in health care facilities adversely affect access to and the provision of services. Mozambique and Senegal (7) mentioned stigma and discrimination towards sex workers and sexual minorities as barriers to their accessing health services. and HIV treatment. The Index is supported jointly by the Global Network of People Living with HIV. National Composite Policy Index The National Composite Policy Index (NCPI) is an integral part of the core UNGASS indicators. There continue to be reports from many parts of the world of violence against and murder of individuals based on their perceived or actual sexual orientation (9–11). 5 SOURCES TO ASSESS STIGMA AND DISCRIMINATION UNGASS country report narratives Country progress reports submitted by governments (7) include a narrative on progress made in the AIDS response. In some instances nongovernmental organizations also submit shadow reports. which provide a point of view different from the official version. several reports note that some health care personnel are likely to discriminate against people living with HIV and deny services to population groups at higher risk such as sex workers and men who have sex with men. the United Nations and bilateral agencies (nongovernmental sources). HIV testing. Together. International Planned Parenthood Federation and UNAIDS. Often these include narratives that provide a rich context on the impact of stigma and discrimination. Such grave situations call for concerted action and advocacy by both human rights and HIV stakeholders. The NCPI is divided into two parts: (a) the government’s responses to the questions and (b) the responses of civil society organizations. in Mexico.

For instance. care. the figure was 60%. 79 countries and territories criminalize samesex sexual relations between consenting adults. stay. policies. the governments of 78 countries (46% of those reporting) acknowledged the existence of laws. leading to the weakening of programme REMOVING PUNITIVE AND DISCRIMINATORY LAWS: HIVRELATED RESTRICTIONS ON ENTRY. HIV prevention. and in Zambia. In Asia and the Pacific.19). up from 75% in 2006. The Global Network of People Living with HIV has implemented the GIPA Report Card in six countries and is currently implementing assessments in four others. nongovernmental sources in 41% of countries reported that the countries had laws. reports that existing laws are often used to harass vulnerable people. for example. In 2010. treatment. and support services and on the rights and dignity of people living with or vulnerable to HIV (14). 66%. nearly 90% of nongovernmental sources reported the existence of laws that pose obstacles to effective HIV responses for key populations at higher risk. with six countries retaining the possibility of applying the death penalty for such acts (15). such restrictions continue in 51 countries— an indicator of the discrimination still faced by people living with HIV in today’s highly mobile world. and support services for populations at higher risk..2) (18. These reports do not capture the full reality of laws that can act as obstacles to the HIV response. in contrast. STAY. stay. 33% of respondents indicated that they either “somewhat agreed” or “strongly agreed” that people living with HIV were meaningfully involved in developing the country’s national AIDS plan. In Kenya. In the Middle East and North Africa 56% of countries. In their narrative UNGASS reports (7). several countries recognized that criminalization of same-sex practices. territories. sources in 67% of the same countries reported the existence of such obstacles. policies. 126 Chapter 5: Human rights and gender equality | 2010 GLOBAL REPORT . Civil society has been leading efforts to assess the nature and quality of this participation. However. policies. care. governments in 96% of countries reported that their national HIV strategy explicitly addressed the involvement of people living with HIV. In 2010. Government and civil society responses to the National Composite Policy Index (NCPI) in this area differ notably. More than 100 countries criminalize some aspect of sex work (16. and entities are reported to impose some form of restriction on the entry. In 2010. Laws. and regulations on access to. China (April). or regulations that posed obstacles to effective HIV service provision for key populations at higher risk. and residence of people living with HIV (Figure 5. regulations. a number of countries lifted their HIV-related restrictions on entry. treatment. sex work. and/or provision of sterile needles and syringes. and uptake of. Fifty-one countries.1). and Namibia (July).17). and residence: the United States of America (January). In 2006. Bangladesh. and regulations that create obstacles to effective HIV responses are increasingly acknowledged but too often remain Countries increasingly acknowledge the demonstrated and potential negative effects of punitive legislation. AND RESIDENCE In 2010. in Nigeria. and 55% in sub-Saharan Africa reported similar laws. Fear of stigma was cited as one of the most significant barriers to greater involvement in the national response in all three countries (13). civil society from 106 countries (62%) reported the same (Figure 5. and policies that obstructed access to prevention.The Greater Involvement of People Living with HIV (GIPA) has been a key human rights principle within the HIV response since the Paris Declaration of 1994. and of punitive law enforcement are barriers to fully effective HIV responses.

South. Percentage of countries reporting non-discrimination laws for people living with HIV Percentage of countries reporting a mechanism to record. stay.Figure 5. document. May 2009). No Yes 5 Figure 5. and South-East Asia (21) Eastern Europe and Central Asia (11) Middle East and North Africa (18) Oceania (13) sub-Saharan Africa (42) North America and Western and Central Europe (34) Chapter 5: Human rights and gender equality | 2010 GLOBAL REPORT 127 . Source: Country Progress Reports 2010. or residence of people living with HIV based on their HIV status. and areas impose some form of restriction on the entry. Source: Mapping of Restrictions on the entry.3 Legal protections against discrimination for people living with HIV Percentage of countries with legal protections against discrimination for people living with HIV and mechanisms for redress. stay. or residence A total of 51 countries. as reported by nongovernmental sources. stay and residence of people living with HIV (UNAIDS. and address cases of discrimination experienced by people living with HIV and/or most-at-risk populations % 20 40 60 80 100 Overall (171) Caribbean (13) Central and South America (19) East. territories. and latest developments as of July 2010.2 HIV-related restrictions on entry.

young people. and people who use drugs (14. when the first UNGASS reports were submitted. and address cases of discrimination experienced by people living with HIV or other people vulnerable to HIV (Figure 5. and Zambia acknowledge that criminalizing homosexuality makes providing services to men who have sex with men more difficult. prisoners and migrants. Saudi Arabia. there is little evidence whether these laws are effectively enforced or whether people living with HIV and other people key in the response have access to justice or can seek redress for wrongs experienced. In 2004. Most worrying. Studies confirm that punitive laws have negative effects on access to HIV services and on the claiming and exercise of human rights by men who have sex with men (20). Parallel to increased acknowledgement of laws that pose obstacles to HIV responses. Despite reporting of an increase in protective laws. In addition. governments in 106 countries (62%) reported having laws or regulations that specify protections for key populations at higher risk such as women. only 56% of countries report having a mechanism to record. more countries report the existence of laws and regulations that protect people living with or vulnerable to HIV from discrimination but data are insufficient to indicate whether they are adequately enforced. Malawi. document. 56 % implementation supporting people at higher risk of exposure to HIV. people who inject drugs. Among those working in the response to HIV another concern is the apparent increased trend of passing laws that criminalize HIV transmission and/or the failure to disclose one’s HIV status. is that the 2010 data indicate that almost one third of countries still do not have such protective legislation. and the Syrian Arab Republic also note that laws that prohibit adultery. and address cases of discrimination experienced by people living with or vulnerable to HIV. men who have sex with men. In 2010. Nongovernmental sources in 112 countries (65%) reported the same.22). Mozambique. Such laws contradict the commitment made by governments in the Political Declaration on HIV/AIDS in 2006 “to promote a social and legal environment that is supportive of and safe for voluntary disclosure of HIV status” (25). Reports from Lebanon. nongovernmental sources in 71% of countries reported the existence of laws protecting people living with HIV from discrimination versus 67% in 2008 and 56% in 2006 (of the same 85 countries reporting in all three years). sex workers. however. and about 20 countries in sub-Saharan Africa have also chosen to do so in the past six years (26). and sex work may hinder HIV prevention efforts (7). nongovernmental sources in only 32% of countries reported the same (of the 88 countries reporting that year). Ghana. only 17% report having mechanisms to record.23. This suggests increased understanding among policy makers that protective laws are important in effectively responding to HIV (Figure 5. Countries in North America and Western Europe have long criminalized HIV transmission. 128 Chapter 5: Human rights and gender equality | 2010 GLOBAL REPORT . sex workers (21. Malaysia’s report recognized the challenges posed by contradictory harm reduction and drug control policies. homosexuality. For instance.3).Percentage of countries reporting having a mechanism to record and address cases of discrimination. while nongovernmental sources in 61% of countries in North Africa and the Middle East report the existence of non-discrimination laws.24). Reports from Botswana. document.4). In 2010.

5 Yes No Missing data Figure 5. Source: Country Progress Reports 2010.5 Legal aid for HIV casework Countries in which nongovernmental sources report legal aid systems for HIV casework.Figure 5. 2010. Yes No Missing data Chapter 5: Human rights and gender equality | 2010 GLOBAL REPORT 129 . Source: Country Progress Reports 2010.4 Non-discrimination laws protecting key populations at higher risk Countries in which nongovernmental sources report non-discrimination laws protecting key populations at higher risk.

practices and HIV epidemics differ around the world.5). the Commission will marshal the evidence on the impact of the law on the HIV response. In other regions. Men who have sex with men continue to bear a high burden of HIV infection even in regions with generalized epidemics. expected in December 2011. the majority of people living with HIV are women. including excessive alcohol use and concurrent sexual relationships. harmful social gender norms. add to the greater biological vulnerability of women and girls being infected with HIV. people living with HIV and representatives of key populations. and utilize opportunities for empowerment (27). gender inequality and violence against women.THE GLOBAL COMMISSION ON HIV AND THE LAW On 24 June 2010. However. the figure has remained the same since 2008. often in concentrated epidemics involving men who have sex with men or people who inject drugs. 130 Chapter 5: Human rights and gender equality | 2010 GLOBAL REPORT . HIV programming has largely neglected same-sex behaviour because of homophobia and the widespread criminalization of homosexuality. The consequences of gender inequalities in terms of low socioeconomic and political status. protective and enabling legal responses to HIV. UNDP and UNAIDS launched the Global Commission on HIV and the Law composed of renowned and independent global leaders in the areas of law. and legal barriers to treatment. The establishment of the Commission is an essential milestone in supporting countries to remove punitive laws. Too often they have little capacity to negotiate safer sex. 13 women become infected for every 10 men infected. Gender equality Although gender relationships. nongovernmental sources in only 51% of countries report having legal aid systems for HIV casework.22:1 in West and East Africa to 1. people living with HIV. gender-based violence and marginalization clearly increase the vulnerability of both women and men to HIV infection. including governments. civil society. and fear of violence. the Commission will hold a number of regional policy dialogues that will allow submissions from regional and national stakeholders. Levels of new HIV infections in sub-Saharan Africa continue to remain higher among women. These submissions will shape the final report and recommendations of the Commission. when 33% of countries reported having such systems. so increasing their risk of acquiring and transmitting HIV. women are more likely to become infected with HIV than are men (Figure 5. The most recent prevalence data show that in subSaharan Africa. a pattern that applies to every subregion in sub-Saharan Africa. men are more likely to be infected with HIV than women. Female-to-male ratios of new HIV infections range from 1. Although this represents an increase from 2006. Many harmful norms related to masculinity and femininity also stigmatize transgender people.6). and make actionable recommendations on how to create effective. public health policy and governance. especially girls and women aged 15–24 years (28. with 75% of countries reporting such systems (NCPI). As an outcome of its first meeting in October 2010. and other sexual minorities. Conversely. access the services they need. In sub-Saharan Africa. men who have sex with men. traditional roles and societal values related to masculinity might encourage boys and men to adopt risky behaviours. drug users. stigma and discrimination that block effective responses to HIV. practices. the Commission will focus on the following issues: criminalization of sex workers. whereas only 48% of low-income countries and 40% of lower-middle-income countries report having them (Figure 5.33:1 in southern Africa. Access to HIV-related legal services is one effective means to protect the human rights of people living with HIV and other key populations as are efforts to sensitize officials engaged in the administration of justice. human rights and public health experts. Through its work. The Commission is supported by a Technical Advisory Group of law. despite the different types of epidemics and predominant modes of transmission in these subregions. men who have sex with men. power imbalances. unequal access to education. One half of people living with HIV globally are women and 76% of all HIV-positive women live in sub-Saharan Africa.29). In the course of 2011. In nearly all countries in sub-Saharan Africa and certain Caribbean countries. Legal aid systems appear to be more common in high-income countries. In subSaharan Africa. policies.

6 People newly infected with HIV.4 Male Female Global Caribbean Central and South America Asia 5 Eastern Europe and Central Asia sub-Saharan Africa North America and Western and Central Europe Figure 5.2 . 2009 Number of people newly infected with HIV annually by sex and geographical region.Figure 5.7 HIV prevalence among young people in sub-Saharan Africa HIV prevalence among people 15–24 years old by sex in selected countries in sub-Saharan Africa. 0 . 2009. Source: UNAIDS 2010.6 People (millions) . Source: UNAIDS 2010.2 1. 15 – 19 years 20 –24 years 1% of females 1% of males BOTSWANA REPUBLIC OF THE CONGO LESOTHO SOUTH AFRICA ZIMBABWE Chapter 5: Human rights and gender equality | 2010 GLOBAL REPORT 131 .8 1 1.4 .

The study found that although men who have sex with men report more casual sexual partners than men in general. Marriage thus serves as a way to protect against possible prosecution and stigma against men who have sex with men (32. data obtained through the Asia Intimate Partner Transmission Study (34) indicate that women are predominantly infected by their husband or intimate partner. prevalence among women rises rapidly at a young age. The authors conclude that programmes that encourage young women to incorporate demands for safer sex into negotiations for gifts and money may ultimately be more effective than those that seek only to restrict transactional sex or highlight its health risks (37). For example. also often have older male sexual partners.“THE NUMBER OF COUNTRIES WITH A SPECIFIC BUDGET FOR HIV ACTIVITIES RELATED TO WOMEN IS LOW: 46% OF REPORTING COUNTRIES. A recent ethnographic study conducted in the United Republic of Tanzania showed that both parents and daughters widely accepted transactional sex.33). young men who have sex with men used condoms with slightly less frequency than men in general (54% versus 57%) (39). As a result. Sociocultural practices significantly contribute to the risk of HIV infection. with higher peaks when women are in their late twenties (35). condom use among was only at about 50%.” Research has found significantly higher levels of infection among men who have sex with men than among men in general. and has also confirmed that many men who have sex with men also have sex with women (30). and material gain. Furthermore. In Asia.to late thirties. while levels of HIV infection among men rise slowly and peak at a lower level than female infection rates when men are in their mid. including sex for power. Data from sub-Saharan Africa indicate that women also engage in multiple concurrent partnerships (36). Understanding the complexities of relationships engaged in by some married and long-term partners is important in focusing the HIV response. and Namibia found that 34% of men who have sex with men were married to women. more likely to live in an urban area. A 2009 study in Brazil (39) shows men who have sex with men have much higher levels of HIV infection than men in general (10. Malawi.7). and a total of 54% reported sex with both men and women in the previous six months (31). 132 Chapter 5: Human rights and gender equality | 2010 GLOBAL REPORT . with rates substantially increasing among women 20–24 years old versus 15–19 years old (Figure 5. despite a comprehensive programme to increase condom use among men who have sex with men. Demographic and health surveys in selected countries in Africa show that young women are at particularly high risk of HIV infection. A recent study conducted in Botswana. who are biologically more susceptible to HIV than men.5% versus 0. This is probably because young women.8%). recent data on HIV infection patterns in India reveal that 90% of women in India were infected within long-term relationships. pleasure. as they are more mobile. Another study found that more affluent women are at greater risk of contracting HIV. especially among young women The effects of gender constructs are reflected in HIV infection rates among young women in Africa. who are more likely than younger men to be infected with HIV. and more able to afford a lifestyle that includes having a higher number of sexual partners (38).

South. Women included Budget included % 20 40 60 80 100 Overall (171) Caribbean (13) Central and South America (19) 5 East.8 Multisectoral HIV strategies specifically including and budgeting for women Percentage of countries in which governments report that multisectoral HIV strategies specifically include and budget for women. Source: Country Progress Reports 2010. and South-East Asia (21) Eastern Europe and Central Asia (11) Middle East and North Africa (18) Oceania (13) sub-Saharan Africa (42) North America and Western and Central Europe (34) Chapter 5: Human rights and gender equality | 2010 GLOBAL REPORT 133 .Figure 5.

and Eastern Europe by GESTOS. but the rate of inclusion of women differs by geographical regions (Figure 5. Central and South America. Violence and HIV infections are often associated and require integrated responses Violence and the threat of violence can hamper women’s ability to adequately protect themselves from HIV infection and/or assert healthy sexual decisionmaking. 4.” Women are included in HIV strategies but budgetary allocations are insufficient Governments in 80% of countries (137 of 171) reported that they include women as a specific component of a multisectoral HIV strategy. underline the urgency to address Millennium Development Goals 3. indicating a greater awareness of the need for and benefits of women-centred AIDS responses. to undergo sterilization or to have an abortion. In addition. with the prevalence of forced first sex among adolescent girls younger than 15 years ranging between 11% and 45% globally. 5 and 6 simultaneously. The WHO study also found that many women have a traumatic experience when engaging in sexual intercourse for the first time. A WHO report on women and health (40) highlights the critical role of gender inequality in increasing vulnerability to HIV infection and other conditions and limiting access to health care services and information. A review of maternal mortality data revealed that HIV-related causes contributed to at least 20% of maternal deaths (41). Recent research carried out by civil society on sexual and reproductive health policies. anecdotal reports indicate that women living with HIV are pressured. According to WHO. Further. In addition. leaving many sexual and reproductive health needs unmet.“VIOLENCE AND THE THREAT OF VIOLENCE CAN HAMPER WOMEN’S ABILITY TO ADEQUATELY PROTECT THEMSELVES FROM HIV INFECTION AND/OR ASSERT HEALTHY SEXUAL DECISION-MAKING. The HIV epidemic is intertwined with sexual and reproductive health Data on unmet sexual and reproductive health needs. In addition. the Caribbean. and the consequences of unintended pregnancies in terms of unsafe abortion. nearly all strategic plans include interventions benefiting women. and three quarters of countries allocate budget accordingly. at least 2. undertaken in 12 countries in sub-Saharan Africa. Countries with high HIV prevalence rates among young women are equally challenged by high teenage pregnancy rates. women living with HIV are more likely to experience violence due to their HIV status (44). Brazil (43) confirms that countries have reproductive and sexual health policies oriented towards women in place but generally fail to translate these into comprehensive services. each year about 16 million women 15–19 years old around the world give birth. younger women.5 million adolescents have unsafe abortions every year (42).8). South-East Asia. especially among young women a population highly affected by HIV and violence. Among countries in sub-Saharan Africa. The number of countries with a specific budget for HIV activities related to women is considerably lower: 46% (79 of the 171) reporting countries. especially those 15–19 134 Chapter 5: Human rights and gender equality | 2010 GLOBAL REPORT . and even forced. with most living in sub-Saharan Africa.

by country. 2002-2008. Serbia. 5 12-20% 20. Japan. Ethiopia.1-40% 40. 2010.1-60% >60% No data Figure 5. and South-East Asia (21) Eastern Europe and Central Asia (11) Middle East and North Africa (18) Oceania (13) sub-Saharan Africa (42) North America and Western and Central Europe (34) Chapter 5: Human rights and gender equality | 2010 GLOBAL REPORT 135 . South.Figure 5. Tanzania and Thailand (WHO Multi-Country Study on Women’s health and Domestic Violence. education and communication. Source: Country Progress Reports 2010.1-50% 50.9 Violence against women Proportion of ever-married women 15–49 years old who ever experienced physical or sexual violence from their most recent spouse or co-resident partner. excepting Bangladesh. Samoa.1-30% 30. Source: Demographic Health Surveys. % 20 40 60 80 100 Overall (171) Caribbean (13) Central and South America (19) East. 2008 or most recent survey. Kenya.10 Governments involving men in reproductive health programmes Percentage of countries in which governments report involving men in reproductive health programmes through information. 2004).

In Swaziland. It is notable that countries might have laws in place to punish rapists. IMAGES. UNGASS reports for several countries in sub-Saharan Africa (7) outline the increased HIV vulnerability of women due to violence and sexual coercion and highlight the link with armed conflict. Reporting on genderbased violence is not even. where men who have sex with men experience violence. sexual and reproductive health. live under the threat of anti-sodomy laws.9 shows that the prevalence of violence against women can be as high as 50% in some countries. including sexual violence against women in refugee camps. UNGASS reports are silent on violence against women and girls. Other countries underline that violence against sex workers affects their capacity to insist on the use of condoms.” 136 Chapter 5: Human rights and gender equality | 2010 GLOBAL REPORT . and are often excluded from HIV responses (47). Engaging men is crucial in effectively responding to HIV Despite evidence of positive changes in men’s and boys’ behaviour and attitudes when they participate in programmes that address HIV. few such programmes are in operation (49). A 2010 study in South Africa (46) confirmed the association between violence and HIV infection. Outside sub-Saharan Africa. which has one of the highest levels of HIV prevalence. and Sasa! have so far only been incorporated to a limited extent in the HIV response. Figure 5. have led in attempting to increase access for men who have sex with men and transgender people. and gender-based violence (48). countries have not reported on violence against men who have non-heterosexual identities or practices and transgender people. indicating that effective programmatic models such as Stepping Stones. rather than nationally funded HIV programmes. Power inequity in relationships and intimate partner violence increased the incident risk of HIV infection among young South African women. but few have legislation that penalizes domestic violence (43). community-based organizations. Prevalence of the population-attributable risk was 14% for power inequity in relationships and 12% for intimate partner violence. were generally at higher risk of physical and/or sexual violence by a partner. UNGASS reporting also confirms that governments in only 60% of countries report having promoted greater involvement of men “MEN WHO HAVE SEX WITH MEN AND TRANSGENDER PEOPLE ALSO FACE INCREASED VULNERABILITY TO HIV INFECTION DUE TO VIOLENCE AND STIGMA. The GESTOS research (43) found that few countries have undertaken focused actions to prevent violence or to empower women survivors of violence. In sub-Saharan Africa. Men who have sex with men and transgender people also face increased vulnerability to HIV infection due to violence and stigma. The limited availability of epidemiological data on violence underlines the urgent need for additional evidence to guide policy and programmatic action to address it. This finding is confirmed by the recent WHO/UNAIDS publication (44). Such “self-help” efforts are hampered where homosexuality is criminalized.years old. Historically. as in sub-Saharan Africa. a 2007 study (45) showed that 33% of females 13–24 years old reported experiencing some form of sexual violence before reaching 18 years of age.

Countries should now take action to decriminalize sex workers. HIV-related stigma and discrimination are still highly prevalent globally and are not yet being sufficiently addressed. policies. and communication on reproductive health (Figure 5. there must be more meaningful involvement of people living with and those vulnerable to HIV in national HIV responses. the AIDS response needs to be women and girls centred and include a dedicated budget to address their needs. ■ Countries need to address the needs of men who have sex with men through prevention interventions that go beyond health service provision. ■ Despite increased reporting on protective laws. as well as meaningful coverage of all affected populations.in reproductive health programmes in information. and regulations that create obstacles to effective HIV responses are increasingly acknowledged by key actors in the response. men who have sex with men and transgender people. For example. ■ To help to realize human rights in the context of HIV. ■ All countries need to ensure that women have access to integrated quality HIV and sexual and reproductive health services that enable women to exercise their rights. fewer men than women access HIVrelated treatment. The GIPA principles must be fully implemented. and reform other laws that block effective responses to HIV. treatment. ■ Given that violence is widespread and that there is a clear association between violence against women and the spread of HIV. institutions and communities. 5 ■ Although progress has been noted. GENDER EQUALITY ■ To achieve universal access goals towards HIV prevention. Countries and other stakeholders should urgently scale up comprehensive programmes that build capacities of HIV-related service providers. national HIV responses must include specific interventions to address violence. ■ ACTION ITEMS HUMAN RIGHTS ■ Laws. address stigma and discrimination in laws. care and support. education.10). and empower those affected by HIV. The failure to engage men also directly affects their health. ■ Men and boys need to be engaged in innovative approaches to change harmful social and cultural practices and norms. as part of HIV prevention. countries and other stakeholders should establish effective enforcement mechanisms and provide people living with HIV and other key populations with access to justice and redress through HIV-related legal services and legal literacy programmes. Chapter 5: Human rights and gender equality | 2010 GLOBAL REPORT 137 . people who use drugs.

policies protecting specific sub-populations No/Disagree Data not available No NCPI report No UNGASS report A NCPI Part A (government response) B NCPI Part B (civil society response) B SUB-SAHARAN AFRICA Angola Benin Botswana Burkina Faso Burundi Cameroon Cape Verde Central African Republic Chad Comoros Congo Côte d’Ivoire Democratic Republic of Congo Equatorial Guinea Eritrea Ethiopia Gabon Gambia Ghana Guinea Guinea-Bissau Kenya Lesotho Liberia Madagascar Malawi Mali Mauritania Mauritius Mozambique Namibia Niger Nigeria Rwanda Sao Tome and Principe Senegal Seychelles Sierra Leone A B A B B A A 138 Chapter 5: Human rights and gender equality | 2010 GLOBAL REPORT IEC activities on fighting Violence Against Women A Yes /Agree Women as a specific component of the national strategic plan Women component of the national strategic plan budgeted . care and support for vulnerable subpopulations Laws & regulations protecting people living with HIV against discrimination Laws. policies obstructing access to prevention. regulations. regulations. vulnerable subpopulations Laws.SCORECARD: HUMAN RIGHTS AND GENDER EQUALITY Mechanism to record. document and address cases of discrimination experienced by people living with HIV. treatment.

OCEANIA EAST ASIA SUB-SAHARAN AFRICA Continued SOUTH AND SOUTH-EAST ASIA Democratic People’s Republic of Korea United Republic of Tanzania Republic of Korea Lao People’s Democratic Republic Tonga China Palau Zambia Papua New Guinea New Zealand Uganda Tuvalu Nauru Japan Solomon Islands South Africa Zimbabwe Swaziland Australia Vanuatu Samoa Togo Fiji Kiribati Micronesia. Federated States of Mongolia Marshall Islands Bhutan Afghanistan Bangladesh Brunei Darussalam Cambodia Indonesia Malaysia India B A B A B B A Laws & regulations protecting people living with HIV against discrimination Laws. policies protecting specific sub-populations Laws. regulations. vulnerable subpopulations Women as a specific component of the national strategic plan Chapter 5: Human rights and gender equality | 2010 GLOBAL REPORT A A Women component of the national strategic plan budgeted IEC activities on fighting Violence Against Women 139 5 . treatment. care and support for vulnerable subpopulations Mechanism to record. policies obstructing access to prevention. document and address cases of discrimination experienced by people living with HIV. regulations.

care and support for vulnerable subpopulations Laws & regulations protecting people living with HIV against discrimination Laws. treatment. regulations. policies protecting specific sub-populations No/Disagree Data not available No NCPI report No UNGASS report A NCPI Part A (government response) B NCPI Part B (civil society response) B SOUTH AND SOUTH-EAST ASIA Continued Maldives Myanmar Nepal Pakistan Philippines Singapore Sri Lanka Thailand Timor-Leste Viet Nam A B A B B A A EASTERN EUROPE AND CENTRAL ASIA Armenia Azerbaijan Belarus Georgia Kazakhstan Kyrgyzstan Moldova. regulations. Republic of Russian Federation Tajikistan Turkmenistan Ukraine Uzbekistan WESTERN AND CENTRAL EUROPE Albania Andorra Austria Belgium Bosnia and Herzegovina Bulgaria Croatia Cyprus Czech Republic Denmark Estonia Finland France Germany 140 Chapter 5: Human rights and gender equality | 2010 GLOBAL REPORT IEC activities on fighting Violence Against Women A Yes /Agree Women as a specific component of the national strategic plan Women component of the national strategic plan budgeted . document and address cases of discrimination experienced by people living with HIV. vulnerable subpopulations Laws. policies obstructing access to prevention.SCORECARD: HUMAN RIGHTS AND GENDER EQUALITY Mechanism to record.

treatment. policies obstructing access to prevention. care and support for vulnerable subpopulations Mechanism to record. vulnerable subpopulations Women as a specific component of the national strategic plan Chapter 5: Human rights and gender equality | 2010 GLOBAL REPORT A A Women component of the national strategic plan budgeted IEC activities on fighting Violence Against Women 141 5 . policies protecting specific sub-populations Laws. regulations. document and address cases of discrimination experienced by people living with HIV.MIDDLE EAST AND NORTH AFRICA Macedonia. The Former Yugoslav Republic of Luxembourg Montenegro Poland San Marino Romania Slovenia Malta Israel Italy Monaco Liechtenstein Netherlands Lithuania Hungary Slovakia Sweden Norway Greece Iceland Ireland Turkey Serbia Latvia Spain Switzerland Portugal NORTH AMERICA WESTERN AND CENTRAL EUROPE Continued United Kingdom of Great Britain & Northern Ireland Mexico United States of America Djibouti Canada Bahrain Algeria B A B A B B A Laws & regulations protecting people living with HIV against discrimination Laws. regulations.

policies obstructing access to prevention. vulnerable subpopulations Laws. regulations. policies protecting specific sub-populations No/Disagree Data not available No NCPI report No UNGASS report A NCPI Part A (government response) B NCPI Part B (civil society response) B MIDDLE EAST AND NORTH AFRICA Continued Egypt Iran. regulations. treatment. document and address cases of discrimination experienced by people living with HIV. care and support for vulnerable subpopulations Laws & regulations protecting people living with HIV against discrimination Laws.SCORECARD: HUMAN RIGHTS AND GENDER EQUALITY Mechanism to record. Islamic Republic of Iraq Jordan Kuwait Lebanon Libyan Arab Jamahiriya Morocco Oman Qatar Saudi Arabia Somalia Sudan Syrian Arab Republic Tunisia United Arab Emirates Yemen A B A B B A A CARIBBEAN Antigua & Barbuda Bahamas Barbados Cuba Dominica Dominican Republic Grenada Haiti Jamaica Saint Kitts and Nevis Saint Lucia Saint Vincent and the Grenadines Trinidad and Tobago CENTRAL AND SOUTH AMERICA Argentina Belize Bolivia Brazil Chile Colombia 142 Chapter 5: Human rights and gender equality | 2010 GLOBAL REPORT IEC activities on fighting Violence Against Women A Yes /Agree Women as a specific component of the national strategic plan Women component of the national strategic plan budgeted .

policies protecting specific sub-populations Laws. care and support for vulnerable subpopulations Mechanism to record. document and address cases of discrimination experienced by people living with HIV. regulations. regulations.CENTRAL AND SOUTH AMERICA Continued Guatemala El Salvador Costa Rica Nicaragua Venezuela Peru Suriname Ecuador Panama Guyana Paraguay Honduras Uruguay B A B A B B A Laws & regulations protecting people living with HIV against discrimination Laws. treatment. vulnerable subpopulations Women as a specific component of the national strategic plan Chapter 5: Human rights and gender equality | 2010 GLOBAL REPORT A A Women component of the national strategic plan budgeted IEC activities on fighting Violence Against Women 143 5 . policies obstructing access to prevention.

CHAPTER 6 144 Chapter 6: HIV investments | 2010 GLOBAL REPORT .

■ HIV prevention programmes largely rely on international funds. domestic resources account for over half of all AIDS-related investments. The United States of America is the largest international donor. ■ One third of countries make the AIDS response a high budgetary priority. ■ The majority of international funding for AIDS comes from bilateral donors. based on disease burden and national income. 88% of spending on AIDS comes from international funding.HIV INVESTMENTS 6 KEY FINDINGS ■ A total of US$ 15. US$ 10 billion short of what is needed in 2010. Chapter 6: HIV investments | 2010 GLOBAL REPORT 145 . In low-income countries.9 billion was available for the AIDS response in 2009. ■ In low. however.and middle-income countries. ■ Investment in treatment and care is increasing—but many countries depend on international assistance for their treatment and care programmes.

CHAPTER 6 | HIV INVESTMENTS » Investing for AIDS is a shared responsibility Investing for AIDS is a shared global responsibility that is paying clear dividends —it saves lives now. philanthropic organizations and individuals to address HIV. international assistance did not increase from 2008 levels. None of this would have been possible without the strong mobilization of the global community and the unprecedented levels of funding provided collectively by donors. As a result of this unprecedented health investment.9 billion for the global AIDS response. In 2009. for the first time. governments. Middle-income countries contributed a far greater proportion of the resources to their national AIDS response. International investment levels have largely reflected the epidemic distribution. Government donors provide an additional 42% and the international philanthropic sector 5% (1). there was a US$ 10 billion gap as. millions of orphans have received basic education and health care. Donors’ HIV-related spending is higher in countries with high HIV prevalence. the largest source of HIV funding—52%—is domestic expenditure. the AIDS response is funded by a complex interplay of domestic public spending. the private sector. In most countries. In many lowand middle-income countries.and middleincome countries. improves the quality of life of people living with HIV. Low-income countries’ share of investment for the national AIDS response was much smaller. HIV prevalence is falling due to programmes that reduce risk behaviour. However. and will lessen future burdens of cost and disease. more than 5 million people are receiving life-saving antiretroviral therapy. 146 Chapter 6: HIV investments | 2010 GLOBAL REPORT . the gap between investment needs and resource availability is widening at a time of fiscal constraints. and more tolerant and enabling social environments have been established in many countries through campaigns to reduce HIV-related stigma and discrimination. more than half of which came from domestic sources in low. multilateral and bilateral aid. In 2009. international donors and governments together provided US$ 15. private-sector and philanthropic support and individual out-of-pocket spending. The sharing of the responsibility has largely matched the financial capabilities of individual countries and the magnitude of national epidemics.

the median level of priority is 0. the percentage of government revenue allocated to the AIDS response was one fifth of the population HIV prevalence. Chapter 6: HIV investments | 2010 GLOBAL REPORT 147 .35.DOMESTIC INVESTMENT PRIORITY INDEX (DIPI) A new UNAIDS Domestic Investment Priority Index attempts to measure the extent of investment priority given by governments to support their national AIDS response. Figure 6. Eight of 14 countries in West and Central Africa and six of 16 countries in east and southern Africa appear to be spending less on the AIDS response than might be expected given their disease burden and government resources. however.1). the two countries in Eastern Europe and Central Asia with the highest HIV prevalence. The Index is calculated by dividing the percentage of government revenue each country directs to the AIDS response by the population HIV prevalence. The Priority Index of a large majority of countries (70%). The Domestic Investment Priority Index implies that both countries could contribute more domestic resources to the AIDS response (Figure 6. Domestic investment priority index = Public expenditure on AIDS response Government revenue 6 x National population People living with HIV On average. Among the 104 countries reporting. Data from 121 countries show that one third of all countries make investments at a level that is commensurate with their national income levels and share of the global epidemic burden. are spending at relatively low levels given their disease burden and ability to pay. Fifty-five countries allocated more than 0. A high value usually indicates a high level of priority.5% of total government revenue.2 shows the distribution of funds to different elements of the epidemic response. falls below this average—suggesting that many countries need to invest more in their AIDS responses. The Russian Federation and Ukraine.

69 0.03 0.72 0.18 0.06 0.Figure 6.03 0.09 0.05 0.31 0.33 0.68 0.04 DIPI=Domestic Investment Priority Index Above median Below median 148 Chapter 6: HIV investments | 2010 GLOBAL REPORT .28 0.1 Domestic Investment Priority Index for countries with the highest HIV prevalence Year DIPI Median spending Botswana Brazil Cameroon China Colombia Congo Côte d’Ivoire Democratic Republic of the Congo Ghana India Indonesia Kenya Lesotho Malawi Mozambique Nigeria Russian Federation South Africa Thailand Uganda Ukraine Viet Nam Zimbabwe 2008 2008 2008 2009 2009 2009 2008 2008 2008 2009 2008 2009 2008 2009 2008 2008 2008 2009 2009 2008 2008 2009 2009 0.29 0.52 0.13 0.33 0.19 0.10 0.80 0.07 0.37 0.05 0.

Figure 6. These disbursements include both bilateral aid (funds disbursed directly from a donor country to a recipient country) and contributions to multilateral organizations (Figure 6. Lowincome countries received 78% of international funds.2 HIV spending in low. Of the 132 countries reporting HIV spending by funding source.1 billion 6 Treatment and care Prevention Programme management and administration strengthening Orphans and vulnerable children Incentives for human resources Social protection and social services Enabling environment Research Overall size of square is proportional to the total amount spent each year.7 billion made available in 2008.3). The top 20 recipients of aid account for 71% of the people living with HIV globally. The United States of America was the largest international Chapter 6: HIV investments | 2010 GLOBAL REPORT 149 .and middle-income countries.3 billion 2008 US$ 4. donor fair share is not being met Donor governments’ actual disbursements for the AIDS response in 2009 stood at US$ 7. The majority of these resources went to the countries most affected by the epidemic. increasing domestic investment priority to the optimum levels is not sufficient to meet the needs of the AIDS response. 70 countries (53%) rely on international funds to finance 50% or more of HIV spending. 2006–2008. Source: Country Progress Reports 2010. International assistance is crucial to sustaining the AIDS response.6 billion in 2009. 2006 US$ 2.and middle-income countries.and middle-income countries HIV spending in current US dollars by programmatic area in 43 low. And for the majority of the low. International investments are not increasing. a slight decrease from the US$ 7.6 billion 2007 US$ 3. with another 14% going to lower-middle-income countries.

2 million 11 89 Australia US$ 99. 2010.9 million 41 59 74 26 66 34 Norway US$ 130.8 million Denmark US$ 193.4 million 39 61 84 16 86 14 32 68 20 80 Netherlands US$ 381.5 million 0 100 Other Governments US$ 73.Figure 6. 150 Chapter 6: HIV investments | 2010 GLOBAL REPORT .3 million Ireland US$ 81.2 million Japan US$ 141.1 million Canada US$ 129. multilateral funding includes Global Fund contributions adjusted to represent the estimated HIV share based on Global Fund grant distribution by disease to date (61% for HIV) and UNITAID contributions adjusted to represent the estimated HIV share based on distribution by disease to date (49% for HIV).3 Channels used by major donor countries for disbursing international AIDS funding in 2009 Source: Kates et al.9 million 20 80 European Union US$ 118.9 million United Kingdom US$ 779 million 13 87 42 58 16 84 Bilateral funding includes HIV-earmarked multilateral funding. % of aid disbursed to Global Fund/UNITAID % of aid disbursed bilaterally Size of the circle is proportional to total disbursements.8 million Spain US$ 163.6 million Sweden US$ 171. Italy US$ 9.9 million Germany US$ 397.3 million 10 90 France US$ 338.

4 billion 12 88 6 Total US$ 7.6 billion 23 77 Chapter 6: HIV investments | 2010 GLOBAL REPORT 151 .United States US$ 4.

In many countries. However. domestic government spending.and middle-income countries. The United Kingdom accounted for 10% of total donor government disbursements for AIDS. provides a vast majority (88%) of its resources directly to countries. Evidence from Zambia shows that. Countries have seen best results when resources are tailored to epidemic patterns and have followed evidence: for example. and Germany and the Netherlands accounted for 5% each. treatment programmes that use the most effective combination of drugs and male circumcision as a priority component of prevention in generalized epidemics. a sizeable proportion (23%) of all international assistance is available through multilateral institutions such as the Global Fund to fight AIDS. National programmes have had to ensure that programme choices are effective and efficient to have the maximum impact in averting new HIV infections and AIDS-related deaths. Donor fair share of international investments for AIDS response is not being met Comparing donor country funding for AIDS with their national gross domestic product (GDP) is one way of determining whether the contribution represents a fair share to the HIV response (Figure 6. Some donors give less in absolute terms than others but dedicate a greater share of their GDP to international assistance on AIDS. the largest donor. International investment funding channels Bilateral funding remains the principal source of international AIDS funds for low. multilateral institutions. programmes promoting abstinence received far more resources than efforts to increase condom use or reduce multiple partners. France. which accounts for 72% of disbursements from multilateral sources. was the main source of AIDS funding in 52 of its 92 recipient countries. Japan and Spain each provided more than two thirds of their HIV-related international assistance through the Global Fund and UNITAID in 2009. without the right mix of behavioural interventions.4). and private and individual out-of-pocket spending). Canada.9 billion (77%) was provided as bilateral aid.donor. The Global Fund. accounting for 58% of all donor-government disbursements for AIDS and for 27% of the funding available for AIDS from all sources (donor governments. Of the US$ 7. US$ 5. Improving cost-effectiveness can help bridge the resource gap The resource availability for the AIDS response has always fallen short of what is needed. The use of antiretroviral drugs for preventing mother-to-child HIV transmission has been reported with costs of US$ 34 per disability-adjusted life-year 152 Chapter 6: HIV investments | 2010 GLOBAL REPORT .6 billion donor governments made available for AIDS in 2009. The United States of America. Tuberculosis and Malaria and UNITAID. the European Union. Most donor countries have the potential to provide substantially more resources than they are currently providing. gains are minimal.

Global Fund contributions are adjusted to represent the estimated HIV share based on Global Fund grant distribution by disease to date (61% for HIV). The resources available are estimated and represent disbursements from all sources. 2010. 2009 Source: Kates J et al.Figure 6.4 Donor share of the world GDP and all resources available for AIDS. Bilateral funding includes multilateral funding earmarked for HIV but does not include the Global Fund or UNITAID. Chapter 6: HIV investments | 2010 GLOBAL REPORT 153 . Bilateral funding includes HIV-earmarked multilateral funding. Share of World GDP Share of All Resources for AIDS % 5 10 15 20 25 30 United States Japan Germany France United Kingdom 6 Italy Spain Canada Australia Netherlands Sweden Norway Denmark Ireland GDP = gross domestic product. UNITAID contributions are adjusted to represent the estimated HIV share based on distributions by disease to date (49% for HIV).

Source: Country Progress Reports 2010. Mechanism. 3TC+NVP+d4T [150+200+30]mg D. 2009 or last available year. EFV+[3TC+ZDV] 600mg+[150+300]mg A B C D E Figure 6. US Dollars per person 0 < 1.5 < 3 3-5 5 . Source: World Health Organization.Figure 6.5 Price trends for commonly used antiretroviral therapy regimens Price trends for some of the most commonly used antiretroviral therapy regimens for adult patients in low-income countries.6 Domestic and international HIV spending per person Domestic and international HIV spending in international US dollars (purchasing power parity) per person by country.5 1. A summary report from the Global Price Reporting. Transaction prices for Antiretroviral Medicines and HIV Diagnostics from 2008 to March 2010. 2010. Geneva May.10 > 10 Not available or not reported 154 Chapter 6: HIV investments | 2010 GLOBAL REPORT . 2008-2010. EFV+FTC+TDF [600mg+200+300]mg C. 2008 2009 2010 (1st quarter) 700 MEDIAN TRANSACTION PRICE (US $/PPY) 600 500 400 A. [FTC+ TDF]+NVP [200+300]mg+200mg 300 200 100 E. [3TC+ZDV]+[LPV+RTV] [150+300]mg +[200+50]mg B.

saved; however, providing full treatment to the pregnant woman saves the life of the mother and protects an infant from HIV infection and orphanhood. There is also scope for innovation in promoting cost–effectiveness. Malawi is considering providing all pregnant women living with HIV with full antiretroviral therapy (for their own health and for stopping the mother-to-child transmission of HIV). Although this is potentially expensive at the beginning, the cumulative benefits over the long term are better mother-to-child outcomes, reduced maternal mortality, reduced orphanhood, and increased school retention rates. Reducing the unit cost of procurement as well as delivery of services is one way to improve value for money. Antiretroviral therapy costs today are in many cases a fraction of what they used to be, due in large part to efficiency gained in service delivery and reduction in commodities prices (Figure 6.5). The median price of the most commonly prescribed regimen for adults has dropped to around US$ 0.17 per day. Prevention costs have also declined. Stopping a single case of infection among infants now costs a mere US$ 5 compared with thousands of dollars a few years ago. The cost of condoms has also declined to as low as US$ 0.04 per unit. Investment for the AIDS response must be predictable and sustainable As resource availability for HIV increased over the last decade, spending on HIV prevention, treatment, care and support have increased. Overall investments for the AIDS response grew by 82% between 2006 and 2008. Treatment and care programmes received 56% and HIV prevention programmes received 20% of the total resources available. Nearly 71 countries depend on international sources for funding more than 50% of their prevention activities. In contrast, the cost of treatment and care programmes on average appears to be shared equally between domestic sources and international sources. However, 26 countries reported that nearly 77% or more of their treatment and care expenditure relies on external sources (Figure 6.6, Figure 6.7 and Figure 6.8). At a time when demand for universal access for prevention and treatment is growing, lack of additional resources is slowing down the pace of achieving results for people. As countries strive to increase their investments for the AIDS response, attention is needed to make long-term resource availability predictable. ■

6

Chapter 6: HIV investments | 2010 GLOBAL REPORT

155

Figure 6.7

Annual HIV domestic and international spending
Annual HIV domestic public and international spending in current US dollars, total and per person living with HIV, among the 15 low- and middle-income countries with the highest spending, 2009 or last available year, international dollars (purchasing power parity).
Source: Country Progress Reports 2010

Income Level

Spending per person living with HIV (International dollars)

Total spending (US$ Millions)

South Africa Russian Federation Kenya Brazil Nigeria China Botswana Uganda Argentina Mexico Thailand Mozambique India Rwanda Colombia
UMI LMI LI $ 1 2
THOUSANDS

3

4

$

500

1000

1500

2000

2500

MILLIONS

UMI=Upper Middle Income

LMI=Lower Middle Income

LI=Low Income

Public

International

156

Chapter 6: HIV investments | 2010 GLOBAL REPORT

Figure 6.8

Regional HIV spending in low- and middle-income countries
Programme management and administration strengthening Enabling environment Social protection and social services Incentives for human resources

HIV spending in current US dollars by region and programmatic area in 106 low- and middle-income countries, 2009 or last available year.
Source: Country Progress Reports 2010.
Treatment and care

Orphans and vulnerable children

Prevention

Caribbean, North, Central, and South America East, South, and South-East Asia sub-Saharan Africa Eastern Europe and Central Asia Middle East and North Africa Oceania Western and Central Europe

All regions total US$ 6.5 billion

Research

6

Caribbean, North, Central, and South America total US$ 1.7 billion

Eastern Europe and Central Asia total US$ 978 million

Oceania total US$ 4.7 million Western and Central Europe total US$ 171.1 million

sub-Saharan Africa total US$ 2.8 billion

East, South, and South-East Asia total US$ 712.9 million

Middle East and North Africa total US$ 67.6 million

Chapter 6: HIV investments | 2010 GLOBAL REPORT

157

158

Chapter 6: HIV investments | 2010 GLOBAL REPORT

ACTION ITEMS

■ The AIDS response must be fully funded. This is a shared responsibility
between governments, donor countries, civil society and the private sector.

■ Donor countries must continue to increase their allocations to the AIDS
response.

■ Countries that have the potential to increase domestic investments must
do so to accelerate progress towards universal access to HIV prevention, treatment, care, and support.

■ Resources for AIDS programmes must be predictable. National strategic
plans must be realistic.

6

■ Each national programme should set priorities to ensure that available
resources are invested appropriately in cost-effective programmes.

■ Donor investments must match country priorities. ■ Investments must be evidence informed and reach populations most in need
first so that the returns are maximized and meet human rights standards.

■ HIV treatment programmes should be expanded urgently and utilize optimal
combinations of high-quality and less-toxic drugs that reduce mortality over the long term.

■ HIV prevention investments are cost-effective when they include combination approaches that maximize synergies rather than isolated interventions.

Chapter 6: HIV investments | 2010 GLOBAL REPORT

159

SCORECARD: HIV INVESTMENTS

Public International Data not available

% of HIV spending from public and international sources
Year Domestic priority to HIV Total prevention Total care and treatment Total HIV spending

25

50

75

25

50

75

25

50

75

%

%

%

SUB-SAHARAN AFRICA

Angola Benin Botswana Burkina Faso Burundi Cameroon Cape Verde

2009 2009 2008 2008 2008 2008 2009 2008 2008 2009 2008 2008 2009 2009 2009 2008 2008 2009 2009 2009 2008 2008 2009 2008 2008 2008 2008 2008 2009 2008 2009 2007 2009 2007 2008 2008 2009 2009 2009 2009 -

0.29 1.42 0.31 1.25 3.11 0.06 0.12 0.34 0.68 0.05 0.28 0.19 0.18 0.23 0.10 0.24 0.46 0.33 0.33 7.03 0.03 0.38 0.03 0.21 0.13 0.61 0.38 0.11 0.18 0.11 0.11 0.72 0.04 0.69 0.67 1.05 -

Central African Republic Chad Comoros Congo, Republic of the Côte d’Ivoire Democratic Republic of Congo Equatorial Guinea Eritrea Ethiopia Gabon Gambia Ghana Guinea Guinea-Bissau Kenya Lesotho Liberia Madagascar Malawi Mali Mauritania Mauritius Mozambique Namibia Niger Nigeria Rwanda Sao Tome and Principe Senegal Seychelles Sierra Leone South Africa Swaziland Togo Uganda United Republic of Tanzania Zambia Zimbabwe

EAST ASIA

China Japan Mongolia Republic of Korea

Democratic People’s Republic of Korea

160

Chapter 6: HIV investments | 2010 GLOBAL REPORT

% of HIV spending from public and international sources
Year Domestic priority to HIV Total prevention Total care and treatment Total HIV spending

25

50

75

25

50

75

25

50

75

%

%

%

OCEANIA

Australia Fiji Kiribati Marshall Islands

2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2008 2009 2008 2009 2009 2008 2007 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2008 2009 2008 2009

0.55 0.00 1.35 0.07 0.29 0.18 0.27 0.19 1.21 0.69 0.43 0.32 0.37 0.05 0.30 0.37 0.35 1.06 1.18 2.06 1.16 0.19 0.88 0.09 2.49

Micronesia, Federated States of Nauru New Zealand Palau Papua New Guinea Samoa Solomon Islands Tonga Tuvalu Vanuatu

SOUTH AND SOUTH-EAST ASIA

Afghanistan Bangladesh Bhutan Brunei Darussalam Cambodia India Indonesia

6

Lao People’s Democratic Republic Malaysia Maldives Myanmar Nepal Pakistan Philippines Singapore Sri Lanka Thailand Timor-Leste Viet Nam

EASTERN EUROPE AND CENTRAL ASIA

Armenia Azerbaijan Belarus Georgia Kazakhstan Kyrgyzstan Moldova Russian Federation Tajikistan Turkmenistan Ukraine Uzbekistan

Chapter 6: HIV investments | 2010 GLOBAL REPORT

161

16 0.02 0.05 0.90 6.05 0.63 2.70 0.05 2.00 0.09 0.37 0.00 MIDDLE EAST AND NORTH AFRICA Algeria Bahrain Djibouti 162 Chapter 6: HIV investments | 2010 GLOBAL REPORT .00 0.38 1.06 The Former Yugoslav Republic of Macedonia Turkey United Kingdom of Great Britain & Northern Ireland NORTH AMERICA Canada Mexico United States of America 2009 2009 2009 1.33 0.82 0.68 0.SCORECARD: HIV INVESTMENTS Public International Data not available % of HIV spending from public and international sources Year Domestic priority to HIV Total prevention Total care and treatment Total HIV spending 25 50 75 25 50 75 25 50 75 % % % WESTERN AND CENTRAL EUROPE Albania Andorra Austria Belgium Bosnia & Herzegovina Bulgaria Croatia Cyprus Czech Republic Denmark Estonia Finland France Germany Greece Hungary Iceland Ireland Israel Italy Latvia Liechtenstein Lithuania Luxembourg Malta Monaco Montenegro Netherlands Norway Poland Portugal Romania San Marino Serbia Slovakia Slovenia Spain Sweden Switzerland 2008 2009 2009 2009 2009 2008 2008 2009 2009 2009 2009 2009 2009 2009 2009 2009 2008 2009 0.65 0.

22 0.68 0.31 0.07 0.61 0.84 3.21 0.52 1.16 0.26 0.00 1.20 1.83 0.80 1.35 0.19 0.21 6 CARIBBEAN Antigua & Barbuda Bahamas Barbados Cuba Dominica Dominican Republic Grenada Haiti Jamaica Saint Kitts & Nevis Saint Lucia Saint Vincent & the Grenadines Trinidad & Tobago CENTRAL AND SOUTH AMERICA Argentina Belize Bolivia Brazil Chile Colombia Costa Rica Ecuador El Salvador Guatemala Guyana Honduras Nicaragua Panama Paraguay Peru Suriname Uruguay Venezuela Chapter 6: HIV investments | 2010 GLOBAL REPORT 163 .00 0.23 0.14 0.06 0.74 1.96 0. Islamic Republic of Iraq Jordan Kuwait Lebanon Libyan Arab Jamahiriya Morocco Oman Qatar Saudi Arabia Somalia Sudan Syrian Arab Republic Tunisia United Arab Emirates Yemen 2008 2008 2009 2009 2008 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2008 2009 2009 2009 2009 2008 2009 2009 2008 2008 2009 2008 2009 2008 2008 2008 2008 2008 2009 2009 2007 2009 0.% of HIV spending from public and international sources Year Domestic priority to HIV Total prevention Total care and treatment Total HIV spending 25 50 75 25 50 75 25 50 75 % % % MIDDLE EAST AND NORTH AFRICA Continued Egypt Iran.36 0.

and children in South Africa. Gregson S et al. World Health Organization. Hallett TB et al. Ministry of Health. 14. Porto-Novo. 2. UNICEF and UNAIDS. Demographic and Health Surveys [web site]. Progress report 2010. 2008. accessed 17 October 2010). HIV decline in Zimbabwe due to reductions in risky sex? Evidence from a comprehensive epidemiological review. 2):ii1–ii7. AIDS. 9. Population Division. 371:1294–1304. National AIDS Control Council. Department of Economic and Social Affairs. 5. 13. UNICEF and UNAIDS. 7. Estimated HIV trends and program effects in Botswana. doi:10. PLoS ONE.html. HSRC Press.measuredhs. accessed 17 October 2010). Gaborone. 2010 (http://www. Stover J et al.html. Progress report of the national response to the 2001 Declaration of Commitment on HIV and AIDS: Botswana country report 2010. 2004. 2008: the health of our children. 2010 (http://www. Population-level effect of HIV on adult mortality and early evidence of reversal after introduction of antiretroviral therapy in Malawi. 371:1603–1611.1093/ije/ dyq055. AIDS. 2010. babies. http://retroconference. Rehle T et al.int/hiv/pub/2010progressreport/report/en/index. MEASURE DHS. Cape Town. 2010.org/2010/ Abstracts/37244. Geneva.who. accessed 17 October 2010). National AIDS Coordinating Agency. 4. accessed 17 October 2010). 12. 2010 (http://www. United Nations. Cleland J et al. Botswana. who. 6. accessed 17 October 2010). Trends in HIV prevalence. Knowledge of HIV status. WHO. 3:e3729. Progress report 2010. ICF Macro. 164 References | 2010 GLOBAL REPORT . Berne.com. accessed 17 October 2010). Geneva. Every death counts: use of mortality audit data for decision making to save the lives of mothers. 23:1565–1573. 2007. San Francisco. Sexually Transmitted Infections. Towards universal access: scaling up priority HIV/AIDS interventions in the health sector. South African National HIV Prevalence. Science.htm. Anand A et al. youth. 8. ART-LINC. HIV decline associated with behavior change in eastern Zimbabwe. Lancet. Behaviour and Communication Survey. Nairobi. 3. 2008. 2010 (http://www. 3. Estimates of HIV incidence from household-based prevalence surveys. sexual risk behaviours and contraceptive need among people living with HIV in Kenya and Malawi. 2009. International Journal of Epidemiology. Population Division [web site]. Rapport de surveillance de l’infection par le VIH et de la syphilis au Benin. National AIDS/STI Control Programme.org/esa/population.int/hiv/pub/2010progressreport/report/en/index. 2010. Ministry of Health.un. Monitoring sexual behaviour in general populations: a synthesis of lessons of the past decade. 24:147–152. Chapter 2 1. Sentinel surveillance of HIV and AIDS in Kenya 2006. Every Death Counts Writing Group. 2010. World Health Organization. Lancet. 2008.org. California. Jahn A et al. New York. 11. Gregson S et al. WHO. Incidence. incidence. 10. Shisana O et al. Towards universal access: scaling up priority HIV/AIDS interventions in the health sector. 15. and adults in South Africa. 16–19 February 2010 (Abstract 37. 311:664–666. 17th Conference on Retroviruses and Opportunistic Infections.art-linc. 2010 (http://www. Benin. 2002 to 2008. Calverton. MD. and risk behaviors among children. 2. 2008. 80 (Suppl. USA. Antiretroviral Treatment in Lower Income Countries (ART-LINC) Collaboration [web site]. 2006.REFERENCES Chapter 1 1.

33. Kenya. and HIV among Southern African men who have sex with men. 2007. 2007. Koleros A. 21. 11–16 July 2004 (Abstract WePeC6001. Sexual concurrency. Ndiaye HD et al. Journal of Acquired Immune Deficiency Syndromes. 95:45–53. PLoS ONE. PLoS ONE. Smith AD et al. Federal Republic of Nigeria. 20. New heterosexually transmitted HIV infections in married or cohabiting couples in urban Zambia and Rwanda: an analysis of survey and clinical data. Uganda National AIDS Commission. Netherlands. 4:e4997. AIDS. 2009. Seroprevalence of HIV. 35. 23. Ameerberg SAG. Lesotho: HIV prevention response and modes of transmission analysis. HIV/STI integrated biological and behavioral surveillance survey (IBBSS) 2007. Uganda: HIV modes of transmission and prevention response analysis. 27. Lane T et al. National AIDS Control Commission. 3:e1411. bisexual practices. 52:249–252. Amsterdam. West Africa HIV/AIDS epidemiology and response synthesis: implications for prevention. 18. Kristin L et al. nlmnih. 2009. Abuja. 2008. Understanding the dynamics of the HIV epidemic in Rwanda: modeling the expected distribution of new HIV infections by exposure group. Federal Ministry of Health. Sanders EJ et al. Drug and Alcohol Dependence. 28. Swaziland: HIV prevention response and modes of transmission analysis. Sexually Transmitted Infections. http://gateway. Maseru. Asiimwe A. 2009. 32. Khobotlo M et al.16.1007/s10461-009-9598-y. AIDS and Behavior. 374:416–422. Mauritius Epidemiology Network on Drug Use report: January–June 2004. Magaret A. Mngadi S et al. Odek-Ogunde M et al. Kenya National AIDS Control Council. accessed 17 October 2010. 86:323–327. Lancet. Mauritius Epidemiology Network on Drug Use. MEASURE Evaluation. 21:2513–2520. HBC and HCV in injecting drug users in Nairobi. 2009. Nnaji I et al. AIDS Vaccine 06. 2008. World Bank. 22–25 May 2010 (Abstract 156). Pittsburgh. Gelmon L et al. risks for HIV infection. Port Louis. HIV prevalence. 19. 371:2183–2191. Parry C et al. Kigali. Sexual practices of MSM in Nigeria and interest in microbicides. Sulliman F. Kenya. Thailand. 2009. 29 August – 1 September 2006 (http://www. Lancet. 2009. Establishing a high risk HIV-negative cohort in Kilifi. 2008. High HIV prevalence among men who have sex with men in Soweto. Regional differences in prevalence of HIV-1 discordance in Africa and enrolment of HIV-1 discordant couples into an HIV-1 prevention trial. South Africa: results from the Soweto men’s study. 29. AIDS. Namibia. Bangkok. cfm?sUID=247babfc-305d-4a0c-94b1-e4120ca23160. 17. Kenya: HIV prevention response and modes of transmission analysis. XV International Conference on AIDS. 30. Baral S et al. 24. Kampala. 34. Men who have sex with men and HIV/AIDS in sub-Saharan Africa. Beyrer C et al.com/serveFile. Mbabane. Kenya: World Health Organization Drug Injecting Study Phase II findings. 22. HIV infection and sexually transmitted infections among men who have sex with men in Senegal. 2009. National Emergency Response Council on HIV/AIDS. 19:2133–2140. Chapman J. 2009. 2008. Nairobi. Wade AS et al. Sanders EJ et al. References | 2010 GLOBAL REPORT 165 R .html. and human rights among men who have sex with men (MSM) in Malawi. and Botswana. 26. 25. 2009. Surprisingly high prevalence of subtype C and specific HIV-1 subtype/CRF distribution in men having sex with men in Senegal.intmedpress. 2005. Microbicides: Building Bridges in HIV Prevention. accessed 17 October 2010). 36. HIV-1 infection in high risk men who have sex with men in Mombasa. Washington. Lowndes CM et al. 2010. Lesotho National AIDS Commission. DC. Rapid assessment of drug-related HIV risk among men who have sex with men in three South African cities. Wabwire-Mangen F et al.gov/MeetingAbstracts/ma?f=102283927. DOI:10. 2004. Pennsylvania. 31.

Tran TN et al. Dahoma MJU et al. 8–11 February 2009 (oral presentation 171LB. Rising HIV prevalence among married and unmarried men who have sex with men: Jinan. Wimonsate W et al.pdf. Indonesia. 53. General Department of Preventive Medicine and HIV/AIDS Control. 38. Lao People’s Democratic Republic. HIV/AIDS estimates and projections 2005–2010. 43. 5):S35–S44. Report of the HIV sentinel sero-surveilance survey 2008 – Myanmar. Hanoi. 18:486–492. Government of Myanmar. Impact of an intensive HIV prevention programme for female sex workers on HIV prevalence among antenatal clinic attenders in Karnataka State. The 2007 estimates for people at risk for and living with HIV in China: progress and challenges. 50. 22(Suppl. Kien Giang and Dong Thap Provinces. estimated HIV incidence. Thailand. National AIDS Commission. Pakistan: an emerging epidemic in injecting and commercial sex networks. Jakarta. Mexico City. 2008. HIV risk in Karachi and Lahore. STI and unprotected anal intercourse among men who have sex with men and men who have sex with men and women in Tamil Nadu. accessed 17 October 2010). 48. Viet Nam Commission for Population.or/Pag/PSession. 55.37. Canada. 2008. 17th International AIDS Conference. Monitoring the impact of project community’s action for AIDS prevention and control in Dien Bien. National AIDS Programme. Vietnam. 53:234–239. Ministry of Public Health. 2005. 46. 2009. http://img. 49. 40. Trends in HIV prevalence. China. follow-up and HIV incidence data. Hanoi. 166 References | 2010 GLOBAL REPORT . Sexual practices. Wang L et al. Mexico. 2009. Ramesh BM et al.com/confs/croi2009/posters/171LB_Solomon_slides. Ministry of Health and Family Welfare. Viwatwongkasem C. 5):S45–S57. Thailand. Bokhari A et al. 5): S101–S108. AIDS. High prevalence of HIV. 22(Suppl. 2009. Journal of Acquired Immune Deficiency Syndromes. 2006. 2008. AIDS and Behavior. 2008. 2008. 23:409–414. Solomon SS et al. AIDS. BMC Public Health. http://www. Quang Tri. 16th Conference on Retroviruses and Opportunistic Infections. 2007. 41. AIDS. Montreal. 22(Suppl. 52. HIV prevalence and factors associated with HIV infection among male injecting drug users under 30: a cross-sectional study in Long An. New Delhi. Viet Nam. Yangon. 2:1143–1152. Nonthaburi. 2008. Mathers BM et al. 372:1733–1745. 47. An Giang.aids2008. 2010. Trends in three decades of HIV/AIDS epidemic in Thailand by nonparametric backcalculation method.aspx?s=246. HIV and sexually transmitted infections among selfidentified men who have sex with men in four high HIV prevalence states in India. 2007. 42. 50:414–418. UNGASS country progress report 2008: India. Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. 2005. 44. Punyacharoensin N. National AIDS Prevention and Alleviation Committee. 3–8 August 2008 (Abstract MOAC0105.thebody. 2009. Sheridan S et al. Country report on the follow-up to the Declaration of Commitment on HIV/AIDS. van Griensven J et al. South India. Ministry of Health. 6:248. Determinants of HIV prevalence among female sex workers in four south Indian states: analysis of cross-sectional surveys in twenty-three districts. Journal of Acquired Immune Deficiency Syndromes. 56. 2009. 2003–2007. AIDS. International Journal of STD and AIDS. Brahmam GNV et al. 13:671–676. HIV prevalence and risk behaviour among men who have sex with men in Vientiane Capital. 54. Moses S et al. National AIDS Control Organisation. accessed 17 October 2010). Thailand: Preliminary baseline. 2006. UNGASS country progress report – Thailand. Lancet. 51. 45. AIDS. 39. Successful start of a preparatory HIV cohort study among men who have sex with men (MSM) in Bangkok. Ruan S et al. India. HIV and substance abuse: the dual epidemics challenging Zanzibar. and risk behavior among men who have sex with men in Bangkok. 2008. 5:129–138. African Journal of Drug and Alcohol Studies.

2008 (http://www. 2007. 64. van de Laar MJ et al. West Indian Medical Journal. 2007. EuroHIV. Secretaría de Estado de Salud Pública y Asistencia Social de República Dominicana. 2009. HIV/AIDS surveillance in Europe: end-year report 2005. United States Agency for International Development. 67. UNAIDS. 66. Country progress report to the Secretary General of the United Nations on the United Nations General Assembly Special Session. syphilis. Washington. HIV among injecting drug users: current epidemiology. 71. Report on the global AIDS epidemic. Secretaría de Estado de Salud Pública y Asistencia Social de República Dominicana. Estimation de la séroprevalence du VIH en Haïti en 2007 selon le milieu de residence urbain et rural pour chacun des 10 départments. Resultados Preliminares de las Estimaciones de VIH/SIDA Nacionales de la República Dominicana 2006. Rapidly increasing prevalence of HIV and syphilis and HIV-1 subtype characterization among men who have sex with men in Jiangsu. 61.unaids. Baral S et al. 13:318–327. 2007. Kyiv. 45:581–587. 4:300–307. 2008. 4:308–313. 2006. Santo Domingo. 62. 2007. Dolan K et al. Jamaica. 2008. hepatitis C. 65. 29). China. 2007. hepatitis B. accessed 17 October 2010). Gaillard EM. HIV/AIDS surveillance in Europe: end-year report 2006. accessed 17 October 2010). 2004 through 2006. Lancet Infectious Diseases. The HIV epidemic in the Caribbean: meeting the challenges of achieving universal access to prevention. Current Opinions in HIV and AIDS. 70. 2007. Sexually Transmitted Infections. 76. Geneva. 2009 (http://www. 68. 2009. biologic markers. República Dominicana: encuesta demográfica y de salud 2007 (ENDESA 2007): resultados básicos. 2007. Geneva. Des Jarlais DC et al. Eurosurveillance. 2005. and sexual risk behavior among men who have sex with men: results of 3 consecutive respondent-driven sampling surveys in Beijing. Sexually Transmitted Diseases. The global epidemic of HIV infection among men who have sex with men. Li A et al. 77.org/en/KnowledgeCentre/Resources/FeatureStories/archive/2009/20090126_ MSMUkraine. Guo H et al. Encuestas de vigilancia del comportamiento sobre VIH/ SIDA/ ITS en RSX y HSH del Área V de Salud. Ma X et al. 73. Centro de Estudios Sociales y Demográficos and Macro Internacional Inc. 2009. Santo Domingo. Santo Domingo. 4:e339. 58. Kruglov YV et al. 75. AIDS and Behavior. 74. Ministry of Health. Eustache L. 75.org/en/ KnowledgeCentre/HIVData/GlobalReport/2008. Institut de Veille Sanitaire. Elevated risk for HIV infection among men who have sex with men in low. PLoS Medicine.57. No. Caribbean Epidemiology Centre. Trends in prevalence of HIV. 84(Suppl.unaids. Sexual behavior and risk factors for HIV infection among homosexual and bisexual men in Thailand. Port of Spain. The most severe HIV epidemic in Europe: Ukraine’s national HIV prevalence estimates for 2007. EuroHIV. 72. 2009. CAREC annual report 2007. 7:32–41. HIV infection in Ukraine in 2007. Figueroa JP. National HIV Programme. and supervised-injection facilities. Current Opinions in HIV and AIDS. 69. HIV/AIDS surveillance in Europe: update 2007. 59. DC. R References | 2010 GLOBAL REPORT 167 .and middle-income countries 2000–2006: a systematic review. UNAIDS. Saint-Maurice. Van Griensven F et al. Hidden HIV epidemic amongst MSM in Eastern Europe and Central Asia. 2008. 63. 2008 (Information Bulletin No. respondent-driven sampling. 2008. Institut de Veille Sanitaire. 36:120–125. HIV in prison in low-income and middle-income countries. No. 60. 13(50):pii=19066. Saint-Maurice. National AIDS Prevention Centre & Ministry of Health. 1):i37–i41. 73.asp. treatment and care. 57:195–203. Journal of Acquired Immune Deficiency Syndromes. 2008.

Chile. 2009. ANRS. 2007.unaids. Trans and Intersex Association. Sentinel surveillance of sexually transmitted infections/HIV and risk behaviors in vulnerable populations in 5 Central American countries. 84. 58:589–591. Recently acquired HIV infection in men who have sex with men (MSM) in France. 87. accessed 17 October 2010. 14(48):pii=19425. Journal of Acquired Immune Deficiency Syndromes. HIV prevalence and risk factors in a Brazilian penitentiary. 97. Journal of Acquired Immune Deficiency Syndromes. 2007. Sabidó M et al. 2000–2006: implications for a European public health strategy.78. Guatemala City. 2008. 23:2197–2204. 80. Journal of Acquired Immune Deficiency Syndromes. Cadernos de Saúde Pública. AIDS knowledge. Understanding the HIV epidemic in the Dominican Republic: a prevention success story in the Caribbean? Journal of Acquired Immune Deficiency Syndromes. 46:101–111. 90. 2005. Washington. Modos de transmisión del VIH en América Latina: resultados de la aplicación del modelo. State-sponsored homophobia: a world survey of laws prohibiting same sex activity between consenting adults. DC. Ottosson D. Sonsonate y San Vicente. Eurosurveillance. Inserm and Ined. 2007. Santa Ana. Barrientos JE et al. 23:1777–1784. Pan American Health Organization. French National Agency for Research on AIDS and Viral Hepatitis (ANRS). Population Services International. 2006. The UALE project: decline in the incidence of HIV and sexually transmitted infections and increase in the use of condoms among sex workers in Guatemala. Likatavicius G et al. Hall HI et al. 94. Alarcón Villaverde JO. 2009. 2009. 1996–2005. 89. 51(Suppl. sifilis y comportamiento en hombres que tienen sexo con hombres en la gran areas metropolitana de Costa Rica. BMC Infectious Diseases. Annals of Epidemiology. 13(49):pii=1909. San Miguel. Western Europe. 2009. 1):S52–S59. 51(Suppl. 2008 (http://data. 2008. An increase in newly diagnosed HIV cases reported among men who have sex with men in Europe. 2008. AIDS. 51(Suppl. Sexually Transmitted Infections. Halperin DT et al. Situation of HIV infections and STIs in the United Kingdom in 2007. Sanchez J et al. United States Centers for Disease Control and Prevention. 2009. Sullivan PS et al. San Jose. Coelho HC et al. Paris. 85. Cadernos de Saúde Pública. International Lesbian. 86. Lattimore S et al. Presidential Commission on HIV and AIDS. Argentina. 168 References | 2010 GLOBAL REPORT . 2008.org/pub/Report/2008/guyana_2008_ country_progress_report_en. 91. 88. Epidemiological surveillance report. HIV prevalence. 98. Re-emergence of the HIV epidemic among men who have sex with men in North America. and condom use among female sex workers in Santiago. Semaille C et al. 7:130. Gay. Estudio de seroprevalencia del virus de immunodeficiencia humana. 22:1071–1077. Buenos Aires. UNGASS country progress report: Republic of Guyana. Estudio TRaC de VIH/SIDA entre trabajadoras sexuales femeninas en San Salvador. 300:520–529. Georgetown. Incidence and diagnoses of HIV infection – Puerto Rico. The HIV/AIDS epidemic in Cuba: description and tentative explanation of its low HIV prevalence. Soto RJ et al. 96. 95. 19:423–431. 79. 82. Eurosurveillance. 83.pdf. 2008. Bezemer D et al. Journal of the American Medical Association. A resurgent HIV-1 epidemic among men who have sex with men in the era of potent antiretroviral therapy. Estimation of HIV incidence in the United States. 92. 2009. 2009. 2003–2008. 2009. 1):S47–S51. 93. 2007. 84:499–505. and Australia. First results of the CSF survey – context of sexuality in France. High HIV and ulcerative transmitted infection incidence estimates among men who have sex with men in Peru: awaiting an effective preventive intervention. 1):S35–S41. MMWR – Morbidity and Mortality Weekly Report. Ministerio de Salud de Costa Rica. National AIDS Program. 2007. de Arazoza H et al. 2008. Government of Guyana. 81. Bisexual. Brussels.

Patterson TL et al. 101. 112. Haff J. 51(Suppl. 110. Sydney. Melbourne.nacs. Coghlan B et al. 83:299–307. Jansen I et al.pdf. 111. Spain. 2007. 115. 2006. 2009.org/pub/Report/2010/iran_2010_country_ progress_report_en. 2010 (http://www. Characterizing the HIV/AIDS epidemic in the Middle East and North Africa: time for strategic action. 20 October 2005. Zamani S et al. 2009. Mexico. National Centre in HIV Epidemiology and Clinical Research. Guy RJ et al. accessed 17 October 2010). Tehran.99. Abu-Raddad LJ et al. Sexually transmitted infections. Annual surveillance report 2009. R References | 2010 GLOBAL REPORT 169 . social. Summary: estimate of HIV prevalence and incidence in Canada. van den Broek IVF et al. Australian Health Review. 109. HIV and risk behaviour among men who have sex with men in Denmark – the 2006 Sex Life Survey. National AIDS Committee Secretariat.pg/resources/documents/ The_2007_Estimation_Report_on_the_HIV_Epidemic_in_PNG. Journal of Infectious Diseases. 100. 14(47):pii=19415. Journal of Acquired Immune Deficiency Syndromes. California. Shawky W et al. 107. Scaling up HIV/AIDS prevention and care in Iranian prisons [slide presentation].html. 2008. Eurosurveillance. The 2007 estimation report on the HIV epidemic in Papua-New Guinea. Australia. 47:369–376. Tehran. org/2010/Abstracts/37331. Ministry of Health and Medical Education. Public Health Agency of Canada. accessed 17 October 2010). Sexual risk behaviour and its determinants among men who have sex with men in Catalonia. 2008. World Health Organization. Journal of Acquired Immune Deficiency Syndromes.org. 102. 17th Conference on Retroviruses and Opportunistic Infections. 13(48):pii=19050. 2004–2005. 2008 (http://www. 116. 118. DC. Cowan SA. Progress report 2009.pdf. 2006. 104. Journal of Acquired Immune Deficiency Syndromes. High prevalence of HIV infection associated with incarceration among communitybased drug users in Tehran. 2009. 2010. Burnet Institute. 114. 106. Towards universal access: scaling up priority HIV/AIDS interventions in the health sector. 16–19 February 2010 (Abstract 35. Brouwer KC et al.unaids. 197:728–732. Journal of Urban Health. Prevalence and correlates of HIV infection among female sex workers in 2 Mexico-US border cities. 117. 42:342–346. 113. and environmental influences associated with HIV infection among injection drug users in Tijuana. 49:294–297. On Monitoring of the United Nations General Assembly Special Session on HIV and AIDS: Islamic Republic of Iran country report. National Institute for Public Health and the Environment. Bilthoven. UNICEF and UNAIDS. Prevalence and correlates of hepatitis C infection among male injection drug users in detention. HIV diagnoses in Australia: diverging epidemics within a low-prevalence country. 2008.int/hiv/2009progressreport/report/en/index. Estimating the lifetime risk of a diagnosis of the HIV infection in 33 states. Mexico. HIV in the Pacific: 1984–2007. Washington. 2009. HIV surveillance and epidemic profile in the Middle East and North Africa. Journal of Urban Health.htm. Hall HI et al. in the Netherlands in 2007. USA. accessed 17 October 2010). World Bank. San Francisco. Port Moresby. Parviz A. Kheirandish P et al. 1):S83–S95. 105. Netherlands. Journal of Acquired Immune Deficiency Syndromes. 108. Folch C et al. University of New South Wales. HIV/AIDS. 2008. 103. Ottawa. Strathdee SA et al. Australia. including HIV. 2009. 2010 (http://data. Iran. accessed 17 October 2010). WHO. Eurosurveillance. 86:902–908. 2008.who. 2009. National AIDS Council and National Department of Health. 2008. Geneva. Increasing trend in HIV-1 incidence among young men who have sex with men in Amsterdam: a 25-year prospective cohort study. http://retroconference. 187:437–440. Meeting of the World Health Organization Strategic and Technical Advisory Committee for HIV. viral hepatitis and sexually transmissible infections in Australia. Individual. Iran. Estimated numbers of men and women infected with HIV/AIDS in Tijuana.

The Global Forum on MSM and HIV (MSMGF) Civil Society Consultation: MSM and Transgender Values and Preferences Regarding HIV.who. 2:8. in press. Kenya HIV prevention response and modes of transmission analysis. A proxy measure for HIV incidence among populations at increased risk to HIV. National Drug and Alcohol Research Centre. 10. Seattle. Increased condom use and decreased HIV/STI prevalence among female sex workers following a targeted prevention program in Karnataka. New HIV infections by mode of transmission in West Africa: a multi-country analysis. University of New South Wales. Ministry of Health and MEASURE Evaluation. 20. 18th International AIDS Conference. International Group on Analysis of Trends in HIV Prevalence. Zambia Sexual Behaviour Survey 2000. 3. Central Statistical Office and MEASURE Evaluation.org/en/ KnowledgeCentre/HIVData/CountryProgress/2010CountryProgressAllCountries. 2010.int/hiv/pub/idu/targetsetting/en/index. 13. Calverton. UNODC and UNAIDS. 18. Analysis of HIV prevention response and modes of HIV transmission: the UNAIDSGAMET supported synthesis process. Technical guide for countries to set targets for universal access to HIV prevention. Global Health Program. 2009. 11. 2008.. regional and national coverage. MD. 2010. Ukrainian Institute of Public Health Policy. New Delhi. 6. in press. WHO.asp. accessed 17 October 2010). 170 References | 2010 GLOBAL REPORT . 5. Lusaka. Ministry of Health. Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. 14. Central Statistical Office and MEASURE Evaluation.pdf. 2010. 7. Mahy M et al. 2002.Chapter 3 1. Lusaka. Mathers B et al. 19. Kenya National AIDS Control Council. 15. treatment and care for people who inject drugs: a systematic review of global.and STI-related Services. 2004. HIV prevention. 17.org/Session. 4. and Macro International Inc. Lusaka. 8. Geneva. Kiev. Central Statistical Office. 2010. Sexually Transmitted Infections. Lancet. Dakar. University of Zambia. Central Statistical Office. 2009. Sunninghill. Geneva. 2010 (http://www. Avahan—the India AIDS initiative: fact sheet. 2009.html. University of Zambia and MEASURE Evaluation. 2009. 372:1733–1745. Journal of HIV/AIDS Surveillance and Epidemiology. Nairobi. Zambia Demographic and Health Survey 2007. Bill & Melinda Gates Foundation. Lusaka. Central Statistical Office. Zambia Sexual Behaviour Survey 2005. UNAIDS. accessed 17 October 2010). experience and needs. Central Statistical Office and MEASURE Evaluation. Trends in HIV prevalence and sexual behaviour among young people aged 15–24 years in countries most affected by HIV. Sydney. Zambia Sexual Behaviour Survey 2009. Senegal. Geneva. Bi-weekly OST monitoring report.unaids. 375:1014–1028. Redefining AIDS in Asia: crafting an effective response. Secretariat to the Reference Group to the United Nations on HIV and Injecting Drug Use. Colvin M et al. Ministry of Health and MEASURE Evaluation. 2006. UNAIDS Regional Support Team for Eastern and Southern Africa. Women who inject drugs: a review of their risks. UNAIDS Regional Support Team for West and Central Africa. UNAIDS/World Bank. Oxford University Press. South India. Central Statistical Office. 2009 (http://www. World Health Organization. Country Progress Reports 2010 [web site]. World Health Organization. 18–23 July 2010 (http://pag. accessed 17 October 2010). 9. 16. Moses S et al. 12.aids2010.unaidsrstesa. Ministry of Health and MEASURE Evaluation. 2009 (http://www. treatment and care for injecting drug users. 2008. in press. accessed 17 October 2010). Mathers B et al.aspz?s=439. Ministry of Health. Zambia Sexual Behaviour Survey 2003. Central Statistical Office. 2. CSO and Macro International Inc. Lancet. Commission on AIDS in Asia. Australia. Austria. Vienna. Central Statistical Office and MEASURE Evaluation. Tropical Diseases Research Centre.org/files/MoT_0.

int/hiv/pub/2010progressreport/report/en/index. HIV and risk environment for people who inject drugs: the past. Food insufficiency is associated with high risk sexual behaviour among women in Botswana and Swaziland. 2010.int/hiv/pub/ arv/adult2010/en/index. 2010. 10:113–130.org/ userfiles/file/womenGirls_AgeDisparate.malecircumcision. 2010 (http://www. accessed 17 October 2010). Weiser SD et al. Science.html. Geneva. Sex Education: Sexuality. UNICEF and UNAIDS. Effectiveness and safety of tenofovir gel. Intergenerational/age-disparate sex: policy and programme action brief. 2008 (http://www. The short-term impacts of a schooling conditional cash transfer programme on the sexual behavior of young women. accessed 17 October 2010). R Chapter 4 1. 29. Abdool Karim Q. Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach. Gichuru M. New York. World Health Organization. Miller CL et al. WHO. 2010 (DOI:10. 2010 (http://www. 2007. 30. Baird S et al. Community and Environment (IDCE). Food insecurity in the context of HIV and AIDS 2031. 55:137–138. Frega R et al. Clark University and International Center for Research on Women (ICRW). Clearinghouse on Male Circumcision for HIV Prevention. present.who.org/unsd/mdg. Clark University and International Center for Research on Women. Oyefara JL. AIDS Behavior. Wildish J. 2010. DC. United Nations Statistics Division. 2010 (http://siteresources. Thirty-month quasi-experimental evaluation follow-up of a national primary school HIV intervention in Kenya. UNAIDS Regional Support Team for West and Central Africa. for the prevention of HIV infection in women. 25. Geneva. 28. World Bank. 26. Lancet. accessed 17 October 2010). 2009 (Policy Research Working Paper 5089).who. 35.pdf.worldbank. 2010. 2010. Durham. accessed 17 October 2010).org/publications/meeting_reports. Revolutionizing the AIDS response: building AIDS resilient communities.1007/s10461-0109693-0). 32. Washington. International Development. Strathdee SA et al. 2. Technical Meeting on Young Women in HIV Hyper-endemic Countries in Southern Africa. 2010 (http://www. accessed 17 October 2010). Millennium Development Goals indicators [database]. References | 2010 GLOBAL REPORT 171 .unaidsrstesa. accessed 17 October 2010). Maticka-Tyndale E. Food insecurity and sexual risk in an HIV endemic community in Uganda. Progress report 2010. HIV/AIDS pandemic and sexual behaviour of female commercial sex workers in Lagos metropolis. accessed 17 October 2010). 2007:1576–1577. Community and Environment. Towards universal access: scaling up priority HIV/AIDS interventions in the health sector. Food insecurity. Towards universal access: scaling up priority HIV/AIDS interventions in the health sector. Meeting reports and presentations [web site]. World Health Organization. Progress report 2010.21. Sunninghill. MA. World Health Organization. 23. DC. aids2031 Social Drivers Working Group. 2010 (http://www. 34. Worcester. 33. an antiretroviral microbicide. 27. A cash transfer program reduces HIV infections among adolescent girls. Leclerc-Madlala S.html. World Health Organization.org/DEC/Resources/HIVExeSummary%28Malawi%29. and future.int/hiv/pub/2010progressreport/report/en/index. 31.un. 376:268–284. PLoS Medicine. NC. 24. World Bank.pdf. Washington. 4:626–635. 2010 (http://unstats. Nigeria. United Nations Children’s Fund and UNAIDS. HIV treatment as prevention: to be or not to be? Journal of Acquired Immune Deficiency Syndromes. Society and Learning. Cohen M. 22. SAHARA J: Journal of Social Aspects of HIV/AIDS Research Alliance. 2010 revision. International Development. Geneva.html.html.who. 2010. 329:1168–1174.

AIDS. Girardi E et al. PLoS One. 5th IAS Conference on HIV Pathogenesis. 2009 (http://ecdc. http://www.org/pag/Abstracts. Shumbusho F et al.org/pag/Abstracts. Lancet. Schneider H. Wood R et al. 2010 (http://www. Shulman D et al.europa. 18. 3–8 August 2008 (Abstract WEAX0105. Golub J et al. regional and national coverage. Qualitative analysis of 2010 UNGASS country progress reports. Badri M. United Nations Development Programme. accessed 17 October 2010). 5th IAS Conference on HIV Pathogenesis. aspx?AID=3370. 6:e1000163. Task-shifting in the pharmacy: a framework for expanding and strengthening services in rural Malawi.aspx?AID=3253. Task shifting for scale-up of HIV care: evaluation of nurse-centered antiretroviral treatment at rural health centers in Rwanda. accessed 17 October 2010). 359:2059–2064. University of New South Wales. http://www. Geneva. Brazil.int/tb/en. New York. World Health Organization. 7. 2010 (http://www. 4. 5th IAS Conference on HIV Pathogenesis. Nurse management is not inferior to doctor management of ARV patients: the CIPRA South Africa randomized trial. Tuberculosis and Malaria. Mexico. A systematic review of task-shifting for HIV treatment and care in Africa.aids2008. Human Resources for Health. 5. 14. 19–22 July 2009 (Abstract TUPED133.unaids. South Africa. Task shifting to mid-level clinical health providers: an evaluation of quality of ART provided by tecnicos de medicina and physicians in Mozambique. http://www. Lancet. Geneva. 12.who. National Centre in HIV Social Research. 19–22 July 2009 (Abstract LBPED03. Migrant health: access to HIV prevention.ias2009. The world health report 2006—Working together for health. 8. 16. accessed 17 October 2010).aspx?AID=3822.org/en/KnowledgeCentre/HIVData/CountryProgress/2010CountryProgressAll Countries. Callaghan M. Gimbel-Sherr K et al. Incidence of tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America. 375:1014–1028. Global tuberculosis control: epidemiology. XVII International AIDS Conference. 9. Treatment and Prevention. 2010. accessed 17 October 2010). 2007. Country Progress Reports 2010 [web site].org/ pag/Abstracts.org/pag/ Abstracts. 2002. 2010. Ford N. http://www. Sydney.int/whr2006/en. World Health Organization. 2010.aspx?SID=321&AID=12944. PLoS Medicine. Mexico City.3. 2006 (http://www. 13.pdf. 41:1772–1782. Ellard J. A nurse-centered primary health care model for HIV care of patients with active tuberculosis: antiretroviral treatment initiation decision making. UNAIDS and the Global Fund to Fight AIDS. 172 References | 2010 GLOBAL REPORT . 2009. UNDP. 6. European Centre for Disease Prevention and Control. UNAIDS. 2010. 19–22 July 2009 (Abstract CDD094. Chapter 5 1. 2005. Lugada E et al. Stockholm. Cape Town. Geneva.ias2009. Human rights programmes in Global Fund–supported HIV responses in Rounds 6 and 7. The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIV-infected patients in Rio de Janeiro. Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study. accessed 17 October 2010). accessed 17 October 2010). strategy financing: WHO report 2010.asp. Cape Town. Treatment and Prevention. Treatment and Prevention.eu/en/publications/Publications/0907_TER_Migrant_health_HIV_Access_to_ treatment. Wood R. Cape Town. 17. Clinical and Infectious Diseases. 10. Rapid implementation of an integrated large scale HIV testing and counseling malaria and diarrhea prevention campaign in rural Kenya. De Wit JBF. Van Rie A et al. Wilson D. 8:8. Mathers B et al. 21:1441–1448. 15. in press.who. HIV prevention. accessed 17 October 2010). South Africa.ias2009. treatment and care for migrant populations in EU/EEA countries. 11. South Africa. treatment and care for people who inject drugs: a systematic review of global. accessed 17 October 2010). 5(8).

Lesotho. accessed 17 October 2010). DC.20. International Gay and Lesbian Human Rights Commission. New York. Toronto. PCB NGO Representatives. Kigali. treatment.pdf. 22–24 June 2010: report by the PCB NGO representative. World Policy Institute. accessed 17 October 2010). Asunción. 2010 (http://data. Sexual orientation and human rights in the Americas. 2009.org/english/bodies/ hrcouncil/docs/14session/A. 14. accessed 17 October 2010). Lancet Infectious Diseases. HIV. People living with HIV Stigma Index study Rwanda. accessed 17 October 2010). Global Database on HIV-specific Travel and Residence Restrictions [online database]. 2003.pdf.icaso. 12.unaids. Geneva. Geneva. Country Progress Reports 2010 [web site]. 19. Kenya. China Central Party School. International Gay and Lesbian Human Rights Commission. 5. Violence on the basis of sexual orientation. UNAIDS. UNAIDS. Report of the Special Rapporteur on the right of everyone to the enjoyment of the highest attainable standard of physical and mental health. UNAIDS. Bisexual.pdf. org/pub/BaseDocument/2010/20100728_hr_poster_en. RRP+ and UNAIDS. 2009. accessed 17 October 2010).hivtravel. human rights. Grover A. CNLS. 6. accessed 17 October 2010). 26th Meeting of the UNAIDS Programme Coordinating Board. Reding A. Institute of Social Development Research. New York. German AIDS Federation.asp. Global Network of People Living with HIV/AIDS. Johnson CA. Trans and Intersex Association. Ottosson D. AVVAIS. Brussels.2. London. Switzerland. 17. 3. R References | 2010 GLOBAL REPORT 173 .state. 7.org/resources/shadow2010_Honduras_2010_UNGASS_ ShadowReport. UNAIDS. Give Stigma the Index Finger! People living with HIV Stigma Index study Scotland.org.HRC. International Council of AIDS Service Organizations. Off the map: how HIV/AIDS programming is failing same-sex practicing people in Africa. International Lesbian.ohchr.org/pub/Agenda/2010/20100504_ngo_report_final_en. GIPA Report Card: pilot phase report. 8. People living with HIV Stigma Index study China. 2010 (http://www. European AIDS Treatment Group and International AIDS Society. Brussels. Making the law work for the HIV response: a snapshot of selected laws that support or block universal access to HIV prevention. stay and residence of people living with HIV.14.htm.pdf. 2009 country reports on human rights practices [web site]. New York. and men who have sex with men. Fundación Vencer and New York. 4. 13. gender identity and gender expression against nonheteronormative women in Asia. 16. Observatorio Ciudadano desde la Sociedad Civil para el Monitoreo sobre los progresos realizados en la aplicación del UNGASS Honduras 2010. 2009. 10:448–449. Geneva. Office of the United Nations High Commissioner for Human Rights. India. Sydney. 18. accessed 17 October 2010). 2010 (http://data. Geneva. International Planned Parenthood Federation. 2007. Washington. care and support. 20. Amsterdam.gov/g/drl/rls/hrrpt/2009/index.unaids. Qualitative analysis of UNGASS 2010 country progress reports. 2008. State-sponsored homophobia—a world survey of laws prohibiting same sex activities between consenting adults. 2010. Mapping of restrictions on entry. 9. United Nations Population Fund. Senior K. 2010. Geneva. Anand Grover. 15. 2009. 11. Trinidad and Tobago. 2010 (http://www. University of New South Wales. Gay. Beijing. 2010 (http://www. United States Separtment of State. Índice de Estigma de personas que viven con VIG e SIDA en Paraguay. 2010. Geneva. 2010 (http://www2.org/en/KnowledgeCentre/HIVData/CountryProgress/2010CountryProgressAll Countries.unaids. 2010 (http://www. 2010. 10.

accessed 17 October 2010). accessed 17 October 2010). 33.pdf. White R. punitive laws.21. Koester S. 29. and human rights in central and eastern Europe and central Asia. 38. Hanson C. Agenda for accelerated country action for women. 23. 4):S5–S16.int/gender/women_health_report/en/index. New York. 2009 (http://data. Sex work. AIDS. 2008 (DOI:10. accessed 17 October 2010).org/pub/report/2009/intimate_partners_report_en. AIDS. People who use drugs.org. and policing practices. The global criminalization scan report 2010: documenting trends. 26. World Health Organization. 2010 (http://www. presenting evidence. 22.pdf. policies. UNAIDS. 25. Bisexual concurrency.pdf. Federative Republic of Brazil. 2009 (http://www. HIV transmission in intimate partner relationships in Asia. Gouws E et al. 2010. 37.unaids. 32. gender equality and HIV. policing policy. UNAIDS.unaids.lambda.org/en/ AboutUNAIDS/Goals/2006Declaration. accessed 17 October 2010). 27. Lancet. “Women’s bodies are shops”: beliefs about transactional sex and implications for understanding gender power and HIV prevention in Tanzania. 30:548–559.gnpplus. United Nations Population Fund. Wamoyi J et al. Blankenship KM. 2002. 35. 2010. Global Network of People Living with HIV. Human Rights Watch and the International Harm Reduction Association. 33:501–523. Population Services Mozambique.ca/ coaction/index. Open Society Institute. http://journals. bisexual partnerships. 2005.php/gha/article/viewArticle/1837. HIV control in low-income countries in sub-Saharan Africa: are the right things done? Global Health Action. girls. 30. Lambda—Mozambican Association for Sexual Minority Rights. Population and Development Review. What works for women and girls: evidence for HIV/AIDS interventions. Sero-discordant couples in five African countries: implications for prevention strategies. 2):S35–S43.hrw. New York. Lancet. and human rights. Criminal law. accessed 17 October 2010). 2010. 2008. Jürgens R et al. HIV/AIDS. Men who have sex with men and HIV/AIDS in sub-Saharan Africa. Smith AD et al. 2009. Gender and AIDS: time to act. 2007. Beyer C et al. Health and Society. National STD and AIDS Commission. Ministry of Health. accessed 17 October 2010).sfu. Study about vulnerability and risk to HIV infection among men who have sex with men in Maputo city. Journal of Law and Medical Ethics. 2009 (http://www. Geneva. 374:416–422.html. Geneva. 34. Political Declaration on HIV/AIDS. and HIV/AIDS: a briefing paper. Hanson H.unaids. Carr R. Geneva. 2010 (http://www. 36.org/en/news/2009/11/30/drugs-punitive-laws-policies-and-policing-practices-andhivaids. 2005. Gay J et al.1837.mz/attachments/589_StudyHSH2. Sexually Transmitted Infections. 40. girls. and HIV risk in female street sex workers and injection drug users. Drugs. 39. Greig A et al. The epidemiology of HIV infection among young people aged 15–24 years in southern Africa.1i0. 2010 (http://data. Pathfinder International.v. 2001 (http://www. gender equality and HIV—operational plan for the UNAIDS action framework: addressing women. Maputo.who. da Silva D et al. Amsterdam. Vilnius. tomorrow’s agenda. 24. 22(Suppl. 31. Geneva. 2008. HIV. Brasilia. accessed 17 October 2010). 7:347–359. Homosexuality and HIV/AIDS stigma in Jamaica. Culture.net/images/stories/Rights_ and_stigma/2010_Global_Criminalisation_Scan. and HIV among southern African men who have sex with men.1007/s10508-010-9646-8). Eurasian Harm Reduction Network.3402/gha. UNAIDS. Archives of Sexual Behavior.pdf. 2010 (DOI:10. Targets and commitments made by Member States at the United Nations General Assembly Special Session on HIV/AIDS: Brazilian responses 2008–2009— country progress report. 376:475–485. De Walque D. 22(Suppl. 28.org/pub/Agenda/2010/20100226_jc1794_agenda_for_accelerated_country_ action_en. accessed 17 October 2010). Women and health: today’s evidence. 2010. 86:323–327. 174 References | 2010 GLOBAL REPORT .

2010 (http://data. Progress report 2010. 4. accessed 17 October 2010). Washington.aids2008-abstract.worldbank. 3–8 August 2008 (Abstract MOPE0393. 42. Baral S et al. World Health Organization. relationship power inequity. Heritage Foundation. accessed 17 October 2010). Intimate partner violence. 376:41–48. UNAIDS.pdf.41. 2010. 5:539–553. 2010 (http://www. References | 2010 GLOBAL REPORT 175 .int/reproductivehealth/publications/ violence/9789241599863/en/index. London. http://www. 46. AIDS 2008—XVII International AIDS Conference. UNAIDS and Menlo Park. Brazil. Global Public Health.org/en/KnowledgeCentre/HIVData/CountryProgress/2010CountryProgressAll Countries. UNICEF. GESTOS. 2010. 2007. UNGASS-AIDS and sexual and reproductive health of women: civil society report 2010. Violence against children in Swaziland—findings from a national survey on violence against children in Swaziland. 2010 (http://www. DC. 2010. DC. A systematic review of HIV epidemiology and risk factors among MSM in sub-Saharan Africa.org/hivaids/ upload/7347-06. accessed 17 October 2010). Mexico.asp. Question gender norms with men to improve health outcomes: evidence of impact. Lancet. Geneva. UNAIDS 2009 data for United Nations General Assembly Special Session on HIV/AIDS indicators. 44.unaids. 2010 (http://www. Men-streaming in sexual and reproductive health and HIV: a toolkit for policy development and advocacy. Heritage Foundation [web site]. 2010 (http://www. accessed 17 October 2010). CA. Adolescent pregnancy: the facts. New York. 5. Development Indicators Databases [online database]. 2. 48. 2010 (http://www. Atlanta. Geneva. 2010 (http://www. Financing the response to AIDS in low. Barker G et al. 45. Geneva. 1980–2008: a systematic analysis of progress towards Millennium Development Goal 5.who. UNICEF and UNAIDS. 3. R Chapter 6 1. Kaiser Family Foundation. and incidence of HIV infection in young women in South Africa: a cohort study. 375:1609–1623.org/aids2008_book_vol1_web.pdf. WHO/UNAIDS. Country Progress Reports 2010 [web site]. org. accessed 17 October 2010). European Commission and other donor governments in 2009. accessed 17 October 2010). Washington. Kates J et al. Jewkes R et al.heritage.int/hiv/pub/2010progressreport/report/en/index. Addressing violence against women and HIV/AIDS: what works? Geneva. Recife. WHO. accessed 17 October 2010).who. Hogan MC et al. IPPF and MenEngage. 49.html. Lancet. United States Centers for Disease Control and Prevention. Mexico City. accessed 17 October 2010). World Health Organization. World Health Organization.html.int/ making_pregnancy_safer/topics/adolescent_pregnancy/en/index.and middle-income countries: international assistance from the G8. Towards universal access: scaling up priority HIV/AIDS interventions in the health sector. Maternal mortality for 181 countries. 47. World Bank.html.who. Geneva. 43.org/data-catalog.kff. 2010. 2010.

ANNEXES 176 Annexes | 2010 GLOBAL REPORT .

2004 TO 2010 208 A1 Annexes | 2010 GLOBAL REPORT 177 . 2009 AND 2001 ANNEX 2 COUNTRY PROGRESS INDICATORS AND DATA.ANNEXES 178 ANNEX 1 HIV AND AIDS ESTIMATES AND DATA.

and related analyses 86 (Suppl 2)”. the quality. Modelling and Projections. In order to calculate regional totals. To allow readers to assess recent trends in the epidemic. older data were used to produce estimates for these countries. Children are defined as those aged 0–14 years.epidem. The wider the bounds are. ADULTS AND CHILDREN Estimated number of adults and children living with HIV in 2009 and 2001. The estimates are given in rounded numbers. in generalized epidemics. whether or not they have developed symptoms of AIDS. country-specific estimates have not been listed in the table. For countries where no recent data were available or where the analysis could not be completed. These bounds reflect the certainty associated with each of the estimates. so there may be minor discrepancies between the regional and global totals and the sum of the country figures. whether or not a population-based survey with HIV testing was conducted. 178 Annex 1: HIV and AIDS estimates and data. Modelling and Projections. Country analysts were trained in the use of these tools during a series of workshops in 2009. the HIV prevalence percent (%) continues to be for adults aged 15–49 years to allow comparisons across countries. software has been developed to model the course of HIV epidemics and their impact. This group is made up of leading researchers in HIV and AIDS. unless stated otherwise. described in reports available at www. 2009 and 2001. ADULTS (15+ YEARS) Estimated number of adults living with HIV. Adults in this report are defined as men and women aged 15+ years. However. Adults are 15 years and over. demography and related areas. we also present 2001 estimates developed using the same methodology and data as for the 2009 estimates. These estimates have been produced and compiled by UNAIDS/WHO. the greater the uncertainty surrounding an estimate. 2009 AND 2001 These estimates include all people with HIV infection. They have been shared with national AIDS programmes for review and comments but are not necessarily the official estimates used by national governments. The extent of uncertainty depends mainly on the type of epidemic. The new estimates in this report are presented together with ranges. The Reference Group assesses the most recent published and unpublished work drawn from research studies in different countries. per the recommendations of the UNAIDS Reference Group on Estimates. unrounded numbers were used in the calculation of rates and regional totals. coverage and consistency of a country’s surveillance system and. According to suggestions from the Reference Group. called ‘plausible bounds’. The general methodology and tools used to produce the country-specific estimates in the table have been described in a series of papers in Sexually Transmitted Infections 2010: “Methods and tools for the 2009 HIV and AIDS estimates and projections. org/. The group also recognizes the burden of infection and disease beyond the age of 49. These changes in procedures and assumptions and improved coordination with countries have resulted in improved estimates of HIV and AIDS for 2009.ANNEX 1 HIV AND AIDS ESTIMATES AND DATA 2009 AND 2001 Epidemiology data tables The estimates and data provided in these tables relate to 2009 and 2001. 2009 and 2001 | 2010 GLOBAL REPORT . in 2009 and 2001. However. The estimates produced by UNAIDS/WHO are based on methods and parameters that are informed by the UNAIDS Reference Group on HIV/AIDS Estimates. ESTIMATED NUMBER OF PEOPLE LIVING WITH HIV. epidemiology. It also reviews advances in the understanding of HIV epidemics and suggests methods to improve the quality and accuracy of the estimates. Notes on specific indicators are listed in the following tables 1.

HIV-RELATED DEATHS: ADULTS AND CHILDREN Estimated number of adults and children who died of HIV-related causes during 2009 and 2001. However. the estimated number of adults (15–49 years) newly infected with HIV in 2009 was divided by the 2009 adult population (15–49 years) not infected at the start of 2009 and similarly for 2001. NEW HIV INFECTIONS ADULT (15–49 YEARS) INCIDENCE To calculate the adult HIV incidence. prevalence data. In analysing prevalence data of key populations at higher risk of HIV. ADULTS NEWLY INFECTED 2009 Estimated number of adults (15+ years) newly infected with HIV in 2009. though whether or not this restricted analysis was used for reporting is not represented in this table.ADULT (15–49 YEARS) PREVALENCE (%) To calculate adult HIV prevalence the estimated number of adults (15–49 years) living with HIV in 2009 was divided by the 2009 adult population (15–49 years) and similarly for 2001. are what are actually available. TRENDS OF HIV PREVALENCE IN KEY POPULATIONS AT HIGHER RISK OF HIV 2. 2009 and 2001 | 2010 GLOBAL REPORT 179 . Annex 1: HIV and AIDS estimates and data. CHILDREN (0–14 YEARS) Estimated number of children under age 15 living with HIV in 2009 and 2001. These indicators are recommended for reporting against the goals of the 2001 United Nations General Assembly Special Session on HIV/AIDS in countries with low-level epidemics or concentrated HIV epidemics. 5. in practice. ADULTS AND CHILDREN NEWLY INFECTED 2009 Estimated number of people newly infected with HIV in 2009. rather than incidence data. WOMEN (15+ YEARS) Estimated number of women (15+ years) living with HIV in 2009 and 2001. In theory. The specific populations at higher risk of HIV in the tables include: • injecting drug users • female sex workers • men who have sex with men A1 3. it is desirable to report on those persons who are newly initiated to behaviours that put them at risk for infection. guidance was provided to encourage this type of reporting. Estimated number of children (0–17 years) in 2009 and 2001 who have lost one or both parents to AIDS. 4. YOUNG MEN (15–24 YEARS) PREVALENCE (%) 2009 Estimated percent of young men (15–24 years) who are living with HIV in 2009. In this round of UNGASS reporting. assessing progress in reducing the occurrence of new infections is best done through monitoring changes in incidence over time. YOUNG WOMEN (15–24 YEARS) PREVALENCE (%) 2009 Estimated percent of young women aged 15–24 who are living with HIV in 2009. ORPHANS DUE TO AIDS ORPHANS (0–17 YEARS) CURRENTLY LIVING.

ESTIMATED PEOPLE LIVING WITH HIV
2009
Adults + Children estimate [low – high estimate] [31 400 000 – 35 300 000] [20 900 000 – 24 200 000] estimate 28 600 000 20 300 000

2001
Adults + Children [low – high estimate] [27 100 000 – 30 300 000] [18 900 000 – 21 700 000] estimate 30 800 000 20 300 000

2009
Adults (15+) [low – high estimate] [29 200 000 – 32 600 000] [19 000 000 – 21 600 000]

GLOBAL SUB-SAHARAN AFRICA Angola Benin Botswana Burkina Faso Burundi Cameroon Central African Republic Chad Comoros Congo Côte d’Ivoire Democratic Republic of the Congo Equatorial Guinea Eritrea Ethiopia Gabon Gambia Ghana Guinea Guinea-Bissau Kenya Lesotho Liberia Madagascar Malawi Mali Mauritania Mauritius Mozambique Namibia Niger Nigeria Rwanda Senegal Sierra Leone South Africa Swaziland Togo Uganda United Republic of Tanzania Zambia Zimbabwe

33 300 000 22 500 000

200 000 60 000 320 000 110 000 180 000 610 000 130 000 210 000 <500 77 000 450 000 … 20 000 25 000 … 46 000 18 000 260 000 79 000 22 000 1 500 000 290 000 37 000 24 000 920 000 76 000 14 000 8800 1 400 000 180 000 61 000 3 300 000 170 000 59 000 49 000 5 600 000 180 000 120 000 1 200 000 1 400 000 980 000 1 200 000

[160 000 – 250 000] [52 000 – 69 000] [300 000 – 350 000] [91 000 – 140 000] [160 000 – 190 000] [540 000 – 670 000] [110 000 – 140 000] [170 000 – 300 000] [<200 – <500] [68 000 – 87 000] [390 000 – 510 000] [430 000 – 560 000] [14 000 – 26 000] [18 000 – 33 000] … [37 000 – 55 000] [12 000 – 26 000] [230 000 – 300 000] [65 000 – 95 000] [18 000 – 26 000] [1 300 000 – 1 600 000] [260 000 – 310 000] [32 000 – 43 000] [19 000 – 30 000] [830 000 – 1 000 000] [61 000 – 96 000] [11 000 – 17 000] [6400 – 12 000] [1 200 000 – 1 500 000] [150 000 – 210 000] [50 000 – 77 000] [2 900 000 – 3 600 000] [140 000 – 190 000] [50 000 – 69 000] [40 000 – 63 000] [5 400 000 – 5 900 000] [170 000 – 200 000] [99 000 – 150 000] [1 100 000 – 1 300 000] [1 300 000 – 1 500 000] [890 000 – 1 100 000] [1 100 000 – 1 300 000]

140 000 50 000 270 000 140 000 170 000 480 000 180 000 140 000 <100 69 000 630 000 … 5700 26 000 … 36 000 4300 250 000 78 000 14 000 1 500 000 240 000 51 000 18 000 860 000 89 000 8900 3100 850 000 160 000 53 000 2 700 000 170 000 33 000 25 000 4 600 000 130 000 100 000 980 000 1 400 000 830 000 1 700 000

[110 000 – 190 000] [42 000 – 62 000] [250 000 – 290 000] [120 000 – 180 000] [160 000 – 190 000] [430 000 – 530 000] [160 000 – 220 000] [99 000 – 180 000] [<100 – <200] [61 000 – 80 000] [560 000 – 710 000] [310 000 – 420 000] [3900 – 9100] [19 000 – 34 000] … [29 000 – 46 000] [2400 – 8400] [220 000 – 280 000] [57 000 – 120 000] [12 000 – 17 000] [1 400 000 – 1 600 000] [220 000 – 270 000] [36 000 – 70 000] [15 000 – 22 000] [770 000 – 960 000] [72 000 – 110 000] [7300 – 11 000] [2 100 – 4 200] [760 000 – 940 000] [140 000 – 200 000] [43 000 – 67 000] [2 300 000 – 3 100 000] [150 000 – 210 000] [29 000 – 38 000] [13 000 – 39 000] [4 500 000 – 4 700 000] [120 000 – 150 000] [82 000 – 130 000] [870 000 – 1 100 000] [1 200 000 – 1 500 000] [750 000 – 900 000] [1 600 000 – 1 800 000]

180 000 55 000 300 000 93 000 150 000 550 000 110 000 180 000 <500 69 000 380 000 … 18 000 22 000 … 43 000 17 000 240 000 70 000 20 000 1 300 000 260 000 31 000 23 000 800 000 66 000 13 000 8700 1 200 000 160 000 53 000 2 900 000 140 000 54 000 46 000 5 300 000 170 000 110 000 1 000 000 1 200 000 860 000 1 000 000

[140 000 – 220 000] [48 000 – 63 000] [280 000 – 330 000] [77 000 – 120 000] [130 000 – 160 000] [500 000 – 610 000] [98 000 – 120 000] [150 000 – 280 000] [<200 – <500] [61 000 – 78 000] [340 000 – 440 000] [380 000 – 490 000] [13 000 – 23 000] [16 000 – 29 000] … [35 000 – 51 000] [11 000 – 24 000] [210 000 – 260 000] [58 000 – 84 000] [16 000 – 24 000] [1 200 000 – 1 400 000] [240 000 – 280 000] [27 000 – 37 000] [18 000 – 28 000] [730 000 – 890 000] [52 000 – 84 000] [11 000 – 16 000] [6300 – 12 000] [1 100 000 – 1 400 000] [140 000 – 190 000] [43 000 – 67 000] [2 600 000 – 3 200 000] [120 000 – 160 000] [46 000 – 63 000] [38 000 – 59 000] [5 100 000 – 5 500 000] [160 000 – 180 000] [91 000 – 140 000] [940 000 – 1 100 000] [1 100 000 – 1 400 000] [800 000 – 940 000] [950 000 – 1 200 000]

180

Annex 1: HIV and AIDS estimates and data, 2009 and 2001 | 2010 GLOBAL REPORT

2001
Adults (15+) estimate [low – high estimate] [25 400 000 – 28 000 000] [17 500 000 – 19 700 000] estimate 0.8 5.0

2009
Adult (15–49) prevalence percent [low – high estimate] [0.7 – 0.8] [4.7 – 5.2] estimate 0.8 5.9

2001
Adult (15–49) prevalence percent [low – high estimate] [0.7 – 0.8] [5.6 – 6.1]

GLOBAL SUB-SAHARAN AFRICA Angola Benin Botswana Burkina Faso Burundi Cameroon Central African Republic Chad Comoros Congo Côte d’Ivoire Democratic Republic of the Congo Equatorial Guinea Eritrea Ethiopia Gabon Gambia Ghana Guinea Guinea-Bissau Kenya Lesotho Liberia Madagascar Malawi Mali Mauritania Mauritius Mozambique Namibia Niger Nigeria Rwanda Senegal Sierra Leone South Africa Swaziland Togo Uganda United Republic of Tanzania Zambia Zimbabwe

26 700 000 18 500 000

130 000 47 000 260 000 120 000 150 000 440 000 170 000 130 000 <100 61 000 570 000 … 5400 23 000 … 34 000 3900 230 000 70 000 13 000 1 300 000 230 000 46 000 17 000 760 000 80 000 8600 3100 800 000 150 000 49 000 2 400 000 150 000 31 000 24 000 4 400 000 130 000 98 000 840 000 1 200 000 730 000 1 500 000

[100 000 – 170 000] [40 000 – 56 000] [240 000 – 280 000] [99 000 – 150 000] [140 000 – 160 000] [400 000 – 490 000] [150 000 – 200 000] [91 000 – 170 000] [<100 – <100] [54 000 – 71 000] [510 000 – 640 000] [270 000 – 360 000] [3700 – 8700] [18 000 – 31 000] … [27 000 – 43 000] [2200 – 7500] [200 000 – 260 000] [52 000 – 100 000] [11 000 – 16 000] [1 200 000 – 1 400 000] [210 000 – 250 000] [33 000 – 63 000] [14 000 – 20 000] [690 000 – 840 000] [66 000 – 98 000] [7100 – 11 000] [2100 – 4200] [720 000 – 870 000] [130 000 – 180 000] [40 000 – 61 000] [2 100 000 – 2 700 000] [140 000 – 170 000] [26 000 – 35 000] [13 000 – 38 000] [4 300 000 – 4 500 000] [120 000 – 140 000] [76 000 – 120 000] [760 000 – 920 000] [1 100 000 – 1 300 000] [670 000 – 790 000] [1 400 000 – 1 700 000]

2.0 1.2 24.8 1.2 3.3 5.3 4.7 3.4 0.1 3.4 3.4 … 5.0 0.8 … 5.2 2.0 1.8 1.3 2.5 6.3 23.6 1.5 0.2 11.0 1.0 0.7 1.0 11.5 13.1 0.8 3.6 2.9 0.9 1.6 17.8 25.9 3.2 6.5 5.6 13.5 14.3

[1.6 – 2.4] [1.0 – 1.3] [23.8 – 25.8] [1.0 – 1.5] [2.9 – 3.5] [4.9 – 5.8] [4.2 – 5.2] [2.8 – 5.1] [<0.1 – 0.1] [3.1 – 3.8] [3.1 – 3.9] [1.2 – 1.6] [3.5 – 6.6] [0.6 – 1.0] … [4.2 – 6.2] [1.3 – 2.9] [1.6 – 2.0] [1.1 – 1.6] [2.0 – 3.0] [5.8 – 6.5] [22.3 – 25.2] [1.3 – 1.8] [0.2 – 0.3] [10.0 – 12.1] [0.8 – 1.3] [0.6 – 0.9] [0.7 – 1.3] [10.6 – 12.2] [11.1 – 15.5] [0.7 – 1.0] [3.3 – 4.0] [2.5 – 3.3] [0.7 – 1.0] [1.4 – 2.1] [17.2 – 18.3] [24.9 – 27.0] [2.5 – 3.8] [5.9 – 6.9] [5.3 – 6.1] [12.8 – 14.1] [13.4 – 15.4]

1.9 1.4 26.3 2.1 5.0 5.5 8.9 3.2 <0.1 3.8 6.5 … 1.9 1.2 … 5.3 0.6 2.3 1.7 2.0 8.4 24.5 3.1 0.2 13.8 1.6 0.6 0.4 9.4 16.1 1.0 3.8 3.7 0.6 1.1 17.1 23.6 3.6 7.0 7.1 14.3 23.7

[1.4 – 2.4] [1.2 – 1.7] [25.5 – 27.4] [1.7 – 2.5] [4.8 – 5.1] [5.1 – 6.0] [8.1 – 10.6] [2.3 – 4.0] [<0.1 – <0.1] [3.4 – 4.4] [5.9 – 7.1] [1.1 – 1.5] [1.3 – 3.1] [0.9 – 1.5] … [4.3 – 6.8] [0.3 – 1.1] [2.0 – 2.5] [1.2 – 2.4] [1.7 – 2.4] [8.1 – 9.0] [23.1 – 26.1] [2.2 – 4.1] [0.2 – 0.3] [12.7 – 15.1] [1.3 – 1.9] [0.5 – 0.7] [0.3 – 0.5] [8.7 – 10.3] [13.6 – 19.0] [0.8 – 1.3] [3.4 – 4.2] [3.4 – 4.4] [0.6 – 0.7] [0.6 – 1.7] [16.7 – 17.5] [22.4 – 24.8] [2.8 – 4.3] [6.4 – 7.4] [6.7 – 7.7] [13.7 – 15.0] [22.8 – 24.9]

A1

Annex 1: HIV and AIDS estimates and data, 2009 and 2001 | 2010 GLOBAL REPORT

181

ESTIMATED PEOPLE LIVING WITH HIV
2009
Women (15+) estimate [low – high estimate] [14 800 000 – 17 200 000] [11 100 000 – 13 200 000] estimate 13 600 000 10 900 000

2001
Women (15+) [low – high estimate] [12 900 000 – 14 700 000] [10 100 000 – 11 700 000] estimate 2 500 000 2 300 000

2009
Children (0–14) [low – high estimate] [1 600 000 – 3 400 000] [1 400 000 – 3 100 000]

GLOBAL SUB-SAHARAN AFRICA Angola Benin Botswana Burkina Faso Burundi Cameroon Central African Republic Chad Comoros Congo Côte d’Ivoire Democratic Republic of the Congo Equatorial Guinea Eritrea Ethiopia Gabon Gambia Ghana Guinea Guinea-Bissau Kenya Lesotho Liberia Madagascar Malawi Mali Mauritania Mauritius Mozambique Namibia Niger Nigeria Rwanda Senegal Sierra Leone South Africa Swaziland Togo Uganda United Republic of Tanzania Zambia Zimbabwe

15 900 000 12 100 000

110 000 32 000 170 000 56 000 90 000 320 000 67 000 110 000 <100 40 000 220 000 … 11 000 13 000 … 25 000 9700 140 000 41 000 12 000 760 000 160 000 19 000 7300 470 000 40 000 4000 2500 760 000 95 000 28 000 1 700 000 88 000 32 000 28 000 3 300 000 100 000 67 000 610 000 730 000 490 000 620 000

[85 000 – 130 000] [27 000 – 37 000] [160 000 – 190 000] [44 000 – 70 000] [78 000 – 100 000] [290 000 – 370 000] [57 000 – 78 000] [88 000 – 160 000] [<100 – <100] [35 000 – 47 000] [190 000 – 260 000] [220 000 – 300 000] [7600 – 14 000] [9800 – 18 000] … [20 000 – 30 000] [6200 – 14 000] [120 000 – 160 000] [34 000 – 50 000] [9300 – 14 000] [650 000 – 860 000] [140 000 – 180 000] [16 000 – 22 000] [5800 – 9000] [410 000 – 530 000] [31 000 – 52 000] [3200 – 4900] [1800 – 3400] [680 000 – 840 000] [79 000 – 110 000] [23 000 – 36 000] [1 500 000 – 1 900 000] [76 000 – 98 000] [27 000 – 38 000] [22 000 – 35 000] [3 000 000 – 3 500 000] [91 000 – 110 000] [54 000 – 83 000] [540 000 – 680 000] [650 000 – 830 000] [440 000 – 550 000] [530 000 – 710 000]

77 000 27 000 150 000 73 000 90 000 260 000 99 000 76 000 <100 36 000 320 000 … 3100 14 000 … 20 000 2300 130 000 41 000 7800 780 000 140 000 27 000 5400 440 000 48 000 2600 <1000 470 000 90 000 25 000 1 400 000 91 000 18 000 14 000 2 600 000 74 000 57 000 490 000 720 000 420 000 890 000

[59 000 – 100 000] [23 000 – 33 000] [140 000 – 160 000] [60 000 – 92 000] [81 000 – 99 000] [230 000 – 290 000] [86 000 – 120 000] [54 000 – 98 000] [<100 – <100] [31 000 – 42 000] [280 000 – 370 000] [160 000 – 220 000] [2100 – 5100] [11 000 – 19 000] … [16 000 – 25 000] [1300 – 4400] [120 000 – 150 000] [30 000 – 61 000] [6400 – 9300] [700 000 – 870 000] [130 000 – 160 000] [19 000 – 37 000] [4500 – 6400] [390 000 – 500 000] [40 000 – 59 000] [2100 – 3200] [<1000 – 1200] [430 000 – 530 000] [76 000 – 110 000] [20 000 – 32 000] [1 200 000 – 1 600 000] [83 000 – 110 000] [16 000 – 21 000] [7500 – 23 000] [2 500 000 – 2 700 000] [69 000 – 82 000] [45 000 – 72 000] [430 000 – 560 000] [640 000 – 800 000] [380 000 – 470 000] [800 000 – 990 000]

22 000 5400 16 000 17 000 28 000 54 000 17 000 23 000 … 7900 63 000 … 1600 3100 … 3200 … 27 000 9000 2100 180 000 28 000 6100 … 120 000 … … … 130 000 16 000 … 360 000 22 000 … 2900 330 000 14 000 11 000 150 000 160 000 120 000 150 000

[12 000 – 35 000] [2900 – 7800] [9900 – 20 000] [8100 – 25 000] [17 000 – 40 000] [29 000 – 78 000] [8200 – 25 000] [12 000 – 35 000] … [4000 – 12 000] [32 000 – 91 000] [33 000 – 86 000] [<1000 – 2600] [1500 – 5000] … [1700 – 4800] … [14 000 – 41 000] [4300 – 14 000] [1100 – 3200] [98 000 – 260 000] [17 000 – 37 000] [3000 – 9900] … [68 000 – 170 000] … … … [70 000 – 180 000] [9100 – 23 000] … [180 000 – 520 000] [11 000 – 34 000] … [1500 – 4500] [190 000 – 440 000] [8300 – 18 000] [3700 – 18 000] [80 000 – 210 000] [83 000 – 240 000] [64 000 – 160 000] [92 000 – 200 000]

182

Annex 1: HIV and AIDS estimates and data, 2009 and 2001 | 2010 GLOBAL REPORT

2001
Children (0–14) estimate [low – high estimate] [1 200 000 – 2 700 000] [1 100 000 – 2 500 000] estimate 0.6 3.4

2009
Young women (15–24) prevalence (%) [low – high estimate] [0.5 – 0.7] [3.0 – 4.2] estimate 0.3 1.4

2009
Young men (15–24) prevalence (%) [low – high estimate] [0.2 – 0.3] [1.2 – 1.7]

GLOBAL SUB-SAHARAN AFRICA Angola Benin Botswana Burkina Faso Burundi Cameroon Central African Republic Chad Comoros Congo Côte d’Ivoire Democratic Republic of the Congo Equatorial Guinea Eritrea Ethiopia Gabon Gambia Ghana Guinea Guinea-Bissau Kenya Lesotho Liberia Madagascar Malawi Mali Mauritania Mauritius Mozambique Namibia Niger Nigeria Rwanda Senegal Sierra Leone South Africa Swaziland Togo Uganda United Republic of Tanzania Zambia Zimbabwe

2 000 000 1 800 000

14 000 3100 14 000 24 000 26 000 33 000 17 000 13 000 … 8300 59 000 … <500 2300 … 2000 … 18 000 8400 <1000 170 000 18 000 4600 … 100 000 … … … 53 000 7900 … 270 000 23 000 … <1000 170 000 7600 6700 150 000 150 000 100 000 160 000

[6900 – 24 000] [1600 – 6600] [7800 – 19 000] [12 000 – 37 000] [16 000 – 36 000] [18 000 – 50 000] [8600 – 25 000] [6400 – 22 000] … [4200 – 12 000] [31 000 – 95 000] [26 000 – 70 000] [<200 – <1000] [1200 – 4100] … [1200 – 3100] … [9900 – 29 000] [3500 – 18 000] [<1000 – 1400] [98 000 – 230 000] [11 000 – 23 000] [2100 – 8400] … [57 000 – 140 000] … … … [30 000 – 77 000] [4400 – 11 000] … [130 000 – 410 000] [11 000 – 38 000] … [<500 – 2100] [97 000 – 220 000] [4700 – 10 000] [2700 – 11 000] [84 000 – 210 000] [83 000 – 210 000] [57 000 – 140 000] [100 000 – 210 000]

1.6 0.7 11.8 0.8 2.1 3.9 2.2 2.5 <0.1 2.6 1.5 … 5.0 0.4 … 3.5 2.4 1.3 0.9 2.0 4.1 14.2 0.7 0.1 6.8 0.5 0.3 0.2 8.6 5.8 0.5 2.9 1.9 0.7 1.5 13.6 15.6 2.2 4.8 3.9 8.9 6.9

[1.1 – 2.2] [0.5 – 1.1] [9.0 – 15.9] [0.6 – 1.2] [1.6 – 2.7] [3.1 – 5.4] [1.4 – 3.1] [1.7 – 5.2] [<0.1 – <0.1] [2.1 – 3.6] [1.1 – 2.3] [0.9 – 1.5] [2.7 – 7.9] [0.2 – 0.7] … [2.1 – 5.2] [1.4 – 4.0] [0.9 – 1.8] [0.6 – 1.3] [1.5 – 2.9] [3.0 – 5.4] [11.2 – 19.2] [0.2 – 1.2] [<0.1 – 0.1] [5.3 – 9.2] [0.2 – 0.9] [0.1 – 0.5] [0.1 – 0.3] [7.0 – 12.1] [3.7 – 8.6] [0.4 – 0.6] [2.3 – 3.9] [1.3 – 2.3] [0.5 – 1.0] [0.9 – 2.5] [12.3 – 15.0] [12.6 – 21.3] [1.5 – 3.1] [4.0 – 6.4] [3.1 – 5.3] [7.3 – 12.0] [5.3 – 9.3]

0.6 0.3 5.2 0.5 1.0 1.6 1.0 1.0 <0.1 1.2 0.7 … 1.9 0.2 … 1.4 0.9 0.5 0.4 0.8 1.8 5.4 0.3 0.1 3.1 0.2 0.4 0.3 3.1 2.3 0.2 1.2 1.3 0.3 0.6 4.5 6.5 0.9 2.3 1.7 4.2 3.3

[0.4 – 0.9] [0.2 – 0.4] [3.7 – 7.3] [0.3 – 0.6] [0.8 – 1.2] [1.2 – 2.1] [0.6 – 1.4] [0.7 – 2.0] [<0.1 – 0.1] [0.9 – 1.6] [0.5 – 1.1] [0.4 – 0.6] [1.0 – 3.2] [0.1 – 0.3] … [0.8 – 2.0] [0.5 – 1.6] [0.4 – 0.7] [0.3 – 0.6] [0.5 – 1.1] [1.3 – 2.4] [4.1 – 7.4] [0.1 – 0.5] [0.1 – 0.4] [2.3 – 4.2] [0.1 – 0.4] [0.2 – 1.4] [0.2 – 0.4] [2.4 – 4.4] [1.3 – 3.6] [0.2 – 0.3] [0.9 – 1.6] [0.9 – 1.6] [0.2 – 0.4] [0.3 – 1.0] [4.1 – 5.0] [4.8 – 8.8] [0.6 – 1.2] [1.8 – 2.8] [1.3 – 2.3] [3.2 – 5.5] [2.5 – 4.4]

A1

Annex 1: HIV and AIDS estimates and data, 2009 and 2001 | 2010 GLOBAL REPORT

183

ESTIMATED NEW HIV INFECTIONS
2009
Adult (15–49) incidence rate estimate [low – high estimate] [<0.10 – <0.10] [0.36 – 0.46] estimate <0.10 0.61

2001
Adult (15–49) incidence rate [low – high estimate] [<0.10 – <0.10] [0.54 – 0.65] estimate 2 600 000 1 800 000

2009
Adults + children newly infected [low – high estimate] [2 300 000 – 2 800 000] [1 600 000 – 2 000 000]

GLOBAL SUB-SAHARAN AFRICA Angola Benin Botswana Burkina Faso Burundi Cameroon Central African Republic Chad Comoros Congo Côte d’Ivoire Democratic Republic of the Congo Equatorial Guinea Eritrea Ethiopia Gabon Gambia Ghana Guinea Guinea-Bissau Kenya Lesotho Liberia Madagascar Malawi Mali Mauritania Mauritius Mozambique Namibia Niger Nigeria Rwanda Senegal Sierra Leone South Africa Swaziland Togo Uganda United Republic of Tanzania Zambia Zimbabwe

<0.10 0.41

0.21 0.10 1.56 <0.10 … 0.53 0.17 … … 0.28 0.11 … … <0.10 … 0.43 … 0.15 0.10 0.21 0.53 2.58 … … 0.95 <0.10 … … 1.19 0.43 <0.10 0.38 0.18 <0.10 0.14 1.49 2.66 0.27 0.74 0.45 1.17 0.84

[0.14 – 0.28] [<0.10 – 0.13] [1.11 – 2.27] [<0.10 – 0.11] [0.17 – 0.28] [0.43 – 0.61] [<0.10 – 0.25] [0.15 – 0.87] [<0.10 – <0.10] [0.23 – 0.35] [<0.10 – 0.20] [0.13 – 0.18] [0.23 – 1.20] [<0.10 – <0.10] … [0.10 – 0.61] [0.21 – 0.83] [0.12 – 0.19] [<0.10 – 0.13] [0.14 – 0.32] [0.34 – 0.70] [2.18 – 3.04] [<0.10 – 0.17] [<0.10 – <0.10] [0.67 – 1.23] [<0.10 – 0.12] [<0.10 – 0.11] [<0.10 – 0.22] [0.99 – 1.35] [<0.10 – 0.93] [<0.10 – <0.10] [0.33 – 0.44] [<0.10 – 0.32] [<0.10 – 0.11] [<0.10 – 0.35] [1.27 – 1.76] [2.19 – 3.14] [0.15 – 0.39] [0.62 – 0.85] [0.34 – 0.57] [0.96 – 1.40] [0.54 – 1.19]

0.22 0.11 3.03 0.11 … 0.59 0.56 … … 0.43 0.39 … … <0.10 … 0.63 … 0.18 0.15 0.32 0.55 2.88 … … 1.35 <0.10 … … 1.77 2.29 <0.10 0.39 0.34 0.10 0.22 2.35 4.07 0.37 0.71 0.64 1.72 1.94

[0.17 – 0.28] [<0.10 – 0.15] [2.64 – 3.48] [<0.10 – 0.16] [0.34 – 0.47] [0.50 – 0.69] [0.43 – 0.69] [0.39 – 0.55] [<0.10 – <0.10] [0.36 – 0.51] [0.30 – 0.51] [0.13 – 0.18] [0.38 – 0.83] [<0.10 – 0.14] … [0.46 – 0.85] [<0.10 – 0.22] [0.15 – 0.22] [0.11 – 0.21] [0.24 – 0.40] [0.38 – 0.76] [2.53 – 3.40] [<0.10 – 0.22] [<0.10 – <0.10] [1.15 – 1.61] [<0.10 – 0.14] [<0.10 – 0.11] [<0.10 – 0.12] [1.56 – 1.96] [1.77 – 2.90] [<0.10 – <0.12] [0.33 – 0.47] [0.26 – 0.41] [<0.10 – 0.12] [0.16 – 0.29] [2.14 – 2.60] [3.72 – 4.46] [0.28 – 0.48] [0.61 – 0.82] [0.55 – 0.76] [1.52 – 1.95] [1.62 – 2.36]

22 000 4900 14 000 6800 … 58 000 5200 … … 6500 17 000 … … 1300 … 3600 … 22 000 6200 2100 110 000 23 000 … … 73 000 4600 … … 130 000 5800 6100 340 000 8800 6000 4700 390 000 14 000 10 000 120 000 100 000 76 000 62 000

[16 000 – 29 000] [3400 – 6500] [10 000 – 20 000] [4300 – 11 000] [11 000 – 17 000] [48 000 – 67 000] [3100 – 7100] [12 000 – 47 000] [<100 – <100] [5200 – 7900] [11 000 – 27 000] [49 000 – 67 000] [1200 – 4500] [<1000 – 2300] … [1300 – 5000] [1900 – 6400] [17 000 – 27 000] [3800 – 8400] [1400 – 2900] [81 000 – 150 000] [20 000 – 27 000] [<1000 – 3800] [1800 – 3700] [57 000 – 91 000] [1300 – 8300] [<1000 – 1900] [<1000 – 1800] [110 000 – 150 000] [2100 – 11 000] [4300 – 8400] [280 000 – 390 000] [3800 – 15 000] [4100 – 7900] [3000 – 9900] [340 000 – 440 000] [12 000 – 16 000] [6200 – 14 000] [100 000 – 140 000] [82 000 – 130 000] [62 000 – 89 000] [45 000 – 80 000]

184

Annex 1: HIV and AIDS estimates and data, 2009 and 2001 | 2010 GLOBAL REPORT

ESTIMATED AIDS-RELATED DEATHS
2009
Adults newly infected estimate [low – high estimate] [2 000 000 – 2 400 000] [1 300 000 – 1 600 000] estimate 1 800 000 1 300 000

2009
AIDS-related deaths in adults + children [low – high estimate] [1 600 000 – 2 100 000] [1 100 000 – 1 500 000] estimate 1 800 000 1 400 000

2001
AIDS-related deaths in adults + children [low – high estimate] [1 600 000 – 2 100 000] [1 200 000 – 1 600 000]

GLOBAL SUB-SAHARAN AFRICA Angola Benin Botswana Burkina Faso Burundi Cameroon Central African Republic Chad Comoros Congo Côte d’Ivoire Democratic Republic of the Congo Equatorial Guinea Eritrea Ethiopia Gabon Gambia Ghana Guinea Guinea-Bissau Kenya Lesotho Liberia Madagascar Malawi Mali Mauritania Mauritius Mozambique Namibia Niger Nigeria Rwanda Senegal Sierra Leone South Africa Swaziland Togo Uganda United Republic of Tanzania Zambia Zimbabwe

2 200 000 1 500 000

17 000 4000 13 000 5000 … 48 000 3600 … … 5100 11 000 … … <1000 … 3100 … 18 000 4800 1600 92 000 20 000 … … 56 000 3400 … … 110 000 4400 4600 270 000 6000 4800 3900 340 000 12 000 8700 100 000 88 000 59 000 48 000

[12 000 – 23 000] [2700 – 5400] [9400 – 19 000] [2800 – 7900] [7000 – 11 000] [39 000 – 56 000] [1800 – 5200] [8000 – 39 000] [<100 – <100] [4100 – 6300] [5700 – 19 000] [38 000 – 52 000] [<1000 – 3800] [<500 – 1700] … [<1000 – 4300] [1600 – 5800] [14 000 – 23 000] [2600 – 6600] [1100 – 2300] [61 000 – 120 000] [17 000 – 24 000] [<200 – 3100] [1600 – 3400] [40 000 – 72 000] [<500 – 6800] [<1000 – 1700] [<1000 – 1800] [91 000 – 120 000] [<1000 – 9300] [3200 – 6100] [230 000 – 310 000] [1100 – 12 000] [3100 – 6300] [2300 – 8900] [300 000 – 400 000] [10 000 – 14 000] [5100 – 12 000] [84 000 – 120 000] [66 000 – 110 000] [48 000 – 71 000] [31 000 – 66 000]

11 000 2700 5800 7100 15 000 37 000 11 000 11 000 <100 5100 36 000 … <1000 1700 … 2400 <1000 18 000 4700 1200 80 000 14 000 3600 1700 51 000 4400 <1000 <500 74 000 6700 4300 220 000 4100 2600 2800 310 000 7000 7700 64 000 86 000 45 000 83 000

[7700 – 16 000] [1800 – 3700] [2300 – 14 000] [4800 – 9700] [12 000 – 17 000] [29 000 – 46 000] [8800 – 13 000] [8100 – 15 000] [<100 – <100] [4100 – 6400] [29 000 – 44 000] [26 000 – 40 000] [<1000 – 1400] [1000 – 2500] … [1600 – 3400] [<500 – 1200] [14 000 – 22 000] [3100 – 6900] [<1000 – 1600] [61 000 – 99 000] [10 000 – 18 000] [2800 – 4600] [1400 – 2000] [38 000 – 67 000] [3000 – 6100] [<1000 – 1000] [<500 – <1000] [57 000 – 92 000] [2500 – 11 000] [3300 – 5600] [170 000 – 260 000] [<1000 – 9700] [1900 – 3500] [2100 – 3700] [260 000 – 390 000] [4600 – 10 000] [5300 – 10 000] [49 000 – 80 000] [69 000 – 110 000] [30 000 – 60 000] [70 000 – 97 000]

10 000 3100 15 000 15 000 14 000 31 000 15 000 8900 <100 5800 51 000 … <500 1800 … 2000 <500 16 000 6300 <1000 120 000 14 000 3900 1300 68 000 7200 <500 <200 43 000 8100 3300 210 000 15 000 1800 <1000 220 000 6800 6400 89 000 110 000 68 000 130 000

[6500 – 14 000] [1900 – 5200] [12 000 – 18 000] [11 000 – 19 000] [12 000 – 17 000] [25 000 – 37 000] [12 000 – 20 000] [5400 – 13 000] [<100 – <100] [4800 – 7100] [37 000 – 66 000] [24 000 – 34 000] [<200 – <500] [1200 – 2600] … [1500 – 2800] [<200 – <1000] [13 000 – 21 000] [3000 – 14 000] [<1000 – <1000] [100 000 – 150 000] [12 000 – 18 000] [2300 – 6200] [1100 – 1600] [57 000 – 81 000] [4200 – 11 000] [<500 – <1000] [<100 – <200] [34 000 – 53 000] [6200 – 11 000] [2500 – 4500] [130 000 – 260 000] [12 000 – 21 000] [1500 – 2300] [<500 – 2200] [180 000 – 260 000] [5700 – 8400] [4600 – 8400] [75 000 – 100 000] [94 000 – 130 000] [57 000 – 78 000] [110 000 – 160 000]

A1

Annex 1: HIV and AIDS estimates and data, 2009 and 2001 | 2010 GLOBAL REPORT

185

ESTIMATED ORPHANS DUE TO AIDS
2009
Orphans (0–17) currently living estimate [low – high estimate] [14 400 000 – 18 800 000] [12 800 000 – 17 000 000] estimate 10 000 000 8 900 000

HIV PREVALENCE (%) IN MOST-AT-RISK GROUPS IN CAPITAL CITY
2001
Orphans (0–17) [low – high estimate] [7 900 000 – 12 500 000] [6 900 000 – 11 200 000] Injecting drug users Year … … HIV (%) … … Female sex workers Year … … HIV (%) … … Men who have sex with men Year … … HIV (%) … …

GLOBAL SUB-SAHARAN AFRICA Angola Benin Botswana Burkina Faso Burundi Cameroon Central African Republic Chad Comoros Congo Côte d’Ivoire Democratic Republic of the Congo Equatorial Guinea Eritrea Ethiopia Gabon Gambia Ghana Guinea Guinea-Bissau Kenya Lesotho Liberia Madagascar Malawi Mali Mauritania Mauritius Mozambique Namibia Niger Nigeria Rwanda Senegal Sierra Leone South Africa Swaziland Togo Uganda United Republic of Tanzania Zambia Zimbabwe

16 600 000 14 800 000

140 000 30 000 93 000 140 000 200 000 330 000 140 000 120 000 <100 51 000 440 000 … 4100 19 000 … 18 000 2800 160 000 59 000 9700 1 200 000 130 000 52 000 11 000 650 000 59 000 3600 <1000 670 000 70 000 57 000 2 500 000 130 000 19 000 15 000 1 900 000 69 000 66 000 1 200 000 1 300 000 690 000 1 000 000

[95 000 – 200 000] [18 000 – 53 000] [71 000 – 120 000] [100 000 – 170 000] [170 000 – 230 000] [270 000 – 420 000] [110 000 – 180 000] [79 000 – 170 000] [<100 – <100] [41 000 – 66 000] [330 000 – 550 000] [350 000 – 510 000] [2500 – 6400] [12 000 – 28 000] … [12 000 – 25 000] [1400 – 6500] [120 000 – 210 000] [34 000 – 120 000] [7700 – 12 000] [980 000 – 1 400 000] [110 000 – 160 000] [34 000 – 76 000] [9 300 – 14 000] [540 000 – 780 000] [36 000 – 93 000] [2700 – 4800] [<500 – <1000] … [50 000 – 96 000] [44 000 – 73 000] [1 800 000 – 3 100 000] [98 000 – 180 000] [15 000 – 25 000] [9 200 – 26 000] [1 600 000 – 2 400 000] [55 000 – 86 000] [47 000 – 89 000] [1 000 000 – 1 400 000] [1 100 000 – 1 500 000] [570 000 – 810 000] [910 000 – 1 200 000]

65 000 13 000 56 000 140 000 130 000 140 000 82 000 50 000 <100 51 000 270 000 … <1000 8 700 … 7 600 <1000 60 000 40 000 2800 820 000 52 000 19 000 9500 430 000 35 000 1500 <200 220 000 30 000 17 000 1 300 000 170 000 8700 2100 580 000 29 000 25 000 1 100 000 840 000 580 000 760 000

[30 000 – 110 000] [5100 – 100 000] [45 000 – 72 000] [100 000 – 190 000] [110 000 – 160 000] [91 000 – 230 000] [54 000 – 120 000] [26 000 – 91 000] [<100 – <100] [34 000 – 73 000] [170 000 – 440 000] [290 000 – 450 000] [<500 – <1000] [4100 – 18 000] … [5200 – 11 000] [<500 – 6400] [42 000 – 120 000] [12 000 – 100 000] [1800 – 3900] [640 000 – 1 100 000] [41 000 – 68 000] [9900 – 33 000] [7600 – 12 000] [330 000 – 550 000] [15 000 – 89 000] [<1000 – 2200] [<100 – <500] … [22 000 – 42 000] [12 000 – 24 000] [420 000 – 1 900 000] [140 000 – 250 000] [6600 – 11 000] [1000 – 7000] [460 000 – 750 000] [23 000 – 37 000] [12 000 – 45 000] [860 000 – 1 400 000] [690 000 – 1 000 000] [410 000 – 770 000] [630 000 – 940 000]

… 2009 … … … … … … … … … … … … … … … … … … … … … … … … … 2009 … … … 2007 … … … … … … … … … …

… 4.2 … … … … … … … … … … … … … … … … … … … … … … … … … 47.1 … … … 5.6 … … … … … … … … … …

… 2009 … 2005 2007 2009 … 2009 … … … … … 2008 … 2010 … 2009 2008 2009 … … … 2007 2006 2006 2007 … … … 2009 2007 … 2006 2005 … … 2005 … … … …

… 24.7 … 16.3 39.8 35.5 … 20.0 … … … … … 7.8 … 23.6 … 25.0 32.7 39.6 … … … 0.5 70.7 35.3 7.6 … … … 35.6 32.7 … 19.8 8.5 … … 44.5 … … … …

… … … … … … … … … … … … … … … … … … … … … … … … … … … … … … … 2007 … 2007 … 2008 … … … … … …

… … … … … … … … … … … … … … … … … … … … … … … … … … … … … … … 13.5 … 21.8 … 13.2 … … … … … …

186

Annex 1: HIV and AIDS estimates and data, 2009 and 2001 | 2010 GLOBAL REPORT

ESTIMATED PEOPLE LIVING WITH HIV 2009 Adults + Children estimate [low – high estimate] [560 000 – 1 000 000] estimate 350 000 2001 Adults + Children [low – high estimate] [250 000 – 480 000] estimate 760 000 2009 Adults (15+) [low – high estimate] [560 000 – 1 000 000] EAST ASIA China Democratic People’s Republic of Korea Japan Mongolia Republic of Korea OCEANIA Australia Fiji New Zealand Papua New Guinea SOUTH AND SOUTH-EAST ASIA Bangladesh Bhutan Cambodia India Indonesia Lao People’s Democratic Republic Malaysia Maldives Myanmar Nepal Pakistan Philippines Singapore Sri Lanka Thailand Viet Nam EASTERN EUROPE AND CENTRAL ASIA Armenia Azerbaijan Belarus Georgia Kazakhstan Kyrgyzstan Republic of Moldova Russian Federation Tajikistan Ukraine Uzbekistan WESTERN AND CENTRAL EUROPE Austria Belgium Bulgaria 770 000 740 000 … 8100 <500 9500 57 000 [540 000 – 1 000 000] … [6300 – 10 000] [<500 – <1000] [7000 – 13 000] [50 000 – 64 000] … … 6500 <100 5200 29 000 [240 000 – 470 000] … [5200 – 8100] [<100 – <200] [4100 – 6700] [23 000 – 35 000] 730 000 … 8100 <500 9500 54 000 [540 000 – 1 000 000] … [6300 – 10 000] [<500 – <1000] [7000 – 13 000] [47 000 – 61 000] 20 000 <1000 2500 34 000 4 100 000 [15 000 – 25 000] [<500 – <1000] [2000 – 3200] [30 000 – 39 000] [3 700 000 – 4 600 000] 13 000 <200 1600 14 000 3 800 000 [10 000 – 16 000] [<100 – <500] [1400 – 2100] [9400 – 21 000] [3 500 000 – 4 200 000] 20 000 <1000 2400 31 000 4 000 000 [15 000 – 25 000] [<500 – <1000] [2000 – 3200] [27 000 – 35 000] [3 600 000 – 4 400 000] 6300 <1000 63 000 2 400 000 310 000 8500 100 000 <100 240 000 64 000 98 000 8700 3400 2800 530 000 280 000 1 400 000 [5200 – 8300] [<1000 – 1500] [42 000 – 90 000] [2 100 000 – 2 800 000] [200 000 – 460 000] [6000 – 13 000] [83 000 – 120 000] [<100 – <100] [200 000 – 290 000] [51 000 – 80 000] [79 000 – 120 000] [6100 – 13 000] [2500 – 4400] [2100 – 3800] [420 000 – 660 000] [220 000 – 350 000] [1 300 000 – 1 600 000] 1100 <200 92 000 2 500 000 11 000 <1000 67 000 <100 250 000 60 000 39 000 1700 2800 1300 640 000 140 000 760 000 [<100 – 2400] [<100 – <500] [63 000 – 130 000] [2 300 000 – 2 900 000] [<100 – 34 000] [<100 – 1700] [57 000 – 80 000] [<100 – <100] [190 000 – 310 000] [49 000 – 72 000] [32 000 – 48 000] [<100 – 4000] [2200 – 3800] [<1000 – 1900] [480 000 – 820 000] [110 000 – 180 000] [670 000 – 890 000] 6200 <1000 56 000 2 300 000 300 000 8300 100 000 <100 230 000 60 000 95 000 8600 3300 2800 520 000 270 000 1 400 000 [5100 – 8100] [<1000 – 1500] [38 000 – 82 000] [2 000 000 – 2 600 000] [200 000 – 460 000] [5800 – 12 000] [83 000 – 120 000] [<100 – <100] [190 000 – 280 000] [48 000 – 75 000] [76 000 – 120 000] [6000 – 13 000] [2400 – 4300] [2100 – 3700] [410 000 – 640 000] [220 000 – 350 000] [1 200 000 – 1 600 000] A1 1900 3600 17 000 3500 13 000 9800 12 000 980 000 9100 350 000 28 000 820 000 [1500 – 2400] [2600 – 5200] [13 000 – 20 000] [2600 – 4900] [9000 – 19 000] [6500 – 16 000] [9900 – 16 000] [840 000 – 1 200 000] [6400 – 13 000] [300 000 – 410 000] [18 000 – 46 000] [720 000 – 910 000] 1400 1300 6300 1200 1800 <1000 12 000 430 000 4100 290 000 <1000 630 000 [1100 – 1700] [<500 – 1700] [5100 – 7800] [<100 – 1700] [<1000 – 3400] [<100 – 11 000] [9900 – 16 000] [350 000 – 550 000] [3100 – 5300] [250 000 – 330 000] [<100 – <100] [570 000 – 700 000] 1900 3500 16 000 3400 13 000 9700 12 000 960 000 8900 350 000 28 000 820 000 [1500 – 2300] [2500 – 5100] [13 000 – 20 000] [2500 – 4800] [8900 – 19 000] [6400 – 16 000] [9800 – 15 000] [830 000 – 1 100 000] [6300 – 12 000] [300 000 – 410 000] [18 000 – 45 000] [720 000 – 910 000] 15 000 14 000 3800 [12 000 – 20 000] [11 000 – 18 000] [2800 – 5200] 5300 12 000 1 800 [3900 – 7000] [9500 – 16 000] [1300 – 2300] 15 000 14 000 3800 [12 000 – 20 000] [11 000 – 18 000] [2700 – 5200] Annex 1: HIV and AIDS estimates and data. 2009 and 2001 | 2010 GLOBAL REPORT 187 .

6] [0.1] [0.3] [0.1] [<0.1 – 0.1] [0.3 – 0.6] [0.2 – 0.1 – <0.6 – 0.7 – 0.1 – <0.2] [0.1 – <0.1 – <0.4 <0.8 – 1.1 <0.3 – 0.4] [0.1 0.1 – 0.1 0.1 [0.1 <0.1 1.4 0.6] [<0.1 – <0.1 – <0.1 – <0.3 0.2] [0.3] … … <0.2 – 0.1 – 0.1] [0.1] [<0.1] [0.6] [0.5 0.1 0.1 0.8 [<0.5 0.4 – 0.2 1.2] [0.2 0.1] [0.8] [0.2 – 0.3] [0.1 – 0.1 – 0.0] [0.8 0.1 <0.2 – 0.5] 1400 1200 6300 1200 1800 <1000 12 000 430 000 4000 290 000 <1000 620 000 [1100 – 1700] [<500 – 1600] [5000 – 7800] [<100 – 1700] [<1000 – 3400] [<100 – 11 000] [9800 – 16 000] [350 000 – 550 000] [3000 – 5200] [250 000 – 330 000] [<100 – <100] [570 000 – 700 000] 0.4 [0.2 – 0.1 – <0.3 0.1 – 0.4 – 0.4 1.1] … [<0.3] [0.2] 5300 12 000 1800 [3900 – 7000] [9500 – 16 000] [1300 – 2300] 0.1] [0.1] … [<0.2] [0. 2009 and 2001 | 2010 GLOBAL REPORT .1 <0.2 <0.1 0.1] [0.1 0.1 – <0.1 0.1 – 0.1 1.1] [<0.1 <0.4 0.1 – 0.2 – 0.1 – 0.3] [0.7 0.4 – 0.1] [0.3 – 0.1 – 0.9] <0.4 0.1] EAST ASIA China Democratic People’s Republic of Korea Japan Mongolia Republic of Korea OCEANIA Australia Fiji New Zealand Papua New Guinea SOUTH AND SOUTH-EAST ASIA Bangladesh Bhutan Cambodia India Indonesia Lao People’s Democratic Republic Malaysia Maldives Myanmar Nepal Pakistan Philippines Singapore Sri Lanka Thailand Viet Nam EASTERN EUROPE AND CENTRAL ASIA Armenia Azerbaijan Belarus Georgia Kazakhstan Kyrgyzstan Republic of Moldova Russian Federation Tajikistan Ukraine Uzbekistan WESTERN AND CENTRAL EUROPE Austria Belgium Bulgaria 350 000 … … 6400 <100 5200 28 000 [240 000 – 470 000] … [5200 – 8100] [<100 – <200] [4100 – 6700] [22 000 – 34 000] 0.1 – 0.5] [<0.3 – 0.1 – <0.2 0.9 – 1.1 0.1] [0.3 0.1] [0.1 – 0.1 – 0.3 0.1 0.1 – 0.3] [0.5 0.1 2001 Adult (15–49) prevalence percent [low – high estimate] [<0.4 – 0.1 – 0.1 2009 Adult (15–49) prevalence percent [low – high estimate] [0.1 <0.1 0.1 – <0.3] [<0.3] [0.1 <0.1] [<0.1 0.1 – 0.1] [<0.1 <0.1 – <0.3] [1.1 – 0.1] [<0.8 – 1.1] [<0.4] [0.1 <0.1 – 0.1 – <0.1 <0.3 [0.2] [0.3] 0.1 – 0.2] [0.1 <0.9] [0.1] estimate <0.4] [0.1] [<0.1 0.1] 188 Annex 1: HIV and AIDS estimates and data.1 – 0.6] [<0.1] [<0.4 – 0.2 – 0.1 0.2 [0.2 – 0.1] [0.1 – <0.4 – 0.6 0.1 – 0.7] [0.0 – 1.3 – 0.1 <0.2 – 0.5 – 0.3 – 0.6] [0.1 0.3 – 0.1 – <0.5 <0.1 – 0.1] [0.3 0.1 – <0.1 0.1 0.1] [<0.4 <0.4] 1100 <100 83 000 2 500 000 11 000 <1000 67 000 <100 250 000 57 000 39 000 1600 2700 1300 610 000 140 000 750 000 [<100 – 2300] [<100 – <500] [58 000 – 110 000] [2 200 000 – 2 800 000] [<100 – 34 000] [<100 – 1700] [56 000 – 80 000] [<100 – <100] [190 000 – 310 000] [47 000 – 69 000] [32 000 – 47 000] [<100 – 3900] [2100 – 3700] [<1000 – 1900] [470 000 – 790 000] [110 000 – 170 000] [660 000 – 880 000] <0.1] [1.4 – 0.1 – 0.6] [0.1 – 0.ESTIMATED PEOPLE LIVING WITH HIV 2001 Adults (15+) estimate [low – high estimate] [250 000 – 480 000] estimate 0.5] [<0.2] 13 000 <200 1600 13 000 3 700 000 [9900 – 16 000] [<100 – <500] [1400 – 2100] [9100 – 19 000] [3 400 000 – 4 100 000] 0.1 – 0.1 – <0.2] 0.2 0.5] [0.1 0.1 0.5 0.1 0.9 0.2 [0.2] [0.1 <0.1 0.1 <0.1 1.1 – 0.0 0.7] [0.2 0.1] [<0.1 – 0.3 [0.8 – 1.1 0.3] [0.1] [0.1] [0.1 – <0.1 – <0.2 – 0.1 – 0.3 0.1] [<0.1 0.1] [0.1 – 0.1] [<0.4 [<0.0 – 1.3 – 2.1] 0.1 <0.2 [<0.3 – 0.5] [0.1] [<0.1] [0.1 – 0.1] [1.1] [<0.5] [0.1] [<0.1 – <0.1] [<0.2 0.1 0.1 [0.1 – 0.9 <0.1 0.1] [0.1 … <0.

2009 and 2001 | 2010 GLOBAL REPORT 189 .2009 Women (15+) estimate [low – high estimate] [160 000 – 300 000] estimate 98 000 2001 Women (15+) [low – high estimate] [71 000 – 140 000] estimate 8000 2009 Children (0–14) [low – high estimate] [3600 – 13 000] EAST ASIA China Democratic People’s Republic of Korea Japan Mongolia Republic of Korea OCEANIA Australia Fiji New Zealand Papua New Guinea SOUTH AND SOUTH-EAST ASIA Bangladesh Bhutan Cambodia India Indonesia Lao People’s Democratic Republic Malaysia Maldives Myanmar Nepal Pakistan Philippines Singapore Sri Lanka Thailand Viet Nam EASTERN EUROPE AND CENTRAL ASIA Armenia Azerbaijan Belarus Georgia Kazakhstan Kyrgyzstan Republic of Moldova Russian Federation Tajikistan Ukraine Uzbekistan WESTERN AND CENTRAL EUROPE Austria Belgium Bulgaria 220 000 230 000 … 2700 <200 2900 25 000 [160 000 – 300 000] … [2100 – 3400] [<100 – <200] [2200 – 4000] [22 000 – 28 000] … … 2200 <100 1600 12 000 [67 000 – 130 000] … [1700 – 2700] [<100 – <100] [1200 – 2000] [9400 – 16 000] … … … … … 3100 … … … … … [1500 – 4800] 6200 <200 <1000 18 000 1 400 000 [4800 – 7800] [<200 – <500] [<1000 – 1000] [16 000 – 21 000] [1 400 000 – 1 700 000] 3900 <100 <1000 7600 1 300 000 [3100 – 4900] [<100 – <100] [<500 – <1000] [5100 – 11 000] [1 300 000 – 1 600 000] … … … 3100 150 000 … … … [1600 – 4800] [97 000 – 200 000] 1900 <500 35 000 880 000 88 000 3500 11 000 <100 81 000 20 000 28 000 2600 1000 <1000 210 000 81 000 690 000 [1500 – 2400] [<200 – <500] [23 000 – 52 000] [730 000 – 1 000 000] [58 000 – 130 000] [2400 – 5500] [8600 – 15 000] [<100 – <100] [67 000 – 96 000] [16 000 – 25 000] [23 000 – 35 000] [1800 – 3900] [<1000 – 1300] [<500 – <1000] [160 000 – 260 000] [63 000 – 100 000] [600 000 – 790 000] <500 <100 51 000 880 000 3200 <500 6100 <100 67 000 19 000 11 000 <500 <1000 <500 220 000 39 000 330 000 [<100 – <1000] [<100 – <100] [34 000 – 71 000] [780 000 – 1 000 000] [<100 – 9600] [<100 – <500] [4100 – 8100] [<100 – <100] [53 000 – 83 000] [15 000 – 22 000] [9000 – 13 000] [<100 – 1100] [<1000 – 1100] [<200 – <500] [160 000 – 300 000] [31 000 – 50 000] [290 000 – 390 000] … … … … … … … … … … … … … … … … 18 000 … … … … … … … … … … … … … … … … [8600 – 29 000] A1 <1000 2100 8300 1500 7700 2800 5100 480 000 2700 170 000 8000 240 000 [<500 – <1000] [1500 – 3000] [6700 – 10 000] [1100 – 2100] [5300 – 11 000] [1900 – 4700] [4100 – 6600] [400 000 – 570 000] [1900 – 3700] [140 000 – 200 000] [4900 – 13 000] [210 000 – 270 000] <500 <1000 2300 <500 1100 <500 3700 190 000 1100 130 000 <500 180 000 [<500 – <1000] [<500 – <1000] [1900 – 2900] [<100 – <1000] [<1000 – 2000] [<100 – 3200] [2900 – 4800] [160 000 – 250 000] [<1000 – 1500] [110 000 – 150 000] [<100 – <100] [160 000 – 200 000] … … … … … … … 15 000 … … … 1400 … … … … … … … [6800 – 24 000] … … … [<1000 – 1800] 4600 4400 1100 [3500 – 5900] [3400 – 5500] [<1000 – 1500] 1600 3700 <500 [1100 – 2100] [2900 – 4800] [<500 – <1000] … … … … … … Annex 1: HIV and AIDS estimates and data.

1 – 0.1 0.1] [0.1 [0.1] [0.2 0.1 <0.1 – 0.1] [0.3] [<0.1 – 0.1 – <0.2 – 0.2 [<0.1 <0.1] [0.4] [0.1] [0.1 – 0.2] [<0.1 [0.1 – <0.1 0.1 0.1 – 0.1 <0.1] [<0.1 0.1 – 0.1 0.1 <0.1 2009 Young men (15–24) prevalence (%) [low – high estimate] [<0.1] [<0.1 0.1 0.1 <0.1] [<0.1] [<0.2] … … … … … … 0.1 – 0.1] [<0.1 – 0.1 – 0.1] [<0.1 – 0.1 <0.1 – 0.1 – 0.1] [0.1 0.2] [<0.1 – 0.1 – 0.1] [<0.1 <0.1 – 0.1 – <0.1 – <0.1] [0.1 – 0.1 0.1 0.1 [<0.1 – 0.1 <0.1 0.1 – 0.1] [0.1] 0.1] 190 Annex 1: HIV and AIDS estimates and data.2] [0.4] [<0.2] [0.2 – 0.2] [<0.1 0.1 – <0.1 – 0.3 – 0.1 <0.1 – 0.1] [<0.1 – <0.9] [<0.1] [<0.1] [<0.2] [<0.1] … [<0.4 – 0.1 – 0.1 0.1 – 0.1 – 0.1 – <0.1 [<0.5] [0.1 0.1] [<0.1] estimate <0.1] [<0.1 <0.1] [0.1] [0.1 – <0.1] [0.1 – 0.1] [<0.1] [<0.3] … … <0.2] [<0.1 <0.4 – 0.1] [<0.1 0.1 0.3] [<0.1 0.1] … … … … … … … 2000 … … … 2200 … … … … … … … [<1000 – 3100] … … … [1300 – 3100] <0.1 – 0.1] EAST ASIA China Democratic People’s Republic of Korea Japan Mongolia Republic of Korea OCEANIA Australia Fiji New Zealand Papua New Guinea SOUTH AND SOUTH-EAST ASIA Bangladesh Bhutan Cambodia India Indonesia Lao People’s Democratic Republic Malaysia Maldives Myanmar Nepal Pakistan Philippines Singapore Sri Lanka Thailand Viet Nam EASTERN EUROPE AND CENTRAL ASIA Armenia Azerbaijan Belarus Georgia Kazakhstan Kyrgyzstan Republic of Moldova Russian Federation Tajikistan Ukraine Uzbekistan WESTERN AND CENTRAL EUROPE Austria Belgium Bulgaria 2800 … … … … … <1000 … … … … … [<500 – 1600] … … <0.2 – 0.1] <0.1 – <0.1] [0.1 0.1] [<0.3] [<0.3 <0.1] [<0.4] [<0.1] [0.1] … [<0.1 – 0.1 0.1 – <0.1] [0.1 0.2] [<0.1] [0.1 – 0.1 – <0.2 – 0.1 2009 Young women (15–24) prevalence (%) [low – high estimate] [<0.3] … … … <1000 100 000 … … … [<500 – 1500] [67 000 – 140 000] 0.1 0.3 0.2 0.1 – <0.ESTIMATED PEOPLE LIVING WITH HIV 2001 Children (0–14) estimate [low – high estimate] [1200 – 5400] estimate <0.1 – 0.1 0.1 <0.1] [0.1 0.3] [<0.1 – 0.1 – 0.1] [<0.2 [<0.3 <0.1] [0.1 – <0.3] [<0.1] [<0.6 – 1.2 – 0.1] [<0.1 – 0. 2009 and 2001 | 2010 GLOBAL REPORT .1 <0.1 – 0.3] [0.1 … 0.1 – 0.1 – <0.1 – 0.1] [0.1 <0.1 <0.2] [<0.3 0.1 0.1 0.1] [0.1 – <0.1 – 0.1 – 0.2 <0.1 – 0.1 – 0.1 – <0.8 0.1] [<0.1 – <0.1 [<0.5] [0.1] [<0.1] 0.1] [<0.1 – 0.1 – 0.1 <0.1 – 0.1 – 0.1 – 0.1 0.1 – 0.1 – <0.6] [<0.1 [<0.1 – 0.1 – 0.1 – <0.1 <0.1 – 0.3] <0.1 – <0.1 0.3 <0.1] [0.1 0.1 – 0.1 – 0.1] [0.1] … … … … … … … … … … … … … … … … 4000 … … … … … … … … … … … … … … … … [2000 – 6100] <0.2 <0.1 0.2] [<0.3] [0.1 0.1 … 0.1 <0.2 <0.1 – 0.1 <0.1 – 0.1 – <0.1 <0.3 – 0.1 <0.1 0.1 – 0.2] [0.1 <0.2] [<0.1 – <0.7] [<0.1] [0.3 0.1 [<0.1 <0.1 – 0.2 <0.1 [<0.1 0.1 – 0.

10] [<0.10] [<0.10 … <0.10 <0.10 – 0.10] [<0.10] [<0.10 – <0.10 – <0.10 – <0.10 <0.10 – <0.16] [<0.14] [<0.10] [0.10 <0.10 [<0.10] estimate 82 000 2009 Adults + children newly infected [low – high estimate] [48 000 – 140 000] EAST ASIA China Democratic People’s Republic of Korea Japan Mongolia Republic of Korea OCEANIA Australia Fiji New Zealand Papua New Guinea SOUTH AND SOUTH-EAST ASIA Bangladesh Bhutan Cambodia India Indonesia Lao People’s Democratic Republic Malaysia Maldives Myanmar Nepal Pakistan Philippines Singapore Sri Lanka Thailand Viet Nam EASTERN EUROPE AND CENTRAL ASIA Armenia Azerbaijan Belarus Georgia Kazakhstan Kyrgyzstan Republic of Moldova Russian Federation Tajikistan Ukraine Uzbekistan WESTERN AND CENTRAL EUROPE Austria Belgium Bulgaria <0.10] [<0.10 – <0.10] [<0.10 – <0.10 … <0.10 – <0.10] [<0.10 – <0.10 … … <0.10 [<0.10] [<0.10 – <0.11 – 0.10] [0.10 <0.10 – <0.12] [<0.10 … … <0.22] [<0.10 [<0.10 <0.10] [<0.10 – <0.10] [<0.10 <0.10] [<0.10 – <0.10 – <0.10 … … <0.10] [<0.10 – <0.10] [<0.10] … … … 0.10 <0.10] estimate <0.10 – <0.13] [<0.10 – <0.10] [<0.10] [<0.10 – <0.10 – <0.10 – <0.10 <0.10 – <0.10 – <0.10 – <0.10] … … … [<0.10 <0.10] [<0.25] [<0.10] [<0.10] [<0.10 – <0.10 … … <0.10 – <0.10 – <0.10 … <0.10] … … … 3200 270 000 [<1000 – 1500] [<100 – <200] [<100 – <200] [2100 – 4800] [240 000 – 320 000] <0.10 … <0.10] [<0.10 – <0.13] [<0.10] [<0.10 – <0.10] [<0.10] [<0.10 – <0.10 – <0.10 … <0.10] <0.10 – <0.10] [<0.10] [<0.10] [<0.10] [<0.10 – <0.10 – <0.16] [<0.10 – <0.10] [<0.10 – <0.10] [<0.10] [<0.10] <0.10 – <0.10 … <0.10] [<0.10] … [<0.10 – <0.10] [<0.10 – <0.10] [<0.10 <0.10 – <0.10 – 0.10 … <0.10 – <0.10] <500 … 1500 <1000 1900 2600 <1000 … 1400 … … 31 000 [<200 – <500] [<500 – 1100] [1100 – 2200] [<500 – 1200] [1200 – 3600] [1400 – 6500] [<1000 – 1200] [67 000 – 120 000] [<1000 – 2300] [16 000 – 32 000] [3100 – 11 000] [23 000 – 40 000] … … … [<0.10 <0.10] [<0.10 … … <0.10] [<0.10 <0.10 – <0.10 2001 Adult (15–49) incidence rate [low – high estimate] [<0.10 – <0.10] [<0.10 <0.10] [<0.10] [<0.10 – <0.10 … 0.10 – 0.10] [<0.10] [<0.10 – <0.10 <0.10] [<0.10 – <0.10] [<0.10 – <0.11] [<0.16] 1400 … 1700 140 000 … … 10 000 … 17 000 4800 … 2100 … <500 12 000 … 130 000 [1000 – 2400] [<200 – <1000] [<1000 – 4200] [110 000 – 160 000] [29 000 – 87 000] [<1000 – 3400] [8400 – 13 000] [<100 – <100] [14 000 – 20 000] [2700 – 7800] [7300 – 15 000] [1200 – 4900] [<100 – <500] [<200 – <1000] [9800 – 15 000] [16 000 – 38 000] [110 000 – 160 000] A1 <0.10 – <0.10] [0.13 <0.10 <0.10 – <0.10 – <0.10 – <0.10 – 0.10 – <0.10 … <0.10] [<0.10 … <0.10 – 0.10 – <0.10] [<0.10 – <0.10] [<0.10 <0.10 [<0.10 <0.10 <0.10 … <0.10 – <0.10 – <0.10] [<0.10] … … <500 <100 <1000 4500 [47 000 – 140 000] … [<200 – <500] [<100 – <200] [<500 – 1000] [3400 – 6000] … … … <0.10 – <0.17 – 0.10 – <0.10 – <0.10] [0.10 … <0.10 – <0.10] [<0.10 – <0.10 – <0.10 … <0.10 [<0.10 – <0.10 [<0.10 … <0.10] … … <0.10 – <0.10 <0.10] [<0.14 [<0.10] [<0.10 [<0.10] [<0.10] [<0.11 – 0.10 – <0.10 – <0.10] [<0.10 – <0.10 – <0.10 – <0.10 – <0.10 – <0. 2009 and 2001 | 2010 GLOBAL REPORT 191 .10 – <0.10] [<0.10] [<0.10 – 0.10 – <0.10] [<0.10] [<0.10 <0.10] … [<0.10 – <0.10] [<0.10 – 0.10] [<0.10 – <0.10] [<0.ESTIMATED NEW HIV INFECTIONS 2009 Adult (15–49) incidence rate estimate [low – high estimate] [<0.10 – <0.10] [<0.10 – <0.10] … … … [<1000 – 2100] [<100 – <500] [<500 – <1000] Annex 1: HIV and AIDS estimates and data.10 – <0.10 <0.

ESTIMATED NEW HIV INFECTIONS 2009 Adults newly infected estimate [low – high estimate] [47 000 – 140 000] ESTIMATED AIDS-RELATED DEATHS 2009 AIDS-related deaths in adults + children estimate 36 000 [low – high estimate] [25 000 – 50 000] estimate 15 000 2001 AIDS-related deaths in adults + children [low – high estimate] [9400 – 28 000] EAST ASIA China Democratic People’s Republic of Korea Japan Mongolia Republic of Korea OCEANIA Australia Fiji New Zealand Papua New Guinea SOUTH AND SOUTH-EAST ASIA Bangladesh Bhutan Cambodia India Indonesia Lao People’s Democratic Republic Malaysia Maldives Myanmar Nepal Pakistan Philippines Singapore Sri Lanka Thailand Viet Nam EASTERN EUROPE AND CENTRAL ASIA Armenia Azerbaijan Belarus Georgia Kazakhstan Kyrgyzstan Republic of Moldova Russian Federation Tajikistan Ukraine Uzbekistan WESTERN AND CENTRAL EUROPE Austria Belgium Bulgaria 81 000 … … <500 <100 <1000 3700 [46 000 – 140 000] … [<200 – <500] [<100 – <100] [<500 – 1000] [2600 – 5300] 26 000 … <100 <100 <500 1400 [24 000 – 49 000] … [<100 – <500] [<100 – <100] [<500 – <1000] [<1000 – 2400] … … <100 <100 <500 <1000 [9100 – 28 000] … [<100 – <200] [<100 – <100] [<100 – <500] [<500 – 1100] … … … 2400 250 000 [<1000 – 1500] [<100 – <200] [<100 – <200] [1400 – 4100] [220 000 – 300 000] <100 <100 <100 1300 260 000 [<100 – <1000] [<100 – <100] [<100 – <100] [<1000 – 1900] [230 000 – 300 000] <100 <100 <100 <1000 230 000 [<100 – <200] [<100 – <100] [<100 – <100] [<500 – <1000] [210 000 – 280 000] 1400 … 1200 120 000 … … 10 000 … 16 000 4300 … 2100 … <500 12 000 … 130 000 [<1000 – 2400] [<200 – <1000] [<200 – 3500] [100 000 – 150 000] [29 000 – 86 000] [<1000 – 3100] [8400 – 13 000] [<100 – <100] [14 000 – 19 000] [2300 – 7200] [6700 – 14 000] [1200 – 4800] [<100 – <500] [<200 – <1000] [9500 – 14 000] [15 000 – 37 000] [100 000 – 150 000] <200 <100 3100 170 000 8300 <200 5800 <100 18 000 4700 5800 <200 <100 <200 28 000 14 000 76 000 [<100 – <500] [<100 – <100] [<1000 – 5600] [150 000 – 200 000] [3800 – 15 000] [<100 – <500] [4500 – 7200] [<100 – <100] [13 000 – 23 000] [3800 – 5700] [4500 – 7400] [<100 – <500] [<100 – <200] [<100 – <500] [21 000 – 37 000] [9500 – 20 000] [60 000 – 96 000] <100 <100 7400 140 000 <200 <100 3900 <100 16 000 4000 1400 <100 <100 <100 52 000 5500 18 000 [<100 – <200] [<100 – <100] [5000 – 11 000] [120 000 – 170 000] [<100 – 1900] [<100 – <100] [3000 – 5200] [<100 – <100] [12 000 – 20 000] [3200 – 4900] [<1000 – 1900] [<100 – <500] [<100 – <500] [<100 – <100] [39 000 – 68 000] [3900 – 7500] [14 000 – 23 000] <500 … 1500 <1000 1900 2600 <1000 … 1300 … … 31 000 [<200 – <500] [<500 – 1100] [1100 – 2200] [<500 – 1200] [1200 – 3600] [1400 – 6500] [<1000 – 1200] [64 000 – 110 000] [<1000 – 2200] [16 000 – 32 000] [3100 – 11 000] [23 000 – 39 000] <100 <200 <1000 <100 <500 <500 <1000 … <500 24 000 <500 8500 [<100 – <200] [<200 – <500] [<500 – <1000] [<100 – <200] [<200 – <1000] [<100 – <500] [<1000 – 1100] … [<500 – <1000] [20 000 – 29 000] [<200 – 1000] [6800 – 19 000] <100 <100 <200 <100 <100 <100 <1000 … <200 13 000 <100 7300 [<100 – <100] [<100 – <100] [<100 – <500] [<100 – <200] [<100 – <100] [<100 – 3300] [<500 – <1000] … [<200 – <500] [9400 – 16 000] [<100 – <100] [5700 – 11 000] … … … [<1000 – 2100] [<100 – <500] [<500 – <1000] <100 <100 <200 [<100 – <100] [<100 – <500] [<200 – <500] <100 <100 <100 [<100 – <100] [<100 – <100] [<100 – <200] 192 Annex 1: HIV and AIDS estimates and data. 2009 and 2001 | 2010 GLOBAL REPORT .

0 8.9 … 28.3 … … 4.3 5.6 … 4.8 … 2.8 … … … 18.6 6.4 … … … … … … … … … … … … … … … … … 73 000 … … … … … … … … … … … … … … … … [59 000 – 91 000] … … … … … … … … … … … … … … … … 15 000 … … … … … … … … … … … … … … … … [9000 – 22 000] 2007 … 2007 2009 2007 … … … 2008 2009 2008 2009 … … 2009 2009 … 1.0 … … 2008 2009 2009 2009 2009 … 2009 2008 … 2009 … … 1.7 … A1 … … … … … … … 37 000 … … … 26 000 … … … … … … … [27 000 – 50 000] … … … [22 000 – 42 000] … … … … … … … 1200 … … … 50 000 … … … … … … … [<1000 – 1700] … … … [41 000 – 60 000] … 2008 2009 2008 2009 2009 … 2009 2008 2009 2009 … … 10.7 6.8 … 2009 2008 … 0.7 2.0 0.5 7.6 … 24.9 14.3 1.5 2.4 0.5 16.9 11.3 … … 8.4 … 2007 … … 2009 2007 … … … 2008 2008 2009 2009 … … 2009 2009 … 0.3 … … 2008 … … 2009 … 0.6 17.6 … … … … … 2009 … 2009 2009 … … 5.6 3.4 … 22.5 13.2 52.6 0.3 Annex 1: HIV and AIDS estimates and data.7 … 2010 2008 … 5.8 3. 2009 and 2001 | 2010 GLOBAL REPORT 193 .4 … … … … 2009 … … … … 4.5 … 0.2 … … 2.7 18.1 2.7 20.3 … 15.2 … … 2008 2009 2007 2009 … … 2009 … 2009 2009 … … 1.4 2.4 9.7 3.8 … 1.2 2.6 0.0 1.3 13.7 6.2 … … 38.8 … … … … … … 1 000 000 … … … … [820 000 – 1 100 000] … … … … 500 000 … … … … [420 000 – 620 000] 2008 … 2004 … … 1.2 … … … 2005 2009 2007 … 2009 … 2008 2009 … 2009 2009 2009 2009 2010 … … … 4.3 20.8 … … … … … … … … … … … … … 2009 2008 2008 4.1 … … 7.3 … 8.2 1.0 2.0 … 4.ESTIMATED ORPHANS DUE TO AIDS 2009 Orphans (0–17) currently living estimate [low – high estimate] [35 000 – 78 000] estimate 18 000 HIV PREVALENCE (%) IN MOST-AT-RISK GROUPS IN CAPITAL CITY 2001 Orphans (0–17) [low – high estimate] [10 000 – 37 000] Injecting drug users Year … HIV (%) … Female sex workers Year … HIV (%) … Men who have sex with men Year … HIV (%) … EAST ASIA China Democratic People’s Republic of Korea Japan Mongolia Republic of Korea OCEANIA Australia Fiji New Zealand Papua New Guinea SOUTH AND SOUTH-EAST ASIA Bangladesh Bhutan Cambodia India Indonesia Lao People’s Democratic Republic Malaysia Maldives Myanmar Nepal Pakistan Philippines Singapore Sri Lanka Thailand Viet Nam EASTERN EUROPE AND CENTRAL ASIA Armenia Azerbaijan Belarus Georgia Kazakhstan Kyrgyzstan Republic of Moldova Russian Federation Tajikistan Ukraine Uzbekistan WESTERN AND CENTRAL EUROPE Austria Belgium Bulgaria 52 000 … … … … … 6300 … … … … … [4000 – 10 000] … … … … … 2700 … … … … … [1900 – 4400] 2009 … … … … … 9.9 7.1 … 36.2 … 3.0 1.8 0.0 2.6 22.8 3.3 … … … … … 2009 … … … … … 0.

ESTIMATED PEOPLE LIVING WITH HIV 2009 Adults + Children estimate [low – high estimate] estimate 2001 Adults + Children [low – high estimate] estimate 2009 Adults (15+) [low – high estimate] Croatia Czech Republic Denmark Estonia Finland France Germany Greece Hungary Iceland Ireland Israel Italy Latvia Lithuania Luxembourg Malta Netherlands Norway Poland Portugal Romania Serbia Slovakia Slovenia Spain Sweden Switzerland Turkey United Kingdom of Great Britain and Northern Ireland MIDDLE EAST AND NORTH AFRICA Algeria Djibouti Egypt Iran (Islamic Republic of) Lebanon Morocco Oman Qatar Somalia Sudan Tunisia <1000 2000 5300 9900 2 600 150 000 67 000 8800 3000 <1000 6900 7500 140 000 8600 1200 <1000 <500 22 000 4000 27 000 42 000 16 000 4900 <500 <1000 130 000 8100 18 000 4600 85 000 460 000 [<1000 – 1 100] [1700 – 2300] [4000 – 6300] [8000 – 12 000] [2200 – 3100] [120 000 – 190 000] [56 000 – 75 000] [7300 – 11 000] [2200 – 3900] [<500 – <1000] [5200 – 8700] [5600 – 9900] [110 000 – 180 000] [6300 – 12 000] [<1000 – 1600] [<1000 – 1200] [<500 – <500] [17 000 – 32 000] [3000 – 5400] [20 000 – 34 000] [32 000 – 53 000] [12 000 – 20 000] [3500 – 7100] [<500 – <500] [<500 – <1000] [120 000 – 150 000] [6100 – 11 000] [13 000 – 24 000] [3400 – 6100] [66 000 – 110 000] [400 000 – 530 000] <1000 1300 3300 4700 1600 120 000 49 000 8100 2800 <500 4500 5200 130 000 4700 <1000 <1000 <500 18 000 3000 21 000 31 000 16 000 1900 <200 <500 120 000 6300 13 000 1700 43 000 180 000 [<500 – <1000] [1200 – 1600] [2800 – 3800] [3800 – 5700] [1300 – 1900] [100 000 – 140 000] [42 000 – 56 000] [6800 – 9500] [2100 – 3700] [<500 – <500] [3400 – 5900] [3900 – 6800] [99 000 – 170 000] [3500 – 6 200] [<1000 – <1000] [<500 – <1000] [<200 – <500] [14 000 – 24 000] [2300 – 4100] [16 000 – 28 000] [24 000 – 41 000] [12 000 – 20 000] [<500 – 2800] [<200 – <500] [<200 – <500] [100 000 – 130 000] [4900 – 8700] [9500 – 17 000] [1300 – 2300] [35 000 – 54 000] [150 000 – 210 000] <1000 2000 5300 9800 2600 150 000 67 000 8800 3000 <1000 6900 7500 140 000 8600 1200 <1000 <500 22 000 4000 27 000 42 000 15 000 4900 <500 <1000 130 000 8100 18 000 4500 85 000 440 000 [<1000 – 1100] [1700 – 2300] [4000 – 6300] [8000 – 12 000] [2200 – 3100] [120 000 – 190 000] [56 000 – 75 000] [7300 – 11 000] [2200 – 3900] [<500 – <1000] [5200 – 8700] [5600 – 9900] [110 000 – 180 000] [6300 – 11 000] [<1000 – 1600] [<1000 – 1200] [<500 – <500] [17 000 – 32 000] [3000 – 5400] [20 000 – 34 000] [32 000 – 53 000] [11 000 – 20 000] [3400 – 7100] [<500 – <500] [<500 – <1000] [120 000 – 150 000] [6100 – 11 000] [13 000 – 24 000] [3300 – 6100] [66 000 – 110 000] [380 000 – 510 000] 18 000 14 000 11 000 92 000 3600 26 000 1100 <200 34 000 260 000 2400 [13 000 – 24 000] [10 000 – 18 000] [8400 – 17 000] [74 000 – 120 000] [2700 – 4800] [19 000 – 34 000] [<1000 – 1400] [<100 – <200] [25 000 – 48 000] [210 000 – 330 000] [1800 – 3300] 6800 12 000 3300 54 000 3800 14 000 <500 <100 11 000 72 000 <1000 [4900 – 9000] [9000 – 16 000] [2900 – 5300] [45 000 – 65 000] [2900 – 5100] [11 000 – 18 000] [<500 – <1000] [<100 – <100] [<500 – 14 000] [35 000 – 98 000] [<500 – 1000] 17 000 13 000 10 000 91 000 3400 25 000 1100 <200 32 000 250 000 2400 [12 000 – 24 000] [9400 – 16 000] [8100 – 16 000] [72 000 – 110 000] [2600 – 4600] [19 000 – 33 000] [<1000 – 1400] [<100 – <200] [23 000 – 46 000] [200 000 – 310 000] [1700 – 3300] 194 Annex 1: HIV and AIDS estimates and data. 2009 and 2001 | 2010 GLOBAL REPORT .

3] [0.1] [<0.3 – 0.1] [0.1 – 0.2] [<0.1 – 0.1 – 0.1] [<0.1 0.1 <0.1 – 0.4 – 0.2] [0.1 0.1] [0.2] [0.1] [0.1] [0.1 – <0.1 <0.7 1.1 – 0.1 0.3] [0.1 – <0.2001 Adults (15+) estimate [low – high estimate] estimate 2009 Adult (15–49) prevalence percent [low – high estimate] estimate 2001 Adult (15–49) prevalence percent [low – high estimate] Croatia Czech Republic Denmark Estonia Finland France Germany Greece Hungary Iceland Ireland Israel Italy Latvia Lithuania Luxembourg Malta Netherlands Norway Poland Portugal Romania Serbia Slovakia Slovenia Spain Sweden Switzerland Turkey United Kingdom of Great Britain and Northern Ireland MIDDLE EAST AND NORTH AFRICA Algeria Djibouti Egypt Iran (Islamic Republic of) Lebanon Morocco Oman Qatar Somalia Sudan Tunisia <1000 1300 3300 4700 1600 120 000 49 000 8000 2800 <500 4500 5100 130 000 4700 <1000 <1000 <500 18 000 3000 21 000 31 000 16 000 1900 <200 <500 110 000 6300 13 000 1700 43 000 170 000 [<500 – <1000] [1200 – 1600] [2800 – 3800] [3800 – 5700] [1300 – 1900] [100 000 – 140 000] [42 000 – 56 000] [6800 – 9500] [2100 – 3700] [<500 – <500] [3400 – 5900] [3900 – 6800] [99 000 – 170 000] [3500 – 6200] [<1000 – <1000] [<500 – <1000] [<200 – <500] [14 000 – 24 000] [2300 – 4100] [16 000 – 28 000] [24 000 – 41 000] [12 000 – 20 000] [<500 – 2700] [<200 – <500] [<200 – <500] [100 000 – 130 000] [4900 – 8700] [9500 – 17 000] [1300 – 2300] [35 000 – 53 000] [150 000 – 200 000] <0.2 – 0.9 – 3.1 – 0.1 – <0.1 – 0.1 <0.1] [0.1 – <0.1] Annex 1: HIV and AIDS estimates and data.2 0.1] [<0.1 0.1 0.1] [0.2 [<0.3] [0.1 <0.1 0.1 – 0.3 0.2 – 0.1] [0.1] [2.2] [0.3 0.1] <0.2 0.2 – 3.1 – 0.1 2.5 0.1 – 0.3] [0.1 0.5 – 0.1 – 0.4] [<0.3 0.1 0.4] [0.1 – <0.1 – <0.3 – 0.2 0.1 <0.3 0.1 – 0.2 – 0.1 – 0.1 – 0.1] [<0.3 – 0.3 0.1 0.1 0.1] [<0.1 – <0.2 1.5] [0.2] [1.5] [<0.1 0.1] [<0.3 – 0.1] [0.1 – 0.1 – 0.1 – <0.3 – 0.1 <0.2 – 0.4 0.4 <0.1] A1 6700 11 000 3200 54 000 3700 14 000 <500 <100 10 000 68 000 <1000 [4800 – 9000] [8600 – 15 000] [2900 – 5300] [44 000 – 64 000] [2800 – 5000] [10 000 – 18 000] [<500 – <500] [<100 – <100] [<500 – 13 000] [34 000 – 89 000] [<500 – 1000] 0.1 – 0.1 0.1] [0.1 – <0.4 0.4] [0.3] [0.1] [0.1 – 0.1 0.9 <0.1] [0.1 – 0.3 <0.1 – 0.1 – <0.2 – 0.4 <0.1] [0.5 – 0.1 0.1 0.1 [0.4] [0.4] [0.9] [<0.2] [<0.2 0.1] [0.1 – 0.9] [<0.8] [<0.2] [<0.1 – 0.4 0.7] [0.3 0.5 <0.1] [0.2] [0.1 0.1 – <0.1 – <0.2] [0.2] [0.5] [0.2 – 0.2 – 0.1 – 0.1 – 0.1 – 0.4] [0.1 – 0.1 0.2] [0.1 0.1 – 0.1] [<0.1] [0.2 – 0.1 – 0.3] <0.1 – 0.5] [0.1 – 0.2] [<0.1 0.9 – 1.1 0.1 <0.5] [<0.1] [<0.1 0.1 – 0.1 [<0.1 <0.0 – 1.5] [<0.1 0.1 0.5 – 1.1] [<0.1 – 0.1] [0.1 – <0.2] [0.1 2.1 0.1] [0.2] [<0.1 <0.6 0.2 – 0.4 – 0.7 0.2] [0.1 0.1 0.1 – 0.2] [0.1 <0.6 0.1 <0.4] [<0.1] [1.3] [0.1] [0.1 0.1 0.1] [0.3] [0.2] [0.3] [0.3 0.2 0.2 – 0.2] [0.1 – <0.1 0.2 0.1 – <0.1 – 0.1 [<0.1 0.2 0.1 – 0.1 – 0.4 <0.1 – <0.1 <0.1 0.1 – 0.1] [<0.4 – 0.2 0.1 – 0.6] [0.1] [0.2 0.1 – <0.1 <0.2 0.1 0.1 – 0.1 0.1 – 0.1] [0.1] [0.2 – 0. 2009 and 2001 | 2010 GLOBAL REPORT 195 .1 – 0.1] [0.0] [0.

2009 and 2001 | 2010 GLOBAL REPORT .ESTIMATED PEOPLE LIVING WITH HIV 2009 Women (15+) estimate [low – high estimate] estimate 2001 Women (15+) [low – high estimate] estimate 2009 Children (0–14) [low – high estimate] Croatia Czech Republic Denmark Estonia Finland France Germany Greece Hungary Iceland Ireland Israel Italy Latvia Lithuania Luxembourg Malta Netherlands Norway Poland Portugal Romania Serbia Slovakia Slovenia Spain Sweden Switzerland Turkey United Kingdom of Great Britain and Northern Ireland MIDDLE EAST AND NORTH AFRICA Algeria Djibouti Egypt Iran (Islamic Republic of) Lebanon Morocco Oman Qatar Somalia Sudan Tunisia <500 <1000 1400 3000 <1000 48 000 12 000 2700 <1000 <200 2000 2200 48 000 2600 <500 <500 <100 6900 1200 8200 13 000 4700 1200 <100 <200 32 000 2500 5700 1400 26 000 210 000 [<500 – <500] [<1000 – <1000] [1100 – 1700] [2400 – 3800] [<1000 – <1000] [38 000 – 59 000] [11 000 – 14 000] [2200 – 3200] [<1000 – 1300] [<200 – <500] [1500 – 2600] [1700 – 2900] [36 000 – 61 000] [1900 – 3500] [<500 – <500] [<500 – <500] [<100 – <200] [5200 – 9700] [<1000 – 1600] [6200 – 11 000] [9900 – 16 000] [3500 – 5900] [<1000 – 1600] [<100 – <200] [<200 – <500] [27 000 – 36 000] [1900 – 3400] [4100 – 7500] [1000 – 1800] [20 000 – 32 000] [180 000 – 240 000] <200 <500 <1000 1400 <500 37 000 9000 2500 <1000 <100 1300 1500 42 000 1400 <500 <200 <100 5400 <1000 6400 9400 4600 <500 <100 <100 28 000 1900 4000 <1000 13 000 74 000 [<200 – <500] [<500 – <500] [<1000 – 1000] [1100 – 1700] [<500 – <1000] [31 000 – 44 000] [7700 – 10 000] [2100 – 2900] [<1000 – 1200] [<100 – <200] [1000 – 1800] [1200 – 2100] [32 000 – 56 000] [1000 – 1800] [<200 – <500] [<200 – <500] [<100 – <100] [4200 – 7400] [<1000 – 1200] [4800 – 8500] [7300 – 12 000] [3600 – 5900] [<100 – <1000] [<100 – <100] [<100 – <100] [23 000 – 32 000] [1500 – 2700] [3000 – 5200] [<500 – <1000] [10 000 – 16 000] [61 000 – 87 000] … … … … … … … … … … … … … … … … … … … … … … … … … … … … … … 21 000 … … … … … … … … … … … … … … … … … … … … … … … … … … … … … … [13 000 – 28 000] 5200 7400 2400 26 000 1100 8100 <500 <100 15 000 140 000 <1000 [3700 – 7200] [5300 – 9500] [2500 – 4900] [20 000 – 33 000] [<1000 – 1400] [6000 – 11 000] [<500 – <500] [<100 – <100] [11 000 – 21 000] [110 000 – 180 000] [<1000 – 1000] 2000 6600 <1000 15 000 1100 4300 <200 <100 4700 39 000 <500 [1500 – 2600] [5000 – 9000] [<1000 – 1600] [12 000 – 18 000] [<1000 – 1500] [3300 – 5600] [<200 – <200] [<100 – <100] [<200 – 6300] [20 000 – 53 000] [<100 – <500] … … … … … … … … … … … … … … … … … … … … … … 196 Annex 1: HIV and AIDS estimates and data.

1 – 0.6] [<0.2 <0.1 0.1 – <0.1] [<0.4] [<0.1 – 0.1 – <0.1 – 0.1 0.1 – 0.1] [0.2] [<0.1 <0.1] [<0.1 – <0.1 – 0.1 – 0.1 <0.1 – 0.2] [<0.1] [<0.1] [0.1] [<0.1 0.6] [0.2 [<0.4 0.1 <0.1 <0.1 – 0.1 0.1 – 0.1 – <0.1 0.1 – 0.1] [<0.1 – 0.2 <0.1 <0.6] [0.2001 Children (0–14) estimate [low – high estimate] estimate 2009 Young women (15–24) prevalence (%) [low – high estimate] estimate 2009 Young men (15–24) prevalence (%) [low – high estimate] Croatia Czech Republic Denmark Estonia Finland France Germany Greece Hungary Iceland Ireland Israel Italy Latvia Lithuania Luxembourg Malta Netherlands Norway Poland Portugal Romania Serbia Slovakia Slovenia Spain Sweden Switzerland Turkey United Kingdom of Great Britain and Northern Ireland MIDDLE EAST AND NORTH AFRICA Algeria Djibouti Egypt Iran (Islamic Republic of) Lebanon Morocco Oman Qatar Somalia Sudan Tunisia … … … … … … … … … … … … … … … … … … … … … … … … … … … … … … 7100 … … … … … … … … … … … … … … … … … … … … … … … … … … … … … … [3800 – 13 000] <0.1] [<0.1 0.1] [0.1] [<0.1 0.2] [0.1] [0.1] [<0.2 0.1 – 0.1 0.1] A1 … … … … … … … … … … … … … … … … … … … … … … <0.2] [<0.9 – 1.1] [<0.1] [<0.1] [<0.9] [<0.1 – 0.1 – 0.2 <0.1 <0.1 <0.1 <0.2 – 0.1 – 0.2] [0.1 – 0.1 0.1] [0.1] 0. 2009 and 2001 | 2010 GLOBAL REPORT 197 .6 1.1 – <0.1 – 0.1 – 0.2] [0.1 – 0.2] [0.1 – 0.1 <0.1 – 0.1 <0.1] [<0.1 0.1] [<0.1 <0.1] [<0.1] [<0.1 <0.1] [0.1] [<0.4 – 1.1 <0.1 [<0.1 <0.1] [<0.1 <0.1 – 0.1 – 0.1 – 0.3 <0.1 – 0.1] [<0.2 – 0.1 0.1] [<0.1 0.1] [<0.1 – 0.1 0.2 <0.1 0.1] [0.1 0.1] [<0.4] [<0.3] [<0.1 0.1 1.4] [<0.1] [0.1 – 0.1 – 0.1 – <0.2 <0.1 – 0.1] [<0.2] [<0.1 0.1 – 0.1 – 0.1 0.1 – 0.1 0.8 <0.9 <0.1 – <0.1 – 0.1] [<0.1 – 0.1 – <0.1 – <0.1 [<0.1 – <0.1 <0.1 – 0.1] [<0.1 – 0.1 <0.1 – 0.1] [0.1] [1.3] <0.3] [<0.9] [<0.7] [0.1 – 0.1 – 0.1 <0.1 – <0.1] [0.1 0.1 – <0.1] [<0.1 0.1 0.3 – 0.1 – <0.1 – 0.3] [<0.1 – 0.1 – <0.1 – <0.1 – 0.0 – 2.4] [<0.2] [<0.1 – <0.7] [<0.1 <0.1] [<0.1 <0.1 0.1] [<0.1 0.2 0.1 [<0.1] [0.1 0.8] [<0.1 – <0.1 – <0.2] [<0.1 – <0.1 0.1 0.1 – 0.1 – 0.1 – 0.1] [<0.1] [0.1 – 0.1] [0.2 – 0.1 <0.1 – 0.1 <0.1 0.4 – 0.1 <0.2] [<0.3] [<0.1 0.1] [<0.1 – 0.1] [<0.3 0.1 0.2] [<0.1] [0.1] [<0.1 – <0.3 0.1 – <0.2] [<0.5 <0.1 – 0.1] Annex 1: HIV and AIDS estimates and data.1 0.1 <0.1] [0.1] [<0.1 – <0.1 0.2] [0.1 – 0.3] [<0.1 <0.1 <0.1 <0.4 – 1.1 0.1 <0.1 <0.1 0.1 – 0.1 0.1 – 0.2] [<0.1 – 0.

10] [<0.10 – <0.10 <0.10 – <0.51] [<0.10 – <0.10] [<0.10] [<0.21] [<0.10 – 0.10] [<0.10 – <0.10] [<0.10 – <0.10 – <0.10 – 0.10] [<0.10] [<0.10] [<0.10 – <0.10 <0.10 – 0.29] [0.10] [<0.10] [<0.10] … … … … … <0.10 – <0.10 – <0.10 – <0.10] [<0.10] [<0.10] [<0.10] [0.10 – <0.10 – <0.10 – <0.10 – <0.10] [<0.10 – <0.10 – <0.10] [<0.10 – <0.10] [<0.10] [<0.10] [<0.10 – <0.10 – <0.10 [<0.10] [<0.10 – <0.10] [<0.11] [<0. 2009 and 2001 | 2010 GLOBAL REPORT .13 – 0.10 [<0.10 – <0.10] [<0.17 – 0.10] [<0.10] [<0.10 – <0.34] [<0.10 … … … … … … … … … … … … … … … <0.10] [<0.10] [<0.10 – <0.10 – <0.10] [<0.10] [<0.10] [<0.10] [<0.10 – <0.10 – <0.10 – <0.10 – <0.10] [<0.10] [<0.10 – <0.10 – <0.10] [<0.10] … 1300 … … … … … … … … … [1100 – 3700] [<1000 – 1800] [<1000 – 2900] [5600 – 11 000] [<100 – <500] [1200 – 5800] [<200 – <500] [<100 – <100] [4200 – 13 000] [38 000 – 74 000] [<500 – <1000] 198 Annex 1: HIV and AIDS estimates and data.10] [<0.10 – <0.10] [<0.10] [<0.10 – <0.10 – <0.10 – <0.25 … … … … … … … … … [<0.10 – <0.10 … … … … … … … … … … … … … … … <0.10] [<0.10 – <0.10 – <0.10] [<0.10] … … … … … 6900 3300 … … … … … … <1000 <100 … … … … … … … … … … … … … … … 75 000 [<100 – <100] [<100 – <100] [<200 – <500] [<1000 – 1000] [<100 – <200] [3900 – 10 000] [2500 – 4200] [<200 – <500] [<100 – <1000] [<100 – <100] [<100 – <500] [<200 – <500] [1700 – 6200] [<500 – 1200] [<100 – <200] [<100 – <100] [<100 – <100] [<500 – 1100] [<100 – <500] [<500 – 1300] [<1000 – 2300] [<500 – 1000] [<500 – <1000] [<100 – <100] [<100 – <200] [2200 – 4100] [<100 – <500] [<500 – 1000] [<500 – <1000] [1500 – 6000] [61 000 – 92 000] … 0.10 – <0.10] [<0.14] [<0.10 – <0.10] [<0.18 – 0.10] [<0.10 – <0.10 – <0.10 – <0.10] [<0.10 – <0.10] [<0.10] [<0.10 – <0.10] [<0.10] [<0.10 – 0.10] [<0.10 – <0.10 – <0.10 – <0.10 – <0.10] [0.29 … … … … … … … … … [<0.10] [<0.10 – <0.10] [<0.10] [<0.10 – <0.10 – <0.10] [<0.10] … 0.10 – <0.10 – <0.10 <0.10 – <0.10] [<0.10 – <0.10] [<0.10 – 0.10 – <0.10] [<0.10] [<0.10] [<0.10 – <0.10] [<0.10 – <0.10] [<0.10 – 0.10] [0.10 … … … … … … <0.10 <0.10 – <0.10] [<0.10 – <0.10 – <0.ESTIMATED NEW HIV INFECTIONS 2009 Adult (15–49) incidence rate estimate [low – high estimate] estimate 2001 Adult (15–49) incidence rate [low – high estimate] estimate 2009 Adults + children newly infected [low – high estimate] Croatia Czech Republic Denmark Estonia Finland France Germany Greece Hungary Iceland Ireland Israel Italy Latvia Lithuania Luxembourg Malta Netherlands Norway Poland Portugal Romania Serbia Slovakia Slovenia Spain Sweden Switzerland Turkey United Kingdom of Great Britain and Northern Ireland MIDDLE EAST AND NORTH AFRICA Algeria Djibouti Egypt Iran (Islamic Republic of) Lebanon Morocco Oman Qatar Somalia Sudan Tunisia … … … … … <0.10 – <0.10 – <0.10] [<0.10] [<0.10 – <0.10 – <0.10 – <0.35] [<0.10 – <0.10] [<0.10] [<0.10] [<0.10 … … … … … … <0.10 – <0.10 – <0.10 – <0.10] [<0.10] [<0.10] [<0.10 – <0.10] [<0.10 – <0.10 – <0.10] [<0.10 – <0.10] … [<0.

ESTIMATED AIDS-RELATED DEATHS 2009 Adults newly infected estimate [low – high estimate] estimate 2009 AIDS-related deaths in adults + children [low – high estimate] estimate 2001 AIDS-related deaths in adults + children [low – high estimate] Croatia Czech Republic Denmark Estonia Finland France Germany Greece Hungary Iceland Ireland Israel Italy Latvia Lithuania Luxembourg Malta Netherlands Norway Poland Portugal Romania Serbia Slovakia Slovenia Spain Sweden Switzerland Turkey United Kingdom of Great Britain and Northern Ireland MIDDLE EAST AND NORTH AFRICA Algeria Djibouti Egypt Iran (Islamic Republic of) Lebanon Morocco Oman Qatar Somalia Sudan Tunisia … … … … … 6800 3300 … … … … … … <1000 <100 … … … … … … … … … … … … … … … 68 000 [<100 – <100] [<100 – <100] [<200 – <500] [<1000 – 1000] [<100 – <200] [3900 – 10 000] [2500 – 4200] [<200 – <500] [<100 – <100] [<100 – <100] [<100 – <500] [<200 – <500] [1700 – 6200] [<500 – 1200] [<100 – <200] [<100 – <100] [<100 – <100] [<500 – 1100] [<100 – <500] [<500 – 1300] [<1000 – 2300] [<500 – 1000] [<500 – <1000] [<100 – <100] [<100 – <200] [2200 – 4100] [<100 – <500] [<500 – 1000] [<500 – <1000] [<100 – <100] [55 000 – 84 000] <100 <100 <100 <500 <100 1700 <1000 <500 <200 <100 <100 <100 <1000 <1000 <100 <100 <100 <100 <100 <200 <500 <1000 <200 <100 <100 1600 <100 <100 <200 <1000 24 000 [<100 – <100] [<100 – <100] [<100 – <200] [<500 – <1000] [<100 – <100] [1400 – 3900] [<1000 – 1900] [<200 – <500] [<100 – <200] [<100 – <100] [<100 – <200] [<100 – <200] [<1000 – 4100] [<500 – <1000] [<100 – <100] [<100 – <100] [<100 – <100] [<100 – <500] [<100 – <200] [<100 – <1000] [<100 – 1300] [<500 – 1200] [<100 – <500] [<100 – <100] [<100 – <100] [1200 – 2000] [<100 – <500] [<100 – <500] [<100 – <500] [<500 – 1600] [20 000 – 27 000] <100 <100 <100 <200 <100 1200 <1000 <500 <500 <100 <100 <100 1300 <200 <100 <100 <100 <100 <100 <100 <500 <500 <500 <100 <100 1800 <100 <200 <100 <500 8300 [<100 – <100] [<100 – <100] [<100 – <100] [<100 – <200] [<100 – <100] [<1000 – 3000] [<500 – <1000] [<500 – <500] [<200 – <500] [<100 – <100] [<100 – <100] [<100 – <100] [<1000 – 2400] [<100 – <500] [<100 – <100] [<100 – <100] [<100 – <100] [<100 – <100] [<100 – <100] [<100 – <200] [<500 – <500] [<200 – <1000] [<100 – <500] [<100 – <100] [<100 – <100] [1500 – 2100] [<100 – <100] [<100 – <500] [<100 – <200] [<200 – <500] [6300 – 11 000] A1 … 1100 … … … … … … … … … [1000 – 3600] [<500 – 1500] [<1000 – 2700] [5400 – 11 000] [<100 – <500] [<100 – <100] [<200 – <500] [<100 – <100] [3700 – 11 000] [34 000 – 67 000] [<500 – <1000] <1000 1000 <500 6400 <500 1200 <100 <100 1600 12 000 <100 [<1000 – 1100] [<1000 – 1400] [<500 – <1000] [5200 – 8000] [<500 – <500] [<1000 – 1600] [<100 – <100] [<100 – <100] [1200 – 2300] [9200 – 15 000] [<100 – <200] <500 <1000 <200 2000 <500 <1000 <100 <100 <1000 3500 <100 [<200 – <500] [<500 – 1400] [<100 – <500] [1600 – 2600] [<200 – <500] [<1000 – 1000] [<100 – <100] [<100 – <100] [<100 – <1000] [<1000 – 6700] [<100 – <100] Annex 1: HIV and AIDS estimates and data. 2009 and 2001 | 2010 GLOBAL REPORT 199 .

0 … … … … … 4.6 … … … … 4.1 … … … … … … … … … … … … … … … … … … … … … … … … … … … … … … … … … … … … … … … … … … … … … … … … … … … … 2009 … … … … 2009 … … … … … 2.1 … … … … 3. 2009 and 2001 | 2010 GLOBAL REPORT .6 8.0 1.8 … … … … 14.0 1.7 … … … … 2.0 … … … … … … … 4.1 4.2 … 8.8 1.ESTIMATED ORPHANS DUE TO AIDS 2009 Orphans (0–17) currently living estimate [low – high estimate] estimate HIV PREVALENCE (%) IN MOST-AT-RISK GROUPS IN CAPITAL CITY 2001 Orphans (0–17) [low – high estimate] Injecting drug users Year HIV (%) Female sex workers Year HIV (%) Men who have sex with men Year HIV (%) Croatia Czech Republic Denmark Estonia Finland France Germany Greece Hungary Iceland Ireland Israel Italy Latvia Lithuania Luxembourg Malta Netherlands Norway Poland Portugal Romania Serbia Slovakia Slovenia Spain Sweden Switzerland Turkey United Kingdom of Great Britain and Northern Ireland MIDDLE EAST AND NORTH AFRICA Algeria Djibouti Egypt Iran (Islamic Republic of) Lebanon Morocco Oman Qatar Somalia Sudan Tunisia … … … … … … … … … … … … … … … … … … … … … … … … … … … … … … 96 000 … … … … … … … … … … … … … … … … … … … … … … … … … … … … … … [73 000 – 120 000] … … … … … … … … … … … … … … … … … … … … … … … … … … … … … … 36 000 … … … … … … … … … … … … … … … … … … … … … … … … … … … … … … [22 000 – 63 000] … 2009 … 2007 2009 … … … … … … … … 2007 2008 2008 … … … … 2008 2009 2008 … … 2008 … 2006 … … … … 0.1 … 2008 2006 … … 2009 … … 2008 2008 2009 … 20.5 0.1 … 62.9 … … … … … … 2006 … … … … … … … … … … … … … … … … … 2009 … … … 2008 … … … … … … … … 7.5 … 10.9 … … 2.9 … … … … … … 2009 2009 2007 … … … … 2009 … … … … 2008 … … … … … … … 2009 2008 … 2009 2008 … 2007 … … … … 2.7 … … … … … … … … 22.8 200 Annex 1: HIV and AIDS estimates and data.5 0.6 10.9 0.4 6.1 … 1.4 … … 2006 … 2008 … … … … … 2009 … … 5.4 … … 5.0 … … … 0.7 … … … … … … … … … … … … … … … … … 1.8 … … 19.6 … 1.3 0.6 11.

2009 and 2001 | 2010 GLOBAL REPORT 201 .ESTIMATED PEOPLE LIVING WITH HIV 2009 Adults + Children estimate [low – high estimate] [1 200 000 – 2 000 000] estimate 1 200 000 2001 Adults + Children [low – high estimate] [960 000 – 1 400 000] estimate 1 500 000 2009 Adults (15+) [low – high estimate] [1 200 000 – 2 000 000] NORTH AMERICA Canada Mexico United States of America CARIBBEAN Bahamas Barbados Cuba Dominican Republic Haiti Jamaica Trinidad and Tobago CENTRAL AND SOUTH AMERICA Argentina Belize Bolivia Brazil Chile Colombia Costa Rica Ecuador El Salvador Guatemala Guyana Honduras Nicaragua Panama Paraguay Peru Suriname Uruguay Venezuela 1 500 000 68 000 220 000 1 200 000 240 000 [53 000 – 83 000] [180 000 – 280 000] [930 000 – 1 700 000] [220 000 – 270 000] 49 000 180 000 940 000 240 000 [40 000 – 62 000] [150 000 – 210 000] [730 000 – 1 200 000] [210 000 – 270 000] 68 000 220 000 1 200 000 220 000 [53 000 – 83 000] [180 000 – 270 000] [930 000 – 1 700 000] [200 000 – 250 000] 6600 2100 7100 57 000 120 000 32 000 15 000 1 400 000 [2600 – 11 000] [1800 – 2500] [5700 – 8900] [49 000 – 66 000] [110 000 – 140 000] [21 000 – 45 000] [11 000 – 19 000] [1 200 000 – 1 600 000] 5900 <1000 2600 54 000 130 000 32 000 10 000 1 100 000 [3900 – 8500] [<1000 – 1 000] [1900 – 3400] [45 000 – 65 000] [110 000 – 160 000] [23 000 – 41 000] [7900 – 14 000] [1 000 000 – 1 300 000] 6100 2100 7000 54 000 110 000 31 000 14 000 1 400 000 [2400 – 11 000] [1800 – 2500] [5600 – 8800] [45 000 – 62 000] [95 000 – 130 000] [20 000 – 43 000] [11 000 – 19 000] [1 200 000 – 1 600 000] 110 000 4800 12 000 … 40 000 160 000 9800 37 000 34 000 62 000 5900 39 000 6900 20 000 13 000 75 000 3700 9900 … [88 000 – 140 000] [4000 – 5700] [9000 – 16 000] [460 000 – 810 000] [32 000 – 51 000] [120 000 – 210 000] [7500 – 13 000] [28 000 – 50 000] [25 000 – 44 000] [47 000 – 82 000] [2700 – 8800] [26 000 – 51 000] [5200 – 9100] [14 000 – 36 000] [9800 – 16 000] [58 000 – 100 000] [2700 – 5300] [8400 – 12 000] … 80 000 3600 12 000 … 24 000 210 000 4400 36 000 25 000 31 000 7800 44 000 3700 26 000 9200 82 000 3300 7000 … [66 000 – 99 000] [3000 – 4200] [9100 – 16 000] [380 000 – 560 000] [19 000 – 31 000] [170 000 – 260 000] [3400 – 5900] [27 000 – 47 000] [19 000 – 33 000] [23 000 – 41 000] [5300 – 12 000] [33 000 – 61 000] [2900 – 4800] [17 000 – 50 000] [7200 – 13 000] [65 000 – 100 000] [2300 – 4500] [5900 – 8200] … 110 000 4400 11 000 … 39 000 150 000 9600 36 000 32 000 60 000 5500 37 000 6700 20 000 12 000 73 000 3600 9600 … [87 000 – 140 000] [3600 – 5300] [8400 – 15 000] [450 000 – 800 000] [31 000 – 50 000] [120 000 – 200 000] [7300 – 12 000] [27 000 – 49 000] [24 000 – 42 000] [45 000 – 79 000] [2400 – 8200] [24 000 – 49 000] [5000 – 8900] [13 000 – 36 000] [9600 – 16 000] [56 000 – 98 000] [2700 – 5100] [8100 – 11 000] … A1 Annex 1: HIV and AIDS estimates and data.

4] [0.4] [1.4 … [0. 2009 and 2001 | 2010 GLOBAL REPORT .0] [1.4 2.4] [0.5 1.7] [0.6 1.2 – 0.3] [0.7 – 1.1] [0.2] [0.3 – 0.7] [1.6] [<0.4 – 0.8 0.4] [0.2 – 0.4] [0.6 – 1.1] 0.4 – 0.1 0.6] 3.6] [0.9 – 2.5] [0.1 – 0.4 – 0.5 <0.7] [0.4 – 0.4 – 0.3 0.1 – 0.3 0.8 1.1] [0.5 2.6] [0.6] [0.0 [0.1 – 0.2 0.1 0.5 0.3 – 0.2 – 0.1] [0.4] [0.3 – 0.2 … 0.3 – 0.7 – 2.9 2.6] [0.2 – 5.1] [2.3 – 2.2 – 0.3 0.7 – 1.9 – 1.3 – 0.2 0.4 1.4 0.4 – 0.2 – 1.3 – 0.6] [0.2 0.2 0.0] [1.9 – 2.8 0.4 – 0.9] [0.3 0.3] [0.6] … 0.5] NORTH AMERICA Canada Mexico United States of America CARIBBEAN Bahamas Barbados Cuba Dominican Republic Haiti Jamaica Trinidad and Tobago CENTRAL AND SOUTH AMERICA Argentina Belize Bolivia Brazil Chile Colombia Costa Rica Ecuador El Salvador Guatemala Guyana Honduras Nicaragua Panama Paraguay Peru Suriname Uruguay Venezuela 1 200 000 49 000 180 000 930 000 220 000 [40 000 – 62 000] [150 000 – 210 000] [730 000 – 1 200 000] [200 000 – 250 000] 0.2 – 0.6] [0.6 1.1 – 0.4 2001 Adult (15–49) prevalence percent [low – high estimate] [0.4] [0.4] [0.8] [0.5] [0.2] [0.3] [0.6] [2.6 – 1.2 … 0.3 – 0.5 [1.3 0.5] 79 000 3300 11 000 … 24 000 210 000 4400 35 000 24 000 30 000 7000 42 000 3600 25 000 9000 81 000 3200 6800 … [65 000 – 97 000] [2800 – 3800] [8600 – 15 000] [360 000 – 550 000] [18 000 – 30 000] [160 000 – 260 000] [3300 – 5800] [26 000 – 46 000] [18 000 – 32 000] [22 000 – 40 000] [4600 – 11 000] [31 000 – 57 000] [2800 – 4700] [16 000 – 49 000] [7000 – 12 000] [64 000 – 99 000] [2300 – 4400] [5800 – 8000] … 0.5] [0.9 – 1.4 – 0.7 – 1.7 – 1.0] [0.2 – 0.3] [0.2 – 0.1] [0.4 1.5] [0.4 – 0.4] … 202 Annex 1: HIV and AIDS estimates and data.7] estimate 0.2 0.1 1.2 0.0] [0.0] [0.4 – 0.2 – 0.0 0.1 – 2.9 1.9 1.5] [1.0 – 1.8 0.ESTIMATED PEOPLE LIVING WITH HIV 2001 Adults (15+) estimate [low – high estimate] [950 000 – 1 400 000] estimate 0.6] [0.9 – 4.4 0.9 1.4 0.1 [0.6] [0.4] [0.0 – 2.7] [0.4] [0.4 – 0.8 0.5 2009 Adult (15–49) prevalence percent [low – high estimate] [0.3 0.5] [1.2] [1.4 0.0] [0.6 – 1.3 – 0.3 0.1 0.8] [0.3 – 3.9 – 2.5 – 1.1 – 0.5 … [0.8 – 1.0 0.1 – 0.2] 5400 <1000 2600 50 000 120 000 31 000 10 000 1 100 000 [3400 – 7600] [<1000 – 1000] [1900 – 3400] [43 000 – 60 000] [100 000 – 140 000] [22 000 – 39 000] [7800 – 14 000] [1 000 000 – 1 200 000] 3.3 0.4] [0.7 1.3] [0.1 1.6 – 1.9 – 1.5 [1.3 – 0.9 0.5 – 1.5 0.5 1.5 1.1 – 2.4 – 0.3 0.2] [0.5 0.

2009 and 2001 | 2010 GLOBAL REPORT 203 .2009 Women (15+) estimate [low – high estimate] [310 000 – 510 000] estimate 270 000 2001 Women (15+) [low – high estimate] [220 000 – 320 000] estimate 4500 2009 Children (0–14) [low – high estimate] [4000 – 5800] NORTH AMERICA Canada Mexico United States of America CARIBBEAN Bahamas Barbados Cuba Dominican Republic Haiti Jamaica Trinidad and Tobago CENTRAL AND SOUTH AMERICA Argentina Belize Bolivia Brazil Chile Colombia Costa Rica Ecuador El Salvador Guatemala Guyana Honduras Nicaragua Panama Paraguay Peru Suriname Uruguay Venezuela 390 000 21 000 59 000 310 000 120 000 [16 000 – 25 000] [47 000 – 75 000] [220 000 – 430 000] [100 000 – 140 000] 15 000 41 000 210 000 120 000 [12 000 – 18 000] [33 000 – 49 000] [160 000 – 270 000] [100 000 – 140 000] … … … 17 000 … … … [8500 – 26 000] 3700 <1000 2200 32 000 67 000 10 000 4700 490 000 [1500 – 6400] [<1000 – <1000] [1700 – 2700] [26 000 – 37 000] [56 000 – 78 000] [6700 – 14 000] [3500 – 6100] [420 000 – 590 000] 3300 <500 <1000 29 000 73 000 9900 3300 370 000 [2100 – 4600] [<500 – <500] [<1000 – 1000] [24 000 – 35 000] [61 000 – 87 000] [7300 – 13 000] [2600 – 4300] [330 000 – 420 000] … … … … 12 000 … … 36 000 … … … … [5700 – 18 000] … … [25 000 – 50 000] 36 000 2600 3600 … 12 000 50 000 2800 11 000 11 000 20 000 2800 12 000 2100 6300 3800 18 000 1100 3100 … [28 000 – 45 000] [2100 – 3100] [2700 – 4800] [180 000 – 330 000] [9700 – 15 000] [38 000 – 65 000] [2100 – 3600] [8400 – 15 000] [8500 – 14 000] [15 000 – 26 000] [1100 – 4200] [7900 – 16 000] [1600 – 2800] [4200 – 11 000] [2900 – 4800] [14 000 – 25 000] [<1000 – 1600] [2600 – 3600] … 25 000 1900 3500 … 7200 65 000 1300 11 000 8000 9600 3800 13 000 1100 7600 2700 15 000 <1000 2100 … [20 000 – 30 000] [1600 – 2200] [2700 – 4600] [140 000 – 210 000] [5500 – 9300] [51 000 – 80 000] [<1000 – 1700] [8200 – 14 000] [6000 – 11 000] [7200 – 13 000] [2400 – 5700] [9700 – 18 000] [<1000 – 1400] [4900 – 15 000] [2100 – 3700] [12 000 – 19 000] [<1000 – 1300] [1800 – 2500] … … … … … … … … … … … … … … … … … … … … … … … … … … … … … … … … … … … … … … … A1 Annex 1: HIV and AIDS estimates and data.

1 – 0.0] 0.0 1.1 0.5 0.3 – 1.1] [<0.0 – 1.3] estimate 0.2 [0.2 0.8] [0.2] [0.2] [0.4] [<0.1 – 0.8 [<0.1 – 0.1 – 0.2 2009 Young women (15–24) prevalence (%) [low – high estimate] [0.1 – 0.1 – 0.2 0.6 0.8] [0.2 – 0.2 – 0.1 0.2 … [0.1 … 0.7] [0.1 – 1.4] [0.0 0.2 2009 Young men (15–24) prevalence (%) [low – high estimate] [0.3] [0.4 0.6 – 1.1] [0.1 0.1 – 0.3 – 0.8 0.3 – 1.1 – 0.1 – 0.3 … [0.2 – 1.5] [0.2] [0.6 0.1 – 0.1 0. 2009 and 2001 | 2010 GLOBAL REPORT .1 – 0.3] [0.1 – 0.1 … 0.2] [0.7 0.3] … 0.4 [<0.3] [0.3] [0.3 0.6] [0.1 1.5] [0.7] [0.1 0.3] [0.1 0.8] [0.2 0.1 0.1 – 0.9] [1.3] [1.1 – 0.4 – 0.3 0.2] [0.1 – 0.4] [0.4 0.2 0.5] [0.3] [0.2 – 1.3] [0.4 – 2.8 – 1.1 0.7 – 1.1 – 0.1 – 0.8] [0.1 – 0.0] … 204 Annex 1: HIV and AIDS estimates and data.3 0.1 – 1.5] … … … … … … … … … … … … … … … … … … … … … … … … … … … … … … … … … … … … … … 0.2 0.7] … … … … 12 000 … … 30 000 … … … … [6300 – 19 000] … … [20 000 – 42 000] 3.8] [0.7 0.2 – 1.5 – 1.1 – 0.2] [0.7] [<0.2 [0.1 – 0.4] [0.1] [0.1] [0.3] [0.6] [0.2 1.1 – 0.4] [0.5] [0.3] [0.2] [0.1 – 0.3 0.7 1.2 – 0.1 0.1 – 0.3 0.5] [0.9 0.2] [0.3] [0.1] [<0.6 1.3 0.1 – 0.1 – 0.1 – 0.4 0.2 0.2 – 2.3] 1.3] [0.1 0.8 0.4 – 3.1 – 0.1 0.8 – 6.1 – 0.1 0.1 – 0.3 0.ESTIMATED PEOPLE LIVING WITH HIV 2001 Children (0–14) estimate [low – high estimate] [2900 – 7700] estimate 0.4 0.7 0.2 – 1.4 – 0.1 – 0.5 – 2.2 – 1.4 – 3.3] [0.0] [0.1 – 0.7] [0.1 – 0.1 0.1] [0.2 0.2 – 0.2 0.0] [0.4] [0.3 0.2 0.2 0.2 – 0.1 – 0.1 – 0.1] [0.6] [0.4] NORTH AMERICA Canada Mexico United States of America CARIBBEAN Bahamas Barbados Cuba Dominican Republic Haiti Jamaica Trinidad and Tobago CENTRAL AND SOUTH AMERICA Argentina Belize Bolivia Brazil Chile Colombia Costa Rica Ecuador El Salvador Guatemala Guyana Honduras Nicaragua Panama Paraguay Peru Suriname Uruguay Venezuela 5200 … … … 18 000 … … … [9100 – 27 000] 0.

10 – <0.20 … … … … … … … … … … … … … … <0.10] [<0.10 – <0.10] [<0.16] [<0.13] [<0.10 – <0.13 … <0.10 0.15] [<0.10 – <0.10 – 0.10 … … [<0.10 – 0.10 – 0.10] [<0.10 [<0.10 – <0.10 [<0.10] … … … <0.10 – 0.10] [<0.10 – 0.11 … … [<0.10 – 0.10 – 0.10 [<0.10 0.10] [<0.10] [<0.10 – <0.10] [0.10 – 0.10] [<0.10 – <0.10 – <0.10] [<0.30 … … … … … … … … … … … … … … 0.10] … 7500 <500 … … … … … … … … … … … … … … <500 … … [4100 – 11 000] [<500 – <1000] [<1000 – 1600] [18 000 – 70 000] [1400 – 4300] [2800 – 16 000] [<500 – 1100] [1100 – 6200] [1200 – 4000] [3600 – 11 000] [<100 – <1000] [<1000 – 3700] [<500 – 1300] [<1000 – 2200] [<1000 – 1600] [2300 – 6700] [<100 – <500] [<500 – <1000] … A1 Annex 1: HIV and AIDS estimates and data.10 – <0.10 – 0.10 – <0.10 – 0.19 … <0.10] [<0.10 0.10] [<0.14] [<0.10 – <0.10] [0.10 – <0.10] [<0.10 – <0.10 – <0.10 – <0.10] [<0.10] [<0.35] [<0.10 – <0.10] [<0.10 … … <0.10 – 0.10 – <0.10 – 0.10 – 0.15 – 0.27] [<0.ESTIMATED NEW HIV INFECTIONS 2009 Adult (15–49) incidence rate estimate [low – high estimate] [<0.10 <0.19] [<0.10 – <0.32] [<0.10 – <0.10 0.10 – <0.19 0.10 – <0.10] [0.14] [<0.10] [<0.10] [<0.23 – 0.10] [<0.10 – 0.10] … … … 3600 8800 2100 … 92 000 [<200 – 1200] [<200 – <500] [<500 – <1000] [1600 – 5000] [6500 – 11 000] [<1000 – 4200] [<1000 – 1800] [70 000 – 120 000] <0.10 – <0.10 <0.10 – <0.13 – 0.13] [<0.12] [<0.17] [<0.16] [<0. 2009 and 2001 | 2010 GLOBAL REPORT 205 .10] [<0.10] [<0.11] [<0.10] [<0.10] [<0.10 2001 Adult (15–49) incidence rate [low – high estimate] [<0.10 – 0.43] [<0.10] … … <0.10 – <0.10 – <0.11] … … 54 000 17 000 [<1000 – 3800] [8800 – 21 000] [24 000 – 110 000] [13 000 – 21 000] … … … <0.23] [0.10 – <0.10 – 0.10 – <0.10 – <0.10 – <0.10 – <0.10 – <0.10 – 0.10 – <0.10] [0.15 0.10 – <0.10] [<0.10 – 0.10 – 0.10] [<0.19] [<0.10 – <0.62] [<0.10] [<0.10 – <0.10 – <0.10 – 0.10] [<0.10 – <0.10] [<0.25] [0.10] [<0.10 – <0.10] estimate <0.21] [<0.11] [<0.10 – <0.10] [<0.10] estimate 70 000 2009 Adults + children newly infected [low – high estimate] [44 000 – 130 000] NORTH AMERICA Canada Mexico United States of America CARIBBEAN Bahamas Barbados Cuba Dominican Republic Haiti Jamaica Trinidad and Tobago CENTRAL AND SOUTH AMERICA Argentina Belize Bolivia Brazil Chile Colombia Costa Rica Ecuador El Salvador Guatemala Guyana Honduras Nicaragua Panama Paraguay Peru Suriname Uruguay Venezuela <0.10] [<0.10] … <0.10 [<0.

2009 and 2001 | 2010 GLOBAL REPORT .ESTIMATED NEW HIV INFECTIONS 2009 Adults newly infected estimate [low – high estimate] [43 000 – 120 000] ESTIMATED AIDS-RELATED DEATHS 2009 AIDS-related deaths in adults + children estimate 26 000 [low – high estimate] [22 000 – 44 000] estimate 30 000 2001 AIDS-related deaths in adults + children [low – high estimate] [26 000 – 35 000] NORTH AMERICA Canada Mexico United States of America CARIBBEAN Bahamas Barbados Cuba Dominican Republic Haiti Jamaica Trinidad and Tobago CENTRAL AND SOUTH AMERICA Argentina Belize Bolivia Brazil Chile Colombia Costa Rica Ecuador El Salvador Guatemala Guyana Honduras Nicaragua Panama Paraguay Peru Suriname Uruguay Venezuela 69 000 … … 54 000 15 000 [<1000 – 3800] [8300 – 20 000] [24 000 – 110 000] [12 000 – 19 000] <1000 … 17 000 12 000 [<500 – <1000] [6400 – 12 000] [13 000 – 36 000] [8500 – 15 000] <1000 … 17 000 19 000 [<500 – <1000] [9800 – 15 000] [14 000 – 23 000] [16 000 – 23 000] … … … 3200 7600 2000 … 87 000 [<100 – 1100] [<200 – <500] [<500 – <1000] [1300 – 4400] [5400 – 10 000] [<1000 – 4000] [<1000 – 1700] [66 000 – 120 000] <500 <100 <100 2300 7100 1200 <1000 58 000 [<200 – <1000] [<100 – <100] [<100 – <500] [1300 – 3400] [5200 – 9400] [<500 – 2100] [<500 – <1000] [43 000 – 70 000] <1000 <100 <200 3900 12 000 2700 <1000 53 000 [<500 – <1000] [<100 – <100] [<100 – <200] [2900 – 5500] [9200 – 14 000] [2100 – 3500] [<500 – <1000] [44 000 – 65 000] 7400 <500 … … … … … … … … … … … … … … <200 … … [4100 – 11 000] [<500 – <1000] [<500 – 1500] [17 000 – 69 000] [1200 – 4000] [2300 – 16 000] [<500 – 1000] [<100 – <100] [1000 – 3800] [3200 – 10 000] [<100 – <1000] [<1000 – 3400] [<500 – 1300] [<1000 – 2100] [<1000 – 1600] [2100 – 6300] [<100 – <500] [<500 – <1000] … 2900 <500 <1000 … … 14 000 <500 2200 1400 2600 <500 2500 <500 1500 <500 5000 <200 … … [1600 – 4500] [<500 – <500] [<1000 – 1200] [2000 – 25 000] [<1000 – 2200] [11 000 – 18 000] [<100 – <1000] [1300 – 3300] [<1000 – 2100] [1600 – 3700] [<100 – <1000] [1700 – 3400] [<200 – <500] [<1000 – 3600] [<500 – <1000] [3800 – 6600] [<200 – <500] … … 2800 <500 <1000 … … 13 000 <100 2800 <1000 1500 <1000 3700 <200 1600 <500 6300 <500 … … [1600 – 4100] [<200 – <500] [<1000 – 1100] [7200 – 24 000] [<500 – 1200] [9800 – 17 000] [<100 – <200] [2100 – 3700] [<200 – 1100] [1000 – 2100] [<1000 – 1300] [2800 – 5000] [<200 – <500] [<1000 – 3200] [<500 – <1000] [5200 – 7900] [<200 – <500] … … 206 Annex 1: HIV and AIDS estimates and data.

6 4.3 … 12.7 … 31.6 12.0 16.ESTIMATED ORPHANS DUE TO AIDS 2009 Orphans (0–17) currently living estimate [low – high estimate] [110 000 – 180 000] estimate 210 000 HIV PREVALENCE (%) IN MOST-AT-RISK GROUPS IN CAPITAL CITY 2001 Orphans (0–17) [low – high estimate] [160 000 – 260 000] Injecting drug users Year … HIV (%) … Female sex workers Year … HIV (%) … Men who have sex with men Year … HIV (%) … NORTH AMERICA Canada Mexico United States of America CARIBBEAN Bahamas Barbados Cuba Dominican Republic Haiti Jamaica Trinidad and Tobago CENTRAL AND SOUTH AMERICA Argentina Belize Bolivia Brazil Chile Colombia Costa Rica Ecuador El Salvador Guatemala Guyana Honduras Nicaragua Panama Paraguay Peru Suriname Uruguay Venezuela 140 000 … … … 140 000 … … … [110 000 – 170 000] … … … 100 000 … … … [63 000 – 170 000] 2008 2009 … … 12.9 … … 2008 2009 … … 14.1 1.9 … … 2009 … 2009 2004 … 2007 … … 25.7 5.8 18.8 … 11.3 … … 1.6 2.9 … … … … … … … … … … … … … … … 2008 … … … … 2008 … … 2009 2006 2009 2006 … … 2008 … … … … 1.9 … … … … 1.1 … A1 Annex 1: HIV and AIDS estimates and data.8 … … … … … … … … … … … … … … … … … … … … … … … … … … … … … … … … … … … … … … … … … … … … … … … … … … … … … … … … … … … … … … … … … … … … … … … … … … … … … … 2008 … … 2009 … … … … … … … … … … … … … … … 11.0 … … … 2009 … … … 0.8 5.1 4.3 19.2 … 9.6 … … 4.7 10.6 … 0.6 20.1 … 9.7 … 9.8 … … … … 2008 … 2008 2009 2009 … 2009 … 2009 2006 2009 2006 2009 … 2008 2009 … 2008 … 11.4 6. 2009 and 2001 | 2010 GLOBAL REPORT 207 .3 4.7 10.9 … … 5.2 … … … … … … … … … 240 000 … … … … … … … [200 000 – 280 000] … … … … … … … 190 000 … … … … … … … [150 000 – 240 000] … … … … … … … … … … … … … … … … … … 2009 2008 2009 2009 … … … … 0.6 10.

regardless of their economic or epidemiological status. There was a substantial increase in the numbers of reports received from Western and Central Europe. the United Nations Joint Programme on HIV/AIDS (UNAIDS) requests Member States to submit biennial reports to UNAIDS—the Country Progress Reports—against a set of standardized core indicators. which resulted in an increase in the response rate for this region from 67% in 2008 to 88% in 2010. thus providing a transparent monitoring of progress towards the targets set in the Declaration of Commitment and the Millennium Development Goals. 2004 to 2010 | 2010 GLOBAL REPORT . The data compiled allow a deeper understanding of the global. where the percentage of Member States submitting Country Progress Reports jumped from 45% in 2008 to 95% in 2010. as seen in figures 1 and 2. When countries chose not to report on a particular indicator. The information provided by Country Progress Reports represents the most comprehensive and readily accessible data on the status of the epidemic and progress being made by countries in the response. they were asked to provide an explanation as to why they chose not to report. or the non-relevance of the particular issue. All countries. as was the case in 2008. No change in response rate was observed in East Asia with three of the five countries in the region submitting reports. All but two regions have response rates above 90%. In the first round of reporting slightly more than half (54%) of Member States reported. were requested to report on all indicators. Countries were expected to consider each indicator in light of the individual dynamics of their epidemic. treatment care and support by 2010. when the first UNGASS Progress Report. 182 countries (94% of UN Member States) submitted Country Progress Reports to UNAIDS. increasing to 64% in 2006 and 77% in 2008. which sets the international standards for monitoring and evaluation. The most remarkable increase in response rates was seen in North Africa and the Middle East. As part of that review process and on behalf of the United Nations SecretaryGeneral. where appropriate. the inapplicability of particular indicators to particular country situations. RESPONSE RATES In 2010. 208 Annex 2: Country progress indicators and data. Member States of the United Nations agreed to systematically review and regularly report on their progress in realizing universal access to HIV prevention. The proportion of Member States submitting such reports has increased consistently over each of the four rounds of reporting. Follow-up to the 2001 UNGASS: Progress Report on the Global Response to HIV/AIDS. The primary purpose of this annex is to compile that data in one place. Details on how the indicators were constructed are available on the UNAIDS Web site in the document UNGASS Monitoring the Declaration of Commitment on HIV/AIDS: Guidelines on the Construction of Core Indicators (March 2009).ANNEX 2 COUNTRY PROGRESS INDICATORS 2004 TO 2010 Monitoring progress in national responses to HIV In adopting the 2001 Declaration of Commitment on HIV/AIDS. INDICATORS Core indicators for reporting have been consolidated and refined in each round of reporting since 2003. This allowed for an analysis that differentiates between an absence of data. was published. as well as regional and national responses to the epidemic. such as orphans and vulnerable children in low-prevalence settings. This ongoing work is done in collaboration with global partners and the UNAIDS Monitoring and Evaluation Reference Group (MERG).

2004 to 2010 | 2010 GLOBAL REPORT 209 .1 Response rates by region and reporting round* UNGASS Submissions by region (UN Member States reporting/total number of UN Member States) * Includes all country progress reports submitted to UNAIDS.Saharan Africa (45) South and South-East Asia (19) East Asia (5) A2 Oceania (14) Western and Central Europe (42) North America (3) North Africa and Middle East (20) Global 2004 (102/191) 2006 (143/192) 2008 (153/192) 2010 (182/192) Annex 2: Country progress indicators and data.Figure A2. including late or incomplete submissions % 10 20 30 40 50 60 70 80 90 100 Caribbean (13) Central and South America (19) Eastern Europe and Central Asia (12) Sub.

1 Countries that did not provide reports on the implementation of the Declaration of Commitment in 2010 (n=10) Andorra Democratic People’s Republic of Korea Republic of Korea France Iceland Iraq Kiribati Liechtenstein San Marino Turkmenistan 210 Annex 2: Country progress indicators and data. 2004 to 2010 | 2010 GLOBAL REPORT .Table A2.

Table A2.2 Countries that provided reports on the implementation of the Declaration of Commitment in 2010 (n=182) Afghanistan Albania Algeria Angola Antigua and Barbuda Argentina Armenia Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bhutan Bolivia Bosnia and Herzegovina Botswana Brazil Brunei Darussalam Bulgaria Burkina Faso Burundi Cambodia Cameroon Canada Cape Verde Central African Republic Chad Chile China Colombia Comoros Congo. Federated States of Moldova Monaco Mongolia Montenegro Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands New Zealand Nicaragua Niger Nigeria Norway Oman Pakistan Palau Panama Papua New Guinea Paraguay Peru Philippines Poland Portugal Qatar Romania Russian Federation Rwanda Saint Kitts and Nevis Saint Lucia Saint Vincent and the Grenadines Samoa Sao Tome and Principe Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Slovakia Slovenia Solomon Islands Somalia South Africa Spain Sri Lanka Sudan Suriname Swaziland Sweden Switzerland Syrian Arab Republic Tajikistan Thailand The Former Yugoslav Republic of Macedonia Timor-Leste Togo Tonga Trinidad and Tobago Tunisia Turkey Tuvalu Uganda Ukraine United Arab Emirates United Kingdom of Great Britain and Northern Ireland United Republic of Tanzania United States of America Uruguay Uzbekistan Vanuatu Venezuela Viet Nam Yemen Zambia Zimbabwe A2 Annex 2: Country progress indicators and data. Republic of the Costa Rica Côte d’Ivoire Croatia Cuba Cyprus Czech Republic Democratic Republic of the Congo Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Fiji Finland Gabon Gambia Georgia Germany Ghana Greece Grenada Guatemala Guinea Guinea-Bissau Guyana Haiti Honduras Hungary India Indonesia Iran. Islamic Republic of Ireland Israel Italy Jamaica Japan Jordan Kazakhstan Kenya Kuwait Kyrgyzstan Lao People’s Democratic Republic Latvia Lebanon Lesotho Liberia Libyan Arab Jamahiriya Lithuania Luxembourg Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Mauritania Mauritius Mexico Micronesia. 2004 to 2010 | 2010 GLOBAL REPORT 211 .

UNAIDS has developed AIDSInfoOnline. It is provided free of charge and installable on a PC or as a web-based service. UNAIDS and UNICEF. including AIDS spending. based on the DevInfo project. including WHO. epidemiological estimates. 2004 to 2010 | 2010 GLOBAL REPORT . 212 Annex 2: Country progress indicators and data. Under development for AIDSInfoOnline are e-learning materials to familiarize users with the tool and its advanced features. interactive exploration of that data. AIDSInfoOnline allows comparison of similar indicators from multiple sources. AIDSInfoOnline’s data visualization capabilities allow for rapid production of charts. AIDSInfoOnline aims to be the leading source of HIV/AIDS data globally and provide its users with the most innovative. country-reported programmatic data and National Composite Policy Index responses from government and civil society. continued sourcing of relevant and complementary data into the database and assistance and guidance to regional and national entities that want to establish HIV/AIDS data hubs. Measure DHS. maps and tables. It contains data from multiple agencies.org To facilitate the use of AIDS-related data in countries and globally.AIDSInfoOnline. along with export of data and graphics to numerous formats for presentation and analysis.www. AIDSInfoOnline is a data visualization and dissemination tool. AIDSInfoOnline is populated with multisectoral HIV data.

WHO and Measure DHS (data collected through the Demographic and Health Survey programme). the US President’s Emergency Plan for AIDS Relief. The Policy Index reports were checked for internal consistency and completeness of the response. (NCPI). it is recognized that obtaining a truly representative national sample may never be feasible. A comprehensive data review was undertaken at UNAIDS to check the completeness and accuracy of the funding matrices submitted. Confusing or illogical values were corrected. Methods are being developed to improve sampling of these often hard-toreach populations. the majority of which were resolved through these communications. even though countries may not be able to attest to the national representativeness of samples used for surveys of key populations at higher risk for HIV. Data issues that were not resolved as of the publication date were not included in the data analyses summarized in this report. 3 Annex 2: Country progress indicators and data. It is strongly recommended that a final workshop is organized with key stakeholders. countries were contacted in cases of substantial missing data and multiple. NCPI responses provided by the government are often more optimistic than those provided by nongovernment respondents. accuracy and harmonization of data in relation to the core indicators. including representatives from networks of people living with HIV and from populations at higher risk of HIV and other vulnerable populations. As there are over 200 data points for each country NCPI. while another part2 is completed by representatives from civil society and bilateral or multilateral organizations. In general. Tuberculosis and Malaria. Over 85% of these 113 countries responded with clarifying information. to present. the majority of countries responded. and key policies and strategies of HIV programmes. is a questionnaire completed through a review of relevant Ensuring country-level representative samples and establishing a global information system regarding programme coverage and risk behaviours for key populations at higher risk for HIV3 present significant technical and ethical challenges. non-consolidated Policy Index submissions. CHALLENGES IN MONITORING KEY POPULATIONS AT RISK The National Composite Policy Index. Due to their complex nature. direct communications were undertaken with national focal points for UNGASS reporting in 113 countries to obtain clarification and resolution of outstanding questions. UNAIDS contacted 150 countries with follow-up data questions. The majority of issues regarding reported data were resolved through these communications. To resolve data issues relating to the Policy Index. such as respondent-driven sampling. 2004 to 2010 | 2010 GLOBAL REPORT 213 . The recommended consultative process for completing the NCPI aims to foster an environment conducive to including both government and nongovernment perspectives in the consolidated NCPI response that is eventually submitted by the government as part of its UNGASS report. A2 1 2 Government officials complete questions on the national strategic plan. and key policies and strategies of HIV programmes. the Global Fund to Fight AIDS. As a result of discrepancies identified in this reconciliation. org. One hundred and eleven countries were contacted with follow-up data questions.   NATIONAL COMPOSITE POLICY INDEX (NCPI) documents and interviewing people most knowledgeable about the topics covered. UNICEF. One part1 of the NCPI is completed by government officials. civil society involvement in the HIV response. political support. but are available alongside individual country reports on the UNAIDS website and on AIDSInfoOnline. discuss and validate the NCPI responses and write-up before the final submission. While new methods may lead to samples that are more representative. In addition. These groups were previously referred to as most-at-risk populations. 67 countries were contacted. Validated data from 171 UN member states were included in the analyses summarized in this report. repeated measures using the same sampling frame and methodology can produce reliable data on trends in behaviours and service coverage. a reconciliation process took place for data reported to UNAIDS. separate validation processes were undertaken for the National AIDS Spending Matrix and the National Composite Policy Index. Nongovernment representatives complete questions on the country’s human rights context in relation to HIV. a questionnaire that assesses progress in the development of national HIV policies and strategies. not all data are included in the data tables presented in this report. However.DATA VALIDATION A comprehensive review of the national Reports was conducted by evaluation specialists at UNAIDS to ensure the completeness.

(2) the country uses an alternate methodology or indicator for tracking this particular issue. In some instances an alternative source was used to provide values when a country submission was not received for that indicator. The purpose of this consultation is to collectively assess the strengths and weaknesses of these data. a number of methodological differences among countries were observed in the approach for data collection on key populations at risk. Such discussions allow for a better understanding of national responses. These differences mostly relate to group definitions. from the perspective of both the government and nongovernmental groups and civil society. where supplementary values were provided by the World Health Organization (Department of Blood Transfusion Safety). It is therefore important to assess potential biases and other weaknesses of all available data in order to obtain the most robust assessment possible of the status of the national response. In some instances these values differ from those originally submitted as a result of the reconciliation process. All recognized differences are systematically presented in the footnotes provided in the tables. which provides an overview of the policy environment and programmatic response regarding key populations at risk in a given country. are likely to produce a bias when measuring service coverage and risk behaviours.The data from behavioural surveillance surveys (BSS). In order to better understand potential biases and accurately interpret the data obtained in these surveys countries were encouraged to report data for these indicators that had been reviewed and endorsed by technical experts within the country. that country has been excluded from the relevant data table. as a part of the monitoring of progress towards the Declaration of Commitment. Where this is the case. measurement tools and time periods applied for the data collection. all available data from previous years are provided in order to allow the reader to examine changes over time. values for these countries from the most recent Demographic and Health Survey or Multiple Indicator Cluster survey are provided. and to obtain consensus on the interpretation of these data. 214 Annex 2: Country progress indicators and data. As such. In the absence of confidence intervals and detailed While they are perhaps most pronounced in monitoring the behaviours and service coverage of key populations at risk of HIV. Some of the Country Progress Report data were still under review with countries at the time of production of this reference report. and no data for that country are available from another comparable source. Values printed in the tables are those endorsed by countries.org. such as monitoring and evaluation technical working groups or national research councils. Countries may not have submitted data for a given indicator because either (1) no data were available with which to construct the indicator according to the UNGASS definition. some values in these data tables may differ from those published in individual Country Progress Reports. The percentages and numbers in the tables are rounded to the nearest whole number. Where possible the year that the data were collected was differentiated from the year of reporting. methodological challenges affect any efforts to obtain national estimates of behaviours and services. NATIONAL CONSULTATION The vast majority of Country Progress Reports received provided information about the consultation process that was used for the validation and interpretation of the data reported. In order to enable the monitoring of trends countries were advised to keep theses biases constant by using a consistent methodology and sampling frame. Where no data were reported for a given indicator. 2004 to 2010 | 2010 GLOBAL REPORT . COUNTRY DATA TABLES The following tables present data submitted to UNAIDS in Country Progress Reports. and contribute to a strengthening of multisectoral responses. it is important to interpret these indicator data alongside the country-reported NCPI. or (3) the country chose not to report on the indicator because it was considered not relevant to the county’s epidemic.unaids. it has been explicitly footnoted in the Indicator Data Tables. These reports are available in full and unaltered on the UNAIDS website at www. An example of this is the blood safety indicator. which are often obtained from urban convenience samples in programme catchment areas. During the global data analysis. Where indicators and methods were consistent across reporting years. In addition to data reported by countries. Countries are strongly encouraged to undertake a consultation process with all relevant stakeholders to review and consolidate national-level data. On a country level.

these values allow for some very simple data triangulation. 2004 to 2010 | 2010 GLOBAL REPORT 215 .mdgs. 60% N/A 61% N/A 61% 50 80% 46 N/A 38 N/A 16 26% 110 24% 119 20% 34 8% 20 57% 91 62% 106 18% N/A 10% N/A 47% 91 55% 106 N/A N/A 47% 55% A2 Annex 2: Country progress indicators and data. five of which are also explicitly included in the core set of indicators used for monitoring progress towards MDG 6 and are available in the MDG database at www.methodological notes with which to interpret original country submissions. These reports include data on 25 standardized core indicators for use in monitoring progress towards the Declaration of Commitment made in the 2001 United Nations General Assembly Special Session on HIV/AIDS (UNGASS).un. However. This report describes and presents individual country data for the 25 UNGASS indicators. MONITORING PROGRESS TOWARDS MILLENNIUM DEVELOPMENT GOAL 6 Table A2.org. Table A2. which should not be misinterpreted as a convergence of values from different sources rather than a repetition of the same data.3 Response rates for the indicators for monitoring progress towards Millennium Development Goal 6: to halt and begin to reverse the HIV epidemic 2004 ANTIRETROVIRAL THERAPY Number of responding countries Response rate ORPHANS’ SCHOOL ATTENDANCE Number of responding countries Response rate YOUNG PEOPLES’ KNOWLEDGE Number of responding countries Response rate CONDOM USE Number of responding countries Response rate PREVALENCE Number of responding countries Response rate 113 2006 118 2008 117 2010 154 Progress towards Millennium Development Goal (MDG) 6. Data for these five indicators are sourced from Country Progress Reports and provided to the United Nations Statistics Division by UNAIDS. “to halt and begin to reverse the HIV epidemic”. UNICEF and WHO.3 shows the response rates for these indicators over the four rounds of UNGASS reporting. is monitored using data contained in Country Progress Report submissions received from Member States of the United Nations. in many instances the DHS or Multiple Indicator Cluster Survey was used as the source of country reporting.

methods have been developed to allow comparison between NASA and NHA for AIDS health expenditures.4 Response rates for AIDS spending 2004 AIDS SPENDING Number of responding countries Response rate N/A 2006 95 2008 106 2010 137 N/A 50% 55% 71% In 2010. Response rates for this indicator increased consistently over each round of reporting: 95 countries reported in 2006. Orphans and vulnerable children. Out of the 122 countries that did report on spending using the AIDS Spending Categories.). Since different countries can choose from among different methodologies and tools to monitor the flow of AIDS funding (e. Prevention. 106 in 2008 and 137 in 2010. Both tools can therefore track AIDS-health expenditures. 5.National commitment indicators AIDS SPENDING 4. When aggregated across multiple countries. 7. 6.g. which is an important component of the UNGASS Declaration of Commitment on HIV/AIDS. Domestic public. A similar alignment process was undertaken for the UNFPA/ UNAIDS/Netherlands Interdisciplinary Demographic Institute Resource Flows Project. 3. Central and South America. reviewed and reported.e. While NASA provide information on expenditures on activities performed outside the health system. AIDS sub-account of the National Health Accounts (NHA) and ad hoc Resource Flows Surveys). International. with more than 80% of the countries on these regions reporting on HIV spending. including public expenditure from its own sources (i. Enabling environment and community development. OVC. 112 countries reported spending on some or all of the sub categories of the eight AIDS Spending Categories such as: Antiretroviral therapy. Definition Domestic and international AIDS spending by categories and financing sources Methodology This indicator is measured using a National AIDS Spending Assessment. Eastern Europe and Central Asia. Some countries reported only total spending (11%) hence spending figures were not disaggregated among the eight AIDS spending categories (Prevention. Prevention of mother-to-child transmission or Blood safety among others. 216 Annex 2: Country progress indicators and data. 137 countries (71% of UN Member States) reported on domestic and international AIDS spending. Care and treatment. Spending categories 1. such government revenues as taxes) and from international sources. 2004 to 2010 | 2010 GLOBAL REPORT . Treatment and care. Programme management and administration strengthening. 2. and provide the basis for resource allocation and improved strategic planning processes. Research (excluding operations research included under programme management). Table A2. the National AIDS Spending Matrix includes a spreadsheet that allows financial data from any of these three methodologies to be easily entered. the data help nationallevel decision-makers monitor the scope and effectiveness of their programmes. Not all countries reported a complete spending matrix. which documents actual expenditures classified by eight AIDS spending categories and by three main sources of financing. 2. it is increasingly important to accurately track in detail both where the funds originate and how they are spent at the national level. 3. Financing sources 1. Incentives for human resources. National AIDS Spending Assessments (NASA). etc. Social protection and social services (excluding orphans and vulnerable children). South and South East Asia and sub-Saharan Africa are the regions with the highest response rate. The data are used to measure national commitment and action. As the national and international response to AIDS continues to scale up. Domestic private (optional for UNGASS reporting). 8. the data help to evaluate the status of the response globally. In addition. Home-based care.

Civil society involvement 3. strategy and programme implementation for the HIV response: Part A—completed by government respondents 1. Some of the questions have been the same since 2004 and the majority of the questions are similar in this reporting round to what they were in 2006 and 2008. Human rights 2. however. it is not used in that sense. in many countries the recipients of blood and blood products remain at unacceptable risk of acquiring life-threatening infections that could easily be prevented. strategies and laws. care and support 5. The establishment of systems to ensure that all donated blood is screened for transfusiontransmissible infections. Strategic plan 2. Care and support Although the NCPI is often referred to as an ‘indicator’ or index. These text boxes facilitate a better understanding of the current country situation. Prevention 4. Purpose To assess progress in ensuring a safe blood supply. Globally. As a result. All countries except one submitted both part A and part B in this year’s round of reporting. Monitoring and evaluation Part B—completed by civil society respondents 1. 171 countries (94%) also submitted the NCPI. Table A2.5 Response rates for the National Composite Policy Index 2004 NATIONAL COMPOSITE POLICY INDEX Number of responding countries Response rate 88 2006 95 2008 137 2010 171 47% 50% 71% 89% Full NCPI reports including the answers from both the standardized responses and the text boxes are found next to the individual country reports on the UNAIDS web site. Representatives from around 2000 organizations. there are significant variations in the extent to which donated blood is screened. Many of the Country Progress reports received in 2010 describe the role the NCPI has had in strengthening in-country collaboration and increasing shared ownership of the HIV response. A small subset of the information available is presented in the following tables. Prevention 4. 2004 to 2010 | 2010 GLOBAL REPORT 217 . Treatment. provide examples of good practice for others to learn from and can pinpoint issues for further improvement. Out of the 182 countries that submitted UNGASS reports. The NCPI is an integral part of the UNGASS set of indicators and has been so since the first reporting round. Many of the standardized responses are complemented with open text boxes.AIDSInfoOnline. The indicator applies to all countries and it is measured A2 Annex 2: Country progress indicators and data. including HIV (and also hepatitis B and C) is a core component of every national blood programme. This is an inspiring increase (in 2004 only 88 countries submitted NCPI reports). Full access to NCPI data is available through www. the majority being civil society organizations. Indicators for health sector interventions BLOOD SAFETY HIV is efficiently transmitted via transfusion of unsafe blood and blood products.GOVERNMENT HIV AND AIDS POLICIES—NATIONAL COMPOSITE POLICY INDEX Purpose To assess progress in the development and implementation of national-level HIV policies.org. The NCPI provides a unique opportunity for the variety of stakeholders to take stock of progress made and to discuss what still needs to be done to support an effective and efficient HIV response. took part in the preparation of the reports. Political support 3. It is the most comprehensive standardized questionnaire available to asses the following broad areas of policy. the screening strategies adopted and the overall quality and effectiveness of the blood screening process. The NCPI is an extensive questionnaire with close to 200 questions. This makes it possible to do trend analyses.

Modelling and Projections methodology were used for all analyses. 2004 to 2010 | 2010 GLOBAL REPORT . To ensure comparability between countries. including those who have died since starting ART. These data can be used to demonstrate the effectiveness of those programmes and highlight obstacles to expanding and improving them.6 Response rates for blood safety 2004 BLOOD SAFETY Number of responding countries Response rate N/A 2006 N/A 2008 130 2010 165 60% 61% 61% 80% RETENTION ON ANTIRETROVIRAL THERAPY AFTER 12 MONTHS N/A N/A 68% 86% ANTIRETROVIRAL THERAPY Purpose To assess the progress of countries in providing antiretroviral combination therapy to adults and children with advanced HIV infection. Definition Percentage of adults and children with advanced HIV infection receiving antiretroviral therapy. Denominator: estimated number of adults and children with advanced HIV infection. As ART is scaled up in countries around the world. Definition Percentage of adults and children with HIV known to be on treatment 12 months after initiation of antiretroviral therapy. Denominator: total number of adults and children who initiated ART who were expected to achieve 12-month outcomes within the reporting period.annually using the WHO Global Database on Blood Safety protocol. it is also important to understand why and how many people drop out of treatment programmes. The goals of any programme of antiretroviral therapy (ART) are to increase survival and quality of life among infected individuals. 218 Annex 2: Country progress indicators and data. denominators estimated using the UNAIDS/WHO Reference group on Estimates. those who have stopped ART and those recorded as lost to follow-up at month 12. Numerator: number of donated blood units screened for HIV in blood centres/blood screening laboratories that have both: (1) followed documented standard operating procedures and (2) participated in an external quality assurance scheme. Numerator: number of adults and children who are on ART at 12 months after initiating treatment.7 Response rates for HIV treatment 2004 HIV TREATMENT Number of responding countries Response rate 113 2006 118 2008 117 2010 154 Table A2. WHO and UNICEF. Numerator: number of adults and children with advanced HIV infection who are currently receiving antiretroviral therapy in accordance with the nationally approved treatment protocol (or WHO/UNAIDS standards) at the end of the reporting period. Purpose To assess progress in retaining infected adults and children on ART. Definition The percentage of donated blood units screened for HIV in a quality-assured manner. Denominator: total number of blood units donated. All analyses of this indicator reflect numerators which were reconciled between UNAIDS. The country-reported denominators are also presented in the data table. The indicator is applicable to all countries and data for the numerator is collected continuously (monthly or quarterly) with the denominator estimated. Table A2.

and antiretroviral prophylaxis for the child. rather than survival rates. Method for projection – all values reported that represent less than 12 month period are projected taking the number of HIV positive pregnant women on antiretrovirals per month and dividing by the number of months the data represents and multiplying by 12 months. To determine survival rates individuals who stopped ART or were lost to follow-up would need to be excluded. Comprehensive programmes to reduce the number of children who become infected with HIV utilize four strategies. For data representing 2007. To ensure comparability between countries. including those on antiretroviral therapy. These are: primary prevention of HIV for women of child bearing age. Intensified TB case-finding and access to quality diagnosis and treatment of TB in accordance with international/national guidelines are essential for improving the quality and quantity of life for people living with HIV. In cases where it is known that a reported data value is not consistent with this definition.8 Response rates for survival (retention) on antiretroviral therapy 2004 SURVIVAL ON ANTIRETROVIRAL THERAPY Number of responding countries Response rate N/A 2006 11 2008 106 2010 143 N/A 6% 55% 74% PREVENTION OF MOTHER-TO-CHILD TRANSMISSION Table A2.9 In the absence of any preventive interventions. some countries did not report data reflecting 12 months and in these instances the data were projected in order to reflect a consistent time period. This can happen during pregnancy. Denominator: estimated number of HIV-infected pregnant women in the last 12 months. Purpose To assess progress in preventing vertical transmission of HIV. denominators estimated using the UNAIDS/WHO Reference group on Estimates. during labour and delivery or after delivery through breastfeeding. All analyses of this indicator reflect numerators which were reconciled between UNAIDS.4 Table A2. Definition Percentage of HIV-infected pregnant women who received antiretrovirals to reduce the risk of mother-to-child transmission. 4 Response rates for prevention of mother to child transmission 2004 PREVENTION OF MOTHER TO CHILD TRANSMISSION Number of responding countries Response rate 52 2006 45 2008 100 2010 135 28% 24% 52% 70% The data tables include additional data on the prevention of mother-to-child transmission provided by the World Health Organization. antiretroviral prophylaxis for the mother. The risk of mother-to-child transmission can be further reduced through the implementation of safe delivery practices and safe breastfeeding. this has been footnoted in the data tables. This indicator measures one of the four prongs—the provision of prophylactic antiretroviral therapy to the mother. 2004 to 2010 | 2010 GLOBAL REPORT 219 . CO-MANAGEMENT OF TUBERCULOSIS AND HIV A2 Tuberculosis (TB) is one of the most common causes of morbidity and mortality in people living with HIV. The country-reported denominators are also presented in the data table. These data were gathered through the joint WHO/UNICEF/UNAIDS monitoring of progress towards Universal Access in the Health Sector. Annex 2: Country progress indicators and data. known as the “four prongs” for the prevention of mother-to-child transmission. infants born to and breastfed by HIV-infected women have roughly a one-in-three chance of acquiring infection themselves. WHO and UNICEF. prevention of unwanted pregnancies for women living with HIV.This indicator reflects retention rates on ART. Modelling and Projections methodology were used for all analyses. Numerator: number of HIV-infected pregnant women who received antiretrovirals during the last 12 months to reduce mother-to-child transmission.

As the number of orphaned and vulnerable children continues to grow. 2004 to 2010 | 2010 GLOBAL REPORT . has lost one or both parents. For the purposes of this indicator an orphan is defined as a child below the age of 18 who has lost one or both parents. lives in a household where at least one adult was seriously ill for at least three of the past 12 months. those supporting families and communities themselves require support. Definition Percentage of estimated HIV-positive incident TB cases that received treatment for TB and HIV. Purpose To assess progress in providing support to households that are caring for orphaned and vulnerable children aged 0–17.Purpose To assess progress in detecting and treating TB in people living with HIV. Numerator: number of orphaned and vulnerable children who live in households that received at least one of four types of support for each child. A child made vulnerable by HIV is below the age of 18. Denominator: total number of orphaned and vulnerable children aged 0–17. in the last 12 months. has a chronically ill parent (regardless of whether the parent lives in the same household as the child). at least one adult died and was sick for three of the four months before he or she died.11 Response rates for support for children affected by HIV and AIDS General population indicators SUPPORT FOR CHILDREN AFFECTED BY HIV AND AIDS SUPPORT FOR CHILDREN AFFECTED BY HIV AND AIDS Number of responding countries Response rate 2004 N/A 2006 8 2008 36 2010 42 Care and support for orphaned children comes from families and communities. orphan prevalence is rising steadily in many countries. and: (i). Denominator: estimated number of incident TB cases in people living with HIV. or (iv). N/A 4% 19% 22% ORPHANS SCHOOL ATTENDANCE AIDS claims young adults just at the time in their lives when they are forming families and bringing up children. As a result. Numerator: number of adults with advanced HIV infection who are currently receiving antiretroviral combination therapy in accordance with the nationally approved treatment protocol (or WHO/UNAIDS standards) and who were started on TB treatment (in accordance with national TB programme guidelines) within the reporting year. or (iii). factors that can further jeopardize children’s chances of completing school education and may lead to the adoption of 220 Annex 2: Country progress indicators and data. Table A2. Definition Percentage of orphaned and vulnerable children aged 0–17 whose households received free basic external support in caring for the child. while fewer relatives within the prime adult ages mean that orphaned children face an increasingly uncertain future. A number of countries chose to report on this indicator using data obtained through HIV testing programmes. or (ii). lives in a household where. These data are not comparable to data obtained through general population-based surveys.10 Response rates for co-management of tuberculosis and HIV 2004 CO-MANAGEMENT OF TUBERCULOSIS AND HIV Number of responding countries Response rate N/A 2006 N/A 2008 88 2010 119 N/A N/A 46% 62% Table A2. Orphanhood is frequently accompanied by prejudice and increased poverty.

Life skills-based education uses participatory exercises to teach behaviours to young people that help them deal with the challenges and demands of everyday life. It can also teach young people how to cope with their emotions and causes of stress. a life skills-based approach helps young people understand and assess the individual. Definition Percentage of schools that provided life skills-based HIV education in the last academic year. Numerator: number of children whose two parents are alive who are living with at least one parent and who attend school.12 N/A N/A 39% 52% Response rates for orphans’ school attendance 2004 ORPHANS’ SCHOOL ATTENDANCE Number of responding countries Response rate N/A 2006 N/A 2008 50 2010 46 A2 YOUNG PEOPLE’S KNOWLEDGE ABOUT HIV PREVENTION N/A N/A 26% 24% LIFE SKILLS-BASED HIV EDUCATION IN SCHOOLS HIV epidemics are sustained primarily through sexual transmission of infection to successive generations of young people. Definition Current school attendance among orphans and non-orphans aged 10–14. It is important therefore to monitor the extent to which AIDS support programmes succeed in securing the educational opportunities of orphaned children. Annex 2: Country progress indicators and data. social and environmental factors that raise and lower the risk of HIV transmission. Purpose To assess progress towards preventing relative disadvantage in school attendance among orphans compared to non-orphans. Denominator: number of children whose two parents are alive who are living with at least one parent. self-awareness. Denominator: number of children who have lost both parents.survival strategies that increase vulnerability to HIV. including delay in sexual debut and reduction in number of sexual partners. it can have a positive effect on behaviours. Table A2. Numerator: number of schools that provided life skillsbased HIV education in the last academic year. Such education can include decision-making and problemsolving skills. Purpose To assess progress towards comprehensive knowledge of the essential facts about HIV transmission. creative and critical thinking. Purpose To assess progress towards implementation of life skillsbased HIV education in all schools. communication and interpersonal relations. Denominator: number of schools surveyed. When adapted specifically for HIV education in schools. Sound knowledge about HIV and AIDS is an essential prerequisite—albeit insufficient in itself— for adoption of behaviours that reduce the risk of HIV transmission. 2004 to 2010 | 2010 GLOBAL REPORT 221 . Part B: Current school attendance of children aged 10–14 both of whose parents are alive and who live with at least one parent. Part A: Current school attendance of orphans aged 10–14 Numerator: number of children who have lost both parents and who attend school.13 Response rates for life skills-based HIV education in schools 2004 LIFE SKILLSBASED HIV EDUCATION IN SCHOOLS Number of responding countries Response rate N/A 2006 N/A 2008 74 2010 99 Table A2. When properly implemented.

Numerator: number of respondents aged 15–49 who have been tested for HIV during the last 12 months and who know their results. 2004 to 2010 | 2010 GLOBAL REPORT . Denominator: number of all respondents aged 15–49. 222 Annex 2: Country progress indicators and data. this should not be taken to imply that all people should be tested annually. It should be noted that while this indicator measures the proportion of the general population who have been tested in a 12 month period.15 Response rates for HIV testing in the general population 2004 2006 N/A 2008 102 2010 116 20% 8% 57% 62% HIV TESTING IN THE GENERAL POPULATION Number of responding countries Response rate N/A N/A N/A 53% 60% HIV TESTING IN THE GENERAL POPULATION HIV testing and counselling is a critical element in the HIV response. Can a person reduce the risk of getting HIV by using a condom every time they have sex? 3. Purpose To assess progress in implementing HIV testing and counselling. as it facilitates HIV treatment and care and other prevention. Can a person get HIV by sharing food with someone who is infected? Denominator: number of all respondents aged 15–24. These data are not comparable to data obtained through general population-based surveys and are footnoted in the data table. at least for women. Table A2. There is also evidence to suggest that first having sex at a later age reduces susceptibility to infection per act of sex. Can a person get HIV from mosquito bites? 5. Finally. Can the risk of HIV transmission be reduced by having sex with only one uninfected partner who has no other partners? 2. Purpose To assess progress in increasing the age at which young women and men aged 15–24 first have sex.14 Response rates for young peoples’ knowledge 2004 YOUNG PEOPLES’ KNOWLEDGE Number of responding countries Response rate 38 2006 16 2008 110 2010 119 Table A2. In addition. A number of countries chose to report on this indicator using data obtained through HIV testing programmes. Trends in the uptake of HIV testing and counselling can be assessed based on the results of successive surveys conducted in the same country over time. Definition Percentage of women and men aged 15–49 who received an HIV test in the last 12 months and who know their results. Definition Percentage of young women and men aged 15–24 who have had sexual intercourse before the age of 15. testing increases the awareness of people living with HIV of their own status and encourages them to take protective measures. Numerator: number of respondents aged 15–24 years who gave the correct answer to all five of the following questions: 1. determined based on their individual behaviour patterns and the nature of the HIV epidemic in their country. HIV testing increases social awareness of HIV and can reduce stigma and discrimination towards people living with HIV. Can a healthy-looking person have HIV? 4.Definition Percentage of young people aged 15–24 who both correctly identify ways of preventing the sexual transmission of HIV and reject major misconceptions about HIV transmission. The frequency with which people should be tested should be SEX BEFORE THE AGE OF 15 A HIV prevention strategy adopted by many countries is to delay the age at which young people first have sex and discourage premarital sexual activity because it reduces their potential exposure to HIV.

Denominator: number of all respondents aged 15–49. Denominator: number of all respondents aged 15–24. Numerator: number of respondents aged 15–49 who reported having had more than one sexual partner in the last 12 months who also reported that a condom was used the last time they had sex. a function of unprotected sex.Numerator: number of respondents aged 15–24 who report the age at which they first had sexual intercourse as under 15 years. 2004 to 2010 | 2010 GLOBAL REPORT 223 . especially among people with multiple sexual partners. Purpose To assess progress towards preventing exposure to HIV through unprotected sex with non-regular partners. Purpose To assess progress in reducing the percentage of people who have higher-risk sex.18 Response rates for condom use during higherrisk sex 2004 CONDOM USE DURING HIGHERRISK SEX Number of responding countries Response rate 34 2006 20 2008 91 2010 106 18% 10% 47% 55% A2 Table A2. Definition Percentage of women and men aged 15–49 who have had sexual intercourse with more than one partner in the last 12 months. Table A2.16 Response rates for sex before the age of 15 2004 SEX BEFORE THE AGE OF 15 Number of responding countries Response rate N/A 2006 23 2008 108 2010 117 N/A 12% 56% 61% Definition Percentage of women and men aged 15–49 who had more than one partner in the past 12 months who used a condom during their last sexual intercourse. for the most part. HIGHER-RISK SEX The spread of HIV is. Numerator: number of respondents aged 15–49 who have had sexual intercourse with more than one partner in the last 12 months .17 Response rates for higher-risk sex 2004 HIGHER-RISK SEX Number of responding countries Response rate 12 2006 19 2008 97 2010 108 6% 10% 51% 56% Annex 2: Country progress indicators and data. CONDOM USE DURING HIGHER-RISK SEX Condom use is effective in protecting against HIV and other infections transmitted through sexual intercourse. Denominator: number of respondents aged 15–49 who reported having had more than one sexual partner in the last 12 months. Table A2. Condom use rates are an important measure of protection against HIV. Individuals who have multiple partners (concurrently or sequentially) have a higher risk of HIV transmission than individuals that do not link into a wider sexual network.

to all five questions. Finally. Numerator: number of respondents from populations at higher risk of HIV who gave the correct answer to all five of the following questions. injecting drug users and men who have sex with men. Purpose To assess progress in building knowledge of the essential facts about HIV transmission among key populations at risk. 1. Can a person get HIV by sharing food with someone who is infected? Denominator: number of respondents from populations at higher risk of HIV who gave answers. In some epidemiological contexts it may be appropriate for members of key populations at higher risk of HIV to be tested annually.19 Response rates for knowledge of key populations at risk 2004 SEX WORKERS Number of responding countries Response rate MEN WHO HAVE SEX WITH MEN Number of responding countries Response rate INJECTING DRUG USERS Number of responding countries Response rate N/A 2006 21 2008 67 2010 84 Concentrated epidemics are sustained by sexual transmission of HIV in paid sex and between men who have sex with men or transmission through the use of contaminated injecting equipment. Purpose To assess progress in implementing HIV testing and counselling among key populations at risk. This indicator should be calculated separately for each population that is considered to be at higher risk of HIV: sex workers. as it facilitates HIV treatment and care and prevention activities. Can a healthy-looking person have HIV? 4. Can a person get HIV from mosquito bites? 5. 224 Annex 2: Country progress indicators and data.Indicators for key populations at higher risk of HIV KNOWLEDGE ABOUT HIV PREVENTION AMONG KEY POPULATIONS AT RISK Table A2. Can a person reduce the risk of getting HIV by using a condom every time they have sex? 3. 2004 to 2010 | 2010 GLOBAL REPORT . This is particularly important in contexts where the behaviours of key populations at risk of HIV are illegal or heavily stigmatized and where any breeches of confidentiality can have serious legal and social ramifications. HIV testing increases social awareness of HIV and can reduce stigma and discrimination towards people living with HIV. and that due care should be taken to protect the rights of those tested. including “don’t know”. Accurate information about HIV and AIDS is an essential prerequisite if people are going to adopt behaviours that reduce their risk of infection. Trends in the uptake of HIV testing and counselling can be assessed based on the results of successive surveys conducted in the same country over time. N/A N/A 11% 16 35% 47 44% 54 N/A N/A 8% 16 24% 33 28% 43 N/A 8% 17% 22% HIV TESTING IN KEY POPULATIONS AT HIGHER RISK OF HIV HIV testing and counselling is a critical element in the HIV response. Definition Percentage of key populations at risk who both correctly identify ways of preventing the sexual transmission of HIV and reject major misconceptions about HIV transmission. It should be noted that HIV testing should be voluntary and confidential. Can the risk of HIV transmission be reduced by having sex with only one uninfected partner who has no other partners? 2. The frequency with which people should be tested should be determined based on their individual behaviour patterns and the nature of the HIV epidemic in their country. testing increases the awareness of people living with HIV of their own status and encourages them to take protective measures. In addition.

However. Numerator: number of respondents from key populations at risk who have been tested for HIV during the last 12 months and who know the results. injecting drug users and men who have sex with men. Purpose To assess progress in preventing exposure to HIV among sex workers through unprotected sex with clients. Numerator: number of respondents from key populations at risk who replied “yes” to both (all three for injecting drug users) of the following questions: Do you know where you can go if you wish to receive an HIV test? In the last twelve months. However. A2 CONDOM USE BY SEX WORKERS Various factors increase the risk of exposure to HIV among sex workers. both from clients and to clients. have you been given sterile needles and syringes? Denominator: total number of respondents from key populations at risk surveyed. Purpose To assess progress in implementing HIV prevention programmes for key populations at risk. as well as to regular partners. non-regular partners and more frequent sexual intercourse. Annex 2: Country progress indicators and data.Definition Percentage of respondents from key populations at risk who received an HIV test in the last 12 months and who know their results. through consistent and correct condom use. Table A2. including multiple. have you been given condoms? (for injecting drug users) In the last twelve months. 2004 to 2010 | 2010 GLOBAL REPORT 225 .20 Response rates for HIV testing in key populations at risk 2004 SEX WORKERS Number of responding countries Response rate MEN WHO HAVE SEX WITH MEN Number of responding countries Response rate INJECTING DRUG USERS Number of responding countries Response rate N/A 2006 21 2008 87 2010 96 Table A2. sex workers can substantially reduce the risk of HIV transmission. Definition Percentage of key populations at risk reached with HIV prevention programmes.21 Response rates for HIV prevention programmes for key populations at risk 2004 2006 27 2008 63 2010 74 N/A N/A 11% 22 45% 70 50% 83 SEX WORKERS Number of responding countries Response rate MEN WHO HAVE SEX WITH MEN Number of responding countries Response rate INJECTING DRUG USERS Number of responding countries Response rate N/A N/A N/A 12% 18 36% 44 43% 59 N/A N/A 14% 18 33% 43 39% 53 N/A 9% 23% 31% N/A N/A 9% 22 22% 30 28% 39 N/A 12% 16% 20% PREVENTION PROGRAMME COVERAGE FOR KEY POPULATIONS AT HIGHER RISK OF HIV Key populations at risk are often difficult to reach with HIV prevention programmes. in order to prevent the spread of HIV among these populations as well as into the general population. it is important that they access these services. This indicator should be calculated separately for each population that is considered to be at higher risk of HIV: sex workers. Denominator: number of respondents from key populations at risk included in the sample.

Table A2. Consequently.23 Response rates for condom use by men who have sex with men 2004 CONDOM USE BY MEN WHO HAVE SEX WITH MEN Number of responding countries Response rate N/A 2006 29 2008 68 2010 82 N/A 15% 35% 43% Table A2. Hence condom use during male-to-male sex may be an important determinant of spousal transmission. Definition Percentage of men reporting the use of a condom the last time they had anal sex with a male partner. Purpose To assess progress in preventing exposure to HIV among men who have unprotected anal sex with a male partner.22 CONDOM USE BY INJECTING DRUG USERS Response rates for condom use by sex workers 2004 CONDOM USE BY SEX WORKERS Number of responding countries Response rate N/A 2006 32 2008 91 2010 101 N/A 17% 47% 53% Safer sexual practices among injecting drug users are essential.Definition Percentage of female and male sex workers reporting the use of a condom with their most recent client. CONDOM USE BY MEN WHO HAVE SEX WITH MEN Condoms can substantially reduce the risk of sexual transmission of HIV. Denominator: number of respondents who reported having commercial sex in the last 12 months. Numerator: number of respondents who reported that a condom was used with their last client in the last 12 months. In addition. even in countries where other modes of HIV transmission predominate. Definition Percentage of injecting drug users reporting the use of a condom the last time they had sexual intercourse.24 Response rates for condom use by injecting drug users 2004 CONDOM USE BY INJECTING DRUG USERS Number of responding countries Response rate N/A 2006 N/A 2008 43 2010 51 N/A N/A 22% 27% 226 Annex 2: Country progress indicators and data. Denominator: number of respondents who report having had sexual intercourse in the last month. Numerator: number of respondents who reported that a condom was used the last time they had anal sex. 2004 to 2010 | 2010 GLOBAL REPORT . men who have anal sex with men may also have female partners. consistent and correct condom use is important for men who have sex with men because of the high risk of HIV transmission during unprotected anal sex. Purpose To assess progress in preventing sexual transmission of HIV. Denominator: number of respondents who reported having had anal sex with a male partner in the last six months. Condom use by injecting drug users is therefore an important aspect of the prevention of HIV sexual transmission. Table A2. The high risk of HIV transmission from contaminated injecting equipment places the sexual partners of injecting drug users at higher risk of HIV. Numerator: number of respondents who reported that a condom was used the last time they had sex.

2004 to 2010 | 2010 GLOBAL REPORT 227 . even in countries where other modes of HIV transmission predominate. Denominator: number of respondents who report injecting drugs in the last month. reduce injecting frequency and reduce the re-use of used injecting equipment. due to the high risk of HIV transmission from contaminated injecting equipment. While this indicator is designed to measure the behavioural outcome of services aimed at reducing the use of contaminated injecting equipment. Numerator: number of respondents who report using sterile injecting equipment the last time they injected drugs. any behaviour changes that are observed may not necessarily be attributable to such services.25 Response rates for safe injecting practices 2004 SAFE INJECTING PRACTICES Number of responding countries Response rate N/A 2006 N/A 2008 44 2010 55 A2 N/A N/A 23% 29% Annex 2: Country progress indicators and data. Table A2. Definition Percentage of injecting drug users reporting the use of sterile injecting equipment the last time they injected.SAFE INJECTING PRACTICES BY INJECTING DRUG USERS Safer injecting practices among injecting drug users are essential. Purpose To assess progress in preventing injecting drug use-associated HIV transmission. Harm-reduction programmes aim to prevent HIV transmission among injecting drug users through a range of services which seek to reduce illicit drug use.

012 69.2% 0.0% 0.6% 84.0% NA/NR 0.2% 0.4% 97.1% 0.0% 0.0% 0.0% 3.0% 2.4% 0.9% 0.4% 8.6% 57.0% 0.5% 93.3% 1.3% 0.1% 1.0% 0.487 1.0% 0.2% NA/NR 0.6% 5.3% 89.8% 90.0% 0.3% 4.3% 34.0% 0.8% 14.0% 0.227 43.0% 0.391 4.8% 5.0% 0.2% 0.0% 0.4% 0.6% 14.2% Central and South America 228 Annex 2: Country progress indicators and data.6% 0.900 38.0% 1.7% 10.9% 0.4% 0.0% NA/NR 5.903 44.8% NA/NR 0.0% NA/NR NA/NR NA/NR 1.262 103.665 14.1% NA/NR NA/NR 28.4% 11.6% 0.629 9.0% 0.5% 9.893 0.0% NA/NR NA/NR NA/NR 4.0% 0.194 1.3% 10.533 209.2% 0.5% 17.0% NA/NR 12.0% 0.509 46.7% 31.3% 80.3% 18.0% NA/NR 0.7% NA/NR 14.6% 65.0% 0.1% 99.0% 0.5% 99.8% 0.5% 0.3% 0.0% 4.5% 8.0% 100.0% 0.0% 0.1% 0.1% NA/NR NA/NR 90.0% 0.0% 100.7% 20.5% 0.420 24.6% 0.773 2.3% 0.343 1.0% 0.0% 0.0% 0.0% 0.0% 0.442 4.4% 36.8% 79.716 15.909 13.0% 0.5% 99.0% 99.0% 2.0% NA/NR NA/NR NA/NR 0.0% 0.0% NA/NR 0.7% NA/NR NA/NR 43.0% 0.0% 1.298 78.8% 6.139 623.0% 0.5% NA/NR NA/NR NA/NR 0.329 0.1% 0.5% 2.4% 32.0% 0.3% 54.616 76.0% 6.0% 0.024 5.178 0.3% 0.9% 6.7% 0.0% 0.3% 0.3% 0.9% 21.1% 0.0% 3.2% 6.3% 1.0% 0.9% 0.0% 0.0% 0.625 2.4% 0.261 39.0% 0.3% 89.0% 0.3% 45.9% 66.350 18.7% NA/NR NA/NR 13.394 7.557 108.9% 0.792 19.0% 0.628 9.0% 31.0% 0.0% 99.0% 0.033 13.889 11.0% 8.0% 0.0% 0.0% 0.9% 0.0% 0.0% 10.0% 0.0% 0.210 1.4% 42.2% 46.8% 0.1% 0.0% 8.3% 79.0% 0.0% 6.0% 0.5% 7.6% 14.0% 0.0% 0.2% 4.0% 67.2% 38.0% 0.8% 100.0% 0.455 248.0% 42.1% 0.0% 0.0% 0.4% 3.7% 0.8% 0.2% 42.3% 5.0% NA/NR 1.2% 8.0% 0.7% 53.1% 0.2% 0.1% 11.0% 0.3% 17.0% 0.6% 3.0% 0. 2004 to 2010 | 2010 GLOBAL REPORT .0% 0.0% 0.0% 0.3% 0.0% 0.7% 4.5% NA/NR NA/NR 7.0% 92.4% 97.2% 0.4% 2.3% 85.7% 81.885 25.9% 1.5% 12.320 12.0% 0.5% 0.416 0.3% 86.0% 0.134 88.0% NA/NR 19.0% 0.COUNTRY REPORTS OF DOMESTIC AND INTERNATIONAL AIDS SPENDING BY SERVICE CATEGORIES AND FINANCING SOURCES SHARE BY FINANCING SOURCE Survey Year Total reported Public domestic public and Domestic international public (%) expenditure million USD International Bilaterals (%) Global Fund (%) UN (%) All other All other multilaterals international (%) sources (%) Caribbean Antigua and Barbuda1 Antigua and Barbuda1 Bahamas Bahamas Barbados Cuba Cuba Cuba Dominica5 Dominica5 Dominican Republic8 Grenada Grenada Saint Kitts and Nevis Saint Kitts and Nevis Saint Kitts and Nevis Saint Vincent and the Grenadines Saint Vincent and the Grenadines Trinidad and Tobago Trinidad and Tobago Trinidad and Tobago Argentina Argentina Belize Bolivia Bolivia Brazil2 Brazil2 Chile4 Colombia Colombia Colombia Costa Rica Ecuador Ecuador El Salvador El Salvador Guatemala Guatemala Honduras Honduras Nicaragua Nicaragua Panama UNGASS Indicator 1 Paraguay 2008 2009 2008 2009 2009 2007 2008 2009 2008 2009 2008 2008 2009 2007 2008 2009 2008 2009 2007 2008 2009 2007 2008 2009 2008 2009 2007 2008 2008 2007 2008 2009 2008 2008 2009 2007 2008 2007 2008 2007 2008 2007 2008 2008 2008 0.0% NA/NR NA/NR NA/NR 2.0% 0.6% 99.648 51.0% 0.0% 0.0% 0.8% 0.4% 96.0% 0.0% 85.418 575.0% 0.0% 7.0% 0.178 23.0% 42.1% 33.7% 90.484 0.2% 17.972 31.8% 58.0% NA/NR NA/NR 0.9% NA/NR NA/NR 6.

078 NA/NR NA/NR 0.283 NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR 0.878 1.222 16.250 21.092 0.853 522.332 1.092 2.922 1.163 NA/NR NA/NR 1.340 0.061 NA/NR NA/NR 0.005 0.388 0.522 0.214 NA/NR NA/NR NA/NR 0.187 6.408 NA/NR NA/NR NA/NR 0.706 1.420 3.669 0.672 56.176 2.464 6.996 NA/NR NA/NR NA/NR 0.427 NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR 0.163 15.490 NA/NR NA/NR NA/NR 0.455 0.652 0.065 4.230 2.422 NA/NR NA/NR 5.350 0.952 1.039 0.269 0.118 77.481 NA/NR NA/NR NA/NR 0.758 12.338 10.968 1.480 13.090 0.441 NA/NR NA/NR 0.314 13.708 0.004 0.024 NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR 0.390 0.193 0.027 41.420 26.541 2.246 0.043 0.349 0.583 2.211 0.664 3.450 NA/NR NA/NR 0.261 11.176 21.347 0.596 16.037 0.550 0.053 NA/NR NA/NR 3.358 0.193 20.184 NA/NR NA/NR 2.033 0.321 9.234 2.784 1.228 1.040 0.072 NA/NR NA/NR 4.915 0.658 0.122 0.483 0.448 NA/NR NA/NR NA/NR 0.962 0.037 0.390 0.753 19.043 2.290 3.100 2.686 NA/NR NA/NR 0.471 5.050 0.132 0.594 2.870 0.692 23.800 0.565 NA/NR NA/NR NA/NR 1.029 0.353 0.613 30.072 0.022 0.384 2.025 NA/NR NA/NR 0.232 0.102 0.158 0.Voluntary Programmes Prevention female tion for social counseling for sex workers of mother and their condom social and behav.731 3.447 NA/NR NA/NR 1.065 NA/NR NA/NR 3.580 34.576 1.348 0.102 NA/NR NA/NR 0.292 NA/NR 11.302 6.399 NA/NR 8.329 NA/NR NA/NR 0.867 2.482 3.902 NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR 0.303 438.434 13.274 2.033 0.998 5.012 0.927 4.787 50.481 5.967 1.535 3.883 1.216 0.000 9.097 NA/NR NA/NR 0.209 8.010 NA/NR 0.031 0.044 0.588 3.106 NA/NR NA/NR 4.649 0.088 0.272 1.012 NA/NR NA/NR 0.008 0.164 NA/NR NA/NR 0.591 NA/NR NA/NR NA/NR 0.826 5.048 0.011 NA/NR NA/NR 8.335 3.283 0.256 1.208 0.036 11.004 NA/NR 0.534 0.350 4.073 NA/NR 0.532 0.044 NA/NR NA/NR 0.555 0.543 16.682 NA/NR NA/NR 2.061 NA/NR NA/NR 0.566 0.005 NA/NR NA/NR 0.241 0.388 1.853 33.182 0.727 15.106 NA/NR NA/NR 0.713 1.987 9.035 0.139 NA/NR NA/NR NA/NR 1.003 0.957 28.821 1.093 12.178 2.491 2.010 83.096 NA/NR 37.007 NA/NR NA/NR 5.531 35.774 10.195 11.404 362.245 NA/NR 0.206 1.170 2.537 NA/NR NA/NR 0.001 NA/NR NA/NR 2.519 2.324 0.127 NA/NR NA/NR NA/NR 0.759 2.703 4.052 0.007 0.492 3.TOTAL HIV EXPENDITURES ON SELECTED SERVICES (MILLION CURRENT USD DOLLARS) Prevention Orphans and vulnerable Total for care Antiretroviral children therapy and treatment Care and Treatment Programme Support Total for Planning.114 NA/NR 0.584 0.214 0.241 0.185 0.582 4.945 NA/NR NA/NR 9.107 0.727 5.681 0.093 NA/NR 32.281 NA/NR 2.015 0.561 NA/NR NA/NR NA/NR 0.694 3.077 0.210 2.693 0.835 2.017 0.111 0.535 6.845 NA/NR NA/NR 1.035 NA/NR NA/NR 7.428 0.881 NA/NR NA/NR NA/NR 0.003 0.103 8.130 0.014 0.795 0.369 0.417 NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR 0.024 NA/NR NA/NR 0.286 NA/NR NA/NR NA/NR 0.618 0.028 NA/NR NA/NR 2.864 5.650 NA/NR NA/NR 0.355 0. programme coordination management and and admin.036 NA/NR 0. 2004 to 2010 | 2010 GLOBAL REPORT 229 .739 28.844 14.194 0.066 2.148 31.534 1.286 0.775 82.604 15.447 0.220 NA/NR NA/NR 0.035 0.016 0.852 0.126 3.035 NA/NR NA/NR 2.164 0.823 0.029 NA/NR NA/NR 0.721 NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR 0.657 NA/NR NA/NR NA/NR 0.449 186.044 NA/NR NA/NR 0.010 NA/NR NA/NR 1.164 NA/NR NA/NR 0.016 6.025 NA/NR NA/NR 0.493 0.063 0.759 53.and testing to child clients for marketing and transmission ioral change MSM and for public and harm reduction commercial for IDUs sector provision NA/NR NA/NR 0.705 35.195 0.896 7.801 0.071 NA/NR NA/NR 0.093 0.990 NA/NR NA/NR 0.075 0.313 2.813 0.013 NA/NR NA/NR 2.764 NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR 0.967 5.238 1.561 6.035 0.426 NA/NR NA/NR NA/NR 0.675 0.008 0.799 1.124 NA/NR NA/NR 0.730 20.732 0.402 1.316 NA/NR NA/NR NA/NR 7.643 3.198 0.609 NA/NR 0.167 10.667 0.759 20.497 A2 Annex 2: Country progress indicators and data.174 0.497 NA/NR NA/NR NA/NR 0.660 5.221 46.programme istration management strengthening Monitoring and evaluation Other HIV expenditures Total for prevention Male and Communica.674 427.450 24.209 5.060 1.316 9.788 21.033 1.644 NA/NR NA/NR NA/NR 1.418 3.184 0.618 8.033 0.080 0.749 2.310 2.010 0.409 3.623 NA/NR NA/NR NA/NR NA/NR NA/NR 0.302 5.548 0.762 4.435 NA/NR NA/NR 0.230 2.164 0.017 0.329 3.043 0.019 NA/NR NA/NR NA/NR NA/NR NA/NR 0.090 25.577 NA/NR NA/NR NA/NR 1.582 0.182 0.290 1.783 37.538 156.036 NA/NR NA/NR 1.447 14.842 1.013 NA/NR NA/NR 0.611 57.051 0.665 0.

9% 3.7% 14.0% 7.6% 27.0% 5.0% 0.0% 13.0% 0.5% 27.0% 0.5% 20.8% 6.0% 0.0% 0.0% 0.7% 0.5% 2.721 3.9% 51.5% 45.1% 0.004 15.6% 71.3% 30.6% 48.056 43.387 22.3% 7.5% 0.1% 0.1% 3.0% 0.3% 3.0% 0.1% 19.0% 0.3% 3.8% 90.605 2.301 5.8% 58.4% 0.6% 0.639 7.8% 69.1% 5.0% 0.8% 8.0% NA/NR 0.1% 2.802 2.0% 1.575 100.5% 51.723 78.7% 0.0% 0.7% 10.0% 0.7% 3.1% 2.534 79.0% 0.8% 99.418 34.178 7.0% 10.0% 100.4% 27.2% 100.0% 14.1% 7.0% 0.4% 22.6% 3.2% 0.5% 63.6% 6.0% 0.9% 3.0% 8.1% 15.660 8.1% 0.9% 1.0% 10.5% 3.6% 37.9% 0.2% 61.0% 0.0% 0.0% 0.871 11.2% 0.0% 0.9% 76.2% 4.7% 0.4% 2.8% 0.578 4.0% 3.9% 99.9% 2.7% 12.1% 0.0% 0.3% 24.6% 23.8% 8.2% 16.0% 6.0% 0.0% NA/NR 0.0% 0.9% 14.1% 1.892 41.002 6.6% 2.3% 87.0% 0.1% 4.0% 0.0% 0.197 5.4% 59.691 3.4% 10.4% 16.0% 0.8% 21.007 5.8% 0.0% 100.6% 13.0% 0.1% 2.6% 40.4% 19.8% 30.616 16.2% 3.2% 24.7% 5.1% 57.535 73.7% 5.2% 9.6% 1.0% 0.8% 40.7% 68.801 323.3% 0.0% 31.8% 0.219 4.987 12.4% 60.0% 0.2% 4.7% 3.099 4.5% 6.7% 1. 2004 to 2010 | 2010 GLOBAL REPORT .0% 4.8% 8.0% 0.479 77.818 71.8% 4.664 2.4% 0.0% 72.0% 3.0% 17.0% 59.3% 90.0% 6.COUNTRY REPORTS OF DOMESTIC AND INTERNATIONAL AIDS SPENDING BY SERVICE CATEGORIES AND FINANCING SOURCES SHARE BY FINANCING SOURCE Survey Year Total reported Public domestic public and Domestic international public (%) expenditure million USD International Bilaterals (%) Global Fund (%) UN (%) All other All other multilaterals international (%) sources (%) Paraguay Peru Peru Peru Uruguay Venezuela Venezuela Venezuela East Asia China China Japan Mongolia Mongolia Armenia Armenia Azerbaijan Azerbaijan Belarus Belarus Georgia Georgia Kazakstan Kyrgyzstan Kyrgyzstan Republic of Moldova Republic of Moldova Russian Federation11 Tajikistan Tajikistan Ukraine Ukraine Uzbekistan Algeria Algeria Djibouti Djibouti Djibouti Egypt Egypt Iran (Islamic Republic of) Jordan Kuwait Kuwait Kuwait Lebanon 2009 2007 2008 2009 2007 2007 2008 2009 2008 2009 2009 2008 2009 2008 2009 2008 2009 2008 2009 2008 2009 2009 2008 2009 2008 2009 2008 2008 2009 2007 2008 2009 2008 2009 2007 2008 2009 2007 2008 2008 2009 2007 2008 2009 2007 11.5% 1.7% 8.0% 0.0% 0.3% 59.0% 0.1% 59.940 3.7% 4.6% 25.0% NA/NR 0.1% 38.0% 5.011 3.9% 0.3% 23.0% 0.1% 0.7% 6.7% 69.0% 0.8% 26.0% 0.044 4.0% 0.0% 0.0% 17.7% NA/NR 0.2% 10.9% 72.0% 46.9% 4.043 8.737 7.1% 0.0% 12.1% 0.6% 1.1% 0.2% 0.4% 4.7% NA/NR 0.4% 72.0% 10.0% 3.1% 11.1% 7.400 67.0% 0.0% 0.482 777.2% 0.1% 1.9% 7.0% 0.0% 0.0% 9.4% 2.5% 56.5% 10.6% 26.0% 0.696 4.3% 37.0% 2.0% 0.9% 12.6% 45.221 2.0% 0.8% 5.0% 0.5% 4.0% 0.7% 0.0% 16.6% 3.778 8.8% 0.0% 7.7% 0.0% 2.7% 58.834 353.2% 32.1% 11.7% 1.1% 1.0% Eastern Europe and Central Asia Middle East and North Africa 230 Annex 2: Country progress indicators and data.1% 2.1% 57.5% 13.3% 9.6% 0.5% 0.0% 14.7% 68.3% 54.0% 65.0% 0.0% 0.5% 15.0% 0.0% 2.0% 0.1% 5.0% 13.4% 0.021 6.0% 100.2% 2.1% 36.8% 93.2% 1.0% 27.062 18.0% 0.538 36.0% 0.796 9.0% 0.0% 0.4% 7.5% 18.8% 36.0% 0.9% 99.9% 0.7% 50.

406 21.711 2.461 0.464 NA/NR NA/NR 1.034 0.197 0. 2004 to 2010 | 2010 GLOBAL REPORT 231 .070 0.156 0.176 0.420 2.031 2.114 1.000 NA/NR NA/NR NA/NR A2 Annex 2: Country progress indicators and data.046 0.278 1.859 0.141 0.345 0.095 NA/NR NA/NR NA/NR 0.031 0.293 0.416 15.006 NA/NR NA/NR NA/NR 0.996 2.689 0.051 0.377 3.863 0.055 0.747 1.452 0.910 2.086 0.101 0.955 1.508 1.013 NA/NR NA/NR NA/NR 2.365 10.120 0.636 59.269 0.100 NA/NR NA/NR NA/NR 0.591 1.621 0.689 16.159 0.763 0.116 0.007 0.437 0.014 0.799 4.541 4.320 0.814 5.020 0.154 0.157 0.727 1.324 4.899 4.244 0.104 0.228 NA/NR NA/NR NA/NR NA/NR NA/NR 0.131 2.012 0.145 0.152 0.096 5.343 2.371 1.024 0.005 0.870 0.408 2.221 0.033 0.065 5.424 0.145 69.964 1.718 NA/NR 0.098 0.867 0.794 2.089 0.588 NA/NR NA/NR NA/NR 0.060 2.003 0.253 0.048 NA/NR 2.002 0.261 0.351 0.940 1.117 0.960 0.112 0.024 0.083 0.022 0.966 6.352 0.653 2.058 9.084 0.667 8.706 2.196 2.081 0.698 10.471 5.342 7.142 0.295 NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR 0.370 0.312 0.481 NA/NR 0.565 181.534 2.785 1.569 1.260 0.595 0.100 0.004 0.029 NA/NR NA/NR NA/NR NA/NR NA/NR 0.835 0.005 0.432 0.078 64.856 2.662 0.245 64.256 4.163 0.325 1.493 4.445 48.149 0.860 NA/NR 1.629 0.060 NA/NR NA/NR NA/NR 0.273 0.208 1.475 0.022 0.000 0.171 NA/NR NA/NR NA/NR 0.393 0.512 3.005 0.669 21.485 0.061 0.413 0.011 0.259 1.050 0.060 0.589 1.341 1.021 NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR 0.010 2.024 0.250 2.188 1.163 0.722 37.241 0.883 1.172 0.359 0.106 0.578 2.181 7.081 45.020 0.779 9.995 15.094 0.138 0.006 0.562 1.504 2.265 0.823 75.949 1.088 0.578 2.002 NA/NR NA/NR 0.099 0.168 0.259 0.071 0.841 10.954 0.307 4.142 0.104 0.239 2.355 3.639 NA/NR 2.138 0.826 1.930 2.359 4.662 6.154 0.023 0.101 0.788 1.147 1.007 NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR 0.683 1.291 0.067 0.819 NA/NR NA/NR NA/NR 0.492 4.090 0.257 0.010 NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR 8.309 NA/NR NA/NR NA/NR 0.064 0.373 0.000 NA/NR 0.153 0.833 0.468 0.185 0.278 4.137 0.042 1.992 2.301 NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR 0.and testing to child clients for marketing and transmission ioral change MSM and for public and harm reduction commercial for IDUs sector provision 1.071 NA/NR NA/NR NA/NR 0.563 0.902 2.021 0.917 2.130 1.187 1.015 0.791 0.600 0.781 2.028 0.521 0.736 NA/NR NA/NR NA/NR 2.152 0.031 0.201 0.005 NA/NR NA/NR 0.350 0.398 0.756 2. programme coordination management and and admin.407 0.135 13.272 2.085 0.087 NA/NR NA/NR NA/NR 1.106 0.065 0.936 0.561 65.430 1.601 20.153 0.076 0.806 0.667 NA/NR 0.878 28.003 0.444 0.299 228.738 1.325 NA/NR NA/NR NA/NR 1.002 NA/NR NA/NR NA/NR 0.194 0.302 NA/NR 1.644 NA/NR NA/NR NA/NR 0.315 0.410 0.687 0.564 0.068 7.607 3.890 0.037 0.107 0.082 0.024 NA/NR 0.385 NA/NR NA/NR NA/NR NA/NR 0.448 1.305 0.094 0.257 0.078 NA/NR NA/NR NA/NR 0.213 0.044 4.035 0.115 6.808 3.500 0.375 0.022 0.172 0.380 1.004 NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR 0.824 0.005 0.014 0.TOTAL HIV EXPENDITURES ON SELECTED SERVICES (MILLION CURRENT USD DOLLARS) Prevention Orphans and vulnerable Total for care Antiretroviral children therapy and treatment Care and Treatment Programme Support Total for Planning.705 0.323 0.794 NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR 0.147 NA/NR NA/NR 0.944 4.697 NA/NR NA/NR NA/NR NA/NR NA/NR 0.299 NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR 0.101 0.351 0.027 0.940 12.133 0.819 NA/NR NA/NR NA/NR 1.075 6.995 1.894 3.541 18.930 1.089 0.978 0.673 1.508 1.065 0.794 8.407 0.861 1.291 0.248 0.423 0.125 37.864 22.550 1.592 0.230 0.276 NA/NR 0.000 0.690 0.463 0.634 447.171 1.132 0.860 NA/NR 0.104 0.218 2.049 7.923 5.227 0.873 1.002 0.091 0.187 73.081 0.181 0.080 0.005 0.100 0.093 NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR 0.972 NA/NR NA/NR 0.311 0.649 0.134 2.397 3.057 3.422 0.443 10.003 NA/NR NA/NR NA/NR NA/NR 0.programme istration management strengthening Monitoring and evaluation Other HIV expenditures Total for prevention Male and Communica.562 1.632 0.402 0.667 0.547 6.402 NA/NR NA/NR NA/NR NA/NR NA/NR 0.860 0.018 0.069 0.Voluntary Programmes Prevention female tion for social counseling for sex workers of mother and their condom social and behav.921 2.393 14.785 1.556 0.410 0.000 0.028 1.422 8.013 0.425 0.361 0.263 0.679 22.679 NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR 0.951 0.681 NA/NR NA/NR NA/NR 0.307 NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR 0.756 0.060 1.

0% 4.0% 0.0% 0.4% 0.067 0.9% NA/NR NA/NR 8.0% NA/NR NA/NR 0.4% 20.5% 88.2% 45.3% 9.1% 0.0% 0.8% 0.1% 36.0% 0.5% 13.0% 100.0% 0.0% 0.0% 2.812 19.210 0.6% 44.355 0.0% 100.7% 0.100 0.389 5.0% 0.0% 1.0% 0.4% 99.0% 0.038 1.1% 16.0% 43.8% 1.584 4.0% NA/NR NA/NR 5.2% 44.1% 14.0% 0.6% 22.7% 0.847 145.0% NA/NR NA/NR 0.8% 5.1% 99.159 37.5% 31.5% 0.0% 1.0% 0.5% 0.7% 0.0% 5.5% 83.1% 15.0% 2.1% 19.4% 1.6% 1.9% 0.8% 0.0% 36.9% 2.4% 10.0% 1.4% 0.792 0.0% 0.1% 6.6% 22.0% 0.0% 0.6% 0.0% 0.0% 21.638 1.0% 100.4% 45.938 53.300 4.0% 11.6% 38.0% 0.2% 0.081 0.4% 5.0% 0.4% 7.5% 3.0% 0.4% 76.0% 1.506 2.6% 27.7% 9.3% 0. Federated States of Micronesia.0% NA/NR NA/NR 0.313 12.0% South and South-East Asia 232 Annex 2: Country progress indicators and data.1% 57.4% 18.0% 0.566 0.1% 35.8% 39.8% 7.0% 0.8% 71.982 1.1% 0.8% 41.002 58.0% 26.5% 9.9% NA/NR NA/NR 47.5% 99.265 26.0% 0.057 0.9% 23.995 5.0% 0.0% 78.0% 0.9% 10.2% 0.0% 0.9% 0.0% 0.8% 16.8% NA/NR NA/NR 0.9% 24.0% 0.1% 38.0% NA/NR NA/NR 7.0% 0.0% 83.9% 0.0% 0.0% 0. Federated States of Nauru Nauru Palau Palau Palau Samoa Solomon Islands Solomon Islands Tonga Tonga Tuvalu Tuvalu Vanuatu Vanuatu Afghanistan Afghanistan Bangladesh Bangladesh Cambodia Cambodia India6 India6 Indonesia 2008 2009 2007 2008 2009 2009 2008 2009 2007 2008 2009 2009 2009 2008 2009 2007 2008 2009 2008 2009 2008 2009 2008 2009 2007 2008 2009 2009 2008 2009 2008 2009 2008 2009 2008 2009 2008 2009 2008 2009 2007 2008 2008 2009 2007 7.7% 0.6% 6.7% 53.0% NA/NR NA/NR 82.3% 8.7% NA/NR NA/NR 68.3% 44.0% 0.8% 3.2% 0.097 0.3% 0.4% 0.3% 1.0% 0.1% 22.539 0.0% 21.0% 0.3% 13.2% 0.0% NA/NR NA/NR 12.3% 0.6% 7.0% 7.0% 0.1% 41.540 0.0% 0.115 3.0% 0.421 1.0% 0.1% 0.2% 0.4% 8.8% 2.037 218.5% 99.8% 24.0% 91.0% 0.2% 46.279 0.1% 17.6% 6.4% 31.0% 13.1% 16.1% 11.4% 0.8% 0.0% 0.956 266.8% 8.057 0.0% 2.0% 0.0% 0.0% 29.3% 62.3% 0.9% 50.977 17.0% 0.578 0.0% NA/NR NA/NR 16.0% 0.5% 0.4% 1.9% 11.5% 16.0% 0.0% 0.3% 0.0% 11.2% 0.0% 0.671 43.COUNTRY REPORTS OF DOMESTIC AND INTERNATIONAL AIDS SPENDING BY SERVICE CATEGORIES AND FINANCING SOURCES SHARE BY FINANCING SOURCE Survey Year Total reported Public domestic public and Domestic international public (%) expenditure million USD International Bilaterals (%) Global Fund (%) UN (%) All other All other multilaterals international (%) sources (%) Lebanon Lebanon Morocco Morocco Oman Saudi Arabia Somalia5 Somalia5 Syrian Arab Republic Syrian Arab Republic Syrian Arab Republic United Arab Emirates Yemen North America Mexico Mexico Oceania Fiji Fiji Fiji Marshall Islands Marshall Islands Micronesia.598 0.4% 43.6% 15. 2004 to 2010 | 2010 GLOBAL REPORT .1% 91.054 0.2% 3.2% 83.1% 0.241 5.5% 26.3% 0.1% 49.259 51.0% 5.0% 0.0% NA/NR NA/NR 36.0% 0.0% 0.0% 0.0% 0.4% NA/NR NA/NR 0.7% 0.0% 0.0% 0.0% 0.9% 6.0% 0.9% 19.092 1.0% 0.0% 0.0% 0.0% 0.0% 0.1% 3.4% 25.450 10.0% 83.849 2.5% 11.0% 2.5% 5.0% 0.6% NA/NR NA/NR 0.0% NA/NR NA/NR 11.986 1.5% 4.9% 7.2% 88.590 140.2% 0.0% 0.575 0.3% 54.0% 0.0% 0.2% 14.2% 42.3% 36.0% 0.

841 A2 Annex 2: Country progress indicators and data.091 0.018 0.014 0.270 NA/NR NA/NR 1.275 0.647 9.264 2.134 0.989 24.264 NA/NR NA/NR 0.263 0.034 0.897 15.048 0.502 0.289 0.040 0.198 0.008 NA/NR 0.461 14.226 0.264 NA/NR NA/NR NA/NR NA/NR NA/NR 6.299 4.300 NA/NR NA/NR 0.382 0.974 71.078 2.022 0.038 0.242 0.018 0.638 NA/NR 8.461 NA/NR NA/NR 4.063 NA/NR NA/NR 0.006 1.636 52.134 9.468 20.002 NA/NR NA/NR 0.002 0.823 4.004 NA/NR NA/NR NA/NR NA/NR 0.079 0.158 0.325 NA/NR NA/NR 0.738 0.089 1.104 0.617 5.482 14.158 0.178 0.496 3.056 0.040 1.685 0.812 0.017 NA/NR NA/NR 4.007 0.424 0.765 1.005 NA/NR NA/NR NA/NR NA/NR 0.472 2.013 0.374 0.027 NA/NR NA/NR NA/NR NA/NR 0.004 0.123 0.184 0.809 24.094 1.962 NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR 1.191 NA/NR NA/NR 1.378 9.021 NA/NR NA/NR NA/NR NA/NR 1.107 2.400 2.012 0.782 0.016 NA/NR NA/NR NA/NR NA/NR NA/NR 0.408 2.050 NA/NR NA/NR 3.044 NA/NR 0.038 0.007 0.537 0.110 0.009 0.015 0.124 0.576 0.269 2.008 NA/NR NA/NR 0.681 0.036 NA/NR 0.821 21.797 0.923 122.843 14.403 13.016 0.028 NA/NR 0.110 0.154 NA/NR NA/NR 2.002 0.135 1.045 NA/NR 0.472 0.305 0.000 NA/NR NA/NR NA/NR 1.910 0.211 1.007 0.084 0.000 0.001 NA/NR NA/NR 2.950 NA/NR NA/NR 4.078 0.061 0.162 3.316 0.275 NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR 0.751 0.001 NA/NR NA/NR NA/NR NA/NR NA/NR 0.666 1.056 NA/NR NA/NR 0.400 0.000 0.502 0.635 0.929 98.713 0.506 0.381 2.102 NA/NR 6.535 15.222 4.524 0.219 0.121 0.071 0.027 0.532 NA/NR NA/NR 0.725 0.014 0.030 NA/NR NA/NR 0.569 0.146 0.015 0.019 0.095 0.039 NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR 13.programme istration management strengthening Monitoring and evaluation Other HIV expenditures Total for prevention Male and Communica.000 0.826 NA/NR 200.043 0.019 0.433 2.022 NA/NR 0.000 0.050 NA/NR NA/NR 0.117 0.582 NA/NR NA/NR 0.836 NA/NR NA/NR 0.063 1.009 NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR 0.001 NA/NR NA/NR 2.027 0.005 NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR 0.612 0.405 0.765 0.044 0.210 NA/NR NA/NR 0.605 0.015 0.848 0.051 0.001 NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR 0.152 0.494 10.008 0.451 1.006 NA/NR NA/NR NA/NR NA/NR 0.225 NA/NR NA/NR NA/NR NA/NR NA/NR 1.032 0.002 0.028 NA/NR 0.596 0.023 0.054 0.477 NA/NR NA/NR 1.314 1. 2004 to 2010 | 2010 GLOBAL REPORT 233 .968 1.491 0.032 NA/NR NA/NR NA/NR NA/NR 0.015 0.013 0.040 0.252 0.245 9.015 0.917 0.170 0.280 21.680 0.025 0.171 0.122 0.TOTAL HIV EXPENDITURES ON SELECTED SERVICES (MILLION CURRENT USD DOLLARS) Prevention Orphans and vulnerable Total for care Antiretroviral children therapy and treatment Care and Treatment Programme Support Total for Planning.103 0.961 NA/NR NA/NR 0.911 4.Voluntary Programmes Prevention female tion for social counseling for sex workers of mother and their condom social and behav.031 0.030 NA/NR NA/NR NA/NR 0.005 NA/NR NA/NR NA/NR NA/NR 0.004 0.365 0.058 0.297 10.041 NA/NR NA/NR NA/NR 0.805 0.091 0.429 0.033 0.085 0.027 NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR 7.919 0.014 0.435 NA/NR NA/NR 7.016 0.524 0.390 NA/NR 156.615 1.003 0.106 0.711 163.005 0.069 0.486 0.788 2.010 NA/NR 0.083 NA/NR NA/NR NA/NR NA/NR 0.421 0.001 NA/NR NA/NR NA/NR NA/NR 0.000 NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR 0.077 3.041 NA/NR NA/NR 0.175 6.548 2.697 0.005 0.027 0.500 0.217 5.162 7.264 0.438 0.012 NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR 0.901 4.467 23.013 NA/NR 0.088 1.302 0.680 1.038 NA/NR NA/NR 0.018 0.538 18.088 NA/NR 0.136 NA/NR NA/NR 0.014 0.083 0.697 0.041 0.001 0.334 23.048 0.178 3.742 0.038 0.001 NA/NR NA/NR NA/NR NA/NR 0.017 NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR 0.052 4.369 NA/NR NA/NR 0. programme coordination management and and admin.016 NA/NR NA/NR 1.009 0.009 0.002 0.172 0.537 0.050 0.440 0.566 17.800 0.912 4.273 19.704 0.104 0.013 0.018 NA/NR 50.275 NA/NR NA/NR 1.456 25.141 0.015 0.209 0.204 0.486 0.569 3.264 1.475 NA/NR 5.and testing to child clients for marketing and transmission ioral change MSM and for public and harm reduction commercial for IDUs sector provision NA/NR NA/NR 3.027 1.507 0.040 1.134 6.348 0.012 0.606 48.023 NA/NR 0.012 0.457 4.263 NA/NR NA/NR NA/NR NA/NR NA/NR 0.098 0.004 NA/NR NA/NR NA/NR NA/NR NA/NR 0.171 52.

147 5.8% 4.5% 1.6% 47.0% 0.1% 39.0% 0.0% 67.0% 0.6% 0.617 13.5% 25.088 1.839 16.2% 12.8% 2.7% 3.7% 0.0% 0.7% 4.0% 7.0% 0.0% 21.0% 0.0% 0.6% 0.3% 25.0% 0.4% 21.9% 18.9% 5.766 24.0% 25.5% 3.4% 1.3% 0.4% 33.1% 1.7% 11.5% 19.7% 4.6% 44.0% 4.7% 1.0% 1.6% 0.0% 2.2% 67.336 48.0% 3.1% 2.5% 0.3% 7.972 2.0% 0.0% 0.7% 85.017 5.0% 7.350 15.466 11.775 1.0% 0.1% 47.1% 0.0% 0.0% 0.4% 0.5% 0.662 14.195 19.0% 0.0% 0.282 8.5% 19.7% 18.2% 25.2% 1.0% 17.2% 0.9% 96.0% 0.1% 9.8% 9.0% 0.0% 100.0% 0.5% 3.0% 0.1% 11.9% 8.803 66.9% 3.5% 16.4% 95.0% 0.568 1.5% 0.0% 0.0% 0.5% 47.7% 36.0% 39.5% 3.COUNTRY REPORTS OF DOMESTIC AND INTERNATIONAL AIDS SPENDING BY SERVICE CATEGORIES AND FINANCING SOURCES SHARE BY FINANCING SOURCE Survey Year Total reported Public domestic public and Domestic international public (%) expenditure million USD International Bilaterals (%) Global Fund (%) UN (%) All other All other multilaterals international (%) sources (%) Indonesia Lao People’s Democratic Republic Lao People’s Democratic Republic Lao People’s Democratic Republic Malaysia Malaysia Myanmar Myanmar Nepal Pakistan Pakistan Philippines Philippines Philippines Singapore Singapore Singapore Sri Lanka Sri Lanka Thailand Thailand Thailand Timor Leste Timor Leste Viet Nam Viet Nam Viet Nam Sub-Saharan Africa Angola Angola Benin Benin Benin Botswana Burkina Faso Burkina Faso Burundi Burundi Cameroon Cameroon Cape Verde Cape Verde Central African Republic Central African Republic Chad Chad 2008 2007 2008 2009 2008 2009 2007 2008 2007 2008 2009 2007 2008 2009 2007 2008 2009 2008 2009 2007 2008 2009 2008 2009 2007 2008 2009 2008 2009 2007 2008 2009 2008 2007 2008 2007 2008 2007 2008 2008 2009 2007 2008 2007 2008 49.645 209.5% 74.1% 22.1% 0.0% 0.3% 10.8% 0.5% 41.1% 15.7% 0.5% 0.3% 0.4% 3.011 25.5% 17.6% 2.0% 14.7% 5.2% 32.123 213.1% 75.9% 45.3% 37.5% 36.555 199.814 102.1% 10.111 10.1% 54.8% 10.563 5.3% 16.060 36.868 36.827 1.0% 100.0% 0.5% 13.7% 5. 2004 to 2010 | 2010 GLOBAL REPORT .2% 33.5% 16.0% 4.5% 18.4% 13.0% 2.289 27.3% 6.2% 1.2% 5.770 28.7% 14.2% 19.8% 15.1% 19.0% 2.0% 87.827 6.0% 0.3% 9.6% 3.0% 0.0% 0.8% 0.559 39.0% 0.789 339.9% 5.1% 4.0% 0.0% 0.5% 34.2% 6.7% 17.8% 98.3% 0.0% 0.2% 11.2% 0.2% 11.3% 2.0% 0.0% 2.1% 87.1% 6.895 40.0% 12.0% 15.3% 21.6% 42.3% 36.2% 3.3% 28.6% 4.3% 29.0% 0.0% 27.802 17.5% 1.0% 7.2% 1.8% 8.9% 6.0% 0.9% 7.332 20.9% 98.338 16.1% 21.5% 96.2% 9.0% 0.9% 85.1% 0.2% 100.0% 0.8% 0.7% 25.6% 12.763 32.8% 0.0% 28.0% 0.0% 8.3% 0.5% 12.0% 37.5% 0.0% 0.997 24.5% 78.0% 0.8% 13.0% 39.4% 3.0% 63.0% 1.0% 8.0% 0.6% 27.9% 22.7% 92.0% 6.4% 93.0% 3.8% 28.7% 0.0% 0.5% 17.8% 64.3% 21.0% 2.570 1.5% 0.7% 9.988 31.9% 0.0% 0.0% 0.3% 16.281 108.2% 1.3% 14.4% 12.7% 0.5% 22.9% 18.2% 1.4% 13.3% 25.1% 16.0% 0.4% 16.9% 0.0% 0.5% 1.0% 5.8% 0.0% 29.0% 13.6% 1.700 32.0% 67.836 20.5% 20.6% 4.0% 0.8% 0.2% 82.4% 8.6% 234 Annex 2: Country progress indicators and data.964 26.9% 18.5% 68.999 4.3% 7.7% 17.7% 2.577 10.8% 1.4% 0.4% 0.0% 0.3% 29.5% 18.9% 0.6% 3.5% 33.0% 1.1% 0.7% 3.0% 11.

542 4.278 5.578 1.349 1.119 0.767 2.636 6.521 0.263 4.608 1.210 4.153 2.608 0.069 0.310 0.000 0.130 1.483 0.783 4.325 0.195 0.324 47.016 6.223 A2 0.406 NA/NR NA/NR 1.604 0.935 1.083 NA/NR NA/NR 0.900 42.664 1.215 7.000 0.251 3.092 3.269 0.529 0.153 6.054 93.000 0.941 0.632 2.684 15.393 0.679 3.324 1.640 0.419 0.956 5.459 16.561 0.540 7.844 15.907 5.683 0.408 3.005 0.030 0.214 1.075 0.330 9.911 5.003 6.630 0.076 143.187 9.792 0.486 NA/NR 0.259 0.260 NA/NR 0.431 1.504 0.288 0.235 2.151 0.418 NA/NR NA/NR 0.604 0.186 3.programme istration management strengthening Monitoring and evaluation Other HIV expenditures Total for prevention Male and Communica.913 4.195 0.110 3.664 2.TOTAL HIV EXPENDITURES ON SELECTED SERVICES (MILLION CURRENT USD DOLLARS) Prevention Orphans and vulnerable Total for care Antiretroviral children therapy and treatment Care and Treatment Programme Support Total for Planning.019 0.147 0.125 1.472 1.948 1.733 1.821 3.665 1.212 1.012 0.061 25.495 3.897 1.719 2.007 0.521 0.and testing to child clients for marketing and transmission ioral change MSM and for public and harm reduction commercial for IDUs sector provision 24.544 1.282 0.213 4.565 NA/NR NA/NR 0.178 0.621 1.166 9.159 NA/NR NA/NR NA/NR 0.122 NA/NR NA/NR NA/NR NA/NR NA/NR 1.050 3.360 2.029 0.521 0.669 12.310 NA/NR 0.065 1.722 0.326 16.956 0.123 0.055 0.646 162.029 0.358 0.248 6.493 0.443 0.017 0.893 0.661 7.330 13.211 0.818 3.Voluntary Programmes Prevention female tion for social counseling for sex workers of mother and their condom social and behav.776 5.017 0.920 6.292 0.562 7.553 2.758 12.061 12.487 7.664 4.667 1.791 0.226 4.582 1.224 0.195 0.379 0.503 9.745 9.721 49.946 1.566 1.625 61.607 2.176 0.634 0.466 3.616 2.025 0.852 2.806 0.890 3.039 NA/NR 0.087 0.528 0.578 165.937 0.151 0.553 39.245 0.210 2.917 28.023 0.188 10.015 0.552 2.578 5.021 0.307 1.670 21.430 2.241 4.060 15.739 8.233 14.096 0.956 0.424 0.945 1.004 0.781 NA/NR 0.096 0.158 0.709 15.874 7.088 5.233 0.107 0.755 1.117 0.135 4.134 0.360 2.649 0.263 0.123 0.236 0.962 9.000 NA/NR NA/NR NA/NR NA/NR NA/NR 2.865 0.607 3.036 0.191 1.793 2.641 0.029 0.036 NA/NR NA/NR NA/NR NA/NR NA/NR 3.736 1.015 0.158 NA/NR NA/NR 0.064 0.763 0.529 0.000 0.710 2.827 9.041 0.500 0.328 2.253 NA/NR 0.918 0.708 NA/NR 0.937 1.376 0.888 0.231 0.088 0.064 12.033 5.126 NA/NR NA/NR 0.000 0.566 0.226 4.160 2.182 0.334 2.459 5.387 3.051 0.000 11.035 3.037 NA/NR NA/NR NA/NR NA/NR NA/NR 3.334 137.435 0.667 5.556 10.443 1.012 NA/NR NA/NR 0.105 8.487 NA/NR NA/NR 0.132 1.924 9.208 0.253 NA/NR NA/NR 0.032 0.197 5.936 1.189 0.101 NA/NR NA/NR 1.607 NA/NR NA/NR NA/NR 0.029 0.965 9.383 13.335 3.295 9.003 0.003 0.218 5.727 80.679 0.449 11.694 2.148 0.763 40.703 0.377 0.497 0.324 5.749 0.680 0.902 6.142 0.645 48.878 1.672 1.008 NA/NR 3.930 2.130 10.785 1.421 1.474 11.031 0.979 0.703 2.459 4.113 0.026 0.529 1.617 0.286 9.323 0.420 8.860 2.085 NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR 2.680 2.714 2.573 5.295 92.462 5.765 1.312 10.624 0.418 1.244 0.643 0.546 8.000 0.012 0.366 0.369 0.447 11.544 3.780 1.531 0.714 1.993 0.915 5.030 0.358 24.047 0.049 0.211 0.571 2.081 0.079 0.381 2.672 0.984 7.031 3.090 0.481 NA/NR NA/NR NA/NR 0.453 NA/NR NA/NR NA/NR NA/NR NA/NR 0.184 NA/NR NA/NR NA/NR 0.344 35.783 1. 2004 to 2010 | 2010 GLOBAL REPORT 235 .402 3.736 10.674 0.000 13.511 0.699 12.309 1.343 NA/NR NA/NR 8.429 3.570 0.245 21.443 1.016 0.278 NA/NR NA/NR NA/NR NA/NR NA/NR 5.362 0.183 0.894 Annex 2: Country progress indicators and data.078 8.300 7.629 0.003 1.301 2.417 3.071 0.884 1.845 3.718 5.053 4. programme coordination management and and admin.575 0.899 5.415 4.000 0.359 2.145 1.528 5.522 3.454 0.252 1.780 NA/NR NA/NR 0.646 2.979 0.089 0.920 1.704 1.207 8.127 0.008 3.018 0.317 3.535 NA/NR NA/NR 0.099 0.561 0.429 3.074 0.036 1.004 NA/NR NA/NR NA/NR NA/NR 0.857 1.297 16.110 2.530 29.019 0.728 0.952 9.872 12.032 8.265 1.009 0.766 7.051 NA/NR 1.615 3.313 0.903 0.185 6.099 10.521 0.082 0.186 45.842 3.010 0.116 0.425 0.230 3.231 NA/NR NA/NR 0.102 19.228 7.353 0.931 2.137 0.287 29.628 6.473 1.330 1.436 0.529 2.188 0.861 10.091 1.418 0.132 1.025 0.160 11.197 1.522 0.339 0.559 5.175 6.073 0.275 2.002 2.846 0.721 4.501 11.016 0.006 1.911 7.060 0.507 1.077 0.694 1.143 0.868 4.133 0.638 2.970 1.109 0.518 2.134 5.077 NA/NR NA/NR NA/NR NA/NR NA/NR 0.861 0.133 7.948 6.766 0.274 NA/NR NA/NR 2.

9% 3.1% 3.256 418.2% 1.8% 23.0% 1.2% 21.1% 16.5% 8.263 4.0% 0.9% 23.1% 14.1% 24.0% 0.4% 5.COUNTRY REPORTS OF DOMESTIC AND INTERNATIONAL AIDS SPENDING BY SERVICE CATEGORIES AND FINANCING SOURCES SHARE BY FINANCING SOURCE Survey Year Total reported Public domestic public and Domestic international public (%) expenditure million USD International Bilaterals (%) Global Fund (%) UN (%) All other All other multilaterals international (%) sources (%) Congo Congo Congo Cote d’Ivoire Cote d’Ivoire Democratic Republic of the Congo Equatorial Guinea Equatorial Guinea Equatorial Guinea Eritrea Eritrea Gabon Gabon Gabon Gambia Gambia Ghana Ghana Guinea Guinea Guinea Guinea-Bissau Guinea-Bissau Kenya Kenya Kenya Lesotho Lesotho Madagascar Malawi Malawi Mali Mali Mozambique Mozambique Niger Niger Nigeria Nigeria Rwanda Rwanda Sao Tome and Principe Sao Tome and Principe Sao Tome and Principe Senegal Seychelles Seychelles Seychelles Sierra Leone 2007 2008 2009 2007 2008 2008 2007 2008 2009 2008 2009 2007 2008 2009 2007 2008 2007 2008 2007 2008 2009 2008 2009 2007 2008 2009 2007 2008 2008 2008 2009 2007 2008 2007 2008 2007 2008 2007 2008 2007 2008 2007 2008 2009 2008 2007 2008 2009 2007 9.1% 0.1% 3.012 62.1% 0.479 0.457 299.8% 0.9% 3.946 14.5% 19.3% 15.7% 11.9% 15.9% 4.0% 7.7% 3.9% 0.6% 6.8% 1.9% 0.8% 1.7% 58.3% 37.1% 24.7% 0.3% 51.0% 0.575 9.0% 0.7% 2.0% 0.4% 4.5% 0.0% 10.6% 8.5% 4.5% 13.9% 55.1% 0.0% 16.8% 2.0% 4.1% 54.5% 9.065 25.9% 35.4% 2.4% 19.0% 21.6% 2.0% 16.9% 26.1% 83.4% 40.2% 25.5% 15.173 10.0% 0.4% 8.7% 7.395 67.6% 2.0% 1.5% 14.0% 12.6% 0.8% 4.0% 60.1% 72.3% 1.5% 45.1% 4.661 10.7% 0.3% 0.4% 11.8% 10.0% 45.797 14.8% 5.1% 3.3% 75.5% 34.800 40.9% 25.7% 3.722 103.0% 41.6% 9.0% 3.0% 6.6% 74.7% 2.0% 0.6% 25.3% 17.812 0.2% 11.5% 65.0% 70.5% 2.0% 19.0% 0.2% 2.0% 2.7% 2.0% 37.2% 16.0% 0.0% 40.0% 0.9% 12.308 37.3% 22.565 110.6% 1.8% 3.3% 20.1% 0.2% 56.852 12.258 53.6% 16.0% 8.0% 0.0% 26.0% 33.0% 6.954 106.9% 11.4% 0.5% 11.4% 0.7% 11.5% 36. 2004 to 2010 | 2010 GLOBAL REPORT .9% 12.0% 51.9% 8.2% 19.3% 0.4% 77.471 11.5% 40.7% 24.6% 25.0% 34.5% 32.9% 25.4% 0.9% 0.0% 0.6% 4.5% 7.0% 0.0% 0.9% 58.9% 6.2% 7.2% 16.3% 2.2% 37.9% 80.542 144.6% 21.5% 0.2% 29.5% 6.0% 52.9% 6.3% 19.664 74.7% 7.866 687.1% 21.8% 1.4% 12.0% 0.7% 18.5% 10.6% 65.0% 4.8% 3.5% 10.2% 14.0% 96.0% 0.3% 5.9% 5.5% 2.8% 24.5% 19.2% 5.011 85.1% 4.6% 42.6% 6.9% 5.1% 15.0% 0.893 4.0% 0.0% 24.5% 14.098 0.9% 15.1% 4.315 11.0% 0.2% 87.390 104.570 0.3% 236 Annex 2: Country progress indicators and data.1% 18.0% 1.6% 5.8% 2.3% 79.1% 8.4% 2.0% 0.8% 19.1% 1.0% 0.5% 30.0% 13.3% 46.1% 28.8% 45.4% 0.522 12.1% 8.3% 0.8% 0.0% 0.0% 5.402 13.0% 0.5% 4.8% 9.6% 18.4% 18.3% 0.2% 5.5% 31.7% 30.4% 3.0% 3.9% 80.0% 3.907 40.7% 30.0% 18.1% 0.9% 6.457 13.0% 0.2% 46.8% 0.648 5.0% 31.1% 0.5% 4.442 11.8% 13.5% 0.184 10.582 659.0% 5.737 81.3% 68.8% 62.1% 68.4% 63.7% 29.7% 23.3% 14.5% 10.9% 45.231 3.629 17.3% 34.4% 7.2% 2.3% 1.5% 2.5% 11.5% 16.5% 47.0% 18.1% 8.9% 0.3% 4.0% 21.827 2.0% 0.2% 5.5% 17.0% 2.985 52.0% 3.4% 0.3% 0.8% 16.7% 4.9% 23.964 1.7% 11.928 7.1% 33.0% 0.5% 2.6% 8.1% 0.093 1.9% 7.3% 10.0% 32.242 394.310 2.0% 0.5% 3.2% 16.9% 15.6% 76.573 0.9% 5.6% 14.

521 0.925 1.811 39.962 1.117 0.000 0.179 2.710 3.246 0.809 6.703 NA/NR 0.019 0.727 0.073 1.009 0.109 31.224 1.249 9.243 0.450 8.043 3.912 27.017 4.004 0.117 0.198 NA/NR NA/NR 0.022 NA/NR NA/NR 0.848 1.165 0.163 0.080 0.794 44.379 0.327 8.003 25.060 5.301 0.779 38.052 0.340 0.412 1.005 0.000 0.055 NA/NR 0.216 0.441 1.959 24.046 NA/NR 1.968 4.292 12.787 4.837 102.943 4.581 0.292 2.071 17.898 0.065 0.344 0.112 33.210 0.448 19.983 13.023 0.352 4.091 0.627 2.119 0.805 14.063 0.335 0.190 0.825 117.087 2.127 12.008 0.022 0.597 0.544 8.332 8.213 0.028 0.119 1.411 28.411 NA/NR NA/NR 0.062 0.080 NA/NR NA/NR 1.091 NA/NR NA/NR NA/NR 0.200 2.270 0.919 38.119 10.015 3.987 28.626 1.826 18.384 1.897 6.868 0.069 1.869 5.013 0.796 18.641 3.675 4.551 376.008 4.879 3.531 1.801 1.112 0.310 158.082 0.895 0.959 23.918 14.602 0.170 2.342 79. 2004 to 2010 | 2010 GLOBAL REPORT 237 .766 NA/NR NA/NR NA/NR 0.308 0.271 0.774 4.880 39.714 1.819 3.968 1.035 4.681 4.026 9.060 0.787 28.887 55.012 NA/NR 0.356 2.953 15.801 0.460 0.670 NA/NR NA/NR 0.124 0.014 0.681 0.215 1.333 2.495 257.850 NA/NR NA/NR 0.978 NA/NR 0.521 10.671 4.422 8.026 0.868 2.065 0.165 0.577 0.524 3.169 2.545 1.225 6.335 0.227 0.084 0.007 3.017 0.440 1.500 NA/NR NA/NR 0.046 2.052 0.028 NA/NR 0.712 1.440 4.052 1.078 0.987 25.273 0.043 2.557 28.791 13.525 0.711 0.003 0.307 3.459 NA/NR 0.543 5.004 0.574 3.473 0.243 0.008 0.066 0.427 4.610 17.484 0.237 2.563 6.325 11.339 2.995 NA/NR 6.123 0.112 0.006 NA/NR 0.802 9.083 0.587 35.176 0.749 2.611 0.231 3.850 3.043 0.091 0.247 0.067 1.704 10.Voluntary Programmes Prevention female tion for social counseling for sex workers of mother and their condom social and behav.280 0.085 0.699 0.694 0.586 0.328 NA/NR NA/NR 1.822 37.612 0.501 12.715 9.003 0.533 3.820 2.075 0.025 0.455 0.078 NA/NR 0.015 0.448 1.007 0.965 1.577 0.119 1.389 13.413 7.753 23.922 9.043 4.728 2.874 1.207 0.478 NA/NR 0.619 181.001 0.494 4.160 2.209 0.852 2.466 11.699 10.273 0.310 0.228 0.676 8.700 0.088 185.010 0.119 0.153 0.045 0.195 0.588 0.650 6.169 2.623 4.118 2.910 4.312 0.124 0.956 2.336 2.117 2.847 1.010 0.083 0.115 0.417 18.596 NA/NR NA/NR NA/NR 0.784 0.606 8.045 6.125 0.514 NA/NR NA/NR NA/NR 0.291 NA/NR NA/NR NA/NR NA/NR NA/NR 0.650 1.061 0.675 8.044 0.008 0.042 0.680 0.374 0.078 0.398 0.472 45.779 A2 Annex 2: Country progress indicators and data.290 0.599 2.000 0.176 1.393 41.839 NA/NR 7.752 1.067 50.069 4.389 2.265 0.425 0.429 1.573 0.028 0.152 4.406 21.130 3.256 0.196 0.113 0.035 1.373 0.598 17.032 0.214 1.112 1.129 6.005 0.654 57.106 0.001 87.173 0.080 NA/NR NA/NR NA/NR 0.438 0.171 0.043 29.246 23.422 0.434 0.091 0.TOTAL HIV EXPENDITURES ON SELECTED SERVICES (MILLION CURRENT USD DOLLARS) Prevention Orphans and vulnerable Total for care Antiretroviral children therapy and treatment Care and Treatment Programme Support Total for Planning.631 4.007 0.001 0.008 0.478 2.004 0.148 0.programme istration management strengthening Monitoring and evaluation Other HIV expenditures Total for prevention Male and Communica.239 7.377 4.730 NA/NR 0.005 1.341 1.and testing to child clients for marketing and transmission ioral change MSM and for public and harm reduction commercial for IDUs sector provision 3.288 67.700 0.588 0.239 1.015 0.193 2.029 0.432 67.184 2.462 0.119 NA/NR NA/NR NA/NR NA/NR 0.211 9.665 5.506 10.406 0.500 0.238 1.327 0.940 0.397 32.287 0.651 1.217 0.022 0.857 11.482 1.114 3.436 207.670 32.102 0.001 NA/NR 0.212 1.485 33.488 0.565 1.003 20.615 135.062 0.358 3.014 0.140 147.586 3.145 0.421 6.562 1.702 6.038 NA/NR NA/NR NA/NR NA/NR 0.026 0.029 2.823 NA/NR NA/NR NA/NR 0.726 0.005 41.231 1.274 0.818 3.178 0.371 1.224 15.527 NA/NR NA/NR 0.228 0.663 0.671 14.949 17.875 5.019 0.981 0.132 3.581 0.110 0.972 9.333 29.698 2.334 3.690 41.310 9.009 0.728 4.459 39.001 0.422 NA/NR 6.303 NA/NR NA/NR NA/NR 0.773 NA/NR NA/NR NA/NR 0.025 7.944 1.190 3.949 36.196 0.159 68.934 226.183 NA/NR 0.631 25.415 NA/NR NA/NR NA/NR 1.742 2.025 1.120 0.042 30.003 0.151 7.503 15.118 0.006 0.044 0.639 5.100 0.001 0.246 0.675 1.289 1.155 0.701 6.235 0.115 29.924 4.227 0. programme coordination management and and admin.544 1.961 0.018 1.239 379.123 1.329 0.273 25.359 12.979 3.498 1.481 1.168 2.308 21.020 0.158 1.196 1.409 8.881 20.324 0.477 1.758 6.850 0.027 0.167 10.925 9.200 0.166 8.029 0.014 0.549 5.336 8.043 NA/NR NA/NR NA/NR 0.061 0.196 0.032 1.003 0.118 1.131 NA/NR 0.358 3.645 NA/NR 0.009 1.020 0.058 1.310 18.075 4.501 0.019 21.257 NA/NR 0.733 0.600 0.478 3.742 39.741 7.694 3.048 18.554 1.628 1.011 0.408 NA/NR 2.683 1.304 NA/NR NA/NR NA/NR 0.545 17.542 4.133 5.041 0.781 6.374 5.966 2.453 7.197 0.192 0.098 0.141 0.020 0.136 0.464 2.895 4.322 4.258 3.476 13.554 0.137 1.409 1.061 0.764 2.700 2.

0% 5.8% 0.9% 8.5% 4.0% 94.058 2.702 8.0% 0.0% 0.2% 0.739 1.520 87.0% NA/NR 0.0% 0. and out-patient clinic visits for care and treatment are not reported.0% 0.0% 0.0% 0. 6 India: The values reported reflect only NACO’s (public) spending from the budgetary funds. federal district and municipal level is not reported.6% 98.155 19.0% 0.0% 12.5% 100. 10 Timor Leste: Original submission for 2008 was for a one and a half year period (Aug.0% 0.7% 1.0% 0.373 96.3% 92.1% 98.212 10.0% 0.908 9.3% 19.0% 100.8% 66.0% 0.0% 0.4% 50.0% 0.0% 0.082 925. 3 Bulgaria opportunistic infection treatment expenditures not reported.8% 5.0% 0.5% 7.9% 4.203 15.000 49.0% 0.7% 0.0% 0.584 6.0% 92.0% 100.0% 0. 7 Montenegro spending includes only the budgeted activities of the GFATM project proposal.7% 83.0% 0.598 22.0% 34.0% 2.548 111.0% 0.0% 0. 9 Switzerland: Only central government funding is reported.0% 70.0% NA/NR NA/NR NA/NR 100.0% 0.9% 0.0% 0.0% 0.311 18.0% 0.0% 0.0% 0.957 10.0% 0.0% 0.5% 0.0% 0.0% 0.3% 98.898 14.777 2.3% NA/NR 4.0% 0.0% 0.0% 0.998 64.0% 0.0% 61.0% 0.241 84. except for acquisition of opportunistic infection drugs.0% 0.7% 99.0% 0.2% NA/NR 56.0% 0.0% 0.0% 0.0% NA/NR NA/NR NA/NR 0.1% 100.673 3.8% 0.4% 0.3% NA/NR 10.694.0% 0.471 0.9% 2.0% 0.0% NA/NR NA/NR NA/NR 0.4% 0.0% 100.0% NA/NR NA/NR NA/NR 0.0% 0.8% 76.0% 0.0% 0.0% 0.4% 0.0% 0.0% 0.0% 0.0% 0.7% 95.8% 6.0% 0.0% 0.2% NA/NR 1.256 551.0% 0.0% 100.4% NA/NR 0.0% 100.0% 0.0% 100.0% 0.843 3.0% 0.000 2. The expenditures were therefore divided in two and distributed equally over the two years.6% NA/NR 0.650 27.367 56.9% 0.4% 43.0% 0.0% 100.1% 0.0% 0.0% 0.0% 0.8% 0.0% 0.4% 30.275 3.0% 0.381 21.279 69.666 9.496 2.0% 56.0% 31.9% 1.7% 0. The current figure for 2008 was derived by adjusting all figures by 2/3.4% 2.0% 100.0% 6. Bulgaria3 Croatia Croatia Croatia Czech Republic Czech Republic Czech Republic Estonia Greece Hungary5 Hungary Hungary Latvia Luxembourg Montenegro7 Montenegro7 Montenegro7 Poland Poland Poland Romania Romania Spain Spain Spain Sweden Sweden Sweden Switzerland9 Switzerland9 The former Yugoslav Republic of Macedonia United Kingdom United Kingdom 238 Annex 2: Country progress indicators and data.0% 0.0% 0. 4 Chilean armed forces HIV-related expenditures were not reported.0% NA/NR 100.0% 0.8% 2.031.0% 0.1% 0.6% 0.714 77. The extra budgetary expenditures by donors and others is not reflected in the table provided and is still under compilation and analysis in a separate study.0% 0.0% 100.0% 21.368 270.COUNTRY REPORTS OF DOMESTIC AND INTERNATIONAL AIDS SPENDING BY SERVICE CATEGORIES AND FINANCING SOURCES SHARE BY FINANCING SOURCE Survey Year Total reported Public domestic public and Domestic international public (%) expenditure million USD International Bilaterals (%) Global Fund (%) UN (%) All other All other multilaterals international (%) sources (%) South Africa South Africa Swaziland Togo Togo Uganda Uganda Zimbabwe Zimbabwe Belgium Bosnia and Herzegovina Bosnia and Herzegovina Bulgaria3 Bulgaria3 1 2008 2009 2007 2007 2008 2007 2008 2008 2009 2008 2008 2009 2007 2008 2009 2007 2008 2009 2007 2008 2009 2008 2008 2007 2008 2009 2009 2009 2007 2008 2009 2007 2008 2009 2008 2009 2007 2008 2009 2007 2008 2009 2008 2009 2008 2007 2008 1.0% 0.0% 0.0% 0.011 296.7% 0.0% 3.7% 0.0% 0.0% 0.659 1.0% 0.0% 0.597 0.0% 0.7% 0.4% 0.0% 0.202 62.0% 0.3% NA/NR 17.0% 52.447 10.0% 0. 8 Dominican Republic: Blood safety expenditures were not reported.4% 1. 2007 – Dec.3% 23.0% 0.0% 2.0% 10.0% 5.0% 0.0% 0.5% 13. 11 Blood safety spending reported by Russia included expenditures such as equipment upgrades.0% 0.0% 0.0% 0.0% 0.2% 0.0% 0.5% 47.0% 0. 5 The country reported biannual figures for HIV spending.088.0% 0.1% 15.0% 0.0% 0.0% NA/NR NA/NR NA/NR 0.0% 0.0% 96.0% 72.2% 97.6% 44.6% 9.0% 0.0% 0.0% 0.0% 0.0% 0.0% NA/NR 0.0% 0.830 41.0% 17.7% 39.0% 10.2% 2. some of which were not HIV related.0% 100.0% 0.0% 0.0% 0.085 14.0% 1.0% 0.0% 100.4% 0.4% 0.7% 40.586 55.204.0% 0.4% 0.0% 0.0% 0.0% 0.0% 3.0% 0.9% 3.0% 0.0% 100.4% 0.0% 0.0% 0.0% 0.0% 0.0% 0.356 1. 2008).0% 0.0% Western and Central Europe Antigua and Barbuda 2008 and 2009 expenditures for HIV patients’ hospitalization.7% 21.5% 100.0% 0.0% 0.413 916. ARV.0% 0.344 39.0% 0.4% 0.5% 0.0% 0. 2 Brazil sub-national spending at state.0% 0.6% 100.9% 0.0% 0.0% 0. 2004 to 2010 | 2010 GLOBAL REPORT .5% 10.1% 0.0% 0.0% 0.0% 0.0% NA/NR NA/NR NA/NR 0.264 7.760 3.3% 26.0% NA/NR 0.0% 0.7% 0.0% 0.0% 100.

206 NA/NR NA/NR 0.881 0.004 12.027 2.482 NA/NR NA/NR 2.921 34.139 0.089 0.204 10.677 7.200 NA/NR NA/NR NA/NR NA/NR NA/NR 0.523 0.358 NA/NR NA/NR 0.805 25.TOTAL HIV EXPENDITURES ON SELECTED SERVICES (MILLION CURRENT USD DOLLARS) Prevention Orphans and vulnerable Total for care Antiretroviral children therapy and treatment Care and Treatment Programme Support Total for Planning.167 0.646 0.026 NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR 0.615 0.214 0.035 51.933 2.832 1. programme coordination management and and admin.147 0.197 0.063 NA/NR NA/NR NA/NR 9.042 NA/NR 4.136 0.456 2.667 54.321 0.767 500.003 0.726 54.993 1.and testing to child clients for marketing and transmission ioral change MSM and for public and harm reduction commercial for IDUs sector provision NA/NR NA/NR 8.100 0.082 2.048 36.367 NA/NR NA/NR 102.010 0.023 0.231 0.027 0.000 0.289 8.017 0.063 0.261 0.350 NA/NR NA/NR 0.168 0.003 0.629 0.867 21.003 NA/NR NA/NR 0.003 NA/NR 0.812 0.989 13.671 0.287 32.969 1.268 9.784 0.733 2.074 2.918 859.204 13.052 NA/NR NA/NR 0.035 51.493 0.011 NA/NR NA/NR NA/NR NA/NR 79.154 0.447 0.531 7.097 25.148 0.025 0.420 2.023 0.496 114.010 81.148 0.710 2.013 0.313 0.494 4.517 NA/NR NA/NR NA/NR 35.677 0.034 0.749 15.051 0.282 NA/NR NA/NR NA/NR NA/NR 0.013 0.243 9.013 NA/NR NA/NR 0.918 859.005 NA/NR NA/NR NA/NR NA/NR 0.591 36.037 0.146 0.477 0.084 0.000 NA/NR NA/NR 0.000 0.450 65.106.176 51.727 13.372 36.857 NA/NR NA/NR 0.055 0.418 0.726 3.489 0.126 0.153 0.088 0.122 NA/NR NA/NR NA/NR 0.107 1.448 0.378 NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR 0.143 NA/NR NA/NR 6.934 147.245 5.748 0.027 0.108 0.246 NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR 2.154 NA/NR 0.671 NA/NR 0.237 5.211 NA/NR 0.277 0.779 12.168 0.713 NA/NR NA/NR 2.116 0.713 0.185 NA/NR 0.067 500.029 0.645 0.147 0.371 0.309 2.598 0.019 1.016 0.366 8.003 0.833 46.052 0.172 1.858 4.880 4.456 0.449 0.996 0.421 6.021 NA/NR NA/NR NA/NR 0.411 0.319 1.103 0.197 0.857 A2 Annex 2: Country progress indicators and data.409 0.781 0.049 3.649 0.942 0.730 0.746 NA/NR 79.879 0.374 21.000 0.066 NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR 0.567 4.897 0.514 0.216 0.154 NA/NR NA/NR NA/NR NA/NR 15.361 997.430 0.136 2.111 0.030 0.649 NA/NR NA/NR NA/NR 4.661 4.016 0.687 19.003 0.Voluntary Programmes Prevention female tion for social counseling for sex workers of mother and their condom social and behav.185 NA/NR NA/NR 6.670 NA/NR NA/NR NA/NR NA/NR NA/NR 0.349 0.005 NA/NR NA/NR NA/NR NA/NR 0.108 27.070 NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR 0. 2004 to 2010 | 2010 GLOBAL REPORT 239 .244 1.562 15.159 0.488 NA/NR NA/NR 0.075 0.293 NA/NR NA/NR NA/NR NA/NR NA/NR 0.197 2.003 0.565 8.726 54.480 4.370 64.219 2.265 1.272 0.068 NA/NR NA/NR 0.532 40.022 NA/NR NA/NR 0.831 2.054 NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR 0.502 NA/NR NA/NR 2.480 1.234 0.594 2.109 NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR 0.301 NA/NR NA/NR NA/NR NA/NR NA/NR 0.369 0.535 0.344 0.440 0.212 NA/NR NA/NR NA/NR NA/NR 0.027 0.508 4.446 2.107 NA/NR 0.736 1.501 0.012 0.614 NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR 0.388 NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR 1.546 2.969 1.198 NA/NR NA/NR NA/NR 0.881 0.831 5.423 1.426 NA/NR NA/NR 0.459 NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR 0.066 NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR 2.326 0.152 0.614 56.295 0.programme istration management strengthening Monitoring and evaluation Other HIV expenditures Total for prevention Male and Communica.003 0.065 0.145 0.483 2.375 0.478 NA/NR NA/NR NA/NR NA/NR 3.284 0.131 3.711 5.277 0.322 0.869 8.128 2.361 997.935 3.001 NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR 6.025 0.289 NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR 0.384 2.611 4.292 56.531 0.017 NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR 0.246 NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR 0.492 0.670 NA/NR NA/NR NA/NR NA/NR NA/NR 0.963 17.017 0.415 0.024 NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR 0.020 32.045 0.130 55.576 NA/NR NA/NR 2.774 0.122 0.566 NA/NR NA/NR NA/NR NA/NR 0.727 5.077 0.502 3.714 NA/NR NA/NR 3.122 857.000 0.307 0.030 0.124 0.149 0.939 35.960 NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR 9.016 0.070 NA/NR NA/NR NA/NR NA/NR 9.018 0.537 12.553 1.114 0.661 0.031 0.442 2.207 NA/NR NA/NR NA/NR NA/NR 2.189 0.243 0.024 NA/NR NA/NR 0.887 70.713 NA/NR NA/NR NA/NR 10.349 NA/NR NA/NR 0.040 54.580 0.139 NA/NR NA/NR NA/NR NA/NR 2.682 0.009 0.617 0.026 NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR NA/NR 0.

5 = High 240 Annex 2: Country progress indicators and data.Civil society involvemnt in planning A &/ B Afghanistan Albania Algeria Andorra Angola Antigua and Barbuda Argentina Armenia Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bhutan Bolivia Bosnia and Herzegovina Botswana Brazil Brunei Darussalam Bulgaria Burkina Faso Burundi Cambodia Cameroon Canada Cape Verde Central African Republic Chad Chile China Colombia Comoros Congo. 2004 to 2010 | 2010 GLOBAL REPORT HIV testing and counselling for TB patients A|B Risk reduction for men who have sex with men National Composite Policy Index (NCPI) 2010 HIV Prevention Services Implementation Treatment Implementation Risk reduction for sex workers HIV testing and counseling Harm reduciton for IDU Antiretroviral therapy Condom promotion Strategic Plan M & E Plan PMTCT NAC . Republic of the Costa Rica Yes/Agree A|B A B 4 5 3 3 2 4 4 0 4 2 3 2 4 1 4 4 3 4 4 3 4 4 5 4 5 3 3 3 5 0 2 1 4 3 5 A A A|B A|B A|B A|B A|B A|B A|B A|B A|B A|B Paediatric AIDS treatment Laws that protect MARPs/ vulnerable population Laws that pose obstacles UNGASS Indicator 2 2004 NCPI Submission 2006 NCPI Submission 2008 NCPI Submission 2010 NCPI Submission No/Disagree Data not available In progress Not applicable Number SCALE: 0= low.

5 = High HIV testing and counselling for TB patients Risk reduction for men who have sex with men National Composite Policy Index (NCPI) 2010 2004 NCPI Submission 2006 NCPI Submission 2008 NCPI Submission 2010 NCPI Submission HIV Prevention Services Implementation Treatment Implementation Risk reduction for sex workers HIV testing and counseling Paediatric AIDS treatment Laws that protect MARPs/ vulnerable population Laws that pose obstacles Harm reduciton for IDU Antiretroviral therapy Condom promotion Strategic Plan M & E Plan PMTCT NAC A2 Annex 2: Country progress indicators and data.Civil society involvemnt in planning A &/ B Croatia Cuba Cyprus Czech Republic Côte d’Ivoire Democratic People’s Republic of Korea Democratic Republic of Congo Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Fiji Finland France Gabon Gambia Georgia Germany Ghana Greece Grenada Guatemala Guinea Guinea-Bissau Guyana Haiti Honduras Hungary Iceland India Indonesia Iran. Islamic Republic of Yes/Agree A|B A B 4 4 5 4 A A A|B A|B A|B A|B A|B A|B A|B A|B A|B A|B A|B 3 1 4 4 3 5 3 3 5 5 2 4 4 3 4 4 3 5 4 2 3 3 4 4 3 4 3 2 2 1 4 No/Disagree Data not available In progress Not applicable Number SCALE: 0= low. 2004 to 2010 | 2010 GLOBAL REPORT 241 .

Federated States of Moldova Monaco Mongolia Montenegro Morocco Mozambique Yes/Agree A|B A B A A A|B A|B A|B A|B A|B A|B A|B A|B A|B A|B 4 3 3 2 3 3 3 4 3 5 4 2 4 5 5 4 4 4 3 5 4 2 1 4 4 4 5 3 No/Disagree Data not available In progress Not applicable Number SCALE: 0= low.Civil society involvemnt in planning A &/ B Iraq Ireland Israel Italy Jamaica Japan Jordan Kazakhstan Kenya Kiribati Kuwait Kyrgyzstan Lao People’s Democratic Republic Latvia Lebanon Lesotho Liberia Libyan Arab Jamahiriya Liechtenstein Lithuania Luxembourg Macedonia. 2004 to 2010 | 2010 GLOBAL REPORT HIV testing and counselling for TB patients A|B Risk reduction for men who have sex with men National Composite Policy Index (NCPI) 2010 2004 NCPI Submission 2006 NCPI Submission 2008 NCPI Submission 2010 NCPI Submission HIV Prevention Services Implementation Treatment Implementation Risk reduction for sex workers HIV testing and counseling Paediatric AIDS treatment Laws that protect MARPs/ vulnerable population Laws that pose obstacles Harm reduciton for IDU Antiretroviral therapy Condom promotion Strategic Plan M & E Plan PMTCT NAC . FYR Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Mauritania Mauritius Mexico Micronesia. 5 = High 242 Annex 2: Country progress indicators and data.

2004 to 2010 | 2010 GLOBAL REPORT 243 .Civil society involvemnt in planning A &/ B Myanmar Namibia Nauru Nepal Netherlands New Zealand Nicaragua Niger Nigeria Paraguay Peru Philippines Poland Portugal Qatar Republic of Korea Romania Russian Federation Rwanda Saint Kitts and Nevis Saint Lucia Saint Vincent and Grenadines Samoa San Marino Sao Tome and Principe Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Slovakia Slovenia Solomon Islands Somalia South Africa Spain Sri Lanka Sudan Suriname Yes/Agree A|B A B 3 A A A|B A|B A|B A|B A|B A|B A|B A|B A|B A|B A|B 4 5 3 4 4 4 3 3 5 2 3 3 3 5 3 3 3 5 4 5 4 2 3 3 3 4 2 3 2 2 2 No/Disagree Data not available In progress Not applicable Number SCALE: 0= low. 5 = High HIV testing and counselling for TB patients Risk reduction for men who have sex with men National Composite Policy Index (NCPI) 2010 2004 NCPI Submission 2006 NCPI Submission 2008 NCPI Submission 2010 NCPI Submission HIV Prevention Services Implementation Treatment Implementation Risk reduction for sex workers HIV testing and counseling Paediatric AIDS treatment Laws that protect MARPs/ vulnerable population Laws that pose obstacles Harm reduciton for IDU Antiretroviral therapy Condom promotion Strategic Plan M & E Plan PMTCT NAC A2 Annex 2: Country progress indicators and data.

Civil society involvemnt in planning A &/ B Swaziland Sweden Switzerland Syrian Arab Republic Tajikistan Thailand Timor-Leste Norway Oman Pakistan Palau Panama Papua New Guinea Togo Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Tuvalu Uganda Ukraine United Arab Emirates United Kingdom of Great Britain and Northern Ireland United Republic of Tanzania United States of America Uruguay Uzbekistan Vanuatu Venezuela Viet Nam Yemen Zambia Zimbabwe Yes/Agree A|B A B 4 4 4 4 3 3 2 1 3 3 5 4 4 2 3 2 5 5 3 4 2 A A A|B A|B A|B A|B A|B A|B A|B A|B A|B A|B 3 4 5 2 2 3 4 4 No/Disagree Data not available In progress Not applicable Number SCALE: 0= low. 2004 to 2010 | 2010 GLOBAL REPORT HIV testing and counselling for TB patients A|B Risk reduction for men who have sex with men National Composite Policy Index (NCPI) 2010 2004 NCPI Submission 2006 NCPI Submission 2008 NCPI Submission 2010 NCPI Submission HIV Prevention Services Implementation Treatment Implementation Risk reduction for sex workers HIV testing and counseling Paediatric AIDS treatment Laws that protect MARPs/ vulnerable population Laws that pose obstacles Harm reduciton for IDU Antiretroviral therapy Condom promotion Strategic Plan M & E Plan PMTCT NAC . 5 = High 244 Annex 2: Country progress indicators and data.

Republic of the Costa Rica Croatia Cuba Cyprus Czech Republic Democratic Republic of the Congo Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador 39 100 33 100 100 100 100 2 100 100 2 100 100 100 100 99 50 2 88 0 100 52 100 100 26 100 100 100 100 100 100 100 100 100 100 100 100 100 99 69 0 100 100 100 3 100 66 100 100 97 100 61 76 100 100 100 100 100 100 86 100 100 100 2 47 100 75 100 100 100 100 100 100 84 100 100 100 62 100 100 100 100 100 100 55 100 100 A2 100 100 100 100 100 86 100 100 100 UNGASS Indicator 3 Annex 2: Country progress indicators and data.PERCENTAGE OF DONATED BLOOD UNITS SCREENED FOR HIV IN A QUALITY-ASSURED MANNER 20071 Indicator Value 2009 Indicator Value Afghanistan Albania Algeria Angola Antigua and Barbuda Argentina Armenia Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bhutan Bolivia Bosnia and Herzegovina Botswana Brazil Brunei Darussalam Bulgaria Burkina Faso Burundi Côte d’Ivoire Cambodia Cameroon Canada Cape Verde Central African Republic Chad China Colombia Comoros Congo. 2004 to 2010 | 2010 GLOBAL REPORT 245 .

Islamic Republic of Ireland Israel Jamaica Japan Jordan Kazakhstan Kenya Kuwait Kyrgyzstan Lao People’s Democratic Republic Latvia Lebanon Lesotho Lithuania Luxembourg Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Mauritania Mauritius Mexico Micronesia. Federated States of Moldova Monaco Mongolia Montenegro 72 100 74 100 100 100 100 100 100 95 100 100 2 88 100 100 100 100 100 100 2 99 99 100 02 94 100 2 100 100 100 100 91 100 53 100 100 100 46 100 100 100 100 100 100 100 100 0 100 100 0 100 100 100 100 100 100 0 100 100 100 100 75 100 0 100 100 48 100 100 100 100 100 100 100 100 100 100 100 52 100 100 100 100 100 100 100 100 100 100 100 97 100 100 100 100 100 94 70 0 246 Annex 2: Country progress indicators and data.PERCENTAGE OF DONATED BLOOD UNITS SCREENED FOR HIV IN A QUALITY-ASSURED MANNER 20071 Indicator Value 2009 Indicator Value Equatorial Guinea Eritrea Estonia Ethiopia Fiji Finland Gabon Georgia Germany Ghana Greece Grenada Guatemala Guinea Guinea-Bissau Guyana Haiti Honduras Hungary India Indonesia Iran. 2004 to 2010 | 2010 GLOBAL REPORT .

3 Data collection started before 2008. Data provided by WHO Department of Blood Transfusion Safety. 2004 to 2010 | 2010 GLOBAL REPORT 247 .20071 Indicator Value 2009 Indicator Value 20071 Indicator Value 2009 Indicator Value Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands New Zealand Nicaragua Niger Nigeria Norway Oman Pakistan Palau Panama Papua New Guinea Paraguay Peru Philippines Poland Portugal Qatar Republic of Korea Romania Russian Federation Rwanda Saint Kitts and Nevis Saint Lucia Saint Vincent and the Grenadines Samoa Sao Tome and Principe Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Slovakia Slovenia Solomon Islands Somalia South Africa Spain Sri Lanka Sudan Suriname Swaziland Sweden Switzerland Syrian Arab Republic 100 36 100 2 100 100 2 100 90 100 100 100 2 87 100 100 100 95 99 100 2 100 70 76 100 100 39 100 100 100 26 100 100 0 100 100 100 100 88 96 100 100 Tajikistan Thailand Timor-Leste Togo Tonga Trinidad and Tobago Tunisia Turkey Uganda Ukraine United Arab Emirates United Kingdom of Great Britain and Northern Ireland United Republic of Tanzania Uruguay Uzbekistan Vanuatu Venezuela Zambia Zimbabwe 97 99 58 2 85 100 100 100 92 100 100 100 100 100 0 100 100 100 100 100 100 100 100 100 36 100 82 91 100 100 100 100 100 100 2 100 100 100 100 100 100 2 0 78 100 100 100 100 100 100 79 100 100 100 100 100 100 86 49 100 100 100 100 100 79 0 A2 100 100 42 100 100 100 100 100 100 100 0 100 100 100 100 1 0 Report date 2007. 2 Annex 2: Country progress indicators and data. but data collection can vary from 2005-2007.

2008b.c Afghanistan Albania Algeria Angola Argentina Armenia Azerbaijan Bangladesh Belarus Belize Benin Bhutan Bolivia (Plurinational State of) Bosnia and Herzegovina Botswana Brazil Bulgaria Burkina Faso Burundi Cambodia Cameroon Cape Verde Central African Republic Chad Chile China Colombia Comoros Congo Cook Islands Costa Rica Côte d’Ivoire Croatia Cuba Democratic People’s Republic of Korea Democratic Republic of the Congo Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Ethiopia Fiji Gabon Gambia 0 110 1 111 14 139 f 40 240 f 100 159 283 1 249 630 12 078 30 758 f 33 117 045 194 984 f 251 21 103 14 343 31 999 59 960 360 10 551 f 17 900 f 10 904 f 48 254 17 551 f 8 9 400 1 2 886 f 51 820 f 398 3 999 0 24 645 f 816 36 f 11 072 f 3 728 291 7 104 839 4 299 f 132 379 39 7 773 770 498 21 548 f Dec 08 Dec 08 Dec 08 Dec 08 Dec 08 Dec 08 Dec 08 Dec 08 Dec 08 Dec 08 Dec 08 Dec 08 Dec 08 Dec 08 Dec 08 Dec 08 Dec 08 Dec 08 Dec 08 Dec 08 Dec 08 Dec 08 Dec 08 Oct 08 Dec 08 Dec 08 Dec 08 Dec 08 Dec 08 Dec 08 Dec 08 Dec 08 Dec 08 Dec 08 Dec 06 Dec 08 Dec 08 Dec 08 Dec 08 Dec 08 Dec 08 Dec 08 Dec 08 Dec 08 Dec 08 Dec 08 Dec 08 Dec 08 Dec 08 Dec 08 REPORTED MONTH AND NUMBER YEAR OF OF PEOPLE REPORT RECEIVING ANTIRETROVIRAL THERAPY. 2004 to 2010 | 2010 GLOBAL REPORT .c 12 114 1 526 20 640 42 815 179 238 353 1 776 855 15 401 … 1 115 38 145 190 … 327 26 448 17 661 37 315 76 228 611 14 474 32 288 12 762 65 481 16 302 12 7 998 … 3 064 72 011 441 5 034 … 34 967 913 38 13 785 5 538 359 8 348 1 645 4 955 176 632 52 9 976 921 655 30 265 Dec 09 Dec 09 Dec 09 Dec 09 Dec 09 Dec 09 Dec 09 Dec 09 Dec 09 Dec 09 Nov 09 Dec 09 Sep 09 Dec 09 Dec 09 Dec 09 Dec 09 Dec 09 Dec 09 Dec 09 Dec 09 Dec 09 Dec 09 Dec 09 Dec 09 Dec 09 Dec 09 Dec 09 Dec 09 Dec 09 Dec 09 Dec 09 Dec 09 Dec 09 Dec 09 Dec 09 Dec 09 Dec 09 Dec 09 Dec 09 Dec 09 Dec 09 Dec 09 Dec 09 Dec 09 Dec 09 UNGASS Indicator 4 MDG 6b indicator Georgia Ghana 248 Annex 2: Country progress indicators and data. 2008-2009.REPORTED NUMBER OF PEOPLE RECEIVING AND NEEDING ANTIRETROVIRAL THERAPY AND COVERAGE. LOW.AND MIDDLE-INCOME COUNTRIESa REPORTED MONTH AND NUMBER YEAR OF OF PEOPLE REPORT RECEIVING ANTIRETROVIRAL THERAPY. 2009b.

d Estimate Low estimate High estimate ESTIMATED ANTIRETROVIRAL THERAPY COVERAGE BASED ON WHO 2006 GUIDELINES. 2009b. 2009b. 2004 to 2010 | 2010 GLOBAL REPORT 249 . 2009b. 2009b ESTIMATED NUMBER OF PEOPLE NEEDING ANTIRETROVIRAL THERAPY BASED ON WHO 2006 GUIDELINES.e Estimate Low estimate High estimate Estimate Low estimate High estimate ESTIMATED NUMBER OF PEOPLE NEEDING ANTIRETROVIRAL THERAPY BASED ON COUNTRY REPORT.ESTIMATED NUMBER OF PEOPLE NEEDING ANTIRETROVIRAL THERAPY BASED ON WHO 2010 GUIDELINES. 2009d … … … … 6 000 86 000 61 000 <1 000 1 100 1 500 6 000 2 100 29 000 <500 6 000 … 170 000 …g 1 400 58 000 91 000 40 000 270 000 … 74 000 90 000 20 000 …h 95 000 <100 35 000 … 4 500 260 000 <1 000 3 500 <1 000 …h 6 400 … 29 000 19 000 3 300 16 000 6 600 14 000 …h <200 21 000 5 000 1 000 130 000 25 000 14 000 1 600 10 000 4 700 10 000 280 000 <200 16 000 3 100 <1 000 110 000 34 000 26 000 3 000 22 000 8 800 18 000 390 000 <500 26 000 7 300 1 300 150 000 3 100 220 000 <500 2 900 <1 000 170 000 4 700 6 100 300 000 <1 000 4 100 <1 000 240 000 8 200 64 000 73 000 17 000 170 000 79 000 <100 30 000 85 000 110 000 24 000 350 000 120 000 <100 41 000 150 000 220 000 1 100 46 000 79 000 28 000 230 000 190 000 390 000 1 800 71 000 100 000 55 000 310 000 4 500 65 000 42 000 <1 000 <1 000 <1 000 4 700 1 800 24 000 <200 4 700 8 000 110 000 74 000 <1 000 1 400 2 000 7 800 2 500 34 000 <500 7 600 … … 25% 24% 70% 24% 21% 23% 29% 40% 53% 14% 19% … 83% … 23% 46% 19% 94% 28% … 19% 36% 63% … 17% 18% 23% … 68% 28% 80% >95% 0% … 14% … 47% 30% 11% 53% 25% 37% … 30% 47% 18% 65% 24% 41% 21% 12% 38% 19% 28% 45% 23% 38% 13% 51% 21% 55% 40% 22% 84% 35% 49% 62% 40% 61% 30% 91% 28% 14% 11% 21% 20% 50% 24% 62% >95% >95% 32% >95% >95% 17% 30% 53% 19% 14% 13% 19% 23% 44% 76% 38% 21% 24% 27% 77% 50% 18% 37% 17% 68% 25% >95% 89% 30% 58% 22% >95% 33% 19% 19% 58% 20% 16% 17% 23% 34% 45% 10% 15% 34% 32% >95% 29% 29% 39% 37% 47% 64% 29% 24% … … 3 700 59 000 50 000 <500 <1 000 <1 000 3 700 1 500 21 000 <200 3 900 … 140 000 …g <1 000 44 000 65 000 33 000 190 000 … 51 000 61 000 16 000 …h 63 000 <100 25 000 … 3 500 180 000 <500 2 900 <500 …h 4 300 … 22 000 16 000 1 900 13 000 4 300 9 700 …h <200 15 000 3 300 <1 000 85 000 18 000 10 000 1 600 8 100 2 800 7 300 200 000 <100 12 000 2 000 <500 69 000 25 000 22 000 3 000 16 000 6 000 13 000 310 000 <200 19 000 5 000 <1 000 100 000 2 500 150 000 <500 2 400 <500 110 000 3 100 4 800 220 000 <1 000 3 400 <1 000 180 000 5 700 41 000 47 000 12 000 97 000 53 000 <100 20 000 61 000 79 000 19 000 210 000 75 000 <100 30 000 120 000 190 000 <1 000 34 000 53 000 24 000 150 000 150 000 300 000 1 100 55 000 78 000 44 000 220 000 2 700 43 000 37 000 <500 <500 <500 3 000 1 200 17 000 <100 3 100 4 900 79 000 58 000 <1 000 <1 000 1 200 4 500 1 800 26 000 <200 5 000 … … 42% 35% 86% 39% 36% 40% 48% 57% 72% 26% 28% … >95% … 38% 60% 27% >95% 41% … 28% 53% 81% … 26% 29% 33% … 86% 39% >95% >95% 0% … 21% … 64% 36% 19% 66% 39% 51% … 52% 66% 28% >95% 36% 55% 25% 12% 51% 27% 39% 58% 38% 53% 18% 77% 29% 77% 54% 22% >95% 58% 68% 86% 73% 86% 45% >95% 44% 20% 16% 32% 29% 64% 33% 75% >95% >95% 47% >95% >95% 24% 41% 68% 31% 22% 21% 26% 35% 68% >95% 67% 31% 40% 41% 94% 65% 29% 48% 23% 86% 34% >95% 101% 50% 77% 33% >95% 51% 31% 26% 74% 32% 26% 28% 40% 49% 59% 16% 22% 56% 48% >95% 47% 51% 71% 59% 69% 88% 53% 36% … 84 250 … 352 418 740 2 852 1 394 20 396 … 5 050 50 161 706 … … 56 241 57 438 40 483 164 070 … 40 334 66 000 15 520 190 000 22 924 12 … … … 164 000 … 5 034 … 283 055 4 235 13 19 410 13 128 1 500 … 3 108 7 182 336 160 … 14 258 1 500 686 70 988 A2 Annex 2: Country progress indicators and data.d Estimate Low estimate High estimate ESTIMATED ANTIRETROVIRAL THERAPY COVERAGE BASED ON WHO 2010 GUIDELINES.

LOW. 2008-2009.AND MIDDLE-INCOME COUNTRIESa REPORTED MONTH AND NUMBER YEAR OF OF PEOPLE REPORT RECEIVING ANTIRETROVIRAL THERAPY. 2009b. 2008b.c Grenada Guatemala Guinea Guinea-Bissau Guyana Haiti Honduras Hungary India Indonesia Iran (Islamic Republic of) Iraq Jamaica Jordan Kazakhstan Kenya Kiribati Kyrgyzstan Lao People’s Democratic Republic Latvia Lebanon Lesotho Liberia Libyan Arab Jamahiriya Lithuania Madagascar Malawi Malaysia Maldives Mali Marshall Islands Mauritania Mauritius Mexico Micronesia (Federated States of) Mongolia Montenegro Morocco Mozambique Myanmar Namibia Nauru Nepal Nicaragua Niger Nigeria Niue Oman Pakistan Palau 46 f 9 694 9 212 1 832 f 2 473 19 990 f 6 288 559 f 234 581 i 10 606 f 878 4 4 444 f 58 707 250 576 f 6 89 1 009 334 285 f 45 262 2 017 f 1 000 127 162 147 497 f 8 197 2 16 475 f 4 1 072 f 491 f 55 599 f 2f 5 25 2 207 128 330 15 191 59 376 0 1 992 f 744 f 2 846 238 659 0 412 875 f 3 Dec 08 Dec 08 Dec 08 Dec 08 Dec 08 Dec 08 Dec 08 Dec 08 Dec 08 Dec 08 Sep 08 Dec 08 Dec 08 Dec 08 Dec 08 Dec 08 Dec 08 Dec 08 Dec 08 Dec 08 Dec 08 Dec 08 Dec 08 Dec 07 Dec 08 Dec 08 Dec 08 Dec 08 Dec 08 Dec 08 Dec 08 Dec 08 Jan 08 Dec 08 Dec 08 Dec 08 Dec 08 Dec 08 Dec 08 Dec 08 Dec 08 Dec 08 Jul 08 Dec 08 Dec 08 Dec 08 Dec 08 Dec 08 Dec 08 Dec 08 REPORTED MONTH AND NUMBER YEAR OF OF PEOPLE REPORT RECEIVING ANTIRETROVIRAL THERAPY.REPORTED NUMBER OF PEOPLE RECEIVING AND NEEDING ANTIRETROVIRAL THERAPY AND COVERAGE.c 54 10 362 14 999 2 764 2 832 26 007 7 075 547 320 074 i 15 442 1 486 … 7 244 63 1 035 336 980 … 231 1 345 439 354 61 736 2 970 … 145 214 198 846 9 962 3 21 100 4 1 401 652 60 911 5 9 31 2 647 170 198 21 138 70 498 … 3 226 1 063 6 445 302 973 … 486 1 320 3 Dec 09 Dec 09 Dec 09 Jul 09 Dec 09 Dec 09 Dec 09 Dec 09 Dec 09 Dec 09 Mar 10 Dec 09 Dec 09 Dec 09 Dec 09 Dec 09 Dec 09 Dec 09 Dec 09 Mar 10 Dec 09 Dec 09 Dec 09 Sep 09 Jan 10 Dec 09 Dec 09 Dec 09 Dec 09 Dec 09 Dec 09 Dec 09 Jan 10 Dec 09 Dec 09 Dec 09 Dec 09 Dec 09 Dec 09 Dec 09 Dec 09 Dec 09 Dec 09 Nov 09 Jan 10 250 Annex 2: Country progress indicators and data. 2004 to 2010 | 2010 GLOBAL REPORT .

2009b ESTIMATED NUMBER OF PEOPLE NEEDING ANTIRETROVIRAL THERAPY BASED ON WHO 2006 GUIDELINES.d Estimate Low estimate High estimate ESTIMATED ANTIRETROVIRAL THERAPY COVERAGE BASED ON WHO 2006 GUIDELINES.d Estimate Low estimate High estimate ESTIMATED ANTIRETROVIRAL THERAPY COVERAGE BASED ON WHO 2010 GUIDELINES. 2004 to 2010 | 2010 GLOBAL REPORT 251 . 2009b.e Estimate Low estimate High estimate Estimate Low estimate High estimate ESTIMATED NUMBER OF PEOPLE NEEDING ANTIRETROVIRAL THERAPY BASED ON COUNTRY REPORT. 2009d 59 … 24 000 38 000 9 100 2 900 60 000 21 000 2 100 73 000 40 000 … 16 000 … 3 800 710 000 … 1 900 2 000 3 600 1 900 130 000 22 000 … <1 000 10 000 440 000 43 000 <100 42 000 … 5 700 2 900 110 000 … <200 … 9 800 570 000 120 000 93 000 … 31 000 2 600 29 000 … <500 36 000 … <500 27 000 <1 000 48 000 26 000 2 100 26 000 36 000 3 300 31 000 1 700 000 7 500 500 000 98 000 77 000 13 000 650 000 140 000 110 000 <100 <200 4 700 2 200 89 000 6 900 3 800 130 000 <500 8 300 370 000 34 000 <100 34 000 <1 000 12 000 500 000 55 000 <100 51 000 <1 000 1 200 2 700 1 500 110 000 17 000 2 700 2 800 4 600 2 500 140 000 27 000 2 600 610 000 5 400 800 000 12 000 20 000 18 000 30 000 7 300 1 700 49 000 16 000 1 600 50 000 33 000 31 000 46 000 11 000 4 200 71 000 27 000 2 600 1 400 000 110 000 48 000 … 44% 40% 30% >95% 43% 33% 27% 26% 21% 4% … 46% … 27% 48% … 12% 67% 12% 18% 48% 14% … 27% 2% 46% 23% 17% 50% … 25% 22% 54% … 8% … 27% 30% 18% 76% … 11% 40% 22% 21% … >95% 4% … 83% 3% >95% 5% 9% 32% 21% 18% 13% 51% 25% 25% 21% 26% 15% 62% 35% 34% 22% 92% 6% 15% 20% 17% 46% 30% 30% 68% 21% 2% 40% 18% 14% 41% 34% 3% 53% 29% 23% 61% 9% 48% 9% 14% 43% 11% 24% >95% 16% 24% 54% 17% 19% 42% 40% 55% 36% 62% 33% 32% 25% 68% 37% 26% 21% 23% 14% 3% 59% 50% 38% >95% 53% 44% 34% 28% 31% 4% … 16 000 27 000 6 000 2 700 43 000 15 000 1 600 790 000 45 000 23 000 … 11 000 … 2 300 520 000 … 1 000 1 300 2 100 1 200 90 000 15 000 … <500 6 000 310 000 26 000 <100 32 000 … 3 500 1 700 86 000 … <100 … 6 300 380 000 75 000 70 000 … 19 000 1 700 19 000 990 000 … <500 21 000 … <200 16 000 <500 27 000 16 000 1 400 15 000 790 000 23 000 2 200 23 000 1 200 000 4 900 310 000 60 000 56 000 8 100 470 000 89 000 86 000 <100 <100 2 800 1 300 69 000 4 300 2 300 98 000 <500 4 900 260 000 22 000 <100 26 000 <500 7 600 370 000 31 000 <100 40 000 <1 000 <1 000 1 600 <1 000 75 000 11 000 1 600 1 900 2 800 1 600 110 000 19 000 1 600 430 000 3 300 610 000 8 500 13 000 12 000 20 000 4 700 1 700 34 000 12 000 1 200 700 000 26 000 18 000 21 000 35 000 7 600 3 700 52 000 18 000 2 000 890 000 64 000 29 000 … 63% 56% 46% >95% 61% 47% 35% 41% 34% 6% … 67% … 45% 65% … 22% >95% 21% 29% 68% 20% … 42% 4% 63% 38% 28% 65% … 41% 38% 71% … 15% … 42% 45% 28% >95% … 17% 62% 33% 31% … >95% 6% … >95% 5% >95% 8% 14% 49% 28% 25% 21% 79% 42% 38% 33% 36% 24% 82% 54% 55% 35% >95% 10% 31% 33% 28% 62% 51% 51% 88% 32% 3% 53% 32% 22% 53% 52% 4% 77% 44% 36% 81% 15% 71% 16% 22% 58% 15% 46% >95% 28% 37% 83% 27% 31% 55% 66% 79% 55% 85% 48% 43% 36% 76% 50% 38% 28% 36% 24% 5% 84% 74% 59% >95% 76% 61% 44% 46% 58% 8% 14 966 22 500 5 885 3 390 38 491 13 356 … 580 000 40 200 16 540 … 14 000 … 1 900 555 000 … 450 1 461 … 1 171 122 818 10 023 … 274 5 000 305 805 20 977 71 31 410 8 2 790 1 587 74 000 5 53 388 5 266 445 672 74 058 76 727 … 16 950 1 580 16 738 882 139 … 513 13 422 … 1 200 000 1 100 000 A2 1 400 000 1 200 000 Annex 2: Country progress indicators and data.ESTIMATED NUMBER OF PEOPLE NEEDING ANTIRETROVIRAL THERAPY BASED ON WHO 2010 GUIDELINES. 2009b. 2009b.

LOW. 2004 to 2010 | 2010 GLOBAL REPORT .c 4 463 6 751 2 073 14 780 750 4 329 984 7 244 75 900 76 726 … 124 162 … 169 12 249 790 139 3 660 … 4 578 971 556 j 207 3 825 k 996 47 241 99 322 216 118 24 31 16 710 … 412 1 000 … 1 200 413 15 871 199 413 2 510 1 753 2 32 302 37 995 274 283 863 218 589 Dec 09 Sep 09 Dec 09 Dec 09 Dec 09 Dec 09 Dec 09 Dec 09 Dec 09 Dec 09 Dec 09 Feb 10 Dec 09 Dec 09 Dec 09 Dec 09 Oct 09 Dec 09 Dec 09 Jul 09 Dec 09 Dec 09 Dec 09 Sep 09 Dec 09 Dec 09 Dec 09 Dec 09 Dec 09 Dec 09 Dec 09 Dec 09 Dec 09 Dec 09 Dec 09 Dec 09 Dec 09 Dec 09 Dec 09 Dec 09 Dec 09 Dec 09 Dec 09 Dec 09 Dec 08 Dec 08 Dec 08 Dec 08 Dec 08 Dec 08 Dec 08 Dec 08 Dec 08 Dec 08 Dec 08 Dec 08 Dec 08 Dec 08 Dec 08 Dec 08 Dec 08 Feb 09 Dec 08 Dec 08 Dec 08 Dec 08 Dec 08 Dec 08 Dec 08 Dec 08 Dec 08 Dec 08 Sep 08 Dec 08 Dec 08 Dec 08 Dec 08 Dec 08 Dec 08 Dec 08 Dec 08 Sep 08 Dec 08 Dec 08 32 701 252 Annex 2: Country progress indicators and data. 2009b.c Panama Papua New Guinea Paraguay Peru Philippines Poland Republic of Moldova Romania Russian Federation Rwanda Saint Kitts and Nevis Saint Lucia Saint Vincent and the Grenadines Samoa Sao Tome and Principe Senegal Serbia Seychelles Sierra Leone Slovakia Solomon Islands Somalia South Africa Sri Lanka Sudan Suriname Swaziland Syrian Arab Republic Tajikistan Thailand The former Yugoslav Republic of Macedonia Timor-Leste Togo Tonga Tunisia Turkey Turkmenistan Tuvalu Uganda Ukraine United Republic of Tanzania Uruguay Uzbekistan Vanuatu Venezuela (Bolivarian Republic of) Viet Nam Yemen Zambia Zimbabwe 3 972 f 5 195 1 613 10 232 f 532 3 822 682 7 434 54 900 63 149 … 85 f 120 f 8 109 9 252 f 842 113 1 950 f 97 3f 413 730 183 142 f 1 151 k 858 73 f 138 f 185 086 f 23 29 11 211 2 326 f 900 0 1 153 718 10 629 f 154 468 … 1 200 2 27 240 f 25 597 189 219 576 f 148 144 f Dec 08 Dec 08 Dec 08 Dec 08 Dec 08 Dec 08 Dec 08 f REPORTED MONTH AND NUMBER YEAR OF OF PEOPLE REPORT RECEIVING ANTIRETROVIRAL THERAPY. 2008-2009.AND MIDDLE-INCOME COUNTRIESa REPORTED MONTH AND NUMBER YEAR OF OF PEOPLE REPORT RECEIVING ANTIRETROVIRAL THERAPY.REPORTED NUMBER OF PEOPLE RECEIVING AND NEEDING ANTIRETROVIRAL THERAPY AND COVERAGE. 2008b.

e Estimate Low estimate High estimate Estimate Low estimate High estimate ESTIMATED NUMBER OF PEOPLE NEEDING ANTIRETROVIRAL THERAPY BASED ON COUNTRY REPORT.ESTIMATED NUMBER OF PEOPLE NEEDING ANTIRETROVIRAL THERAPY BASED ON WHO 2010 GUIDELINES.d Estimate Low estimate High estimate ESTIMATED ANTIRETROVIRAL THERAPY COVERAGE BASED ON WHO 2010 GUIDELINES. 2009b. 2009d 20 836 9 061 3 066 20 201 919 5 000 2 780 7 244 79 116 104 900 … 134 182 … 1 096 12 000 13 000 5 600 40 000 2 000 20 000 5 800 9 000 …h 88 000 … … … … … 24 000 2 100 … 20 000 <200 … 10 000 1 100 74 000 1 900 80 000 … 3 000 350 000 … … 58 000 … <1 000 1 600 … … 520 000 160 000 660 000 5 100 …g … …g 110 000 … 440 000 640 000 8 200 10 000 4 200 33 000 1 000 14 000 4 800 5 300 320 000 71 000 22 000 16 000 7 400 48 000 2 800 27 000 7 200 13 000 460 000 100 000 37% 52% 37% 37% 37% 22% 17% 81% … 88% … … … … … 21% 42% 28% 31% 27% 16% 14% 55% 16% 74% 54% 65% 49% 44% 75% 31% 20% >95% 24% >95% 8 400 8 800 3 600 26 000 1 300 17 000 3 500 7 700 …h 72 000 … … … … … 6 100 6 500 2 900 22 000 <1 000 12 000 2 900 4 700 180 000 55 000 14 000 11 000 4 500 31 000 1 800 22 000 4 400 10 000 280 000 88 000 53% 77% 57% 57% 60% 26% 28% 95% … >95% … … … … … 32% 59% 46% 47% 42% 19% 22% 71% 27% 87% 73% >95% 70% 67% >95% 35% 34% >95% 42% >95% 20 000 1 600 16 000 <200 7 300 <1 000 60 000 1 400 71 000 2 300 280 000 28 000 2 700 24 000 <500 13 000 2 800 000 1 400 90 000 2 600 88 000 3 900 440 000 51% 38% … 18% 62% … 6% 37% 20% 5% 53% 59% … 11% 61% … … 43% 30% 15% 46% 4% 35% 15% 4% 39% 53% 8% 50% 62% 51% 23% 86% 8% 39% 26% 6% 72% 66% 14% 78% 17 000 1 400 … 13 000 <200 … 6 300 1 700 000 <1 000 46 000 1 300 56 000 … 1 700 290 000 … … 13 000 1 100 9 400 <100 4 200 1 500 000 <500 34 000 1 000 47 000 1 300 230 000 21 000 1 800 16 000 <200 8 700 2 000 000 <1 000 61 000 1 700 65 000 2 300 350 000 72% 55% … 29% 78% … 9% 56% 33% 8% 76% 85% … 19% 76% … … 58% 44% 22% 56% 7% 48% 24% 6% 57% 72% 14% 62% 92% 75% 39% >95% 14% 65% 45% 11% >95% >95% 25% 95% 16 198 950 146 7 277 … 4 5 213 1 630 000 510 45 466 … 52 965 … 579 285 271 442 151 2 600 000 2 500 000 A2 44 000 <1 000 1 200 73 000 1 000 2 100 29% … 53% 62% … … 23% 41% 48% 38% 72% 84% 40 000 … <1 000 1 100 … … 29 000 <500 <1 000 51 000 <1 000 1 500 42% … 79% 90% … … 33% 60% 67% 57% >95% >95% 33 030 … 470 1 400 … 1 430 000 140 000 580 000 4 300 600 000 190 000 750 000 6 100 39% 10% 30% 49% … … … 33% 9% 27% 41% 46% 11% 34% 59% 380 000 99 000 450 000 3 700 …g … …g 300 000 85 000 380 000 3 100 450 000 110 000 550 000 4 400 53% 16% 44% 67% … … … 44% 14% 36% 57% 67% 19% 53% 81% 373 383 33 016 361 295 3 018 2 850 2 161 510 84 000 380 000 580 000 150 000 510 000 720 000 34% … 64% 34% 26% 56% 30% 45% 75% 38% 85 000 … 330 000 450 000 67 000 270 000 390 000 110 000 390 000 520 000 45% … 85% 49% 35% 72% 42% 56% >95% 57% 67 047 3 150 416 533 389 895 Annex 2: Country progress indicators and data. 2004 to 2010 | 2010 GLOBAL REPORT 253 . 2009b.d Estimate Low estimate High estimate ESTIMATED ANTIRETROVIRAL THERAPY COVERAGE BASED ON WHO 2006 GUIDELINES. 2009b ESTIMATED NUMBER OF PEOPLE NEEDING ANTIRETROVIRAL THERAPY BASED ON WHO 2006 GUIDELINES. 2009b.

2005-2008 Andorra Antigua and Barbuda Australia Austria Bahamas Bahrain Barbados Belgium Brunei Darussalam Canada Cyprus Czech Republic Denmark Estonia Finland France Germany Greece Iceland Ireland Israel Italy Japan Kuwait Luxembourg Malta Monaco Netherlands New Zealand Norway Portugal Qatar Republic of Korea San Marino Saudi Arabia Singapore Slovenia Spain Sweden Switzerland Trinidad and Tobago United Arab Emirates United Kingdom United States of America 25 148 9 933 2 250 1 244 … 719 6 928 10 27 000 151 570 3 000 772 450 79 680 36 500 3 746 100 l 1 600 2 876 95 000 48 … 344 65 45 7 919 … 900 12 366 … … … 865 … 157 82 710 2 800 … 3 172 59 39 556 268 000 l Dec 08 Sep 07 Dec 07 <05 Jul 07 Dec 08 Dec 06 Dec 08 Dec 05 Dec 08 Dec 08 Jun 07 Dec 05 Apr 07 Dec 08 Dec 07 Dec 08 Dec 08 Dec 07 Jun 07 Dec 08 Dec 07 Aug 06 Dec 08 Dec 08 Dec 07 <05 Dec 05 Dec 08 Dec 08 Dec 06 Dec 07 Sep 07 Dec 07 Dec 08 Sep 07 MONTH AND REPORTED YEAR OF NUMBER REPORT OF PEOPLE RECEIVING ANTIRETROVIRAL THERAPY. HIGH INCOME COUNTRIESa MONTH AND REPORTED YEAR OF NUMBER REPORT OF PEOPLE RECEIVING ANTIRETROVIRAL THERAPY. 2004 to 2010 | 2010 GLOBAL REPORT . 2009 … 98 … 1 800 1 506 … 804 … 15 … 187 706 3 000 1 263 … … 37 000 … … … … … 94 131 434 100 … … 1 204 … 18 107 70 … … … … … 79 500 4 185 … 2 639 … 39 704 … Dec 09 Dec 09 Dec 09 Dec 09 Dec 09 Jan 09 Jun 09 Mar 09 Dec 09 Dec 09 Dec 09 Jun 09 Dec 09 Oct 09 Oct 09 Dec 09 Jan 10 Dec 09 Sep 09 Dec 09 Dec 09 254 Annex 2: Country progress indicators and data.REPORTED NUMBER OF PEOPLE RECEIVING AND NEEDING ANTIRETROVIRAL THERAPY AND COVERAGE. 2008-2009.

Overall. The main AIDS Disease Management organisation. southern Sudan. f Updated 2008 value. the government reported that 285 074 people were receiving antiretroviral therapy through the public sector sites. The ranges in coverage estimates are based on plausibility bounds in the denominator: that is.xls). j The number collected from public sector health facilities only is 919 923 and was provided by the Department of Health based on routine monitoring data. The majority of these facilities report people currently on treatment.… Data not available or not applicable. reported that they had 51 633 patients on treatment in 2009. and the government estimated that this represents the majority of people on treatment in the private sector. 1829. but only South Africa and India have specified how many of the total number number of people on treatment received it through private facilities. a Countries classified by World Bank income status. as appropriate. 2004 to 2010 | 2010 GLOBAL REPORT 255 . when available. b Antiretroviral therapy data by age and available. h At the request of the country. 1996. i By December 2009.int/entity/hiv/data/tuapr2009_annex1.who. A further estimated 35 000 people were treated in the unorganized private sector – the same figure as in 2008. c Private sector data have been included in the total number of people on treatment. low and high estimates of need. See last year’s annex (http://www. only ranges in the estimates are being presented. k Two separate reports were received for 2009 from Sudan: northern Sudan. e The coverage estimates are based on the estimated unrounded numbers of people receiving antiretroviral therapy and the estimated unrounded need for antiretroviral therapy (based on UNAIDS/WHO methodology). as they may reflect the situation in early 2004 or even 2003. d The needs estimates are based on the methods described in the explanatory notes. g Estimates of the number of people needing antitretroviral therapy are currently being reviewed and will be adjusted. based on ongoing data collection and analysis. The figure of 1151 for 2008 applies to northern Sudan only. an estimated 320 074 people were receiving antiretroviral therapy by the end of 2009. A2 Annex 2: Country progress indicators and data. Aid for AIDS. including those enrolled through private facilities. l ‘<05’ indicates that data exist but no update has been received since December 2004. These data should be interpreted cautiously.

AND MIDDLEINCOME COUNTRIES.PEOPLE RECEIVING ANTIRETROVIRAL THERAPY IN LOW. 2009.AND MIDDLE-INCOME COUNTRIESa REPORTED NUMBER OF MALES AND FEMALES RECEIVING ANTIRETROVIRAL THERAPY Month and year of report Males % of total Females % of total Afghanistan Albania Algeria Angola Argentina Armenia Azerbaijan Bangladesh Belarus Belize Benin Bhutan Bolivia (Plurinational State of) Bosnia and Herzegovina Botswana Brazil Bulgaria Burkina Faso Burundi Cambodia Cameroon Cape Verde Central African Republic Chad Chile China Colombia Comoros Congo Cook Islands Costa Rica Côte d’Ivoire Croatia Cuba Democratic People’s Republic of Korea Democratic Republic of the Congo Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Ethiopia Fiji Gabon Gambia Dec 08 e Dec 08 e Dec 09 Dec 09 d Nov 09 Dec 09 Dec 09 Dec 09 d Dec 09 Dec 09 d Dec 09 Dec 09 Dec 09 Dec 09 Dec 09 Dec 09 Dec 08 Dec 09 Dec 09 d Dec 09 Dec 08 d Dec 09 Dec 09 Dec 09 Dec 09 Dec 09 Dec 09 Dec 08 e Dec 09 Dec 09 Dec 09 d Dec 09 Dec 09 Dec 08 d. 2004 to 2010 | 2010 GLOBAL REPORT . AND ESTIMATED CHILDREN RECEIVING AND NEEDING ANTIRETROVIRAL THERAPY. LOW.e Dec 09 d Dec 08 d Dec 08 d Dec 09 Dec 09 … … 762 2 444 26 791 114 178 … 1 032 444 6 468 14 721 26 56 566 106 769 223 8 609 5 869 17 873 25 196 272 4 321 11 888 10 376 38 350 12 254 6 3 565 … … 21 603 366 4 027 … … 451 10 … … … 4 262 235 2 153 90 527 25 3 492 … 468 10 477 71% 33% 60% 28% 43% 45% 48% 35% 49% 91% 30% 83% 80% 58% 52% 42% 47% 65% 70% 39% 57% 68% 33% 33% 48% 33% 45% 45% 37% 81% 59% 75% 50% 40% 51% 31% 64% 64% 75% … … 739 5 440 15 250 65 60 … 744 411 8 933 16 394 11 88 624 79 867 104 17 839 11 792 19 442 51 032 339 5 229 20 400 2 386 26 659 4 043 6 5 347 … … 50 408 75 1 007 … … 462 1 … … … 2 842 604 2 802 111 693 27 6 484 … 187 20 954 29% 67% 40% 72% 57% 55% 52% 65% 51% 9% 70% 17% 20% 42% 48% 58% 53% 35% 30% 61% 43% 32% 67% 67% 52% 67% 55% 55% 63% 19% 41% 25% 50% 60% 49% 69% 36% 36% 25% UNGASS Indicator 4 MDG 6b indicator Georgia Ghana 256 Annex 2: Country progress indicators and data. AND COVERAGE.

REPORTED NUMBER OF ADULTS AND CHILDREN RECEIVING ANTIRETROVIRAL THERAPY Month and year of report Adults (15+) % of total Children (<15) % of total ESTIMATED NUMBER OF CHILDREN NEED.ESTIMATED ANTIRETROVIRAL THERAPY ING ANTIRETROVIRAL THERAPY BASED COVERAGE AMONG CHILDREN. 2004 to 2010 | 2010 GLOBAL REPORT 257 . ON UNAIDS/WHO METHODS. 2009b DECEMBER 2009c Estimate Low estimate High estimate Estimate Low estimate High estimate Dec 09 Dec 09 Dec 09 Dec 09 Dec 08 e Dec 09 Dec 09 Dec 08 e Dec 09 Dec 09 Dec 09 Dec 08 Dec 09 Dec 09 Jan 09 Dec 08 d Dec 09 Dec 09 Dec 09 Dec 09 Dec 09 e Dec 09 Dec 09 Dec 09 d Dec 08 e Dec 09 Jan 09 Dec 08 e Dec 08 Dec 09 Dec 09 Dec 09 Dec 09 12 99 1 429 19 092 40 041 172 235 277 1 681 775 14 266 29 1 065 37 136 700 178 697 324 25 094 16 065 33 677 73 114 574 13 750 31 514 10 865 63 887 … 11 8 912 1 3 003 67 662 438 5 014 … 100% 87% 94% 93% 95% 96% 99% 98% 95% 91% 93% 97% 96% 97% 94% 96% 99% 95% 91% 90% 96% 94% 95% 98% 98% 98% 92% 95% 100% 98% 94% 99% 100% 0 15 97 1 548 2 000 7 3 6 95 80 1 135 1 50 1 8 490 7 939 3 1 354 1 596 3 638 3 114 37 724 774 186 1 594 … 1 488 0 61 4 349 3 20 … 0% 13% 6% 8% 5% 4% 1% 2% 5% 9% 7% 3% 4% 3% 6% 4% 1% 5% 9% 10% 4% 6% 5% 2% 2% 2% 8% 5% 0% 2% 6% 1% 0% … … … 12 000 … … … … … … 2 700 … … … 9 400 …f … 8 000 14 000 … 28 000 … 7 600 12 000 … … … … 4 000 … … 29 000 … … … <100 14 000 <100 <100 <100 17 000 <500 <1 000 <500 <100 1 100 <500 <1 000 27 000 <100 <1 000 <500 <100 6 700 <200 42 000 <100 <100 <100 46 000 <1 000 2 900 1 000 <500 1 500 1 500 2 400 74 000 <100 2 500 1 300 <100 20 000 3 600 6 600 <500 2 100 1 000 <100 2 000 11 000 19 000 <1 000 7 600 3 400 <100 5 900 8 200 8 200 <100 3 900 8 500 2 800 15 000 11 000 12 000 <100 12 000 20 000 6 100 41 000 <100 6 300 <500 <100 <100 <100 <100 <200 1 500 <100 <200 <500 18 000 <1 000 <100 <200 <200 <200 <500 4 100 <100 <1 000 … … … 13% … … … … … … 41% … … … 90% … … 17% 11% … 11% … 9% 6% … … … … 12% … … 15% … … … … 4% … … … … … 3% 21% … … 17% … … 12% 27% 39% 12% 20% 2% 14% 14% 20% 11% 25% 62% 8% 84% >95% 36% 28% 7% 45% 38% >95% 34% 88% >95% 24% 9% 2% 23% 8% 33% 10% 30% 22% >95% 30% >95% 59% 6% 4% 21% 21% <1% 14% 8% 20% 12% 59% 74% <1% 50% 24% 76% 65% 10% 11% 8% 60% 8% >95% >95% 33% 35% 19% >95% 20% 36% 8% >95% 54% 3% 6% 77% 28% 28% 8% 8% >95% 25% >95% >95% 9% 16% >95% 66% 77% 33% 28% A2 Dec 08 e Dec 09 Dec 09 Dec 08 e Dec 09 Dec 09 Dec 09 Dec 09 Dec 09 Dec 09 Nov 09 Dec 09 Dec 08 e Dec 09 Dec 09 20 470 889 37 10 266 5 131 332 8 048 1 618 4 631 166 640 51 9 701 461 627 28 648 83% 97% 97% 93% 93% 92% 96% 98% 93% 94% 98% 97% 60% 96% 95% 4 053 24 1 782 407 27 300 27 324 9 992 1 275 309 28 1 617 17% 3% 3% 7% 7% 8% 4% 2% 7% 6% 2% 3% 40% 4% 5% …g <1 000 … … … … … <1 000 1 500 …g … 1 600 … … 13 000 Annex 2: Country progress indicators and data.

2009.AND MIDDLE-INCOME COUNTRIESa REPORTED NUMBER OF MALES AND FEMALES RECEIVING ANTIRETROVIRAL THERAPY Month and year of report Males % of total Females % of total Grenada Guatemala Guinea Guinea-Bissau Guyana Haiti Honduras Hungary India Indonesia Iran (Islamic Republic of) Iraq Jamaica Jordan Kazakhstan Kenya Kiribati Kyrgyzstan Lao People’s Democratic Republic Latvia Lebanon Lesotho Liberia Libyan Arab Jamahiriya Lithuania Madagascar Malawi Malaysia Maldives Mali Marshall Islands Mauritania Mauritius Mexico Micronesia (Federated States of) Mongolia Montenegro Morocco Mozambique Myanmar Namibia Nauru Nepal Nicaragua Niger Nigeria Niue Oman Pakistan Palau Panama Dec 09 Dec 09 Dec 09 Dec 09 Dec 08 e Dec 09 Dec 09 Dec 08 d. AND ESTIMATED CHILDREN RECEIVING AND NEEDING ANTIRETROVIRAL THERAPY.AND MIDDLEINCOME COUNTRIES.e Dec 09 Sep 09 d Dec 08 Jul 09 Dec 09 Dec 09 Dec 09 Dec 08 Dec 08 e Dec 09 Dec 09 3 7 596 1 723 … 47 384 2 1 26 1 372 43 159 11 987 26 212 0 1 928 679 2 836 105 122 0 262 944 1 … 100% 36% 25% 52% 78% 40% 11% 84% 52% 37% 57% 37% 60% 64% 44% 35% 64% 72% 33% 0 13 504 3 678 … 13 527 3 8 5 1 275 72 854 9 151 44 365 0 1 298 384 3 609 197 851 0 150 376 2 … 0% 64% 75% 48% 22% 60% 89% 16% 48% 63% 43% 63% 40% 36% 56% 65% 36% 28% 67% 258 Annex 2: Country progress indicators and data.e Dec 09 d Dec 08 e Jan 10 Dec 08 Dec 08 e Jan 10 Sep 09 d. 2004 to 2010 | 2010 GLOBAL REPORT .PEOPLE RECEIVING ANTIRETROVIRAL THERAPY IN LOW. LOW.e Jan 10 Dec 09 Dec 08 e Dec 09 Dec 09 Dec 09 Dec 09 27 5 904 5 850 840 1 113 10 871 3 323 467 168 598 7 934 1 198 4 … 44 691 107 401 … 158 722 240 … 22 471 1 079 … 113 106 … … 53% 57% 39% 30% 45% 42% 47% 84% 59% 75% 81% 100% 76% 67% 36% 68% 54% 72% 36% 24 4 458 9 149 1 924 1 360 15 136 3 752 86 115 036 2 682 288 0 … 14 344 190 429 … 73 623 94 … 39 265 1 891 … 47% 43% 61% 70% 55% 58% 53% 16% 41% 25% 19% 0% 24% 33% 64% 32% 46% 28% 64% 78% 32 108 … … 22% Dec 09 Dec 09 Dec 09 Dec 09 Dec 09 Dec 09 Dec 09 Mar 10 Dec 09 Sep 09 d. AND COVERAGE.

e Dec 08 e Dec 09 e Dec 09 Dec 09 Dec 09 Dec 08 e Dec 09 Dec 09 Dec 09 Dec 09 Dec 09 Dec 09 Dec 09 Mar 10 Dec 09 Dec 09 Dec 09 Sep 09 Dec 08 Jul 09 Dec 09 Dec 09 Dec 09 Dec 08 Dec 09 Dec 09 Dec 09 Dec 09 51 9 594 14 325 2 646 2 308 24 909 6 356 553 302 122 10 260 1 432 4 6 808 56 844 308 610 6 130 1 250 413 … 42 224 2 704 … 143 209 181 482 7 696 3 19 834 4 1 359 … 59 317 5 9 30 2 502 160 805 19 603 62 310 0 3 048 1 007 6 187 284 881 0 460 1 263 3 4 207 94% 93% 96% 96% 93% 96% 90% 99% 94% 97% 96% 100% 94% 97% 82% 92% 100% 56% 93% 94% 93% 91% 99% 98% 91% 94% 100% 94% 100% 97% 97% 100% 100% 97% 95% 94% 93% 88% 94% 95% 96% 94% 95% 96% 100% 94% 3 768 674 118 165 1 098 719 6 17 952 356 54 0 436 2 191 28 370 0 101 95 26 9 3 038 266 … 2 5 17 364 501 0 1 266 0 42 … 1 594 0 0 1 145 9 393 1 535 8 188 0 178 56 258 18 092 0 26 57 0 256 6% 7% 4% 4% 7% 4% 10% 1% 6% 3% 4% 0% 6% 3% 18% 8% 0% 44% 7% 6% 7% 9% 1% 2% 9% 6% 0% 6% 0% 3% 3% 0% 0% 3% 5% 6% 7% 12% 6% 5% 4% 6% 5% 4% 0% 6% … … 4 400 1 100 … 5 700 … … … … … … … … … 89 000 … … … … … 13 000 2 900 … … … 61 000 … … … … … … … … … … … 66 000 … 9 200 … … … … 180 000 … … … … … <500 <500 <100 <1 000 <100 2 300 <1 000 <100 1 800 94 000 2 600 <200 5 900 270 000 <200 36 000 1 900 7 300 <500 93 000 4 900 13 000 <100 <100 <200 <100 1 300 <500 <100 3 200 <100 <500 34 000 <1 000 <100 2 300 <100 <1 000 84 000 <1 000 <100 7 200 <100 <100 <100 <100 7 800 1 400 <100 <500 <100 <200 18 000 4 500 <100 48 000 <200 130 000 <500 <1 000 <1 000 2 100 <1 000 <200 2 700 <1 000 <100 30 000 <1 000 <500 2 500 6 900 1 700 <500 8 600 1 800 <100 76 000 2 600 1 300 … … 15% 10% … 19% … … … … … … … … … 32% … … … … … 23% 9% … … … 29% … … … … … … … … … … … 14% … 89% … … … … 10% … … … … … 79% >95% >95% 2% >95% 8% 7% 34% 4% 7% 23% 79% 15% 19% 29% 10% 32% 65% >95% 26% 83% >95% 0% 0% 50% >95% 9% 28% 20% 1% 21% 88% 0% 18% 67% 2% 51% 94% 0% 55% >95% 36% 34% 9% 17% 6% >95% >95% >95% 28% 39% 19% >95% 22% >95% 59% 52% >95% 31% 10% 7% 73% 13% 40% 29% 24% 14% 4% 77% 32% 21% 92% 41% 81% >95% 59% 48% 14% A2 Annex 2: Country progress indicators and data. ON UNAIDS/WHO METHODS. 2009b DECEMBER 2009c Estimate Low estimate High estimate Estimate Low estimate High estimate Dec 09 Dec 09 Dec 09 Dec 09 Dec 08 e Dec 09 Dec 09 Dec 08 e Dec 09 e Dec 08 e Jan 10 Dec 08 Dec 09 Dec 08 e Jan 10 Dec 09 Dec 08 Jan 10 Dec 09 Dec 09 Dec 07 d.REPORTED NUMBER OF ADULTS AND CHILDREN RECEIVING ANTIRETROVIRAL THERAPY Month and year of report Adults (15+) % of total Children (<15) % of total ESTIMATED NUMBER OF CHILDREN NEED. 2004 to 2010 | 2010 GLOBAL REPORT 259 .ESTIMATED ANTIRETROVIRAL THERAPY ING ANTIRETROVIRAL THERAPY BASED COVERAGE AMONG CHILDREN.

based on ongoing data collection and analysis. AND ESTIMATED CHILDREN RECEIVING AND NEEDING ANTIRETROVIRAL THERAPY. a Countries classified by World Bank income status. b The needs estimates are based on the methods described in the explanatory notes to the annexes. i Breakdowns by sex and age groups were only received for northern Sudan. c The coverage estimates are based on the estimated unrounded numbers of children receiving antiretroviral therapy and the estimated unrounded need for antiretroviral therapy (based on UNAIDS/WHO methodology). only ranges in the estimates are being presented. The ranges in coverage estimates are based on plausibility bounds in the denominator: that is. low and high estimates of need.e Dec 08 Dec 09 Oct 09 d Dec 09 Dec 09 d.AND MIDDLEINCOME COUNTRIES. whereas only ranges are given for countries with a low or concentrated epidemic.h Dec 09 Dec 09 Dec 09 2 936 1 022 10 346 726 3 130 571 3 538 … 29 795 … 59 87 … 62 4 427 598 78 1 542 70 1 … 349 967 120 1 141 … 17 300 66 218 … 43% 69% 70% 97% 72% 58% 49% 39% 48% 54% 37% 36% 76% 56% 37% 72% 25% 35% 58% 57% 37% 67% 68% 3 815 461 4 434 24 1 199 413 3 706 … 46 931 … 65 75 … 107 7 822 192 61 2 680 27 3 … 649 939 87 855 … 29 941 33 104 … 57% 31% 30% 3% 28% 42% 51% 61% 52% 46% 63% 64% 24% 44% 63% 28% 75% 65% 42% 43% 63% 33% 32% … Data not available or not applicable. f The latest available breakdowns are not as recent as the latest reported national-level data.AND MIDDLE-INCOME COUNTRIESa REPORTED NUMBER OF MALES AND FEMALES RECEIVING ANTIRETROVIRAL THERAPY Month and year of report Males % of total Females % of total Papua New Guinea Paraguay Peru Philippines Poland Republic of Moldova Romania Russian Federation Rwanda Saint Kitts and Nevis Saint Lucia Saint Vincent and the Grenadines Samoa Sao Tome and Principe Senegal Serbia Seychelles Sierra Leone Slovakia Solomon Islands Somalia South Africa Sri Lanka Sudan Dec 09 Dec 08 d Dec 09 Dec 09 Dec 09 Dec 09 Dec 09 Dec 09 Dec 09 Dec 09 Dec 09 Dec 09 Dec 09 Dec 09 Nov 08 d. 2004 to 2010 | 2010 GLOBAL REPORT . therefore data should be interpreted cautiously. e The latest available breakdowns refer to partial or cumulative data sets and do not reflect national-level data. AND COVERAGE. Suriname Swaziland Syrian Arab Republic Tajikistan Thailand The former Yugoslav Republic of Macedonia Timor-Leste Togo Tonga Tunisia Turkey Turkmenistan Tuvalu Uganda Ukraine United Republic of Tanzania Uruguay Uzbekistan Vanuatu Venezuela (Bolivarian Republic of) Viet Nam Yemen Zambia Zimbabwe Dec 09 Dec 09 Sep 09 d.e Dec 08 e Dec 09 Dec 08 d Dec 09 Sep 09 d Dec 09 Sep 09 d Dec 09 Dec 09 Dec 09 Dec 09 18 15 5 307 … 262 … … 1 64 604 8 356 70 558 … … 0 23 338 16 854 123 124 189 49 701 75% 48% 32% 64% 6 16 11 403 … 150 … … 25% 52% 68% 36% 100% 37% 53% 36% 0 110 763 7 515 126 854 … … 0% 63% 47% 64% 0% 72% 72% 65% 44% 37% 2 8 964 6 558 66 159 674 85 625 100% 28% 28% 35% 56% 63% 260 Annex 2: Country progress indicators and data. g Estimates of the number of children needing antitretroviral therapy are currently being reviewed and will be adjusted.PEOPLE RECEIVING ANTIRETROVIRAL THERAPY IN LOW. The estimates for individual countries may differ according to the local methods used. h At the request of the country. 2009 LOW. as appropriate. d Point estimates and ranges are given for countries with a generalized epidemic.

h Dec 08 e Dec 09 Dec 09 Dec 09 Sep 09 Dec 09 Dec 09 Dec 09 Dec 08 Dec 09 Dec 07 d.e Dec 09 Sep 08 Dec 09 Dec 08 Dec 06 Dec 07 d.ESTIMATED ANTIRETROVIRAL THERAPY ING ANTIRETROVIRAL THERAPY BASED COVERAGE AMONG CHILDREN. 2009b DECEMBER 2009c Estimate Low estimate High estimate Estimate Low estimate High estimate Dec 09 Dec 08 e Dec 09 Dec 08 e Dec 09 Dec 09 Dec 09 Dec 08 e Dec 09 Dec 09 Dec 09 Dec 08 e Dec 09 Dec 09 Dec 09 Dec 09 Dec 08 Dec 09 Dec 08 e Oct 09 Dec 09 Dec 09 d.e Dec 09 Dec 09 Dec 09 Dec 08 e Dec 09 Feb 10 6 324 1 483 14 263 521 4 192 950 7 052 52 902 70 047 … 121 159 … 104 11 455 779 130 3 423 97 4 404 885 286 196 … 778 42 469 91 313 208 042 23 28 15 682 2 400 … … 1 187 000 14 151 186 591 2 350 … 1 31 518 36 008 265 262 743 197 068 94% 92% 97% 98% 97% 97% 97% 96% 91% 98% 98% 95% 94% 99% 94% 94% 100% 100% 98% 91% 95% 91% 90% 92% 97% 96% 96% 90% 94% 100% 97% 427 130 517 11 137 34 192 1 998 6 679 … 3 3 … 5 794 11 9 237 0 0 9 86 270 11 188 80 4 772 8 9 8 076 1 3 1 028 0 12 9 … 6% 8% 3% 2% 3% 3% 3% 4% 9% 2% 2% 5% 6% 1% 6% 6% 0% 0% 2% 9% 5% 9% 10% 8% 3% 4% 4% 10% 6% 0% 3% 1 700 … … … … … … … 11 000 … … … … … … … … 1 700 … … … 160 000 … 8 700 … 6 800 … … … … … 5 200 … … … … <1 000 <200 <500 <100 <100 <100 <500 3 400 7 000 2 600 <500 1 400 <200 <100 <100 <500 12 000 17 000 26% … … … … … … … 60% … … … … … 17% 49% 36% 8% >95% 45% 52% 17% 40% 49% >95% >95% 30% >95% >95% 71% 60% >95% 1 600 <100 <1 000 <100 <1 000 92 000 <100 4 400 <100 4 400 <100 7 900 4 300 <100 2 600 <100 1 900 210 000 <100 13 000 <200 9 000 <200 11 000 … … … 14% … … … 54% … 2% h … 70% … … … … … 18% 55% 9% 0% 0% 41% 34% 1% 74% 53% 5% 73% 51% >95% 25% 0% 1% 94% 92% 4% >95% >95% 21% >95% 1 800 <100 <100 8 800 <100 <100 20% … … … … … 12% 35% 10% 58% 86% 21% A2 100% 93% 89% 94% 94% 50% 98% 95% 97% 93% 90% 0 13 413 1 720 12 822 160 225 1 784 1 987 9 21 120 21 521 0% 7% 11% 6% 6% 50% 2% 5% 3% 7% 10% … 76 000 … 75 000 … …f … …f … … 59 000 71 000 32 000 43 000 82 000 95 000 1 700 3 700 41 000 1 500 38 000 <100 110 000 2 500 110 000 <200 18% … 17% … … … … … … 36% 30% 12% 69% 11% 81% 33% >95% 34% >95% 54% 26% 23% >95% 65% 50% Annex 2: Country progress indicators and data.REPORTED NUMBER OF ADULTS AND CHILDREN RECEIVING ANTIRETROVIRAL THERAPY Month and year of report Adults (15+) % of total Children (<15) % of total ESTIMATED NUMBER OF CHILDREN NEED. 2004 to 2010 | 2010 GLOBAL REPORT 261 . ON UNAIDS/WHO METHODS.

2004 to 2010 | 2010 GLOBAL REPORT .PERCENTAGE OF ADULTS AND CHILDREN WITH HIV KNOWN TO BE ON TREATMENT 12 MONTHS AFTER INITIATION OF ANTIRETROVIRAL THERAPY1 2005 Males Females Both sexes Total <15 Albania Algeria Angola Antigua and Barbuda Argentina Armenia Austria Azerbaijan Bahamas Bangladesh Barbados Belarus Belize Benin Bolivia Bosnia and Herzegovina Botswana Brazil Brunei Darussalam Bulgaria Burkina Faso Burundi Cambodia Cameroon Cape Verde Central African Republic Chad Chile China Colombia Comoros Costa Rica Côte d’Ivoire Croatia Cuba Cyprus Democratic Republic of the Congo Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Ethiopia Fiji Finland Gabon Gambia Georgia Germany Ghana 85 100 90 86 92 93 94 15+ 93 89 88 UNGASS Indicator 24 Greece 262 Annex 2: Country progress indicators and data.

2004 to 2010 | 2010 GLOBAL REPORT 263 .2007 Males Females Both sexes Total 2009 Males Females Both sexes Total <15 15+ <15 15+ 89 98 59 53 80 57 68 93 74 57 100 43 71 96 77 97 90 84 86 68 95 74 55 2 90 84 86 3 70 95 75 73 97 82 96 86 100 97 97 100 3 85 4 98 67 89 77 77 96 93 85 93 71 82 96 86 85 33 77 77 94 97 100 89 97 73 81 87 96 88 85 91 73 80 88 96 89 85 38 89 84 40 86 100 96 91 60 91 88 96 96 0 82 0 100 85 100 90 97 96 85 76 100 3 91 89 97 96 89 93 100 81 90 91 87 88 77 90 72 83 89 78 87 81 62 73 61 61 78 75 90 94 98 89 79 88 75 30 100 100 98 75 77 77 97 88 77 87 79 77 90 77 91 90 89 78 76 88 79 72 91 99 86 80 91 93 99 99 67 90 99 67 90 83 90 87 92 88 81 47 94 82 100 94 67 86 88 94 97 92 82 90 87 92 88 50 82 100 54 86 100 14 86 100 100 98 100 89 94 89 94 11 A2 66 72 62 70 70 82 78 100 77 100 77 100 77 77 100 83 95 95 74 95 75 90 70 89 90 90 85 93 70 100 50 71 77 95 62 86 80 96 100 95 63 75 78 58 71 79 90 58 92 75 5 78 96 97 98 79 87 83 88 96 93 87 72 8 83 50 82 87 81 83 95 86 81 79 90 100 97 97 Annex 2: Country progress indicators and data.

Federated States of Moldova Mongolia Montenegro Morocco Mozambique Myanmar Namibia Nepal New Zealand Nicaragua Niger Nigeria Oman Pakistan Palau Panama Papua New Guinea Paraguay Peru Philippines 15+ 82 100 83 91 2 98 6 264 Annex 2: Country progress indicators and data.PERCENTAGE OF ADULTS AND CHILDREN WITH HIV KNOWN TO BE ON TREATMENT 12 MONTHS AFTER INITIATION OF ANTIRETROVIRAL THERAPY1 2005 Males Females Both sexes Total <15 Grenada Guatemala Guinea GuineaBissau Guyana Haiti Honduras Hungary India Indonesia Iran. Islamic Republic of Jamaica Japan Jordan Kazakhstan Kenya Kuwait Kyrgyzstan Lao People’s Democratic Republic Lebanon Lesotho Lithuania Luxembourg Madagascar Malawi Malaysia Maldives Mali Marshall Islands Mauritania Mauritius Mexico Micronesia. 2004 to 2010 | 2010 GLOBAL REPORT .

2004 to 2010 | 2010 GLOBAL REPORT 265 .2007 Males Females Both sexes Total 2009 Males Females Both sexes Total <15 83 100 100 15+ 83 88 91 62 56 82 75 81 70 76 99 67 83 79 85 75 81 99 <15 100 90 19 65 65 95 100 15+ 50 82 81 84 73 78 99 60 83 78 7 84 72 79 99 89 65 8 70 78 97 73 75 84 91 99 98 83 99 99 80 78 79 75 78 88 78 88 100 98 69 72 68 70 70 92 99 8 95 73 100 100 80 100 85 97 100 100 0 82 100 95 69 100 66 95 96 75 80 7 100 73 95 100 81 72 61 8 73 68 87 70 90 74 54 57 90 75 71 100 93 79 66 90 73 58 68 90 100 74 58 94 69 87 67 93 83 87 91 100 89 97 100 79 88 89 95 79 100 88 89 95 79 8 87 100 72 50 95 93 88 100 88 100 75 8 91 88 80 91 98 8 67 100 72 72 100 84 90 72 72 100 85 72 100 3 92 85 50 92 94 88 100 82 67 75 20 93 88 87 67 60 87 67 3 60 3 93 97 90 82 69 71 85 98 100 36 92 47 95 47 95 87 100 67 30 85 96 100 56 14 87 96 10 6 95 100 67 44 85 96 100 3 96 61 49 85 96 82 91 91 94 67 95 67 84 95 72 79 67 70 100 88 94 85 94 80 98 90 100 83 89 50 93 100 50 97 85 89 100 85 100 35 93 50 95 93 96 100 88 100 75 91 87 80 90 A2 96 70 83 95 70 83 38 76 91 87 77 82 85 86 90 Annex 2: Country progress indicators and data.

2 Represents cumulative survival. 266 Annex 2: Country progress indicators and data. 8 Reflects greater than 12 months survival. 3 Represents <10 persons alive and still on ART in last 12 months. 2004 to 2010 | 2010 GLOBAL REPORT . 7 Represents 2007.PERCENTAGE OF ADULTS AND CHILDREN WITH HIV KNOWN TO BE ON TREATMENT 12 MONTHS AFTER INITIATION OF ANTIRETROVIRAL THERAPY1 2005 Males Females Both sexes Total <15 Portugal Qatar Romania Russian Federation Rwanda Saint Kitts and Nevis Saint Lucia Saint Vincent and the Grenadines Sao Tome and Principe Senegal Seychelles Sierra Leone Slovakia Solomon Islands Somalia South Africa Sri Lanka Sudan Suriname Swaziland Sweden Switzerland Syrian Arab Republic Tajikistan Thailand The former Yugoslav Republic of Macedonia TimorLeste Togo Trinidad and Tobago Tunisia Turkey Tuvalu Uganda Ukraine United Arab Emirates United Kingdom of Great Britain and Northern Ireland United Republic of Tanzania Uruguay Uzbekistan Venezuela Viet Nam Zambia Zimbabwe 69 75 70 15+ 80 100 72 1 Data values represent 1 cohort with 12 month minimum survival. 6 Represents 8 month survival. unless otherwise noted. 5 Represents 2006. with patients lost to followup and death included in the denominator.

2004 to 2010 | 2010 GLOBAL REPORT 267 .2007 Males Females Both sexes Total 2009 Males Females Both sexes Total <15 15+ <15 15+ 84 100 100 0 100 100 93 79 91 100 100 43 65 79 62 97 80 82 94 43 100 53 100 50 100 98 63 74 98 62 75 89 55 81 94 84 89 100 53 64 80 63 92 55 85 43 90 93 26 65 84 61 85 50 90 90 16 3 24 90 88 65 64 89 57 85 44 90 64 99 89 100 57 85 44 3 90 9 92 23 100 88 73 83 91 76 78 100 100 77 96 54 78 71 100 71 93 100 90 100 58 85 78 98 96 86 57 78 100 93 63 77 99 94 84 93 100 90 100 100 93 100 100 90 100 100 82 83 100 100 100 100 86 88 95 8 100 100 86 88 85 94 84 90 100 72 93 57 62 77 99 100 58 85 8 78 78 95 86 96 8 100 86 85 99 A2 92 84 79 89 89 65 74 84 86 93 87 90 92 81 88 82 88 93 72 77 80 87 81 87 80 84 84 87 81 84 84 75 Annex 2: Country progress indicators and data.

2004 to 2010 | 2010 GLOBAL REPORT .PREVENTING MOTHER-TOCHILD TRANSMISSION OF HIV IN LOW. 2009a Afghanistan Albania Algeria Angola Argentina Armenia Azerbaijan Bangladesh Belarus Belize Benin Bhutan Bolivia (Plurinational State of) Bosnia and Herzegovina Botswana Brazil Bulgaria Burkina Faso Burundi Cambodia Cameroon Cape Verde Central African Republic Chad Chile China Colombia Comoros Congo Cook Islands Costa Rica Côte d’Ivoire Croatia Cuba Democratic People’s Republic of Korea Democratic Republic of the Congo Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Ethiopia Fiji Gabon Gambia Georgia UNGASS Indicator 5 Ghana PERIOD NUMBER OF PREGNANT WOMEN LIVING WITH HIV WHO RECEIVED ANTIRETROVIRALS FOR PREVENTING MOTHER-TO-CHILD TRANSMISSION … … 65 3 053 2 039 13 11 7 194 63 1 703 19 105 1 12 406 5 988 9 2 084 1 837 798 9 092 61 2 157 989 121 1 554 519 1 441 … 31 11 064 2 50 … 2 232 63 2 949 477 11 170 365 464 6 721 5 577 885 12 3 643 Jan 09–Dec 09 Jan 09–Dec 09 Jan 09–Dec 09 Jan 09–Dec 09 Jan 09–Dec 09 Jan 09–Dec 09 Jan 08–Dec 08 Jan 09–Dec 09 Jan 09–Dec 09 Jan 09–Dec 09 Jan 09–Nov 09 Jan 09–Dec 09 Jan 09–Sep 09 Jan 09–Dec 09 Jan 09–Dec 09 Jan 08–Dec 08 Jan 09–Dec 09 Jan 09–Dec 09 Jan 09–Dec 09 Jan 09–Dec 09 Jan 09–Dec 09 Jan 08–Dec 08 Jan 09–Dec 09 Jan 09–Dec 09 Jan 08–Dec 08 Jan 09–Dec 09 Jan 09–Dec 09 Jan 09–Dec 09 Jan 08–Dec 08 Jan 09–Dec 09 Jan 08–Dec 08 Jan 09–Dec 09 Jan 09–Dec 09 Jan 09–Dec 09 Jan 09–Dec 09 Jan 09–Dec 09 Jan 09–Dec 09 Jan 09–Dec 09 Jan 09–Dec 09 Jan 09–Dec 09 Jan 09–Dec 09 Jan 09–Dec 09 Jan 09–Dec 09 Jan 09–Dec 09 Jan 09–Dec 09 Jan 09–Dec 09 268 Annex 2: Country progress indicators and data.AND MIDDLE-INCOME COUNTRIES.

ESTIMATED NUMBER OF PREGNANT WOMEN LIVING WITH HIV NEEDING ANTIRETROVIRALS FOR PREVENTING MOTHER-TO-CHILD TRANSMISSION BASED ON UNAIDS/WHO METHODSb Estimate Low estimate High estimate ESTIMATED PERCENTAGE OF PREGNANT WOMEN LIVING WITH HIV WHO RECEIVED ANTIRETROVIRALS FOR PREVENTING MOTHER-TO-CHILD TRANSMISSIONc Estimate Low estimate High estimate … … … 16 000 … … … … … … 3 700 … … … 13 000 … … 6 500 15 000 … 34 000 … 6 300 16 000 … … … … 3 800 … … 20 000 … … … …d <1 000 … … … … … 1 400 1 400 …d … 1 900 … … 13 000 <1 000 <500 <200 <500 <1 000 <1 000 17 000 <100 <1 000 <1 000 <100 6 900 3 000 <1 000 <500 <1 000 2 300 2 200 51 000 <100 2 900 2 000 <100 20 000 <100 10 000 <100 <100 <100 20 000 <500 <200 31 000 <100 <200 <100 54 000 1 000 3 200 8 300 <500 2 600 <1 000 <100 1 900 9 500 29 000 <1 000 11 000 3 900 <100 5 600 6 900 3 700 <100 3 500 8 400 <1 000 18 000 17 000 12 000 <100 11 000 21 000 3 000 50 000 <200 8 400 <1 000 <100 <100 <100 <100 <200 1 900 <100 <200 <500 25 000 2 400 <100 <500 <200 <500 <500 5 800 <100 <500 … … … 19% … … … … … … 46% … … … >95% … … 32% 12% … 27% … 34% 6% … … … … 12% … … 54% … … … … 10% … … … … … 26% 34% … … 30% … … 27% 32% 48% 3% 19% 16% 21% 13% 28% 20% 43% 19% 18% 95% >95% 10% 71% 50% 71% 40% >95% 60% >95% 86% 53% 4% 6% 11% 21% 17% 36% 15% 39% 53% >95% 67% >95% 23% 3% 15% 14% 13% 10% 8% 67% 12% 55% 59% 55% 33% 23% 74% 49% 23% 19% 9% 26% 18% >95% >95% 82% 60% 22% >95% 50% 14% 12% 86% 65% 5% 4% >95% 22% 29% 95% 22% 59% 36% >95% >95% 17% 13% >95% 61% 92% >95% 83% A2 Annex 2: Country progress indicators and data. 2004 to 2010 | 2010 GLOBAL REPORT 269 .

2004 to 2010 | 2010 GLOBAL REPORT .PREVENTING MOTHER-TOCHILD TRANSMISSION OF HIV IN LOW.AND MIDDLE-INCOME COUNTRIES. 2009a Grenada Guatemala Guinea Guinea-Bissau Guyana Haiti Honduras Hungary India Indonesia Iran (Islamic Republic of) Iraq Jamaica Jordan Kazakhstan Kenya Kiribati Kyrgyzstan Lao People’s Democratic Republic Latvia Lebanon Lesotho Liberia Libyan Arab Jamahiriya Lithuania Madagascar Malawi Malaysia Maldives Mali Marshall Islands Mauritania Mauritius Mexico Micronesia (Federated States of) Mongolia Montenegro Morocco Mozambique Myanmar Namibia Nauru Nepal Nicaragua Niger Nigeria Niue Oman Pakistan Palau PERIOD NUMBER OF PREGNANT WOMEN LIVING WITH HIV WHO RECEIVED ANTIRETROVIRALS FOR PREVENTING MOTHER-TO-CHILD TRANSMISSION 2 440 783 383 183 2 960 255 5 11 319 196 25 0 379 0 193 58 591 0 58 24 56 … 8 846 377 … 12 17 33 156 300 0 1 710 1 68 41 124 … 1 0 90 68 248 2 398 6 744 … 56 91 1 737 44 723 … 9 25 … Jan 09–Dec 09 Jan 09–Dec 09 Jul 08–Jun 09 Jan 09–Dec 09 Jan 09–Dec 09 Jan 09–Dec 09 Jan 09–Dec 09 Jan 09–Dec 09 Jan 09–Dec 09 Jan 09–Dec 09 Jan 09–Dec 09 Apr 08–Mar 09 Jan 09–Dec 09 Jan 09–Dec 09 Jan 09–Dec 09 Jan 09–Dec 09 Jan 09–Dec 09 Jan 09–Dec 09 Oct 08–Sep 09 Jan 09–Dec 09 Jan 09–Dec 09 Jan 09–Dec 09 Jan 09–Dec 09 Jan 09–Dec 09 Jan 09–Dec 09 Jan 09–Dec 09 Jan 09–Dec 09 Jan 09–Dec 09 Jan 09–Dec 09 Jan 09–Dec 09 Jan 09–Dec 09 Jan 09–Dec 09 Jan 09–Dec 09 Jan 08–Dec 08 Mar 08–Feb 09 Jan 08–Dec 08 Jan 09–Dec 09 Jan 09–Dec 09 Jan 09–Dec 09 Jan 09–Dec 09 Jan 08–Dec 08 Jan 09–Dec 09 Jan 09–Dec 09 Jan 09–Dec 09 270 Annex 2: Country progress indicators and data.

ESTIMATED NUMBER OF PREGNANT WOMEN LIVING WITH HIV NEEDING ANTIRETROVIRALS FOR PREVENTING MOTHER-TO-CHILD TRANSMISSION BASED ON UNAIDS/WHO METHODSb Estimate Low estimate High estimate ESTIMATED PERCENTAGE OF PREGNANT WOMEN LIVING WITH HIV WHO RECEIVED ANTIRETROVIRALS FOR PREVENTING MOTHER-TO-CHILD TRANSMISSIONc Estimate Low estimate High estimate … … 4 600 1 600 … 5 000 … … … … … … … … … 81 000 … … … … … 14 000 2 400 … … … 57 000 … … … … … … … <200 <100 1 500 <1 000 <200 4 500 <100 <500 31 000 <100 <100 2 100 <100 1 100 83 000 <1 000 <100 6 700 <100 <200 <100 <100 8 400 1 100 <500 <500 <200 <100 18 000 3 700 <200 41 000 <1 000 120 000 <200 <1 000 <1 000 2 300 <1 000 <100 2 600 <500 <100 23 000 1 100 <500 2 900 7 200 2 400 <500 7 500 1 300 <100 65 000 4 600 1 300 … … 17% 24% … 60% … … … … … … … … … 73% … … … … … 64% 16% … … … 58% … … … … … … … … 12% 33% 3% 37% >95% 9% 92% 1% 40% 55% 0% 26% >95% 5% >95% >95% 0% 82% 48% 10% >95% 33% 23% 5% 52% >95% 20% >95% 38% 50% >95% >95% 46% >95% 15% 11% 16% 88% 39% 20% 14% 17% 4% 2% 56% 34% 49% >95% >95% 82% 63% 48% 17% 7% A2 … … … 97 000 … 7 700 … … … … 210 000 … … … … <100 <200 53 000 1 800 4 100 <1 000 <100 2 300 110 000 <100 1 000 <100 <1 000 130 000 5 600 11 000 2 100 <500 7 000 300 000 <100 3 700 … … … 70% … 88% … … … … 22% … … … … 10% 13% 51% 43% 61% 3% 45% 25% 15% 29% 1% 33% 49% >95% >95% >95% 10% >95% 74% 42% >95% 2% Annex 2: Country progress indicators and data. 2004 to 2010 | 2010 GLOBAL REPORT 271 .

AND MIDDLE-INCOME COUNTRIES. whereas only ranges are given for countries with a low-level or concentrated epidemic. The coverage estimates are based on the numbers of pregnant women living with HIV receiving antiretrovirals and the estimated unrounded need for antiretrovirals (based on UNAIDS/WHO methods).PREVENTING MOTHER-TOCHILD TRANSMISSION OF HIV IN LOW. low and high estimates of need. Point estimates and ranges are given for countries with a generalized epidemic. 2009a Panama Papua New Guinea Paraguay Peru Philippines Poland Republic of Moldova Romania Russian Federation Rwanda Saint Kitts and Nevis Saint Lucia Saint Vincent and the Grenadines Samoa Sao Tome and Principe Senegal Serbia Seychelles Sierra Leone Slovakia Solomon Islands Somalia South Africa Sri Lanka Sudan Suriname Swaziland Syrian Arab Republic Tajikistan Thailand The former Yugoslav Republic of Macedonia Timor-Leste Togo Tonga Tunisia Turkey Turkmenistan Tuvalu Uganda Ukraine a b PERIOD NUMBER OF PREGNANT WOMEN LIVING WITH HIV WHO RECEIVED ANTIRETROVIRALS FOR PREVENTING MOTHER-TO-CHILD TRANSMISSION 118 263 148 550 3 81 109 152 9 380 7 030 1 6 14 … 11 917 2 12 637 2 1 0 188 200 4 245 83 8 182 2 25 5 457 0 1 1 451 … 3 4 … … 46 948 3 645 58 833 70 304 … 233 1 372 13 47 175 28 208 Jan 09–Dec 09 Jan 09–Dec 09 Jan 09–Dec 09 Jan 09–Dec 09 Jan 09–Dec 09 Jan 09–Dec 09 Jan 09–Dec 09 Jan 09–Dec 09 Jan 08–Dec 08 Jan 09–Dec 09 Jan 09–Dec 09 Jan 06–Dec 06 Jan 09–Dec 09 Jan 09–Dec 09 Jan 08–Dec 08 Jan 09–Dec 09 Jan 09–Dec 09 Jan 09–Dec 09 Jan 09–Dec 09 Jan 09–Dec 09 Jan 09–Dec 09 Jan 09–Dec 09 Jan 09–Dec 09 Jan 08–Dec 08 Jan 09–Dec 09 Jan 09–Dec 09 Jan 09–Dec 09 Oct 08–Sep 09 Jan 09–Dec 09 Jan 08–Dec 08 Jan 09–Dec 09 Jan 09–Dec 09 Jan 09–Dec 09 Jan 09–Dec 09 Jan 09–Dec 09 Jan 09–Dec 09 Jan 09–Dec 09 Jan 09–Dec 09 Jan 09–Dec 09 Jan 09–Dec 09 Jan 09–Dec 09 Jan 09–Dec 09 Jan 09–Dec 09 Jan 09–Dec 09 c d Countries classified by World Bank income status. The needs estimates are based on the methods described in the explanatory notes. The ranges in coverage estimates are based on plausibility bounds in the denominator: that is. 2004 to 2010 | 2010 GLOBAL REPORT . The estimates for individual countries may differ according to the local methods used. The data may include double-counting. United Republic of Tanzania Uruguay Uzbekistan Vanuatu Venezuela (Bolivarian Republic of) Viet Nam Yemen Zambia Zimbabwe 272 Annex 2: Country progress indicators and data.

ESTIMATED NUMBER OF PREGNANT WOMEN LIVING WITH HIV NEEDING ANTIRETROVIRALS FOR PREVENTING MOTHER-TO-CHILD TRANSMISSION BASED ON UNAIDS/WHO METHODSb Estimate Low estimate High estimate ESTIMATED PERCENTAGE OF PREGNANT WOMEN LIVING WITH HIV WHO RECEIVED ANTIRETROVIRALS FOR PREVENTING MOTHER-TO-CHILD TRANSMISSIONc Estimate Low estimate High estimate … 2 000 … … … … … … … 11 000 … … … … … … … … 3 300 … … … 210 000 … 14 000 … 9 300 … … … … … 5 600 … … … … … 88 000 … 84 000 … …d … …d … … 68 000 50 000 <200 <1 000 <200 <500 <100 <100 <100 <100 5 100 5 400 <1 000 3 000 <500 1 700 <500 <500 <200 <500 16 000 16 000 … 13% … … … … … … … 65% … … … … … 19% 9% 38% 33% 1% 27% 71% 76% 57% 43% >95% 27% >95% >95% 4% >95% >95% >95% >95% >95% 2 000 <100 1 800 <100 1 000 120 000 <100 7 300 <100 5 700 <100 4 900 5 900 <100 5 100 <100 3 700 290 000 <100 22 000 <200 12 000 <500 8 300 … … … 19% … … … 88% … 2% … 88% … 16% 3% 12% 50% 0% 66% 9% 1% 82% 68% 9% 45% 10% 36% >95% 0% >95% 31% 3% >95% >95% 36% >95% … 66% … 2 200 <100 <100 9 400 <100 <200 26% … … … … … 48 000 1 200 45 000 <100 130 000 4 800 120 000 <500 53% … 70% … … … … 1 700 37 000 28 000 4 700 94 000 69 000 … … 69% 56% 50% 41% >95% >95% 29% 79% 37% 76% 48% 31% >95% >95% >95% >95% 6% 3% 25% 13% 15% 67% A2 Annex 2: Country progress indicators and data. 2004 to 2010 | 2010 GLOBAL REPORT 273 .

AND MIDDLE-INCOME COUNTRIESa Afghanistan Albania Algeria Angola Argentina Armenia Azerbaijan Bangladesh Belarus Belize Benin Bhutan Bolivia (Plurinational State of) Bosnia and Herzegovina Botswana Brazil Bulgaria Burkina Faso Burundi Cambodia Cameroon Cape Verde Central African Republic Chad Chile China Colombia Comoros Congo Cook Islands Costa Rica Côte d’Ivoire Croatia Cuba Democratic People’s Republic of Korea Democratic Republic of the Congo Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Ethiopia Fiji Gabon Supplemental data received obtained by World Health Organization through the monitoring of progress towards Universal Access in the Health Sector Gambia Georgia Ghana PREGNANT WOMEN TESTED FOR HIV Reported number Estimated coverage … … … 203 463 598 123d 40 679 172 153d 91 150 186e 6 310 171 532f … 73 369 1 012 44 386h 2 381 280d … 310 583 113 053 153 884 291 473 8 500 43 775 32 119 144 772 3 741 337k 353 764 1 034 28 699 … … 342 698 … 122 611e … 253 297 9 371 947 114 046 286 211e 1 750g 65 712 16 228 46 544d 488 554 9 041d 9 321 31 071 58 769d 388 254 9% 39% … 51% >95% <1% 53% 63% 25% 16% 52% 23% 50% >95% 51% >95% 47% 42% 40% 42% 41% 71% 28% 6% 57% 20% 39% 5% 23% 28% 3% 93% 79% 26% 87% 86% >95% <1% >95% 85% 49% 274 Annex 2: Country progress indicators and data. 2004 to 2010 | 2010 GLOBAL REPORT .MATERNAL AND INFANT HIV TESTING AND INFANT PROPHYLAXIS IN LOW.

38 6 696 … 0 .....INFANTS BORN TO WOMEN LIVING WITH HIV RECEIVING ANTIRETROVIRALS FOR PREVENTING MOTHER-TOCHILD TRANSMISSION Reported number Estimated coverage INFANTS BORN TO WOMEN LIVING WITH HIV RECEIVING CO-TRIMOXAZOLE PROPHYLAXIS WITHIN TWO MONTHS OF BIRTH Reported number Estimated coverage INFANTS BORN TO WOMEN LIVING WITH HIV RECEIVING A VIROLOGICAL TEST BY TWO MONTHS OF AGE Reported number Estimated coverage ... 1 701 248 1 615 . … … 2 435 2 280d 9 14d 12 195 51 1 473 13d 28g 0 14 073i 7 511d … 2 140 1 332 730 8 378 67 1 380 676 .... 2004 to 2010 | 2010 GLOBAL REPORT 275 . … … 15% >95% 75% 11% 12% >95% 26% 39% >95% 10% … >95% >95% 33% 9% 45% 25% … 22% 4% 28% 12% 17% 16% 33% 33% 0% 2 435 2 160d 2 13d 16 148 … 1 473 7d 27d 0 8 232j … … 1 815 1 332 203g 8 378 67 887 676 … … … 1 548 … 44 … … 1g … 6% 6% … 59% 56% 1% 42% 11% 31% 15% 10% 16% 20% 58% 13% 396 22 1 … … … 176 … 225d 1 076 2d 219d 99 19d … 17% 3% 20% 12% 8% 58% 34% 1% 4% … 1% 38% 17% 15% 28% 9% 12% 25% … 14% 4% 39% 58% 10% … 65% 15% >95% 17% 10% 16% >95% … … … … … 0 15d … 192 53 … … 23d 0 … 2 306d … 199 … … 8 940 67 40 … … … 83 0 444 … 44 … … 50 … … … 1 391d 5 5g … … … 1 375 1d … … 19d … 58% 4% 10% … 20% 1% 3% 67% 38% 4% 0% 12% 26% … 1% 3% 32% 8% … >95% 27% 0% 12% A2 Annex 2: Country progress indicators and data. 2 232 36d 1 1 133 315 2g 216 164 424d 5 025 1d 312 230 19d 1 730 m ..

MATERNAL AND INFANT HIV TESTING AND INFANT PROPHYLAXIS IN LOW.AND MIDDLE-INCOME COUNTRIESa Grenada Guatemala Guinea Guinea-Bissau Guyana Haiti Honduras Hungary India Indonesia Iran (Islamic Republic of) Iraq Jamaica Jordan Kazakhstan Kenya Kiribati Kyrgyzstan Lao People’s Democratic Republic Latvia Lebanon Lesotho Liberia Libyan Arab Jamahiriya Lithuania Madagascar Malawi Malaysia Maldives Mali Marshall Islands Mauritania Mauritius Mexico Micronesia (Federated States of) Mongolia Montenegro Morocco Mozambique Myanmar Namibia Nauru Nepal Nicaragua Niger Nigeria Niue Oman Pakistan Palau Panama PREGNANT WOMEN TESTED FOR HIV Reported number Estimated coverage 1 229 102 957 39 893 13 864o 14 283e 154 835 103 562 8 357d 5 717 819 10 026 158q 1 550d 28 659d 0 434 548e 961 990 1 159 171 480e 3 094 20 608 … 29 626 32 659 … 30 057 140 261 316 000 403 287s 3 911 86 814 … 6 371d 15 026 757 863d … … … 2 723d 672 020 182 760 51 970 … 65 791 81 686 158 695 820 865 … 30 875 10 277 … 59 334 60% 23% 10% 21% >95% 57% 51% 8% 21% <1% <1% <1% 55% 0% >95% 63% … >95% 2% 88% 50% 22% 95% 20% 52% 73% 67% 16% 6% 83% 37% <1% 77% 18% 88% 9% 58% 19% 13% 50% <1% 85% 276 Annex 2: Country progress indicators and data. 2004 to 2010 | 2010 GLOBAL REPORT .

89 81 708 15 905 ... 1 1g 20d 41 266 1 697 7 120 . 12 8 23 773 163 0 810 ..u 17% 5% 23% 1 … 4d … … … … 17% 1% 6% 63% 6% 2% 21% 0% 23% 10 81 … 6 101r … 4 15 … … 1% 63% 3% 21% 1% Annex 2: Country progress indicators and data. 2004 to 2010 | 2010 GLOBAL REPORT 277 .INFANTS BORN TO WOMEN LIVING WITH HIV RECEIVING ANTIRETROVIRALS FOR PREVENTING MOTHER-TOCHILD TRANSMISSION Reported number Estimated coverage INFANTS BORN TO WOMEN LIVING WITH HIV RECEIVING CO-TRIMOXAZOLE PROPHYLAXIS WITHIN TWO MONTHS OF BIRTH Reported number Estimated coverage INFANTS BORN TO WOMEN LIVING WITH HIV RECEIVING A VIROLOGICAL TEST BY TWO MONTHS OF AGE Reported number Estimated coverage 2 159d 231n 143d 206 … 255 5 11 593 165d 24d 0d 605d 0 198 39 482 0 60 18d … 0 4 240 194 ... 15d 53 58d . 154d..u … 9% 5% 9% >95% 35% 26% 27% 6% 3% … >95% … 68% 49% … 51% 7% 0% 31% 8% >95% 1% 41% 54% 0% 19% 4% 73% 2% 2 222d 801n … 97p 448d … 5 … 25g 20d 0d … 0 204 4 043 0 70 17d 52 … 1 542d 45r … … … 28 079 163 0 722 … 18g 48 … … … 13% 17% >95% 9% 26% 1% 3% … … 70% 5% … 59% 7% 84% 11% 2% 0 … … 0 … … 309 … … … 7d … … 0 188 … 0 0 … … … 4 621 109r … 10 … … 0% 42% 1% … 64% … 0% 33% 5% >95% 49% 54% 0% 17% 5% 66% … 163 0 531 … … … … … 54% 0% 13% A2 17% … 5% 43% 46% 93% 7% 63% 15% 8% 21% 1% 56% 1 … 19d … 858 … … 75 81 309 3 927t … 4 0 … 62d....... 4 16 .

† … 480 814‡ 4 211 532 484e 175 223 21% 47% >95% >95% 47% 95% 71% >95% >95% 35% 5% … 44% <1% <1% >95% 4% 3% 91% 73% <1% 39% 82% <1% 20% 64% >95% 66% 95% 74% 21% 32% <1% >95% 46% 278 Annex 2: Country progress indicators and data.MATERNAL AND INFANT HIV TESTING AND INFANT PROPHYLAXIS IN LOW. 2004 to 2010 | 2010 GLOBAL REPORT .w 294 457 … … 2 635e … 6 475e 166 830 5 665d 1 650 99 256 … 41d 1 131 1 099 712e 13 475 33 127x 8 885d 25 769 4g 76 297 797 047 … 71d 42 101 … … … … … 968 157* 555 535e 1 194 172 47 428d 414 346*** 1 499d.AND MIDDLE-INCOME COUNTRIESa Papua New Guinea Paraguay Peru Philippines Poland Republic of Moldova Romania Russian Federation Rwanda Saint Kitts and Nevis Saint Lucia Saint Vincent and the Grenadines Samoa Sao Tome and Principe Senegal Serbia Seychelles Sierra Leone Slovakia Solomon Islands Somalia South Africa Sri Lanka Sudan Suriname Swaziland Syrian Arab Republic Tajikistan Thailand The former Yugoslav Republic of Macedonia Timor-Leste Togo Tonga Tunisia Turkey Turkmenistan Tuvalu Uganda Ukraine United Republic of Tanzania Uruguay Uzbekistan Vanuatu Venezuela (Bolivarian Republic of) Viet Nam Yemen Zambia Zimbabwe PREGNANT WOMEN TESTED FOR HIV Reported number Estimated coverage 43 942 73 123 599 012e …v … 45 557e 100 589 1 468 091d.

..... ..... 19 5 722 … 1d 1 508 . 24 554 3 840 43 119 … 399 0d 274 1 511 10 26 743 17 331 13% 62% 43% 1% 41% >95% >95% >95% 62% 19 85 … 3 69 33 7 … 7 222 … … 1% 36% 2% 41% 37% 6% 67% … … … 2 69 112 192 … 5 646 … … 52% 1% 41% >95% >95% … … 11% 2% … 16% … 0% 56% 15% <1% >95% 82% 12% 88% 14 … 17 … 0 7 363d … 0d 0 43 394 4 34z … 9 189 … 23 2 074 … … … 0% … 11% 14 … … 339 1 0 0d … … … 9% 2% … 0% 0% 20% 15% <1% >95% 15% 32% … … 0 … 9 … … 1g … … … 1% 16% 0% … 27% 4% … 945 … 0 … … … 0% 17% 614 … 0 … … … 5 607 11% 0% A2 28% >95% 51% … … … 48% … 39% 35% … 3 021 8 348** … … … … 944 8 25 139 13 852 30% … 37% 28% >95% 10% 6% 69% 13% … 2 033 11 345 … 2 … … … 0 35 824 … … 53% Annex 2: Country progress indicators and data... 1 … … .. 15 .INFANTS BORN TO WOMEN LIVING WITH HIV RECEIVING ANTIRETROVIRALS FOR PREVENTING MOTHER-TOCHILD TRANSMISSION Reported number Estimated coverage INFANTS BORN TO WOMEN LIVING WITH HIV RECEIVING CO-TRIMOXAZOLE PROPHYLAXIS WITHIN TWO MONTHS OF BIRTH Reported number Estimated coverage INFANTS BORN TO WOMEN LIVING WITH HIV RECEIVING A VIROLOGICAL TEST BY TWO MONTHS OF AGE Reported number Estimated coverage 251 148 426 2 69 118 192 8 744d 6 684 . 17 433 1 7 518d … 1d 6 119 395d 4 56y 91d 7 655 . 2004 to 2010 | 2010 GLOBAL REPORT 279 .

AND MIDDLE-INCOME COUNTRIESa a b c d e f g h i j k l m n o p q r s t u v w x y z * ** *** † ‡ Countries classified by World Bank income status. some infants may be lost to follow up. The reported number of pregnant women tested for HIV was higher than the estimated number of pregnant women. southern Sudan reported “no data” stating that services have just been initiated and co-trimoxazole was initially not part of the supplies for PMTCT. there was a substantial increase in the number of pregnant women tested for HIV. Lolowai Hospital and Norsup Hospital. The latest reported data are to December 2007. giving a total of 56. A data value of 26 was reported. Now all pregnant women are now recommended for VCT. Now only the new regimen is used and is still being scaled up. Vila Central Hospital. The latest data reported are to August 2007. 2004 to 2010 | 2010 GLOBAL REPORT . No reference l. Data are collected on a monthly data reporting form at 6 weeks. The data are reported for the period July 2008-July 2009. Russian Federation reported 4 827 215 pregnant women being tested for HIV. The data may include double-counting. Only partial data were collected. not at 2 months. Data are collected from 453 priority counties out of a total of 2860. Data for southern Sudan are expected to be ready in next reporting period. Two separate reports were received from Sudan: Northern Sudan reported 19 986 for the period between January-December 2009. Two separate reports were received from Sudan: Northern Sudan reported 34 for the period between January-December 2009. 95% of the estimated number of births in Russia (1 545 359) was used as a proxy and most likely represents the total number of tests conducted among pregnant women. which represent about 70% of total ANC cases. Only public data were reported. Four out of ten Implementing partners reported for this indicator. The data are from three of four paediatric care clinics. Leneakel Hospital. The data cannot specify whether data reported were for infants within two months of birth. coverage was already >95% in these countries. Data are based on the number of pregnant women having access to antenatal clinics/maternity hospitals who know their HIV status. data are adjusted. Number of tests were reported. This is due to the transition from the old regimen of single-dose nevirapine to the new regimen of single-dose nevirapine at birth and Zidovudine and Lamivudine for 1 or 6 weeks as relevant. Data may be under-reported. southern Sudan reported 13 141 to November 2009. Data suggest that around two-thirds of infants who started cotrimoxazole. The data value was from one site only and for the period September-November 2009. thus in the regional and global analysis. only those pregnant women with risky behaviour or those who had sexual partners with risky behaviour were recommended for VCT. up from the last reported value of 58 063 in 2007. Data are based on total number tested and received results. Data are from 323 out of 364 maternity hospitals with PMTCT services. No reference c. only 77% of pregnant women were reached through VCT by the end of 2009. The latest reported data are to December 2008. labour/delivery and postpartum cannot be deduplicated. No reference b. Data reported in 2009 is lower than reported value of 2 450 in 2008.MATERNAL AND INFANT HIV TESTING AND INFANT PROPHYLAXIS IN LOW. In 2009. Last year. however. which were both still used in 2008. as tests for women who tested more than once at ANC. As the number of pregnant women tested likely reflects double or triple counting. giving a total of 33 127. Two separate reports were received from Sudan: Northern Sudan reported 34 for the period between January-December 2009. but the policy is for all infants to start co-trimoxazole at 6 weeks of age. Data are under-reported. 280 Annex 2: Country progress indicators and data. southern Sudan reported 22 to November 2009. Data were collected from Northern District Hospital. started within two months of birth. implying a coverage of >100%. Previously. Therefore.

PERCENTAGE OF ESTIMATED HIV-POSITIVE INCIDENT TB CASES THAT RECEIVED TREATMENT FOR TB AND HIV TREATMENT FOR TB AND HIV 2007 2009 Adults treated Afghanistan Albania Algeria Angola Argentina Armenia Austria Azerbaijan Bahamas Barbados Belarus Belize Benin Bolivia Bosnia and Herzegovina Brazil Brunei Darussalam Bulgaria Burkina Faso Burundi Cote d’Ivoire Cambodia Cameroon Cape Verde Central African Republic Chad China Colombia Comoros Costa Rica Croatia Cuba Czech Republic Democratic Republic of the Congo Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Ethiopia Fiji Finland Gabon Georgia Ghana Grenada Guatemala Guinea 0 109 245 2658 2 0 521 34 63 1 322 150 162 13 3 46 901 3 3671 994 32 199 3 26 2 136 9 157 60 415 15 82 2 % of patients treated <1 87 1 55 59 1 4 81 100 72 69 31 41 Adults treated 4 4 111 359 250 6 12 62 15 138 629 94 25 3333 1 % of patients treated 1 99 20 83 100 53 100 73 16 51 25 26 5 50 4 3 31 5 3 61 36 70 45 0 100 97 60 5 23 67 42 2 50 11 5 41 90 2 23 503 594 1633 526 117 1 10 3 15 13 61 414 7560 343 0 100 100 90 36 31 3 A2 <1 100 115 1 40 724 170 2 260 3 100 13 40 13 71 2 37 205 4515 0 366 76 531 1 342 335 171 33 67 100 11 6 10 33 61 UNGASS Indicator 6 Guinea-Bissau Annex 2: Country progress indicators and data. 2004 to 2010 | 2010 GLOBAL REPORT 281 .

Islamic Republic of Jamaica Japan Jordan Kazakhstan Kenya Kuwait Kyrgyzstan Lao People’s Democratic Republic Latvia Lebanon Lesotho Liberia Lithuania Malawi Malaysia Malta Marshall Islands Mauritania Mauritius Mexico Moldova Morocco Mozambique Myanmar Nepal New Zealand Nicaragua Niger Nigeria Oman Panama Papua New Guinea Paraguay Peru Philippines Poland Portugal Qatar Russian Federation Rwanda Saint Kitts and Nevis Saint Lucia Saint Vincent and the Grenadines Sao Tome and Principe 2 2 4 0 463 270 320 20 93 99 70 13 197 28 625 321 95 3 806 23 88 1008 5 18 910 72 27 3 52 18 10 0 76 61 383 7 19 400 % of patients treated Adults treated 75 % of patients treated 94 24 33 100 4 3 32 94 43 23 0 52 5 71 <1 3 23 2409 203 1 2693 2976 20 72 83 33 120 16 0 103 14116 0 177 85 57 148 1 8 2235 926 13 27 38 16 30 100 100 6 100 77 39 22 10 11 5 100 77 3 69 100 35 20 71 80 38 70 33 5 4929 390 6 2 86 1. 4 100 50 100 2 100 40 9 100 27 77 6679 1148 1 3 10 282 Annex 2: Country progress indicators and data. 4 16 78 10 73 41 46 1 55 7 216 63 103 5622 959 8 14 1 56 5 35 14 11 49 176 1 40 271 18 788 3 171 127 72 529 309 0 39 1.PERCENTAGE OF ESTIMATED HIV-POSITIVE INCIDENT TB CASES THAT RECEIVED TREATMENT FOR TB AND HIV TREATMENT FOR TB AND HIV 2007 2009 Adults treated Guyana Haiti Honduras Hungary India Indonesia Iran. 2004 to 2010 | 2010 GLOBAL REPORT .

thus indicator for 2007 assumes cases evenly spread over each year. 2004 to 2010 | 2010 GLOBAL REPORT 283 . 3 Denominator is the total number of TB cases reported in 2007. data reported from 4 geographical regions only – Ulyanovskaya oblast. and Altayskiy kray 5 Data collection started before 2008.PERCENTAGE OF ESTIMATED HIV-POSITIVE INCIDENT TB CASES THAT RECEIVED TREATMENT FOR TB AND HIV TREATMENT FOR TB AND HIV 2007 2009 Adults treated Senegal Seychelles Slovakia Slovenia Somalia South Africa Sri Lanka Sudan Suriname Sweden Syrian Arab Republic Tajikistan Thailand The former Yugoslav Republic of Macedonia Togo Trinidad and Tobago Tunisia Turkey Uganda Ukraine United Kingdom of Great Britain and Northern Ireland United Republic of Tanzania Uruguay Venezuela Viet Nam Yemen Zambia 21103 390 188 20 411 47 6 2260 2 44 0 14 159 382 319 11 % of patients treated 15 100 2 Adults treated 259 2 0 % of patients treated 6 100 0 3 42 10 8 60 100 14 26 2 50 3 59 42 576 3 823 15 57 0 8 23 1 2 52 4151 21 94 6 11 4 6 55 60 21 2 18 062 15 740 310 12 25 15 35 5918 18 81 1818 25 6951 100 30 18 22 28 41 A2 1 Estimate of denominator provided by WHO (Global Tuberculosis Control Report 2008). Tverskaya oblast. For Russian Federation. Annex 2: Country progress indicators and data. 4 For Mauritania. data available for 2 year period only. Saratovskaya oblast. 2 No denominator is available.

2004 to 2010 | 2010 GLOBAL REPORT . Hong Kong SAR China. Macao SAR Colombia Comoros Congo Cook Islands Costa Rica Côte d’Ivoire Cuba Democratic People’s Republic of Korea Democratic Republic of the Congo Djibouti Dominica Ecuador Egypt Supplemental data obtained by the World Health Organization through annual reporting of national tuberculosis programmes El Salvador Equatorial Guinea Estonia 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 1175 211 4 0 2023 4 131 521 297 46 256 662 2 89 3845 1105 5 6 0 0 306 0 115 17 15 15 9 36 0 190 17 629 38 8 17 6 0 35 0 8 4 0 0 42 0 5 6 0 0 29 0 6 9 1 36 0 17 93 51 0 0 3 0 0 1 167 0 0 57 0 29 6128 39 744 4817 2857 28 246 18 677 282 3749 0 63 227 3993 336 5031 117 205 0 476 17 253 687 4036 8668 981 1305 3597 7494 57 1230 0 2511 40 1 1018 0 99 0 41 5207 3 1467 959 617 1081 0 1467 7935 503 423 526 0 15 9112 8668 768 18 677 11732 617 66 0 0 808 0 2176 9 0 0 99 0 3674 0 427 0 1072 11 0 237 0 99 0 1633 3 0 41 88 1249 1 606 17 0 0 0 78 1 0 0 0 1561 2009 0 0 0 0 0 0 2009 2009 2009 2009 2009 2009 2009 2009 20 630 1819 4 2262 3204 1650 720 380 4173 197 1 443 11 204 121 39 1435 0 0 11 58 0 0 656 152 1 443 11 71 0 21 5161 12 89 67 0 2 1 97 0 284 Annex 2: Country progress indicators and data.TREATMENT AND HIV TESTING OF TB PATIENTS Survey Year TB patients TB patients (new and (new and re-treatment) re-treatment) with an HIV recorded as HIV-positive test result recorded in the TB register HIV-positive HIV-positive TB patients TB patients started or started or continued on continued on co-trimoxazole antiretroviral therapy (ART) preventive therapy (CPT) People registered as HIV-positive screened for TB at least once during year People registered as HIV-positive given isoniazid prophylaxis (treatment of latent TB infection) Afghanistan Albania American Samoa Andorra Angola Antigua and Barbuda Argentina Armenia Australia Bahamas Bahrain Bangladesh Barbados Belarus Belize Benin Bolivia (Plurinational State of) Bosnia and Herzegovina Botswana Brazil Burkina Faso Burundi Cambodia Cameroon Cape Verde Central African Republic Chad China China.

TREATMENT AND HIV TESTING OF TB PATIENTS Survey Year TB patients TB patients (new and (new and re-treatment) re-treatment) with an HIV recorded as HIV-positive test result recorded in the TB register HIV-positive HIV-positive TB patients TB patients started or started or continued on continued on co-trimoxazole antiretroviral therapy (ART) preventive therapy (CPT) People registered as HIV-positive screened for TB at least once during year People registered as HIV-positive given isoniazid prophylaxis (treatment of latent TB infection) Ethiopia Fiji French Polynesia Gabon Gambia Ghana Grenada Guam Guatemala Guinea Guyana Honduras India Indonesia Iran (Islamic Republic of) Iraq Israel Jamaica Jordan Kenya Kiribati Kuwait Kyrgyzstan Lao People’s Democratic Republic Latvia Lebanon Lesotho Liberia Libyan Arab Jamahiriya Lithuania Malawi Malaysia Mali Malta Marshall Islands Mauritania Mauritius Mexico Micronesia (Federated States of) Monaco Mongolia Montenegro Montserrat Morocco Mozambique Myanmar Namibia Nauru 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 56 040 144 12 1130 2045 9870 5 63 1920 5444 562 1619 258 037 2782 700 6121 20 96 387 96 676 152 933 6615 11098 0 0 667 326 2218 1 0 342 1288 156 192 31058 479 223 1 20 29 0 42294 0 4 88 7516 0 0 348 1601 1 0 342 520 116 192 4515 0 0 348 35 531 1 0 342 84 87 170 201 24112 30 2403 0 0 1238 10730 1 7 525 893 764 280903 2812 11400 7 20 15 14116 11 0 58 2 0 418 0 0 0 0 250 162 96 28 1 47 0 8 0 38989 0 4 0 14250 0 4 12 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 686 830 298 10 563 5964 950 19 289 15 192 3760 30 98 199 110 4196 179 73 25 8084 72 144 14 13329 1644 585 4 2 23 7 945 159 44 25 7636 30 25 2235 35 0 148 12748 164 263 0 7 945 6185 164 61 2 5 216 4 210 2368 0 2156 0 0 0 0 0 676 0 97 0 19 A2 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 49 3993 91 77 38 087 4174 9849 0 0 0 0 25 056 1015 5676 0 0 0 0 22183 981 5192 0 0 0 0 5622 681 1995 0 53 1 4972 24330 489 87529 0 0 0 0 0 2429 333 17737 0 Annex 2: Country progress indicators and data. 2004 to 2010 | 2010 GLOBAL REPORT 285 .

TREATMENT AND HIV TESTING OF TB PATIENTS Survey Year TB patients TB patients (new and (new and re-treatment) re-treatment) with an HIV recorded as HIV-positive test result recorded in the TB register HIV-positive HIV-positive TB patients TB patients started or started or continued on continued on co-trimoxazole antiretroviral therapy (ART) preventive therapy (CPT) People registered as HIV-positive screened for TB at least once during year People registered as HIV-positive given isoniazid prophylaxis (treatment of latent TB infection) New Zealand Nicaragua Niger Nigeria Niue Northern Mariana Islands Oman Pakistan Palau Panama Papua New Guinea Paraguay Peru Philippines Puerto Rico Qatar Romania Russian Federation Rwanda Saint Kitts and Nevis Saint Lucia Saint Vincent and the Grenadines Samoa San Marino Sao Tome and Principe Saudi Arabia Senegal Seychelles Sierra Leone Singapore Solomon Islands Somalia South Africa Sudan Suriname Swaziland Tajikistan Thailand The Former Yugoslav Republic of Macedonia Timor-Leste Togo Tonga Trinidad and Tobago Tunisia Tuvalu Uganda Ukraine 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 137 1081 2424 64 246 0 32 334 4714 19 1494 1305 239 11 893 1136 59 619 5755 204 624 7448 4 11 13 0 4 30 300 16 813 0 0 3 7 0 107 196 133 697 1 8 0 209 7442 2529 0 4 7 0 0 2329 0 0 3 0 0 72 121 0 3 0 169 1448 1239 0 4 1 0 1 235 753 12 152 4 5 273 0 1361 1 0 0 188 10451 0 7730 0 0 3 7 0 5486 0 0 3 7 0 107 195 112 0 1 116 2917 1853 0 0 0 0 0 196 30 30 60 60 79 1929 6906 15 8625 1121 0 698 197 448 16 168 154 8272 3714 49 955 10 49 455 3 987 52 0 96 114 523 692 49 6895 49 8202 10 386 3 3 123 2 10 2 0 52 0 0 89 80 954 296 6 0 5930 0 7 48 314 375 25 22 4151 8 433 662 1482 0 0 23583 435 25 172 0 127 2009 2009 2009 2009 2009 2009 2009 2009 2009 43 108 1429 8 306 130 0 31 695 0 0 357 0 95 2 0 17 131 3380 0 0 0 22 0 0 14 731 0 0 94 0 17 2 0 3766 915 12 12 1 335 35 0 57 679 0 2 0 0 4 24 0 286 Annex 2: Country progress indicators and data. 2004 to 2010 | 2010 GLOBAL REPORT .

2004 to 2010 | 2010 GLOBAL REPORT 287 .TREATMENT AND HIV TESTING OF TB PATIENTS Survey Year TB patients TB patients (new and (new and re-treatment) re-treatment) with an HIV recorded as HIV-positive test result recorded in the TB register HIV-positive HIV-positive TB patients TB patients started or started or continued on continued on co-trimoxazole antiretroviral therapy (ART) preventive therapy (CPT) People registered as HIV-positive screened for TB at least once during year People registered as HIV-positive given isoniazid prophylaxis (treatment of latent TB infection) United Republic of Tanzania United States of America Uruguay Uzbekistan Vanuatu Venezuela (Bolivarian Republic of) Viet Nam Wallis and Futuna Islands West Bank and Gaza Strip Yemen Zambia Zimbabwe 2009 2009 2009 2009 2009 56 162 7032 666 21 453 11 21 031 703 109 357 0 19 007 6639 5526 153 0 89 0 18 37 0 3022 3 1056 0 2009 2009 2009 2009 2009 2009 2009 4856 34 907 9 35 34 992 28 006 487 5934 0 0 23 584 21 967 0 5265 0 0 15 041 102 354 0 0 10 009 30 158 7092 0 0 102 1500 0 0 A2 Annex 2: Country progress indicators and data.

2004 to 2010 | 2010 GLOBAL REPORT . Republic of the Costa Rica Croatia Cuba Democratic Republic of the Congo Djibouti Dominican Republic Eritrea Ethiopia Finland Gabon Ghana Guinea Guinea-Bissau Haiti Honduras Indonesia Kenya Lesotho Madagascar Malawi Mali Mozambique Namibia Nigeria Rwanda Saint Lucia Saint Vincent and the Grenadines Senegal Seychelles Sierra Leone South Africa Swaziland Togo Turkey Uganda United Republic of Tanzania 10 2007 2006 2005 2007 2007 2006 2006 2006 2006 2005 13 2007 2006 44 1 100 1 1 67 1 41 60 2 100 1 11 51 1 16 31 2007 2007 2005 2007 17 10 1 13 69 1 2005 39 2004 2003 10 25 7 2006 2007 53 2 45 1 2007 2006 2007 2006 2006 2004 4 2007 2007 2004 4 99 10 21 17 1 8 5 41 2006 2007 100 1 100 1 2004 34 2007 2006 2006 2006 2006 51 50 1 91 9 20 2 2006 69 1 UNGASS Indicator 10 MDG 6a indicator Zambia Zimbabwe 288 Annex 2: Country progress indicators and data.PERCENTAGE OF ORPHANED AND VULNERABLE CHILDREN AGED 0-17 WHOSE HOUSEHOLDS RECEIVED FREE BASIC EXTERNAL SUPPORT IN CARING FOR THE CHILD 2005 Survey year Coverage 2007 Survey year Coverage Angola Barbados Benin Botswana Burkina Faso Burundi Côte d’Ivoire Cameroon Central African Republic Chad Congo.

2009
Survey year Coverage

MOST RECENT DHS (OR MICS)3
Survey year Coverage

2009 2009 2009 2008 2008 2009 2009 2009 2006 2009 2009

17 100 7 31 5 7 27 16 7 35 2006 7 2005 9

2009 2007 2009 2008 2004 2009 2010 2008 2009 2005 2009 2007 2007 2010 2006 2009 2008 2006 2008 2005 2009 2008 2007 2005 2009 2006 2007 2010 2008 2006 2009

100 9 14 37 3 100 20 7 17 5 0 13 21 2005 5 2007 9

19 17 22 17 6 13 83 2006 2008 2005 17 6 13

A2

43 1 75 41 60 2006 16 16 21 2007 2005-06 16 28 11
1

2007

41

Methodology not harmonized with UNGASS 2008 guidelines. 2 Differs from value provided by UNICEF. 3 Demographic Health Survey (or Multiple Indicator Cluster Survey).

Annex 2: Country progress indicators and data, 2004 to 2010 | 2010 GLOBAL REPORT

289

RATIO OF ORPHANS TO NON-ORPHANS AGED 10-14 ATTENDING SCHOOL
Angola Argentina Bahamas Belize Benin Bolivia Botswana Burkina Faso Burundi Côte d’Ivoire Cambodia Cameroon Central African Republic Chad Colombia Comoros Congo, Republic of the Croatia Cuba Democratic Republic of the Congo Dominican Republic Equatorial Guinea Eritrea Ethiopia Finland Gabon Gambia Ghana Guinea Guinea-Bissau Guyana Haiti Honduras India Indonesia Iran, Islamic Republic of Japan Kenya Lesotho Madagascar Malawi Mali Mauritania Moldova Mozambique Namibia Nicaragua UNGASS Indicator 12 MDG 6a indicator Niger Nigeria

ORPHANS SCHOOL ATTENDENCE
2003 2005 2007 2009

Ratio

Survey year

Ratio

Survey year 2001 2005

Ratio

Survey year 2009 2009 2006

Ratio

0.90

0.90 1.03

0.87 1.00 0.66 0.00

2006 2003 0.99 2007 0.70 0.83 0.94 0.91 0.96 0.59 2005 2007 2005 2005 2005 2006 2006 2006 2004 2005

0.85 0.741 0.87 0.85 1.213 0.83 0.89 0.96 1.03 0.851

2009

2007 2009 2005 2006 2006 2004

1.15 0.69 0.83 0.91 0.97 1.17

1.12 1.00 1.00

2009 2009

0.88 1.00

0.72 0.95

2007

0.771

2007 2006

0.77 0.71

2002 0.60 0.98 0.85 0.93 1.13 1.03 2004

0.831 2004 >0.99 1.14 0.87 1.044 0.731 0.97 0.951 0.871 0.721 0.841 2007 2008 2008 0.94 0.81 1.00 1.05 1.00 0.97 0.87 0.72 0.52 0.91 1.01 0.66 1.17 2005 2005 0.86 1.08 2008 0.76 2010 0.90 0.84

2007 2006 2006 2005 2006 2005 2000 2006 2002

0.74 0.87 0.65 0.93 0.72

2005 2003 2004

0.97 0.80 0.97

2003 2007 2004

0.951 0.95 0.83

2007 2009 2006 2006 2007 2010

0.47 0.92 1.07 0.87 2005 0.97

2004 2007 2007 2006 2007

0.80 1.00 0.88 0.67 0.86

2008 2006 2006 2008

290

Annex 2: Country progress indicators and data, 2004 to 2010 | 2010 GLOBAL REPORT

RATIO OF ORPHANS TO NON-ORPHANS AGED 10-14 ATTENDING SCHOOL
Papua New Guinea Rwanda Saint Lucia Saint Vincent and the Grenadines Senegal Sierra Leone Somalia South Africa Spain Sudan Swaziland Thailand Togo Turkey Uganda United Republic of Tanzania Zambia Zimbabwe

ORPHANS SCHOOL ATTENDENCE
2003 2005 2007 2009

Ratio

Survey year

Ratio

Survey year

Ratio

Survey year

Ratio

2007 0.80 2005 2007

0.86 0.82 1.76 2

2006 2005 2009 2008

0.86 0.82 1.38 1.00 0.62 0.99 0.00 0.80 0.97 0.99 0.96 0.00

0.74 0.71 0.65 0.95 0.96 0.91 0.96 0.95 0.74 0.87 0.85 2005 0.17

2007 2005 2006 2007

1.25 2 0.83 0.78 0.812 2008 2007 2006 2008

2007 2006 2007 2007 2000 2007 2005 2006

0.97 0.93 0.94 0.70 2 0.95 0.64 1.02 2 0.95

2006 2005 2007 2010 2008 2006

0.92

A2

1 2

Demographic and Health Survey value provided by MEASURE DHS (www.measuredhs.com). Data collection method differs from the UNGASS recommended methodology. 3 Differs from value provided by UNICEF. 4 Multiple Indicator Cluster Survey based on small denominators, typically 25-49 unweighted cases.

Annex 2: Country progress indicators and data, 2004 to 2010 | 2010 GLOBAL REPORT

291

PERCENTAGE OF SCHOOLS THAT PROVIDED LIFE SKILLSBASED HIV EDUCATION IN THE LAST ACADEMIC YEAR

2007
Afghanistan Angola Antigua and Barbuda Argentina Azerbaijan Bahamas Bangladesh Barbados Belarus Belize Bosnia and Herzegovina Botswana Brazil Bulgaria Burkina Faso Burundi Côte d’Ivoire Cambodia Cameroon Cape Verde Central African Republic Chad Comoros Congo, Republic of the Costa Rica Croatia Cuba Czech Republic Democratic Republic of the Congo Djibouti Dominica Dominican Republic Ecuador El Salvador Eritrea Ethiopia Finland Gabon Gambia Germany Ghana Grenada Guatemala Guinea Guyana Haiti 4 26 70 95 35 33 50 58 0 100 1 100 15 4 15 82 100 5 71 6 1 64 1 26 24 100 41 79 19 72 1 13

2009
1

100 3 100 78 0 85 13 38

100 63 1 17 10 66 2 34 61 100 27 75 27 63 100 5 94 59

0

68 38 100 8 63 100 31 38 100 35 1
1

79 94 2 82 62 13

UNGASS Indicator 11

292

Annex 2: Country progress indicators and data, 2004 to 2010 | 2010 GLOBAL REPORT

2007
Honduras India Indonesia Iran, Islamic Republic of Jamaica Japan Kazakhstan Kenya Kyrgyzstan Lao People’s Democratic Republic Lesotho Liberia Luxembourg Malaysia Mali Mexico Moldova Montenegro Namibia Nepal Nicaragua Niger Nigeria Oman Pakistan Papua New Guinea Portugal Romania Russian Federation Saint Kitts and Nevis Saint Lucia Saint Vincent and the Grenadines Sao Tome and Principe Serbia Seychelles Singapore South Africa Sudan Suriname Swaziland Sweden Tajikistan Timor-Leste Togo Turkey Tuvalu 0 100 51 96 91 87 100 1 100 64 82 6 25 79 6 8 8 34 27 93 10 0 24 72 39

2009
11 31 Ukraine Uruguay Uzbekistan Vanuatu 44 100 81 100 84 Venezuela Viet Nam Yemen Zambia Zimbabwe

2007
57

2009
59 90 100 8 100 34 4 60 100 100

32

74 88 2 100 01 49 0 27 8 88 82 23 100

100 100 1 67 92 45 59 100

A2

100 100 100 13 0 85 100 5 0 0

100

1

Data collection started before 2008.

Annex 2: Country progress indicators and data, 2004 to 2010 | 2010 GLOBAL REPORT

293

YOUNG WOMEN AND MEN AGED 15-24 WHO CORRECTLY IDENTIFY WAYS OF PREVENTING THE SEXUAL TRANSMISSION OF HIV AND WHO REJECT MAJOR MISCONCEPTIONS

2003
Females

2005
Survey year Males Females

15-24 Albania Algeria Angola Antigua and Barbuda Argentina Armenia Azerbaijan Bangladesh Barbados Belarus Belize Benin Bolivia Bosnia and Herzegovina Botswana Brazil Bulgaria Burkina Faso Burundi Côte d’Ivoire Cambodia Cameroon Cape Verde Central African Republic Chad Chile China Colombia Comoros Congo, Republic of the Costa Rica Croatia Cuba Cyprus Democratic Republic of the Congo Djibouti Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Gabon Gambia Georgia Germany Ghana 2003 15 4 33 52 10 5 5 24 16 37 16 2004 2004 28 22 2 <1

15-24

15-24

43

35

11

8

4

4

34

27

40

36

UNGASS Indicator 13 MDG 6a indicator

Greece

294

Annex 2: Country progress indicators and data, 2004 to 2010 | 2010 GLOBAL REPORT

2007
Survey year Males Females Both sexes

2009
Survey year Males Females Both sexes

MOST RECENT DHS (OR MICS)1
Survey year Males Females

15-24

15-24

15-24 2008

15-24 22 32

15-24 36 16 25

15-24

2006 2006 2005 2005 2007 2005 2007 2006 2006 83 42 24 70 26 35 25

16 21 89 34 21 65 26 16

16 23 48 86 36

2006 2009 2008 2006 5 22 52 68 47 34 28

28 93 2005 15% 5% 23% 5%

5 13 49 72 53 34 30

5 18 50 70 50 34 24

2006

22 68 26 20

2008 2009 2009 2009 2008 2008

2006 2008

35% 28%

16% 25%

2006

44 2008 2008 39 53 21 29 45 17 45 35 65 26 20 78 45 50 25 21 39 13 50 27 68 17 8 85 42 52 23 25 35 15 48 30 67 20 11 82 85 2005 2005 2005 2004 2005 2006 2004 28% 45% 35% 36% 27% 20% 18% 50% 27% 36% 17% 8% 2003 23% 15%

2006 2007 2005 2005 2006 2006 2005 2006 2004 2007 2007

18 45 28 45 37 31 20 50

21 46 31 18 49 32 38 22 8 55

19 45 22 47 32 38 24 11 42

2009 2008 2007 2009 2005 2004 2009 2006 2004 2009 2008

2005 2006 2006 2006 2007 2006 2007 2006

22 43 16 55 10 29 34 31

10 42 25 61 11 22 41 27

13 42 20 58 10 26 37 29

2009

22

8

14

2009

22%

8%

2008

A2
21 23 34 18 15 18 41 5 27 2 77 28 33 58 78 37 21 53 55 77 32 2005 33% 21% 2002 37% 17 21 37 11 2007 34% 41% 2007 21% 15%

2007 2008 2007 2007 2008 2006 2008

2007 2005 2007 2005 2005 2007 2007

28 33 58 34

37 21 60 25 4

32 24 59 29

2007 2005 2010

2009 2008 27 23 25 2009 34 27 28 50 38 2008 34% 28%

Annex 2: Country progress indicators and data, 2004 to 2010 | 2010 GLOBAL REPORT

295

2004 to 2010 | 2010 GLOBAL REPORT .YOUNG WOMEN AND MEN AGED 15-24 WHO CORRECTLY IDENTIFY WAYS OF PREVENTING THE SEXUAL TRANSMISSION OF HIV AND WHO REJECT MAJOR MISCONCEPTIONS 2003 Females 2005 Survey year Males Females 15-24 Grenada Guatemala Guinea Guinea-Bissau Guyana Haiti Honduras India Indonesia Iran. Islamic Republic of Jamaica Japan Kazakhstan Kenya Kyrgyzstan Latvia Lesotho Liberia Lithuania Madagascar Malawi Malaysia Mali Marshall Islands Mauritania Mauritius Mexico Micronesia Moldova Mongolia Montenegro Morocco Mozambique Myanmar Namibia Nepal Nicaragua Niger Nigeria Norway Oman Palau Panama Papua New Guinea Peru Philippines Russian Federation Rwanda Saint Kitts and Nevis Saint Lucia Saint Vincent and the Grenadines Samoa 23 5 19 32 2005 34 2003 2005 18 26 2005 7 8 36 14 15-24 15-24 80 58 16 36 19 24 3 5 296 Annex 2: Country progress indicators and data.

2004 to 2010 | 2010 GLOBAL REPORT 297 .2007 Survey year Males Females Both sexes 2009 Survey year Males Females Both sexes MOST RECENT DHS (OR MICS)1 Survey year Males Females 15-24 2006 2002 2007 2006 2005 2006 2005 2006 34 40 39 33 43 10 20 15-24 40 9 12 18 44 32 89 24 15-24 41 9 16 39 35 77 28 2008 2009 2008 2008 2005 2005 2009 2007 2008 15-24 15-24 15-24 24 23 13 40 44 14 15 38 29 55 33 22 20 13 34 30 35 15 17 43 32 48 37 23 22 13 46 35 40 14 16 40 30 2003 35 2004 19% 27% 16% 36% 22% 39% 27% 21% 19% 24% 18% 27% 47% 34% 2005 2005 2005-06 2005-06 36% 47% 40% 53% 34% 30% 20% 2005 23% 17% 2004 2004 2007 2006 2007 23 18 30 3 47 20 33 3 35 19 32 3 2008 2008 2008 2008 2009 2009 2006 2009 67 50 57 42 59 39 14 57 34 54 42 54 27 5 62 41 2007 2003-04 2006 46 45 45 2008 2006 2008 42 23 55 32 7 2004 2006 2007 2006 2006 2004 2002 2006 2005 2006 2007 2004 2007 2006 2007 2006 2005 22 8 18 4 20 6 22 2006 2007 2007 18 0 26 17 18 2006-07 27 15 26 16 2008 2009 2007 2007 2003 2009 2007 47 62 44 16 27 66 4 0 12 26 28 35 54 61 59 48 65 28 13 21 67 4 27 15 17 20 39 51 57 40 32 14 24 65 4 27 14 22 23 37 52 52 60 49 2005 54% 51% 2007 2008 19% 21% 48 2006 2006 2001 2006 2007 2008 2007 2006 2008 16% 33% 62% 44% 65% 28% 22% 13% 22% 2006 2006 na 34% 12% 36% 39 19 42 16 41 18 2005 na na 39 62 44 16 25 25 65 28 81 13 20 28 63 32 81 14 23 A2 2006 27 2008 2009 2007 2006 2007 2005 2006 2006 2006 61 59 57 40 33 54 35 51 55 34 52 52 59 49 2008 2009 2005 2005 2005 2008 2008 Annex 2: Country progress indicators and data.

2004 to 2010 | 2010 GLOBAL REPORT .YOUNG WOMEN AND MEN AGED 15-24 WHO CORRECTLY IDENTIFY WAYS OF PREVENTING THE SEXUAL TRANSMISSION OF HIV AND WHO REJECT MAJOR MISCONCEPTIONS 2003 Females 2005 Survey year Males Females 15-24 Sao Tome and Principe Senegal Serbia Seychelles Sierra Leone Singapore Solomon Islands Somalia South Africa Spain Sri Lanka Sudan Suriname Swaziland Sweden Tajikistan Thailand The former Yugoslav Republic of Macedonia Timor-Leste Togo Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Tuvalu Uganda Ukraine United Kingdom of Great Britain and Northern Ireland United Republic of Tanzania Uruguay Uzbekistan Vanuatu Viet Nam Zambia Zimbabwe 25 26 2005 2003 3 26 28 33 20 27 27 20 2004 16 11 15-24 15-24 13 8 46 56 41 54 1 Demographic Health Survey (or Multiple Indicator Cluster Survey). 298 Annex 2: Country progress indicators and data.

2007 Survey year Males Females Both sexes 2009 Survey year Males Females Both sexes MOST RECENT DHS (OR MICS)1 Survey year Males Females 15-24 2006 2005 2006 2003 2007 2007 2006 15 24 20 59 15-24 15-24 2008 15-24 15-24 15-24 2008-09 43% 24% 43% 19% 19 21 67 20 4 22 20 63 2005 2006 2008 24 20 28 19 21 17 23 20 2005 2008 28% 17% 17 2008 4 2006 2008 2008 30 4 27 17 7 41 52 59 11 44 18 21 59 52 61 9 30 25 36 44 51 52 60 10 37 22 2007 52% 52% 7 29 2007 2006 2007 2007 2006 2007 2007 2007 10 7 41 8 41 52 11 40 22 51 56 2006 2006 2006 2006 2009 2008 2006 2007 2008 2007 2008 52 11 47 19 59 52 11 33 26 44 26 2007 2005 2006 2007 38 39 35 29 39 27 37 2009 5 11 8 2000 3% 38% 43% 32% 45% 2007 32 42 33 40 2010 2009 61 40 39 41 48 2006 40 2007 2007 2008 2007 52 48 50 2008 2009 2008 2005 2007 2006 50 37 46 42 34 44 46 35 45 2009 2007 2009 44 37 41 34 53 42 23 14 39 44 11 65 40 34 13 42 35 2005 2007 2005-06 50% 37% 46% 42% 34% 44% 2007-08 42% 39% A2 Annex 2: Country progress indicators and data. 2004 to 2010 | 2010 GLOBAL REPORT 299 .

2004 to 2010 | 2010 GLOBAL REPORT . Republic of the Costa Rica Cuba Cyprus Czech Republic Democratic Republic of the Congo Djibouti Dominican Republic Ecuador El Salvador Eritrea Estonia Ethiopia Fiji Finland Gabon Gambia Georgia Germany Ghana Greece Grenada 40 2003 10 2004 10 2004 2004 14 13 <1 23 16 36 47 15-24 24 26 9 6 15 <1 35 10 10 42 UNGASS Indicator 15 Guatemala 300 Annex 2: Country progress indicators and data.PERCENTAGE OF YOUNG WOMEN AND MEN AGED 15-24 WHO HAVE HAD SEXUAL INTERCOURSE BEFORE THE AGE OF 15 20051 Survey year Males Females 15-24 Albania Angola Antigua and Barbuda Argentina Armenia Azerbaijan Bahamas Bangladesh Barbados Belarus Belize Benin Bolivia Bosnia and Herzegovina Botswana Brazil Bulgaria Burkina Faso Burundi Côte d’Ivoire Cambodia Cameroon Cape Verde Central African Republic Chad Chile Colombia Comoros Congo.

20071 Survey year Males Females Both sexes 20091 Survey year Males Females Both sexes MOST RECENT DHS (OR MICS)2 Survey year Males Females 15-24 15-24 15-24 2008 15-24 1 37 15-24 1 23 15-24 2006 2006 2005 2007 36 27 11 28 19 <1 32 25 23 3 2009 2008 2006 2009 30 19 2005 3 1 1 0 1 1 70 12 22 7 11 22 13 17 5 41 11 9 5 0 23 26 36 10 13 16 25 1 41 31 16 2 5 13 7 58 24 20 4 8 17 8 18 3 29 5 7 3 1 35 13 52 26 8 8 20 15 4 18 2 15 11 11 4 35 8 8 4 21 1 31 26 48 2006 2007 2005 2007 2006 2006 4 8 11 13 1 4 6 12 2 5 9 12 2008 2009 2009 2009 2008 2006 2008 13 13 12 7 2006 1 2009 2008 2008 2006 2007 2005 2005 2006 2006 2005 2006 2004 2006 2007 13 3 15 <1 41 20 19 12 7 7 3 19 1 14 24 33 39 6 10 6 18 1 30 30 35 9 37 2009 2008 2007 2009 2005 2004 2009 2006 2004 2009 1996 2003 2005 2005 2004 2005 2006 2004 2005 4 15 0 11 41 13 10 7 19 1 20 24 25 26 13 10 22 24 3 18 7 19 2007 24 15 2007 18 18 2009 25 20 2005 2006 2006 2007 27 15 33 15 24 7 15 1 24 11 24 8 2008 2008 32 3 18 11 24 A2 2006 2007 2004 2003 2007 2005 2007 2007 2006 2005 2006 2007 2006 2002 31 24 54 10 2 23 33 10 21 11 16 28 29 27 10 12 50 2007 2008 2007 2008 2007 2005 2009 2002 11 2 27 28 11 16 30 8 28 15 2000 42 11 2005 2 13 16 38 14 5 2 25 2 11 24 25 11 2010 24 10 35 32 20 12 7 20 9 2005 2008 2009 2008 12 4 22 16 14 8 10 8 13 2008 16 11 1999 10 4 8 Annex 2: Country progress indicators and data. 2004 to 2010 | 2010 GLOBAL REPORT 301 .

Islamic Republic of Jamaica Japan Kazakhstan Kenya Kyrgyzstan Latvia Lebanon Lesotho Liberia Lithuania Luxembourg Madagascar Malawi Malaysia Mali Malta Marshall Islands Mauritania Mauritius Mexico Micronesia.PERCENTAGE OF YOUNG WOMEN AND MEN AGED 15-24 WHO HAVE HAD SEXUAL INTERCOURSE BEFORE THE AGE OF 15 20051 Survey year Males Females 15-24 Guinea Guinea-Bissau Guyana Haiti Honduras India Indonesia Iran. Federated States of Moldova Mongolia Montenegro Morocco Mozambique Myanmar Namibia Nepal Nicaragua Niger Nigeria Norway Pakistan Palau Panama Papua New Guinea Paraguay Peru Philippines Portugal Romania Russian Federation Rwanda Saint Kitts and Nevis 2004 17 2005 5 2005 2005 34 3 2003 22 2004 27 2005 20 2005 16 15-24 18 17 14 31 24 <1 15 8 302 Annex 2: Country progress indicators and data. 2004 to 2010 | 2010 GLOBAL REPORT .

20071 Survey year Males Females Both sexes 20091 Survey year Males Females Both sexes MOST RECENT DHS (OR MICS)2 Survey year Males Females 15-24 2007 2006 2005 2006 2005 2006 2005 2004 2004 2007 2003 2007 2007 2004 2005 2006 2006 2006 2006 2006 2007 2004 2005 3 4 5 17 12 22 33 8 20 29 9 16 30 43 19 2 20 15-24 31 22 12 15 11 4 15-24 25 21 23 13 3 2009 2008 2009 2005 2006 2009 2007 2007 2008 15-24 25 26 19 43 19 2 0 7 57 7 22 6 15-24 29 16 10 15 11 10 0 1 16 0 11 0 15-24 26 21 14 23 13 0 0 4 36 4 2003 3 4 2004 13 9 6 17 29 14 2009 2005 2005-06 2005-06 2007 2 43 15 11 10 2005 17 22 9 3 14 <1 9 6 10 39 9 9 21 5 12 4 8 2006 16 36 2008 2006 2009 2004 2001 8 18 18 9 14 5 7 27 10 4 17 7 15 18 15 25 6 14 14 5 4 15 5 21 7 19 14 7 4 22 13 2 8 25 1 18 1 0 1 25 1 7 7 1 5 25 1 2006 2006 2001 2006 2007 2009 5 7 8 17 30 8 12 11 10 13 36 30 17 10 15 21 7 64 7 6 3 4 10 8 8 6 7 22 2005 13 4 2007 2008 2008 6 2 12 9 10 24 8 2006 2008 5 6 18 4 7 8 12 30 16 1992 2009 25 0 25 2005 9 1 2007 27 14 2006 5 25 13 13 16 2003-04 2004 9 14 15 15 2004 2008 2008 2009 2007 25 10 14 1 4 6 14 14 2 4 2006 2009 2007 2007 2008 2005 2006 2006 2005 2007 2007 2004 2007 2007 2006 2005 2006 2006 2007 2007 8 3 4 8 26 18 1 <1 2 1 28 7 14 4 1 3 5 28 12 14 25 10 2008 2009 2007 2007 2009 2007 2006 A2 8 5 1 39 15 <1 5 2008 2009 4 2007 2008 2008 4 4 6 2006 2007 2005 2006 17 12 13 36 3 3 4 10 10 7 7 22 2009 2005 2005 Annex 2: Country progress indicators and data. 2004 to 2010 | 2010 GLOBAL REPORT 303 .

Demographic Health Survey (or Multiple Indicator Cluster Survey).PERCENTAGE OF YOUNG WOMEN AND MEN AGED 15-24 WHO HAVE HAD SEXUAL INTERCOURSE BEFORE THE AGE OF 15 20051 Survey year Males Females 15-24 Saint Lucia Saint Vincent and the Grenadines Samoa Sao Tome and Principe Senegal Serbia Sierra Leone Singapore Solomon Islands South Africa Spain Sri Lanka Sudan Suriname Swaziland Sweden Switzerland Tajikistan Thailand The former Yugoslav Republic of Macedonia Togo Trinidad and Tobago Tunisia Turkmenistan Tuvalu Uganda Ukraine United Kingdom of Great Britain and Northern Ireland United Republic of Tanzania Uruguay Uzbekistan Viet Nam Zambia Zimbabwe 9 11 2005 63 15-24 37 7 8 1 2 Methodology may vary for individual countries. 2004 to 2010 | 2010 GLOBAL REPORT . 304 Annex 2: Country progress indicators and data.

20071 Survey year Males Females Both sexes 20091 Survey year Males Females Both sexes MOST RECENT DHS (OR MICS)2 Survey year Males Females 15-24 2006 2006 2006 2005 2005 2007 2005 2003 2007 2006 2007 2007 2007 2006 2006 2007 2007 2007 7 5 15 10 1 21 8 13 12 25 3 5 18 32 31 15-24 20 14 15-24 26 22 2005 2008 2008 15-24 32 31 11 12 4 11 44 11 30 15-24 20 14 5 9 1 25 22 6 18 1 15-24 26 22 9 2008-09 12 12 11 9 9 25 10 2 2008 29 9 2005 9 10 25 2005 2006 2008 2008 2 12 11 2 8 15 3 8 2008 2008 2006 2009 2006 2006 2009 2007 2008 2006 2007 2007 2009 2007 5 19 9 1 8 9 13 52 15 4 9 7 24 7 0 1 1 10 14 2 0 6 22 8 0 5 5 11 36 2000 7 2006 2 2007 12 2 16 1 0 1998 0 19 2007 5 7 41 7 21 7 <1 5 1 10 <1 6 19 8 1 13 5 11 12 4 2006 2007 12 7 16 3 15 5 2010 2009 2001 2005 2007 2005 2007 2006 14 10 25 1 16 5 12 13 10 <1 14 5 13 11 18 <1 15 5 2001 2008 2008 2009 2009 2006 2007 14 10 44 1 0 16 4 12 11 30 0 0 13 5 13 10 37 1 0 14 5 1996 2005 2007 2005-06 0 16 5 1 1 14 5 2007-08 10 11 A2 Annex 2: Country progress indicators and data. 2004 to 2010 | 2010 GLOBAL REPORT 305 .

Republic of the Costa Rica Cuba Cyprus Czech Republic Democratic Republic of the Congo Djibouti Dominican Republic Eritrea Estonia Ethiopia Gabon Gambia Germany Ghana Greece Grenada Guatemala Guinea Guinea-Bissau Guyana Haiti Honduras Hungary India Indonesia 2000 24 1999 26 2000 2000 7 24 1996 16 2000 1997 19 1998 2000 1998 41 33 1999 13 1996 2000 9 15-49 15-24 25-49 <1 4 4 2 1 5 <1 10 9 19 25 6 19 25 1 3 11 8 2 4 6 1 14 3 20 5 18 4 15 15 1 11 13 UNGASS Indicator 16 306 Annex 2: Country progress indicators and data.PERCENTAGE OF WOMEN AND MEN AGED 15-49 WHO HAVE HAD SEXUAL INTERCOURSE WITH MORE THAN ONE PARTNER IN THE LAST 12 MONTHS 20031 Survey Year Males Females Both sexes 15-49 Albania Angola Antigua and Barbuda Armenia Azerbaijan Bangladesh Belarus Belize Benin Bolivia Bosnia and Herzegovina Botswana Brazil Bulgaria Burkina Faso Burundi Côte d’Ivoire Cambodia Cameroon Canada Cape Verde Central African Republic Chad Chile Colombia Comoros Congo. 2004 to 2010 | 2010 GLOBAL REPORT .

2004 to 2010 | 2010 GLOBAL REPORT 307 .20051 Survey Year Males Females Both sexes 20074 Survey Year Males Females Both sexes 15-49 15-49 15-24 25-49 15-49 15-49 15-49 15-19 20-24 25-49 2006 2006 2005 9 <1 6 3 2005 2007 2006 2001 2003 22 15 1 1 7 10 8 7 2006 2006 51 25 38 55 54 46 26 18 33 13 2 12 14 42 35 8 18 21 82 17 25 27 62 4 25 32 30 11 14 15 8 2003 2005 2005 2004 2005 2004 2005 2005 15 24 6 31 36 17 1 4 <1 6 3 1 3 5 12 2 15 19 6 9 15 4 22 19 10 2007 2005 2006 2004 2006 2005 2006 2004 2006 2007 2003 14 31 6 40 69 24 2 17 12 24 28 37 35 25 1 4 <1 8 43 62 1 2 43 4 8 35 10 6 7 16 3 18 13 52 11 2 8 7 11 14 39 23 15 2 15 1 17 86 6 4 6 6 18 4 20 71 14 9 14 35 3 9 16 3 17 36 10 6 9 24 7 15 16 2005 2006 2006 2007 19 22 16 29 13 22 2007 2002 23 2 13 13 2007 2007 2005 2 <1 1 2 2005 2007 2006 2007 2003 10 1 4 7 2006 2007 2006 2002 2005 2005 2005 2006 2006 1 25 7 23 2 1 1 1 <1 1 1 11 6 11 14 3 13 2005 2006 2005 2006 2005 2006 22 30 23 3 51 35 22 2 33 30 13 25 9 23 16 8 4 4 19 <1 38 12 22 40 2 8 13 2 1 1 1 2 9 17 21 2 43 29 26 2 20 21 13 8 5 12 4 5 10 22 17 1 53 11 25 26 2 36 9 16 A2 2 43 22 19 34 6 5 7 48 30 19 10 7 16 18 16 8 8 13 6 9 4 Annex 2: Country progress indicators and data.

2004 to 2010 | 2010 GLOBAL REPORT .PERCENTAGE OF WOMEN AND MEN AGED 15-49 WHO HAVE HAD SEXUAL INTERCOURSE WITH MORE THAN ONE PARTNER IN THE LAST 12 MONTHS 20031 Survey Year Males Females Both sexes 15-49 Iran. Federated States of Moldova Mongolia Morocco Mozambique Myanmar Namibia Nepal Nicaragua Niger Nigeria Palau Panama Papua New Guinea Paraguay Peru Philippines Poland Portugal Russian Federation Rwanda Saint Kitts and Nevis Saint Lucia Saint Vincent and the Grenadines Sao Tome and Principe Senegal Serbia Seychelles Sierra Leone Singapore Solomon Islands South Africa Spain Sri Lanka Sudan 2000 2 1996 23 2000 2001 2001 1998 10 16 3 2000 1996 15 13 1998 24 15-49 15-24 25-49 3 16 11 1 6 9 2 1 1 9 10 7 5 <1 4 9 <1 1 2 308 Annex 2: Country progress indicators and data. Islamic Republic of Jamaica Japan Kazakhstan Kenya Kyrgyzstan Lebanon Lesotho Liberia Lithuania Madagascar Malawi Mali Malta Marshall Islands Mauritius Mexico Micronesia.

20051 Survey Year Males Females Both sexes 20074 Survey Year Males Females Both sexes 15-49 15-49 15-24 25-49 15-49 15-49 15-49 15-19 20-24 25-49 2004 2007 2003 12 2 7 7 2003 2007 2004 2004 21 8 11 16 2005 2007 2004 2004 2001 17 9 17 3 1 1 11 4 5 9 6 11 2004 2005 2006 2006 2004 2003 48 25 12 28 24 30 43 20 1 23 23 9 8 11 5 2 2 4 11 26 3 1 2 18 1 29 15 5 15 17 16 41 7 1 5 21 5 2 5 19 4 1 4 30 5 6 6 9 1 1 <1 <1 41 9 3 10 23 6 21 15 5 2005 11 1 9 4 2007 2005 2007 16 54 37 52 16 2 2 24 3 2 8 54 19 29 9 2 2 10 11 14 60 10 1 5 3 36 19 27 34 15 2 4 10 13 11 5 2003 30 5 18 17 2004 2007 2007 2006 19 7 2 2 14 5 7 9 19 1 2 9 2003 15 2 5 10 2005 2006 2007 13 33 8 20 3 53 42 25 25 42 23 9 7 3 27 3 2 12 8 6 2000 2003 6 <1 2006 2005 2006 A2 5 9 <1 19 25 10 4 11 11 36 2 18 13 <1 7 15 2 36 35 17 8 26 17 21 4 10 20 2 1 1 3 2 18 10 15 4 8 13 7 32 32 11 24 9 7 <1 16 <1 26 1 13 2 2005 3 <1 1 2 2005 2006 2007 2006 2005 13 1 4 10 2005 2006 2003 2005 2007 2005 2003 2007 Annex 2: Country progress indicators and data. 2004 to 2010 | 2010 GLOBAL REPORT 309 .

15-24 years. 5 Demographic Health Survey (or Multiple Indicator Cluster Survey).PERCENTAGE OF WOMEN AND MEN AGED 15-49 WHO HAVE HAD SEXUAL INTERCOURSE WITH MORE THAN ONE PARTNER IN THE LAST 12 MONTHS 20031 Survey Year Males Females Both sexes 15-49 Suriname Swaziland Sweden Switzerland Tajikistan Thailand Timor-Leste Togo Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Tuvalu Uganda Ukraine United Arab Emirates United Kingdom of Great Britain and Northern Ireland United Republic of Tanzania United States of America Uruguay Vanuatu Viet Nam Zambia Zimbabwe 1996 1999 27 13 1999 29 1995 8 2000 1998 21 15-49 15-24 25-49 3 13 13 <1 1 5 4 9 17 20 4 2 18 6 12 8 1 2 Data provided by MEASURE DHS. 4 Methodology may vary for individual countries. 3 25-64 years only. 2004 to 2010 | 2010 GLOBAL REPORT . 310 Annex 2: Country progress indicators and data.

2004 to 2010 | 2010 GLOBAL REPORT 311 .20051 Survey Year Males Females Both sexes 20074 Survey Year Males Females Both sexes 15-49 15-49 15-24 25-49 2006 2007 2007 2007 2006 2006 2007 2007 2007 15-49 15-49 15-49 3 15-19 20-24 25-49 14 23 18 18 26 94 2 23 10 1 6 79 15 13 23 14 6 9 16 85 15 15 33 25 3 24 10 17 34 26 9 18 22 15 11 10 7 17 19 20 11 2001 18 2 6 12 2006 2007 21 21 2 7 12 14 3 18 9 23 16 11 2001 2004 23 3 10 15 2006 2007 2005 2002 2006 14 21 9 2 2 1 6 10 4 9 13 6 2005 2007 2006 25 20 23 1 14 14 15 5 11 <1 1 1 20 13 17 <1 7 7 30 46 28 <1 3 7 35 16 35 1 7 9 11 <1 9 6 A2 Annex 2: Country progress indicators and data.

2004 to 2010 | 2010 GLOBAL REPORT .PERCENTAGE OF WOMEN AND MEN AGED 15-49 WHO HAVE HAD SEXUAL INTERCOURSE WITH MORE THAN ONE PARTNER IN THE LAST 12 MONTHS 20094 Survey Year Males Females Males 15-49 Albania Angola Antigua and Barbuda Armenia Azerbaijan Bangladesh Belarus Belize Benin Bolivia Bosnia and Herzegovina Botswana Brazil Bulgaria Burkina Faso Burundi Côte d’Ivoire Cambodia Cameroon Canada Cape Verde Central African Republic Chad Chile Colombia Comoros Congo. Republic of the Costa Rica Cuba Cyprus Czech Republic Democratic People’s Republic of Korea Democratic Republic of the Congo Djibouti Dominican Republic Equatorial Guinea Eritrea Estonia Ethiopia Gabon Gambia Germany Ghana Greece Grenada Guatemala Guinea Guinea-Bissau Guyana 2008 2008 2008 2009 2005 37 10 23 12 2009 2008 2009 13 11 32 2007 2005 2010 23 3 57 2007 2008 2007 2006 30 17 2008 29 2008 34 2009 2006 2004 2009 2005 2003 2009 24 29 54 21 17 21 2006 2005 2009 2009 2006 2008 2009 2008 2008 2009 2008 2007 2005 2005 2004 31 6 40 6 12 22 15 21 12 64 16 76 29 27 2008 2009 5 25 15-49 0 3 15-19 2 10 20-24 15 31 25-49 27 3 39 10 5 1 28 11 5 10 16 28 17 27 18 21 5 9 18 14 27 11 7 57 12 2 5 0 9 42 6 1 7 3 4 7 12 21 5 66 27 24 32 2 35 93 12 7 16 26 74 43 26 33 9 45 80 29 20 29 16 78 27 30 7 40 36 21 21 9 34 33 47 36 26 3 4 10 70 33 19 90 43 18 27 21 0 33 7 1 22 1 10 1 1 14 0 54 23 3 50 13 31 8 13 31 2 63 30 10 35 18 41 18 29 4 55 10 15 28 10 41 9 26 UNGASS Indicator 16 Haiti 312 Annex 2: Country progress indicators and data.

2004 to 2010 | 2010 GLOBAL REPORT 313 .20094 Females MOST RECENT DHS (OR MICS)5 Survey year Males Females 15-19 0 4 20-24 0 4 25-49 15-49 15-49 2 2005 2006 2007 9 6 0 0 9 4 1 26 6 1 5 5 0 2006 2008 21 12 1 4 56 10 6 7 0 20 71 5 1 5 4 13 63 14 3 6 0 11 62 7 1 10 6 7 55 2 3 0 6 27 2003 2005 2005 2004 2005 2006 1 6 2 2005 3 2004 17 1 15 24 6 31 36 1 4 0 6 3 9 10 5 2009 29 7 43 28 18 A2 3 56 10 4 85 7 2 2007 1995 19 0 34 14 1 28 1 9 1 1 22 0 44 17 2 27 1 13 2 2 0 28 5 1 17 1 2005 9 1 1 2009 2005 23 1 1 25 2 2008 11 1 2005 2000 2 46 0 14 24 6 3 3 2007 17 3 Annex 2: Country progress indicators and data.

Islamic Republic of Jamaica Japan Kazakhstan Kenya Kyrgyzstan Lebanon Lesotho Liberia Lithuania Madagascar Malawi Mali Malta Marshall Islands Mauritius Mexico Micronesia.PERCENTAGE OF WOMEN AND MEN AGED 15-49 WHO HAVE HAD SEXUAL INTERCOURSE WITH MORE THAN ONE PARTNER IN THE LAST 12 MONTHS 20094 Survey Year Males Females Males 15-49 Honduras Hungary India Indonesia Iran. 2004 to 2010 | 2010 GLOBAL REPORT . Federated States of Moldova Mongolia Morocco Mozambique Myanmar Namibia Nepal Nicaragua Niger Nigeria Palau Panama Papua New Guinea Paraguay Peru Philippines Poland Portugal Russian Federation Rwanda Saint Kitts and Nevis Saint Lucia Saint Vincent and the Grenadines Sao Tome and Principe Senegal Serbia Seychelles Sierra Leone Singapore 2008 21 2007 2008 2005 2005 2007 2008 2008 2005 2006 42 24 22 13 11 27 21 3 2007 2006 2007 2008 2009 2007 2008 2008 14 45 37 9 19 2007 2009 2006 2006 37 20 13 11 2006 2009 45 18 2006 2008 2009 2004 2006 2009 2007 2008 9 25 7 32 23 22 26 2006 2009 2009 2007 2008 2008 1999 2008 2008 2009 2004 19 85 9 0 12 62 22 22 9 22 15-49 1 25 3 15-19 32 1 0 20-24 29 5 0 14 81 31 12 32 25-49 14 1 0 1 17 7 4 1 1 11 50 16 4 16 61 21 11 7 8 16 14 27 24 9 64 23 47 26 21 15 11 20 8 16 1 6 3 15 3 5 93 11 59 41 18 2 2 3 0 2 2 1 4 9 41 1 6 1 18 25 9 31 62 54 38 48 34 76 6 27 18 5 26 10 1 6 24 11 17 22 17 17 29 15 9 9 0 25 10 1 1 1 5 45 32 0 43 36 1 23 16 4 16 21 4 11 12 52 23 9 25 23 13 19 8 34 314 Annex 2: Country progress indicators and data.

2004 to 2010 | 2010 GLOBAL REPORT 315 .20094 Females MOST RECENT DHS (OR MICS)5 Survey year Males Females 15-19 1 0 20-24 1 0 25-49 0 0 2005-06 2005-06 15-49 15-49 1 1 0 1 17 2 1 0 1 23 8 2 2 2004 21 18 17 9 15 7 8 6 3 1 1 3 14 4 1 2003 12 12 3 1 21 3 31 2 8 2 1 9 4 22 3 6 2 1 2 2 7 2007 2003-04 2004 2006 2007 3 5 1 2005 11 1 4 0 1 1 1 3 36 23 0 7 1 4 0 4 2 1 5 13 41 0 8 3 2 0 2009 2006 2006 2001 11 2 12 10 3 2 0 1 1 1 1 4 5 46 1 4 1 2006 2008 A2 2004-08 2003 6 1 26 14 0 22 13 0 7 8 0 2000 2 0 10 3 1 1 7 15 2 1 4 6 5 18 2 1 12 2008 16 4 2005 13 2 1 Annex 2: Country progress indicators and data.

4 Methodology may vary for individual countries. 316 Annex 2: Country progress indicators and data. 2004 to 2010 | 2010 GLOBAL REPORT . 15-24 years. 3 25-64 years only. 5 Demographic Health Survey (or Multiple Indicator Cluster Survey).PERCENTAGE OF WOMEN AND MEN AGED 15-49 WHO HAVE HAD SEXUAL INTERCOURSE WITH MORE THAN ONE PARTNER IN THE LAST 12 MONTHS 20094 Survey Year Males Females Males 15-49 Solomon Islands South Africa Spain South Africa Sri Lanka Suriname Swaziland Sweden Switzerland Tajikistan Thailand Timor-Leste Togo Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Tuvalu Uganda Ukraine United Arab Emirates United Kingdom of Great Britain and Northern Ireland United Republic of Tanzania United States of America Uruguay Vanuatu Viet Nam Zambia Zimbabwe 2007 2008 2009 2007 2007 23 53 2 14 28 2007 2010 2009 5 29 23 2009 37 2006 2006 2009 2007 2008 2006 2008 2007 2008 14 42 18 15 18 92 26 2008 2008 2008 2008 19 91 19 15-49 24 4 4 1 1 51 10 5 1 6 15-19 71 20-24 82 25-49 26 37 8 30 47 20 20 16 15 19 31 27 14 1 4 7 13 18 18 41 1 20 2008 2008 15 18 8 3 4 25 18 13 24 11 27 0 1 9 40 1 5 18 52 5 14 34 14 18 29 1 2 Data provided by MEASURE DHS.

20094 Females MOST RECENT DHS (OR MICS)5 Survey year Males Females 15-19 45 20-24 32 25-49 6 15-49 15-49 4 49 1 24 7 10 4 53 3 18 11 2 2007 14 2 7 7 4 1998 21 3 2000 0 3 1 10 1 2006 7 2007 21 13 0 2 2 24 2 3 5 3 2007-08 18 3 16 0 2 8 16 0 1 12 9 2005 1 8 2007 2005-06 1 14 9 0 1 1 A2 Annex 2: Country progress indicators and data. 2004 to 2010 | 2010 GLOBAL REPORT 317 .

Republic of the Costa Rica Cuba Cyprus Democratic Republic of the Congo Djibouti Dominican Republic El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Gabon Germany Ghana Greece Grenada Guatemala Guinea Guinea-Bissau Guyana Haiti Honduras Hungary India Indonesia 2000 21 1999 24 2000 2000 20 40 1996 9 2000 1997 20 1998 23 1998 45 1999 55 2000 32 15-49 15-24 25-49 36 23 13 56 53 27 34 17 10 22 22 17 19 7 10 11 26 43 41 10 29 9 31 17 30 30 16 UNGASS Indicator 17 Iran. 2004 to 2010 | 2010 GLOBAL REPORT . Islamic Republic of 318 Annex 2: Country progress indicators and data.PERCENTAGE OF WOMEN AND MEN AGED 15-49 WHO HAD MORE THAN ONE SEXUAL PARTNER IN THE PAST 12 MONTHS REPORTING THE USE OF A CONDOM DURING THEIR LAST SEXUAL INTERCOURSE 20031 Survey Year Males Females Both sexes 15-49 Albania Angola Antigua and Barbuda Argentina Armenia Azerbaijan Bangladesh Belarus Belize Benin Bolivia Bosnia and Herzegovina Botswana Brazil Bulgaria Burkina Faso Burundi Côte d’Ivoire Cambodia Cameroon Canada Cape Verde Central African Republic Chad Chile Colombia Congo.

2004 to 2010 | 2010 GLOBAL REPORT 319 .20051 Survey Year Males Females Both sexes 20076 Survey Year Males Females Both sexes 15-49 15-49 15-24 25-49 2005 2006 2006 2005 15-49 15-49 15-49 15-19 20-24 25-49 46 48 18 44 32 87 46 26 48 40 44 31 2005 58 2006 2005 2007 35 62 60 35 61 42 76 31 68 36 49 2006 72 73 71 2003 2005 2005 2004 2005 2004 2005 2005 43 38 41 38 69 20 44 41 35 57 7 31 68 59 53 78 33 26 28 59 2007 2004 2005 2006 2006 2005 2006 2004 2006 36 55 52 40 55 23 72 20 30 43 15 41 63 42 51 45 34 12 41 16 46 7 18 21 11 33 53 33 38 49 44 39 48 19 58 69 47 83 61 70 61 45 73 62 61 30 42 23 43 47 28 30 13 39 61 37 32 24 72 34 29 53 25 35 12 30 30 23 2005 2006 2006 2007 2002 35 33 45 27 2007 54 44 34 A2 2007 2005 9 2005 2007 2007 2003 22 33 39 2006 2007 2006 2002 2005 2005 2005 2006 2006 23 24 53 34 20 56 21 27 12 49 23 38 17 2005 2005 2006 2006 2006 32 53 34 38 67 26 56 21 32 62 31 53 33 37 66 61 68 66 41 53 23 33 71 68 54 55 52 67 61 61 47 35 58 63 58 43 50 27 75 64 52 72 2 55 24 70 2 61 43 71 2 58 61 38 65 2 64 47 73 2 34 71 2 Annex 2: Country progress indicators and data.

PERCENTAGE OF WOMEN AND MEN AGED 15-49 WHO HAD MORE THAN ONE SEXUAL PARTNER IN THE PAST 12 MONTHS REPORTING THE USE OF A CONDOM DURING THEIR LAST SEXUAL INTERCOURSE 20031 Survey Year Males Females Both sexes 15-49 Jamaica Japan Kazakhstan Kenya Kyrgyzstan Lebanon Lesotho Liberia Lithuania Madagascar Malawi Mali Malta Marshall Islands Mauritania Mauritius Mexico Micronesia. Federated States of Moldova Mongolia Morocco Mozambique Myanmar Namibia Nepal Nicaragua Niger Nigeria Palau Panama Papua New Guinea Paraguay Peru Philippines Portugal Russian Federation Rwanda Saint Kitts and Nevis Saint Lucia Saint Vincent and the Grenadines Samoa Sao Tome and Principe Senegal Serbia Sierra Leone Singapore South Africa Spain Suriname Swaziland Sweden Switzerland 2000 28 2000 2001 1998 26 2000 65 2000 1996 14 34 1998 36 15-49 15-24 25-49 18 38 30 15 26 7 45 19 28 72 56 15 30 320 Annex 2: Country progress indicators and data. 2004 to 2010 | 2010 GLOBAL REPORT .

20051 Survey Year Males Females Both sexes 20076 Survey Year Males Females Both sexes 15-49 15-49 15-24 25-49 2004 2007 15-49 67 82 33 81 72 41 46 13 47 38 19 10 44 20 15-49 53 82 12 75 67 19 20 5 30 17 15 46 15-49 64 82 30 80 72 34 44 8 38 20 18 10 44 15-19 20-24 25-49 88 48 85 49 93 47 78 40 77 17 2003 33 12 47 17 2003 2007 2004 2004 41 19 47 26 2004 2007 26 44 2004 2004 2001 9 20 16 2 16 14 12 32 27 6 13 13 2004 2004 2006 2006 2007 2004 2003 8 35 19 17 50 8 47 29 19 43 78 8 33 34 43 14 2005 45 22 56 28 2007 2005 2007 48 34 61 19 74 54 60 75 14 66 19 49 34 62 18 68 45 63 28 79 50 61 28 76 52 2003 19 14 38 10 2003 2007 2006 2001 2006 10 60 7 62 8 44 23 56 44 56 62 60 43 48 50 59 49 43 38 2003 22 13 34 17 2005 2006 2007 2006 45 26 2003 22 2003 22 A2 14 39 52 57 3 8 67 45 59 59 60 52 37 42 64 46 49 56 58 83 62 61 51 48 50 80 14 72 51 56 39 73 59 59 51 78 59 2005 8 14 2005 2006 2007 2006 2006 8 48 62 2005 31 21 61 22 2005 2006 2007 2007 2005 2003 2006 2007 2007 62 11 51 67 50 56 62 37 26 0 47 42 57 52 Annex 2: Country progress indicators and data. 2004 to 2010 | 2010 GLOBAL REPORT 321 .

5 No reference 5. data from two cities only.PERCENTAGE OF WOMEN AND MEN AGED 15-49 WHO HAD MORE THAN ONE SEXUAL PARTNER IN THE PAST 12 MONTHS REPORTING THE USE OF A CONDOM DURING THEIR LAST SEXUAL INTERCOURSE 20031 Survey Year Males Females Both sexes 15-49 Tajikistan Thailand Timor-Leste Togo Tonga Tunisia Turkey Tuvalu Uganda Ukraine United Kingdom of Great Britain and Northern Ireland United Republic of Tanzania Uruguay Viet Nam Zambia Zimbabwe 1996 1999 31 40 1999 22 1995 18 1998 33 15-49 15-24 25-49 21 42 25 8 24 9 16 25 17 18 46 36 56 23 30 1 2 Data provided by MEASURE DHS. 6 Methodology may vary for individual countries. 7 Demographic Health Survey (or Multiple Indicator Cluster Survey). 2004 to 2010 | 2010 GLOBAL REPORT . 3 female is 15-24 years only. 322 Annex 2: Country progress indicators and data. 4 No reference 4.

20051 Survey Year Males Females Both sexes 20076 Survey Year Males Females Both sexes 15-49 15-49 15-24 25-49 2006 2006 2007 15-49 15-49 15-49 65 15-19 53 63 72 20-24 69 49 76 25-49 53 73 14 69 51 73 50 71 2007 2001 24 25 2006 2007 42 75 58 41 61 53 42 72 52 71 30 45 41 72 77 64 2001 2004 2005 2001 2006 29 58 27 36 21 41 40 57 20 24 2007 2006 21 37 23 2005 2007 10 50 69 1 50 71 5 38 65 0 37 47 7 44 68 0 46 64 15 38 76 0 39 50 15 41 81 1 49 67 5 56 0 48 68 A2 Annex 2: Country progress indicators and data. 2004 to 2010 | 2010 GLOBAL REPORT 323 .

PERCENTAGE OF WOMEN AND MEN AGED 15-49 WHO HAD MORE THAN ONE SEXUAL PARTNER IN THE PAST 12 MONTHS REPORTING THE USE OF A CONDOM DURING THEIR LAST SEXUAL INTERCOURSE 20096 Survey Year Males Females Males 15-49 Albania Angola Antigua and Barbuda Argentina Armenia Azerbaijan Bangladesh Belarus Belize Benin Bolivia Bosnia and Herzegovina Botswana Brazil Bulgaria Burkina Faso Burundi Côte d’Ivoire Cambodia Cameroon Canada Cape Verde Central African Republic Chad Chile Colombia Congo. 2004 to 2010 | 2010 GLOBAL REPORT . Republic of the Costa Rica Cuba Cyprus Democratic People’s Republic of Korea Democratic Republic of the Congo Djibouti Dominican Republic El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Gabon Germany Ghana Greece Grenada Guatemala Guinea Guinea-Bissau Guyana Haiti Honduras 2008 2008 2009 2009 2005 2006 2009 100 64 65 34 62 2007 2005 2010 2009 2008 2009 61 9 35 64 26 23 2007 2008 2007 2008 2006 45 16 2008 48 2009 2006 2004 2009 2005 2009 28 75 60 16 55 2006 2005 2009 2009 2006 2008 2009 2008 2008 2009 2008 2007 2005 2005 2004 38 41 38 82 43 71 69 26 33 70 66 17 35 2008 2008 2009 40 42 15-49 15-19 20-24 50 25-49 45 48 56 35 26 68 56 21 80 81 49 44 71 70 43 39 24 54 61 11 31 80 34 64 78 41 9 35 59 41 7 38 31 29 38 83 76 71 93 64 86 57 83 88 58 70 94 61 72 56 75 79 33 60 25 24 28 66 30 57 18 55 14 48 49 37 24 7 35 81 28 33 72 19 70 57 12 35 42 22 49 17 24 55 48 21 27 66 30 74 24 33 79 65 86 42 5 59 24 40 65 49 25 68 62 70 56 18 5 34 61 22 20 47 65 58 23 77 UNGASS Indicator 17 Hungary 324 Annex 2: Country progress indicators and data.

2004 to 2010 | 2010 GLOBAL REPORT 325 .20096 Females MOST RECENT DHS (OR MICS)7 Survey year Males Females 15-19 20-24 25-49 15-49 15-49 47 51 42 2005 2006 69 58 20 77 77 35 46 50 10 2006 58 26 0 17 21 2008 85 52 60 76 45 0 47 78 83 37 65 86 45 100 37 60 75 35 2 27 41 2003 2005 2005 2004 2005 2006 2004 49 35 24 34 36 26 31 27 33 2005 2009 78 30 35 43 38 41 38 69 44 41 8 35 57 16 7 31 28 29 7 47 37 83 10 90 31 79 7 36 81 2007 2007 16 45 8 35 A2 1995 56 24 58 23 13 57 31 34 33 2005 30 51 24 43 46 18 17 18 45 2008 11 23 2005 66 48 19 26 2009 2005 2005-06 2000 54 9 40 26 26 18 24 65 34 20 48 21 27 Annex 2: Country progress indicators and data.

Islamic Republic of Jamaica Japan Kazakhstan Kenya Kyrgyzstan Lebanon Lesotho Liberia Lithuania Madagascar Malawi Mali Malta Marshall Islands Mauritania Mauritius Mexico Micronesia.PERCENTAGE OF WOMEN AND MEN AGED 15-49 WHO HAD MORE THAN ONE SEXUAL PARTNER IN THE PAST 12 MONTHS REPORTING THE USE OF A CONDOM DURING THEIR LAST SEXUAL INTERCOURSE 20096 Survey Year Males Females Males 15-49 India Indonesia Iran. Federated States of Moldova Mongolia Morocco Mozambique Myanmar Namibia Nepal Nicaragua Niger Nigeria Palau Panama Papua New Guinea Paraguay Peru Philippines Portugal Russian Federation Rwanda Saint Kitts and Nevis Saint Lucia Saint Vincent and the Grenadines Samoa Sao Tome and Principe Senegal Serbia Sierra Leone Singapore South Africa Spain 2008 2008 77 2007 2008 2005 2005 2007 2008 2008 2008 2005 2006 2008 60 62 71 15 48 55 52 25 2007 2006 2007 2008 2009 2008 2008 2008 72 7 66 0 25 40 2007 2009 2006 2006 61 22 45 74 2006 2009 52 2008 37 2009 2007 2008 2008 2008 2008 2008 2009 2004 2009 2006 2008 2008 2004 2006 2009 2007 20 39 80 20 23 65 72 37 81 79 60 55 65 15-49 15-19 100 20-24 70 100 25-49 100 58 63 52 64 32 62 52 90 77 83 69 87 60 59 65 84 67 77 60 28 5 36 40 85 25 26 21 3 14 43 76 14 52 65 20 12 60 29 3 16 17 72 10 15 31 31 85 21 47 38 75 23 0 66 19 8 39 23 9 0 5 25 46 45 19 39 81 59 40 41 67 84 35 71 81 15 40 4 94 0 47 38 73 74 62 81 0 32 43 80 71 64 49 0 18 39 65 47 43 25 62 62 48 37 61 7 68 65 83 14 63 77 34 64 326 Annex 2: Country progress indicators and data. 2004 to 2010 | 2010 GLOBAL REPORT .

2004 to 2010 | 2010 GLOBAL REPORT 327 .20096 Females MOST RECENT DHS (OR MICS)7 Survey year Males Females 15-19 20-24 25-49 2005-06 15-49 23 15-49 12 60 45 76 71 100 39 11 4 16 14 80 9 17 67 64 70 36 56 48 22 2 23 21 50 7 14 9 8 9 17 75 14 2004 2007 2003-04 2004 2006 41 22 9 20 12 19 14 2 16 8 48 59 2003 33 12 60 14 50 2005 45 22 31 77 12 69 0 17 5 82 65 56 32 0 46 30 37 0 14 8 32 55 50 15 0 2009 2006 2006 22 74 30 24 66 19 16 8 28 60 7 0 4 8 39 41 2001 2006 2008 7 33 8 23 A2 2007 2008 31 2005 8 14 55 50 59 53 67 11 54 71 14 53 4 2008-09 2005 2008 33 32 15 28 21 7 Annex 2: Country progress indicators and data.

7 Demographic Health Survey (or Multiple Indicator Cluster Survey).PERCENTAGE OF WOMEN AND MEN AGED 15-49 WHO HAD MORE THAN ONE SEXUAL PARTNER IN THE PAST 12 MONTHS REPORTING THE USE OF A CONDOM DURING THEIR LAST SEXUAL INTERCOURSE 20096 Survey Year Males Females Males 15-49 Suriname Swaziland Sweden Switzerland Tajikistan Thailand Timor-Leste Togo Tonga Tunisia Turkey Tuvalu Uganda Ukraine United Kingdom of Great Britain and Northern Ireland United Republic of Tanzania Uruguay Viet Nam Zambia Zimbabwe 2006 2005 27 36 2007 2010 2009 45 16 60 2006 2006 2009 2007 2008 2006 2008 2007 2008 2009 56 36 99 60 53 25 73 15-49 80 55 27 87 19 14 69 15-19 20-24 25-49 74 33 74 64 38 61 50 55 73 22 77 72 9 61 84 73 51 2008 2008 2007 82 16 69 75 7 65 33 41 10 78 50 71 27 80 40 56 15 56 23 22 1 2 Data provided by MEASURE DHS. 6 Methodology may vary for individual countries. 5 No reference 5. 328 Annex 2: Country progress indicators and data. 3 female is 15-24 years only. 2004 to 2010 | 2010 GLOBAL REPORT . 4 No reference 4. data from two cities only.

2004 to 2010 | 2010 GLOBAL REPORT 329 .20096 Females MOST RECENT DHS (OR MICS)7 Survey year Males Females 15-19 20-24 25-49 15-49 15-49 52 26 20 63 69 19 56 29 42 49 72 55 2007 56 55 15 50 64 1998 33 21 2006 100 75 54 2007 20 46 24 48 10 71 8 86 6 56 2007-08 2005 2007 22 58 28 36 21 33 41 43 2005-06 A2 Annex 2: Country progress indicators and data.

Time Period Males Females 15-24 Albania Armenia Armenia Azerbaijan Belize Benin Benin Benin Bolivia Bolivia Bosnia and Herzegovina Botswana Botswana Brazil Brazil Bulgaria Burkina Faso Burkina Faso Burkina Faso Burundi Cambodia Cameroon Cameroon Cameroon Cape Verde Central African Republic Chad Colombia Colombia Congo Congo. NON-COHABITING PARTNER.PERCENTAGE OF YOUNG PEOPLE AGED 15-24 YEARS WHO SAY THEY USED A CONDOM THE LAST TIME THEY HAD SEX WITH A NONMARITAL. OF THOSE WHO HAVE HAD SEX WITH SUCH A PARTNER IN THE LAST 12 MONTHS. 2004 to 2010 | 2010 GLOBAL REPORT . MDG 6a indicator Haiti Haiti Honduras 330 Annex 2: Country progress indicators and data. Democratic Republic of the Côte d’Ivoire Côte d’Ivoire Djibouti Dominican Republic Dominican Republic Dominican Republic Eritrea Ethiopia Ethiopia Gabon Gambia Gambia Ghana Ghana Ghana Guinea Guinea Guinea-Bissau Guyana 2008-2009 2005 2000 2006 2006 2006 2001 1996 2008 2003 2006 2001 1996 2004 1996 2005 1998–1999 2006 2003 2005 2005 2006 2004 1998 2005 2006 2004 2005 2000 2005 2007 1998–1999 2005 2005 2007 2002 1996 1995 2005 2000 2000 2006 2000 2008 2006 2003 2005 1999 2006 2005 2005–2006 2000 2005-2006 68 43 30 46 56 52 37 32 38 27 56 53 51 70 52 48 81 50 31 48 57 31 79 60 25 84 67 59 70 56 49 37 – 88 85 45 35 55 86 44 31 15-24 25 50 28 19 9 20 71 75 32 57 41 64 54 25 62 47 16 56 41 17 36 30 20 17 25 39 26 44 29 12 28 17 33 54 28 42 33 26 17 39 62 29 19 24 Supplemental data obtained by UNICEF through the Multiple Indicator Cluster Survey and Demographics Health Survey programmes.

United Republic of Tanzania. 2004 to 2010 | 2010 GLOBAL REPORT 331 . United Republic of Tanzania. United Republic of 2005–2006 2001 1999 2008-2009 2003 1998 2006 2004 2007 2003-2004 2006 2004 2000 1995–1996 2006 2001 2007 2008 2005 2006 2008 2003 2006-2007 2000 – 2006 2001 2001 2006 1998 2008 2007 2003 2004-2006 2004–2005 2000 2008 2003 2005 2000 2008-2009 2006 2005 2006 2008 2005 2007 2003 1998 2006 2006–2007 2007-2008 2004–2005 70 49 46 26 72 22 52 25 40 55 63 46 37 30 49 33 81 69 17 78 52 48 22 12 58 47 38 31 36 30 22 76 63 37 59 65 64 47 43 15-24 22 51 32 40 25 14 56 50 14 5 40 35 32 17 14 9 60 44 66 44 29 64 48 10 Tanzania.Time Period Males Females Time Period Males Females 15-24 India India Kazakhstan Kenya Kenya Kenya Kyrgyzstan Lesotho Liberia Madagascar Malawi Malawi Malawi Mali Mali Mali Marshall Islands Moldova Moldova Montenegro Mozambique Mozambique Namibia Namibia Nauru Nepal Nepal Nicaragua Niger Niger Nigeria Nigeria Nigeria Peru Peru Peru Philippines Philippines Rwanda Rwanda Sao Tome and Principe Sao Tome and Principe Senegal Serbia Sierra Leone Sierra Leone Solomon Islands South Africa South Africa Suriname Swaziland Tanzania. United Republic of Tanzania. United Republic of The former Yugoslav Republic of Macedonia Togo Togo Trinidad and Tobago Tuvalu Uganda Uganda Uganda Uganda Ukraine Uzbekistan Uzbekistan Viet Nam Zambia Zambia Zambia Zambia Zambia Zambia Zimbabwe 17 18 7 36 39 24 34 32 19 13 11 26 23 54 56 36 74 10 20 17 52 20 49 54 46 34 Zimbabwe Zimbabwe 2003–2004 1999 1996 15-24 47 31 31 15-24 42 21 18 2005 2006 1998 2006 2007 2004–2005 2006 2001 1995 2007 2006 2002 2005 2001–2002 2007 2005 2003 2000 1996 2005–2006 1999 1994 50 68 42 48 38 40 41 39 68 69 61 44 55 55 62 42 71 41 70 50 22 51 – 53 38 44 25 68 61 33 38 26 35 38 20 42 42 42 A2 Annex 2: Country progress indicators and data.

Republic of the Costa Rica Cuba Cyprus Democratic Republic of the Congo Djibouti Dominican Republic Ecuador El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Gabon Gambia Germany 2005 2007 2005 2007 2006 2 50 1 8 14 2007 2007 2007 19 2007 2007 2005 2006 2004 2006 2005 2006 2004 2007 2006 2007 2005 2007 2006 10 15 2 22 2 11 2 3 81 28 18 91 1 3 5 7 2007 2006 87 1 2006 2006 2006 2007 97 1 26 8 10 12 2006 2006 2006 2005 0 7 2007 15-49 15-19 20-24 25-49 15-49 27 1 4 0 11 1 1 5 25 8 4 12 99 1 33 9 20 15 87 1 0 7 86 1 0 17 88 1 0 15 87 1 0 26 35 5 31 10 99 1 31 9 15 14 87 1 23 93 1 4 3 5 10 17 1 35 2 27 2 3 71 32 15 91 1 2 2 3 3 10 0 8 28 92 1 3 6 6 13 19 1 33 27 93 1 4 4 6 13 17 1 48 21 92 1 3 4 5 32 10 16 1 28 2 19 2 1 17 4 32 4 80 1 32 3 12 1 30 2007 4 4 21 11 2 8 7 5 22 13 5 23 12 4 20 6 2 64 1 12 11 33 1 54 1 62 1 2 59 1 10 13 UNGASS Indicator 7 Ghana 332 Annex 2: Country progress indicators and data.PERCENTAGE OF WOMEN AND MEN AGED 15-49 WHO RECEIVED AN HIV TEST IN THE LAST 12 MONTHS AND WHO KNOW THEIR RESULTS 2007 Survey Year Males Females Both sexes 15-49 Afghanistan Albania Algeria Angola Antigua and Barbuda Argentina Armenia Austria Azerbaijan Bahamas Barbados Belarus Belgium Belize Benin Bhutan Bolivia Bosnia and Herzegovina Botswana Brazil Bulgaria Burkina Faso Burundi Côte d’Ivoire Cambodia Cameroon Canada Cape Verde Central African Republic Chad Chile China Colombia Congo. 2004 to 2010 | 2010 GLOBAL REPORT .

2009 Survey Year Males Females Both sexes Males Females MOST RECENT DHS (OR MICS) Survey Year Males Females 15-49 15-49 15-49 15-19 20-24 25-49 15-19 20-24 25-49 15-49 15-49 2008 2009 2009 2009 2008 2009 2009 2009 2009 2009 2008 2009 2008 2008 2009 2007 2008 2005 2005 2004 2009 2006 2004 2009 2007 2009 2008 2009 1 6 35 0 12 65 9 80 23 0 2 1 5 10 0 7 0 15 13 2005 100 2006 1 16 30 92 2 91 38 10 8 23 16 3 5 14 19 15 2 19 22 7 26 4 17 42 98 2 62 62 16 7 18 16 4 3 10 32 17 0 40 36 8 32 2 16 37 95 2 93 41 13 8 21 16 3 4 11 26 16 1 30 30 8 29 2 6 9 5 11 9 1 7 2 26 2 39 1 17 1 53 0 66 2005 2009 9% 9% 2 1 3 3 2 8 11 23 4 6 20 25 2 2 5 13 3 5 10 50 5 3 12 38 2005 2005 2004 2005 2006 2004 3% 5% 7% 10% 6% 2% 1% 4% 3% 5% 10% 2003 2% 29 36 39 71 65 61 1 10 12 85 1 15 32 90 3 22 35 94 2 4 11 15 90 1 19 52 86 3 23 46 100 2 2006 2008 5% 2% 7% A2 2007 2008 2007 2008 2006 2008 2005 2010 2009 2009 4 19 4 21 10 4 20 1 14 5 4 55 17 5 24 2 14 12 8 4 48 12 14 4 22 10 2007 2007 4% 19% 4% 21% 33 10 44 14 4 15 2 66 12 7 57 13 13 7 2 12 7 2 11 2 26 17 6 11 4 64 14 5 6 2 36 6 3 29 4 51 16 8 14 1 79 12 7 2008 4% 7% 2005 2% 2% Annex 2: Country progress indicators and data. 2004 to 2010 | 2010 GLOBAL REPORT 333 .

2004 to 2010 | 2010 GLOBAL REPORT .PERCENTAGE OF WOMEN AND MEN AGED 15-49 WHO RECEIVED AN HIV TEST IN THE LAST 12 MONTHS AND WHO KNOW THEIR RESULTS 2007 Survey Year Males Females Both sexes 15-49 Greece Grenada Guatemala Guinea Guinea-Bissau Guyana Haiti Honduras Hungary India Israel Jamaica Japan Kazakhstan Kenya Lesotho Liberia Lithuania Madagascar Malawi Malaysia Mali Marshall Islands Mauritania Mauritius Mexico Moldova Mongolia Montenegro Morocco Mozambique Myanmar Namibia Nauru Nicaragua Niger Nigeria Oman Palau Panama Papua New Guinea Peru Philippines Poland Portugal Russian Federation Rwanda Saint Kitts and Nevis Saint Lucia Saint Vincent and the Grenadines Sao Tome and Principe Senegal 2005 2 2007 2005 2006 2007 2006 34 1 8 30 1 11 2003 2007 2 2006 2007 2006 2005 4 9 2007 18 2006 2007 2004 61 2 2007 2004 2007 2007 2006 2006 2007 2004 2006 2007 6 3 56 1 10 24 1 13 2004 2006 2007 2003 2005 4 8 5 12 2005 2006 2005 2006 2006 2007 2006 10 5 21 1 0 1 3 2007 2006 13 6 15-49 11 13 1 5 11 8 23 1 0 1 19 5 7 6 20 1 03 15-19 5 3 1 7 3 20-24 9 19 2 17 8 25-49 16 10 2 11 8 15-49 12 10 2 11 7 23 1 0 0 16 2 14 2 14 17 1 15 16 98 1 7 14 6 24 1 11 1 75 1 2 4 2 4 9 7 5 7 8 24 1 7 67 1 3 2 67 1 4 50 1 31 3 5 60 1 5 21 10 3 21 11 8 11 3 41 2 29 5 2 8 16 1 3 1 31 3 9 2 2 3 27 1 10 4 61 3 26 4 2 8 20 1 51 2 27 7 3 11 14 1 2 23 5 2 9 11 38 1 12 39 1 12 6 12 12 20 1 4 35 1 16 37 1 13 10 1 34 1 11 10 1 36 1 10 1 1 1 1 1 334 Annex 2: Country progress indicators and data.

2004 to 2010 | 2010 GLOBAL REPORT 335 .2009 Survey Year Males Females Both sexes Males Females MOST RECENT DHS (OR MICS) Survey Year Males Females 15-49 2009 2009 2008 2008 2008 2009 2005 2006 2009 2008 2008 2008 2009 2006 2009 2008 2004 2009 2006 2007 2007 2008 2009 2008 2009 2007 2009 2006 2006 2009 2007 2006 2007 2009 2008 2009 2008 2008 2008 2009 2009 2009 2005 2005 2007 2008 2009 2005 34 8 100 2 18 32 11 10 6 5 4 12 6 9 12 18 100 3 22 10 6 10 8 2 16 12 22 5 21 3 20 20 23 22 96 3 15-49 11 87 4 11 27 8 23 3 35 24 29 2 20 7 15-49 18 88 4 4 11 25 7 23 3 28 22 15-19 8 98 2 9 2 4 2 8 12 13 20-24 23 27 3 14 6 19 3 22 21 25 3 22 10 3 23 8 9 25-49 23 96 4 14 10 27 4 27 22 26 3 15-19 5 85 3 7 4 10 1 26 15 18 2 18 5 20-24 14 100 6 14 10 27 3 49 29 39 2 29 10 4 27 9 19 42 25-49 12 88 4 2005 12 2005 8 27 5 35 25 30 1 2003 2004 2007 2004 2004 3 21 2006 2005-06 2005 15-49 15-49 3% 10% 5% 1% 11% 8% 1% 1% 8% 5% 2% 1% 8% 3% 7% 6% 2% 0% 7% 3% 2 18 0 16 4 98 3 22 3 6 16 32 4 14 11 29 100 5 2 11 18 12 4 30 1 17 34 12 39 12 100 1 18 33 11 10 36 12 100 1 4 100 1 12 100 1 9 100 2 8 100 1 12 100 1 16 100 1 2008-09 2005 23% 2% 31% 1% 8 32 4 21 43 14 18 30 13 17 2 12 100 18 12 5 22 3 0 1 11 8 6 12 7 7 8 9 0 10 0 8 23 5 47 17 8 26 1 30 31 17 15 36 13 15 2005 11% 12% 45 12 3 36 2007 2008 1% 1 5 2 9 5 16 2 5 2 13 2 14 2006 2008 2% 7% 1% 7% 100 3 22 5 6 13 32 1 5 12 11 6 5 6 100 12 11 16 100 100 9 13 13 7 13 100 19 12 36 100 100 13 12 2006 18% 29% 2009 9% 15% 4 5 3 11 8 9 1 17 3 24 3 18 18 33 2005 10% 12% A2 Annex 2: Country progress indicators and data.

PERCENTAGE OF WOMEN AND MEN AGED 15-49 WHO RECEIVED AN HIV TEST IN THE LAST 12 MONTHS AND WHO KNOW THEIR RESULTS 2007 Survey Year Males Females Both sexes 15-49 Seychelles Sierra Leone Singapore Slovakia Solomon Islands Somalia South Africa Spain Sri Lanka Sudan Suriname Swaziland Sweden Switzerland Tajikistan Thailand The former Yugoslav Republic of Macedonia Togo Tonga Trinidad and Tobago Tunisia Turkey Tuvalu Uganda Ukraine United Kingdom of Great Britain and Northern Ireland United Republic of Tanzania Uruguay Vanuatu Viet Nam Zambia Zimbabwe 2005 2007 2006 3 12 7 2006 2007 10 11 1 2006 100 1 2006 2007 2007 2006 7 41 16 2006 2007 9 2004 2006 2003 2007 01 51 90 1 2006 2007 2007 100 81 9 1 15-49 100 91 7 1 15-19 100 0 1 20-24 100 13 1 25-49 100 8 1 15-49 100 1 91 8 31 90 1 01 30 22 7 21 22 6 5 21 16 18 7 51 22 19 21 7 90 1 01 90 1 01 90 1 01 41 90 1 25 01 16 7 31 19 2006 2007 16 3 15 2 10 3 17 3 17 16 81 100 1 12 20 1 12 1 19 1 16 1 100 1 100 1 100 1 100 1 12 16 1 2006 2007 2007 11 31 21 36 20 19 2 19 7 15 1 10 4 20 3 19 9 20 3 17 7 20 2 15 7 1 2 Methodology not harmonized with UNGASS 2008 guidelines. 14-26 years. 3 15-24 years. 2004 to 2010 | 2010 GLOBAL REPORT . 336 Annex 2: Country progress indicators and data.

2009 Survey Year Males Females Both sexes Males Females MOST RECENT DHS (OR MICS) Survey Year Males Females 15-49 15-49 15-49 15-19 20-24 25-49 15-19 20-24 25-49 15-49 15-49 2008 2009 2008 2003 2008 2008 2009 2006 2006 2007 2009 2008 2006 3 4 2 0 2 5 3 6 4 2008 3% 4% 3 5 7 3 5 4 25 2 5 4 5 33 29 30 9 12 9 16 22 22 5 22 16 18 7 19 2 4 2 7 20 9 15 20 11 10 9 0 16 28 25 6 22 25 31 7 19 2007 9% 22% 2005 2007 2008 16 3 15 16 13 73 16 18 2 9 2 3 19 3 17 2009 2009 2007 2010 2009 3 13 12 1 3 15 2 14 6 20 13 9 12 12 9 18 15 3 15 16 3 4 3 2006 2007 10% 7% 12% 12% 2008 2008 2007 2008 2005 2006 3 19 19 12 3 12 6 19 17 11 2 19 4 19 18 11 2 15 2 11 4 5 21 27 2 22 22 5 15 9 11 23 20 6 20 18 2005 3% 12% 7% 2% 19% 7% 2007-08 19% 19% 7 14 13 13 22 20 2007 2005-06 A2 Annex 2: Country progress indicators and data. 2004 to 2010 | 2010 GLOBAL REPORT 337 .

4 36 4 24 44 34 44 63 64 21 4 13 83 3 36 25 4 3 4 31 . 4 32 4 40 2. 6 21 38 28 84 26 4 63 4 37 26 8 26 63 69 69 59 35 67 30 7 24 27 7 8 37 31 35 6 30 24 25 8 7 60 36 39 26 8 3 3 36 7 27 8 3 37 UNGASS Indicator 14 Kenya 338 Annex 2: Country progress indicators and data.PERCENTAGE OF SEX WORKERS. 2004 to 2010 | 2010 GLOBAL REPORT . INJECTING DRUG USERS AND MEN WHO HAVE SEX WITH MEN WHO BOTH CORRECTLY IDENTIFY WAYS OF PREVENTING THE SEXUAL TRANSMISSION OF HIV AND WHO REJECT MAJOR MISCONCEPTIONS ABOUT HIV TRANSMISSION SEX WORKERS 2005 20071 2009 All Afghanistan Albania Angola Argentina Armenia Azerbaijan Bahamas Bangladesh Barbados Belarus Belize Benin Bolivia Bosnia and Herzegovina Brazil Bulgaria Burundi Côte d’Ivoire Cameroon Chad Chile China Colombia Congo. 4 35 44 2 32 40 2 37 52 7 32 7 81 7 5 41 54 38 37 52 32 81 5 54 24 40 52 49 61 60 62 56 30 2. Islamic Republic of Jamaica Kazakhstan 26 24 1 67 24 4 4 24 23 69 49 All Male Female All 2 69 Male Female 2 69 67 6 54 4 54 96 43 43 30 31 67 60 48 31 37 3. Republic of the Costa Rica Croatia Cuba Czech Republic Democratic Republic of the Congo Dominican Republic Ecuador El Salvador Eritrea Estonia Ethiopia Gabon Georgia Greece Guatemala Guinea Guinea-Bissau Guyana Haiti Honduras Hungary India Indonesia Iran. 4 50 4 30 31 37 3 50 31 7 67 60 48 42 35 4 44 2. 4 30 2 31 73 31 73 47 3 6 60 83 3.

INJECTING DRUG USERS 2005 2007 1 MEN WHO HAVE SEX WITH MEN 2009 2005 2007 2009 All All Male Female All 29 Male 29 Female All All All 18 56 60 68 69 56 33 7 14 61 20 5 58 20 51 68 19 7 58 20 33 19 59 20 53 0 38 45 14 63 42 55 22 5 29 22 28 34 36 32 37 37 39 32 31 62 38 27 56 54 74 36 36 28 7 72 96 7 65 36 49 48 52 57 56 63 37 55 51 3 49 85 54 88 59 71 73 59 3 25 75 3 52 60 7 A2 75 3 74 3 7 60 3 36 41 5 41 38 38 02 74 33 25 7 10 33 7 67 36 21 27 7 58 24 63 58 24 63 68 15 63 59 7 24 77 24 58 24 76 30 69 15 80 66 43 42 47 37 7 87 100 30 44 7 7 68 Annex 2: Country progress indicators and data. 2004 to 2010 | 2010 GLOBAL REPORT 339 .

6 Transgender. Timor-Leste Togo Tunisia Turkey Ukraine Uzbekistan Viet Nam Zambia 24 35 4 41 41 35 42 22 8 48 4 48 51 36 51 340 Annex 2: Country progress indicators and data. but data collection can vary from 2005-2007. 7 Data collection started before 2008. 4 49 58 4 29 4 54 47 58 29 29 47 29 47 71 32 33 4 10 3 91 35 4 21 3 91 41 30 11 33 <1 3 92 35 33 7 13 91 7 35 7 20 2 14 4 36 4 36 4 2 14 36 36 30 11 45 36 7 28 23 91 81 71 36 11 33 1 92 35 17 5 30 11 45 36 72 41 4 41 41 7 14 17 41 13 6 10 4 78 46 4 46 41 4 28 23 100 75 10 25 79 46 4 45 41 29 21 32 71 31 38 29 60 32 100 31 41 25 10 47 45 67 46 43 42 47 7 52 13 67 50 43 24 52 13 51 36 51 1 Report date 2007. INJECTING DRUG USERS AND MEN WHO HAVE SEX WITH MEN WHO BOTH CORRECTLY IDENTIFY WAYS OF PREVENTING THE SEXUAL TRANSMISSION OF HIV AND WHO REJECT MAJOR MISCONCEPTIONS ABOUT HIV TRANSMISSION SEX WORKERS 2005 20071 2009 All Kyrgyzstan Lao People’s Democratic Republic Latvia Lithuania Madagascar Malawi Malaysia Mali Mauritania Mauritius Mexico Moldova Mongolia Montenegro Morocco Myanmar Nepal Niger Nigeria Pakistan Panama Papua New Guinea Paraguay Peru Philippines Romania Russian Federation Rwanda Saint Lucia Sao Tome and Principe Senegal Serbia Somalia South Africa Sri Lanka Sudan Suriname Swaziland Sweden Tajikistan Thailand The former Yugoslav Republic of Macedonia 14 17 72 35 90 1 All 36 4 Male Female 36 All 89 Male Female 89 21 24 4 30 24 45 41 45 41 38 78 2 38 22 7 22 2 2.PERCENTAGE OF SEX WORKERS. 2004 to 2010 | 2010 GLOBAL REPORT . 3 Methodology not harmonized with UNGASS 2008 guidelines. 4 Females only. 5 Males only. 2 Data collection started before 2005.

INJECTING DRUG USERS 2005 2007 1 MEN WHO HAVE SEX WITH MEN 2009 2005 2007 2009 All All 64 Male 62 Female 69 All 51 Male 49 Female 61 All 7 All 89 All 31 3 45 44 50 39 48 39 98 2 50 62 2 37 64 64 66 14 65 65 67 38 48 2 66 47 23 54 7 76 50 66 5 34 66 34 20 36 68 34 7 23 76 68 34 26 78 71 30 73 26 18 30 46 13 3 27 24 47 10 3 23 63 43 33 3 45 10 40 15 44 10 40 15 57 8 42 19 40 10 45 26 66 78 7 71 7 49 22 34 35 27 45 44 68 64 44 7 64 61 75 65 24 20 A2 65 46 49 45 51 55 63 55 78 59 25 26 27 34 32 47 34 7 32 47 34 41 41 7 27 54 24 21 34 47 38 3. 5 47 38 3 45 55 46 49 24 55 46 49 20 53 50 55 3 49 47 23 71 47 60 Annex 2: Country progress indicators and data. 2004 to 2010 | 2010 GLOBAL REPORT 341 .

4 60 59 4 46 4 70 2. 2004 to 2010 | 2010 GLOBAL REPORT . 4 54 86 4 60 4 41 4 11 3 Male 9 3 Female 11 3 All 1 23 90 6 Male Female 1 23 17 82 41 6 18 7 86 56 47 57 86 60 10 7 86 56 47 77 15 59 72 2 70 2 17 7 59 37 7 77 7 7 72 15 57 59 77 17 43 74 21 0 96 74 98 46 59 59 65 74 74 7 97 26 7 89 44 76 26 89 77 88 3 27 29 35 67 48 14 93 92 28 23 33 31 60 34 29 7 88 89 3 61 70 11 3 22 3 43 69 12 74 74 55 33 31 24 88 61 70 93 7 89 14 93 89 48 34 67 UNGASS Indicator 9 Malaysia 342 Annex 2: Country progress indicators and data. INJECTING DRUG USERS. 4 77 4 37 72 2.PERCENTAGE OF SEX WORKERS. 4 93 4 92 4 28 4 23 4 29 73 88 3. AND MEN WHO HAVE SEX WITH MEN REACHED WITH HIV PREVENTION PROGRAMMES1 SEX WORKERS 20071 2009 All Afghanistan Angola Argentina Armenia Azerbaijan Bahamas Bangladesh Belarus Benin Bolivia Bosnia and Herzegovina Brazil Bulgaria Burkina Faso Burundi Côte d’Ivoire Cameroon Chad Chile China Colombia Comoros Costa Rica Cuba Czech Republic Democratic Republic of the Congo Djibouti Dominican Republic Ecuador El Salvador Eritrea Estonia Gabon Georgia Ghana Greece Guatemala Guinea Guyana Honduras Hungary India Indonesia Jamaica Kazakhstan Kyrgyzstan Lao People’s Democratic Republic Latvia Lebanon Lithuania Malawi <1 3 43 4 69 86 4 40 60 71 3 89 3.

INJECTING DRUG USERS 2007 2009 MEN WHO HAVE SEX WITH MEN 2007 2009 All Male Female All 17 Male 17 Female All All 98 54 55 44 2 82 56 82 54 90 61 27 64 0 2 2 64 0 64 0 51 32 40 47 45 60 52 52 52 30 39 37 38 0 48 13 90 10 22 71 87 85 100 3 100 7 57 25 25 25 39 38 45 38 75 26 56 64 92 65 49 62 56 17 5 17 11 11 19 75 17 24 15 45 44 3 78 3 58 56 7 66 7 74 75 7 7 A2 31 7 55 18 9 43 60 36 22 52 61 48 40 48 3 77 3 44 55 43 7 60 44 7 68 78 3 78 3 38 47 45 53 7 15 3 40 7 100 3 43 Annex 2: Country progress indicators and data. 2004 to 2010 | 2010 GLOBAL REPORT 343 .

5 Males only. 4 63 2. AND MEN WHO HAVE SEX WITH MEN REACHED WITH HIV PREVENTION PROGRAMMES1 SEX WORKERS 20071 2009 All Mexico Moldova Mongolia Montenegro Morocco Myanmar Nepal Nigeria Norway Pakistan Panama Papua New Guinea Paraguay Peru Philippines Romania Russian Federation Saint Lucia Sao Tome and Principe Senegal Serbia Sierra Leone Singapore Slovenia Sudan Swaziland Sweden Tajikistan Togo Tunisia Turkey Ukraine United Republic of Tanzania Uzbekistan Viet Nam Zambia 65 3. 344 Annex 2: Country progress indicators and data. 2004 to 2010 | 2010 GLOBAL REPORT . 3 Methodology not harmonized with UNGASS 2008 guidelines. Data collection started before 2005. 4 50 3 60 4 76 73 4 80 3.PERCENTAGE OF SEX WORKERS. 7 Data collection started before 2008. 4 Females only.3 47 71 47 100 43 51 82 38 63 41 2 100 50 51 84 38 19 38 1 2 Report date 2007. 4 42 4 69 4 77 3. 4 39 14 4 33 76 31 4 18 42 49 4 36 96 64 Male 55 Female 28 96 All 60 15 74 44 Male 61 Female 59 15 74 43 45 49 76 49 56 39 49 7 76 93 49 7 41 49 33 73 23 78 31 80 14 10 76 7 31 7 13 73 6 78 31 55 33 22 55 33 22 80 3 30 73 100 3 2 77 3 100 3 75 55 3 60 81 42 69 58 68 71 65 3 63 2. INJECTING DRUG USERS. but data collection can vary from 2005-2007.

INJECTING DRUG USERS 2007 2009 MEN WHO HAVE SEX WITH MEN 2007 2009 All 5 89 Male 5 89 Female 4 89 All 20 7 Male 22 7 Female 13 8 All 18 86 67 All 38 77 53 78 5 78 57 59 7 16 3 51 53 57 60 51 89 10 44 54 47 69 77 60 7 56 7 89 7 10 14 24 13 33 28 21 11 14 11 11 17 21 19 59 17 29 100 85 7 21 19 25 14 85 27 25 26 21 30 41 8 64 8 63 12 69 54 46 53 22 46 45 30 50 32 31 33 19 50 63 34 43 3 43 3 15 32 15 49 26 42 24 A2 Annex 2: Country progress indicators and data. 2004 to 2010 | 2010 GLOBAL REPORT 345 .

2004 to 2010 | 2010 GLOBAL REPORT . 4 80 4 74 82 5 89 59 5 92 5 86 2 61 61 2. 5 50 3 78 91 44 67 80 76 83 57 4 88 4 78 5 91 5 63 80 5 76 5 83 5 88 4 95 5 99 74 2. 5 61 4 74 5 95 98 99 74 2 96 99 74 2. 5 96 5 99 5 74 2. Islamic Republic of Jamaica Japan Jordan Kazakhstan 84 55 48 56 95 69 96 96 96 74 74 77 100 77 40 44 32 89 100 89 50 3.4.PERCENTAGE OF FEMALE AND MALE SEX WORKERS REPORTING THE USE OF A CONDOM WITH THEIR MOST RECENT CLIENT 20057 All Males Females 20077 All Males Females Afghanistan Angola Argentina Armenia Azerbaijan Bangladesh Barbados Belarus Benin Bolivia Bosnia and Herzegovina Brazil Bulgaria Burkina Faso Burundi Côte d’Ivoire Cambodia Cameroon Canada Cape Verde Chad Chile China Colombia Comoros Costa Rica Croatia Cuba Democratic Republic of the Congo Djibouti Dominican Republic Ecuador Egypt El Salvador Eritrea Estonia Ethiopia Gabon Georgia Germany Ghana Greece Guatemala Guinea Guinea-Bissau Guyana Haiti Honduras India Indonesia Iran. 5 82 82 97 59 92 63 56 61 2 96 2 95 96 76 5 94 5 87 5 67 94 5 98 96 100 5 89 5 90 5 68 69 55 5 84 71 72 91 97 100 60 89 90 66 88 68 55 53 94 84 67 94 89 97 97 5 97 UNGASS Indicator 18 Kenya 346 Annex 2: Country progress indicators and data.

5 75 1.20097 All Males Females 58 81 5 99 1. 2004 to 2010 | 2010 GLOBAL REPORT 347 . 5 63 1 70 25 5 87 5 76 5 93 99 1 82 1. 5 97 5 65 1. 5 89 98 56 62 1. 5 97 99 1. 5 51 5 96 5 79 87 91 62 57 9 31 90 45 94 98 77 99 64 5 97 65 93 61 79 83 66 55 97 65 51 96 88 A2 Annex 2: Country progress indicators and data. 5 98 1. 5 53 63 62 94 81 97 94 81 21 1 45 5 94 1. 5 73 5 97 90 98 44 58 81 99 75 67 70 25 87 76 90 94 99 82 97 99 73 38 5 85 5 38 1 73 1 85 96 59 59 1. 5 76 99 5 64 55 96 1 65 5 93 5 61 5 90 80 83 5 68 1 55 1.

6 Males only. 5 100 72 79 89 68 98 20 75 86 88 84 78 78 33 5 93 76 75 84 33 86 65 97 4 1 Data collection started before 2008. 5 Females only. Ukraine Uruguay Uzbekistan Vanuatu Viet Nam Zambia Zimbabwe 80 80 86 5 65 5 90 90 97 4. 5 81 4 4. 3 Data collection period not defined. 6 72 44 82 348 Annex 2: Country progress indicators and data. 5 96 98 94 38 67 50 96 38 93 5 92 5 54 5 81 96 5 98 5 23 92 7 91 37 92 34 76 94 5 76 65 85 77 85 5 92 5 87 5 86 87 99 5 68 5 47 4 34 4 77 69 99 100 2 96 96 93 92 54 93 77 96 98 21 64 71 42 50 45 84 94 78 96 65 46 2 85 92 87 60 99 68 99 65 89 5 70 98 5 22 75 5 96 4. 4 Methodology not harmonized with UNGASS 2008 guidelines.PERCENTAGE OF FEMALE AND MALE SEX WORKERS REPORTING THE USE OF A CONDOM WITH THEIR MOST RECENT CLIENT 20057 All Males Females 20077 All Males Females Kyrgyzstan Lao People’s Democratic Republic Lebanon Lithuania Madagascar Malawi Malaysia Mali Mauritania Mauritius Mexico Moldova Mongolia Montenegro Morocco Myanmar Nepal Nicaragua Niger Nigeria Pakistan Panama Papua New Guinea Paraguay Peru Philippines Poland Romania Russian Federation Rwanda Sao Tome and Principe Senegal Serbia Sierra Leone Singapore Somalia Sri Lanka Sudan Suriname Swaziland Sweden Switzerland Tajikistan Thailand The former Yugoslav Republic of Macedonia Timor-Leste Togo Tunisia Turkey 81 83 59 89 84 5 84 34 4 77 5 79 69 5 35 2 99 5 100 2. 7 Methodology may vary for individual countries. 2004 to 2010 | 2010 GLOBAL REPORT . 2 Data collection started before 2005.

2004 to 2010 | 2010 GLOBAL REPORT 349 . 5 88 1. 5 91 99 93 65 98 71 87 97 89 68 1 25 89 1. 5 38 76 1 50 33 64 42 85 98 43 84 53 64 45 99 88 66 91 90 73 54 96 75 65 5 98 5 71 5 87 1. 5 78 5 76 93 67 20 72 1. 5 62 91 5 90 5 72 1 54 1. 6 89 45 87 14 84 92 75 65 89 52 42 88 81 67 78 A2 Annex 2: Country progress indicators and data. 5 45 5 87 87 5 19 84 5 92 5 78 1 88 52 5 88 5 76 6 81 5 67 1. 5 96 5 38 74 85 5 98 1. 5 97 1.20097 All Males Females 94 5 94 94 92 92 94 5 92 5 61 99 1.

2004 to 2010 | 2010 GLOBAL REPORT .PERCENTAGE OF MEN REPORTING THE USE OF A CONDOM THE LAST TIME THEY HAD ANAL SEX WITH A MALE PARTNER 20055 Argentina Armenia Australia Azerbaijan Bahamas Bangladesh Barbados Belarus Bolivia Bosnia and Herzegovina Brazil Bulgaria Burkina Faso Côte d’Ivoire Cambodia Cameroon Canada Chile China Costa Rica Cuba Czech Republic Denmark Dominican Republic Egypt El Salvador Estonia Fiji Georgia Germany Ghana Greece Guatemala Guyana Haiti Honduras Hungary India Indonesia Iran. 4 69 24 67 20095 47 57 69 31 1 61 69 56 48 46 47 86 70 52 42 86 43 62 1 29 64 71 55 56 73 65 52 30 73 79 2 83 47 66 13 1 55 47 62 58 48 89 78 81 73 47 59 11 78 84 73 1 47 1 25 58 39 57 38 1 73 55 66 75 81 24 4 65 76 50 39 4 58 54 52 2 79 48 64 47 21 54 UNGASS Indicator 19 350 Annex 2: Country progress indicators and data. Islamic Republic of Jamaica Japan Kazakhstan Kenya Kyrgyzstan Lao People’s Democratic Republic Latvia Lebanon Lithuania Malaysia Mali Mauritius Mexico Moldova 63 68 48 20 54 41 62 49 30 20075 91 84 58 3.

4 Methodology not harmonized with UNGASS 2008 guidelines. 2004 to 2010 | 2010 GLOBAL REPORT 351 . Annex 2: Country progress indicators and data. 3 Data collection period not defined.20055 Mongolia Myanmar Nepal Nicaragua Nigeria Norway Pakistan Panama Papua New Guinea Paraguay Peru Philippines Poland Portugal Romania Russian Federation Rwanda Saint Lucia Senegal Serbia Singapore Slovenia South Africa Spain Sri Lanka Suriname Sweden Switzerland Thailand The former Yugoslav Republic of Macedonia Timor-Leste Togo Trinidad and Tobago Tunisia Turkey Tuvalu Ukraine United Kingdom of Great Britain and Northern Ireland Uruguay Uzbekistan Vanuatu Viet Nam 72 29 45 39 46 8 84 13 20075 67 74 53 24 86 88 4 47 32 32 2. Data collection started before 2005. 4 20095 78 82 75 36 53 53 86 51 63 32 43 73 60 74 55 2 43 56 50 63 76 67 17 75 4 43 35 66 61 89 42 4 80 4 88 56 60 47 2 61 89 1 51 80 56 38 72 40 37 63 39 64 A2 63 1 47 61 61 87 63 66 1 2 Data collection started before 2008. 5 Methodology may vary for individual countries.

2 Data Collection period started before 2005. 3 Methodology not harmonized with UNGASS 2008 guidelines. Afghanistan Argentina Armenia Australia Azerbaijan Bangladesh Belarus Benin Bosnia and Herzegovina Brazil Bulgaria Canada China Croatia Egypt Estonia Georgia Greece India Indonesia Iran. 6 Methodology may vary for individual countries.6 All Males Females 20096 All Males Females UNGASS Indicator 20 1 Report date 2007. Islamic Republic of Japan Jordan Kazakhstan Kyrgyzstan Latvia Lebanon Luxembourg Malaysia Mauritius Mexico Moldova Montenegro Morocco Myanmar Nepal Nigeria Pakistan Paraguay Philippines Portugal Romania Russian Federation Serbia Spain Sweden Switzerland Tajikistan Thailand The former Yugoslav Republic of Macedonia Tunisia Turkey Ukraine United Kingdom of Great Britain and Northern Ireland Uzbekistan Viet Nam 35 64 56 20 3 18 2 44 59 23 4 19 43 34 3 63 56 20 3 44 57 23 18 32 3 28 43 3 65 55 20 3 55 65 5 35 27 15 43 5 59 30 30 70 38 39 5 36 50 66 78 16 36 33 27 16 43 56 29 25 8 68 33 37 42 35 55 66 78 16 36 33 43 35 42 68 48 4 48 34 33 65 4 37 11 38 15 3 52 13 2 29 68 13 38 4 66 33 66 48 74 113 34 33 65 37 11 40 15 3 30 30 35 30 36 9 34 46 53 43 49 28 31 28 36 13 78 51 66 31 22 22 38 17 45 29 55 7 50 5 28 42 51 35 48 46 55 47 48 15 2 27 73 12 38 66 21 33 02 38 52 21 29 41 12 78 51 66 31 23 39 18 46 29 8 53 26 45 51 25 12 21 68 36 68 37 39 31 0 31 12 40 29 0 42 40 29 51 25 50 3 36 35 51 10 55 28 53 3 33 19 42 3 47 51 9 55 51 13 56 50 45 39 36 3. 4 37 36 3 50 44 26 52 43 25 52 46 32 352 Annex 2: Country progress indicators and data.PERCENTAGE OF INJECTING DRUG USERS REPORTING THE USE A CONDOM THE LAST TIME THEY HAD SEXUAL INTERCOURSE 20071. 2004 to 2010 | 2010 GLOBAL REPORT . but data collection can vary from 2005 to 2007. 4 Males only. 5 Data collection period started before 2008.

2004 to 2010 | 2010 GLOBAL REPORT 353 . 5 Males only. 3 Data collection period undefined. 4 Methodology not harmonized with UNGASS guidelines. Afghanistan Albania Argentina Armenia Australia Azerbaijan Bangladesh Belarus Belgium Benin Bosnia and Herzegovina Brazil Bulgaria Canada China Egypt Georgia Greece Hungary India Indonesia Iran.PERCENTAGE OF INJECTING DRUG USERS REPORTING THE USE OF STERILE INJECTING EQUIPMENT THE LAST TIME THEY INJECTED 20076 All Males Females 20096 All Males Females UNGASS Indicator 21 1 2 Data collection period started before 2008. Islamic Republic of Japan Kazakhstan Kyrgyzstan Latvia Lebanon Lithuania Luxembourg Malaysia Maldives Mauritius Mexico Moldova Montenegro Morocco Myanmar Nepal Nigeria Pakistan Paraguay Philippines Portugal Romania Russian Federation Serbia Spain Sweden Switzerland Tajikistan Thailand The former Yugoslav Republic of Macedonia Timor-Leste Tunisia Turkey Ukraine United Kingdom of Great Britain and Northern Ireland Uzbekistan Viet Nam 46 65 95 71 4 77 34 71 64 95 67 93 94 82 91 80 62 32 1 87 53 31 87 54 86 72 48 74 87 88 1 74 63 82 98 71 83 72 72 40 99 24 71 81 99 89 77 71 85 69 85 83 80 81 58 94 1 63 63 73 78 94 34 71 74 70 62 32 87 31 90 87 72 401 48 65 88 33 25 5 25 68 3. Data Collection period started before 2005. 4 41 93 5 67 25 26 42 93 23 32 84 68 82 2 75 47 5 59 77 90 60 4 82 2 75 47 59 76 87 63 4 89 2 62 58 81 96 04 83 88 75 65 85 98 90 94 62 55 80 97 28 2 32 2 14 96 7 96 5 89 80 48 28 2 82 32 2 15 96 7 96 89 28 80 47 30 2 83 33 2 9 95 12 74 39 99 7 81 99 89 77 84 71 86 85 81 58 95 61 63 73 3 29 43 100 12 86 79 63 17 2 81 86 A2 94 59 83 76 73 58 92 84 64 69 11 38 94 4 32 38 95 4 35 35 92 4 21 73 73 69 10 84 9 85 13 81 87 81 82 95 89 82 81 95 84 77 81 23 89 5 23 89 25 Annex 2: Country progress indicators and data. 6 Methodology may vary for individual countries.

5 96 5 78 52 5 97 5 54 33 5 39 33 64 2 87 4 96 67 93 56 97 55 33 52 7 97 7 64 28 52 93 52 65 28 66 93 5 58 5 93 58 43 93 7 66 93 43 UNGASS Indicator 8 354 Annex 2: Country progress indicators and data.PERCENTAGE OF SEX WORKERS. Republic of the Costa Rica Cuba Czech Republic Democratic Republic of the Congo Denmark Djibouti Dominican Republic Ecuador El Salvador Eritrea Estonia Ethiopia Finland Gabon Georgia Germany Ghana Greece Guatemala Guinea Guinea-Bissau 24 3 38 49 25 36 33 All 11 5 Male Female 11 All 4 Male Female 4 42 5 38 18 5 63 5 42 65 18 63 35 62 82 67 35 44 6 4 4 73 85 87 45 14 18 60 58 100 65 51 68 6 73 4. AND MEN WHO HAVE SEX WITH MEN THAT HAVE RECEIVED AN HIV TEST IN THE LAST 12 MONTHS AND WHO KNOW THEIR RESULTS SEX WORKERS 2005 20071 2009 All Afghanistan Albania Algeria Angola Argentina Armenia Australia Azerbaijan Bahamas Bangladesh Barbados Belarus Belgium Benin Bolivia Bosnia and Herzegovina Brazil Bulgaria Burkina Faso Burundi Côte d’Ivoire Cambodia Cameroon Canada Chad Chile China Colombia Comoros Congo. 5 37 2 36 7 85 36 85 67 89 64 2. INJECTING DRUG USERS. 5 8 5 73 4 63 30 47 73 7 85 87 45 14 85 4 78 4 53 94 4 38 2 51 68 32 2 58 100 65 7 51 7 68 7 51 5 68 5 32 2. 2004 to 2010 | 2010 GLOBAL REPORT . 5 38 7 38 85 37 42 0 100 29 5 82 71 29 85 37 100 7 49 36 38 32 35 35 35 37 2. 4 53 5 94 4. 5 63 5 30 5 78 4 96 2. 5 38 2.

2004 to 2010 | 2010 GLOBAL REPORT 355 .INJECTING DRUG USERS 2005 2007 1 MEN WHO HAVE SEX WITH MEN 2009 2005 20071 2009 All All 6 Male Female All 22 17 Male 22 Female All All All 45 15 47 21 23 57 4 5 3 39 36 49 3 49 49 47 57 36 7 25 5 4 56 35 25 58 40 33 100 4 53 6 38 53 36 52 31 13 48 47 49 29 28 10 2. 4 35 26 19 42 100 57 4 35 7 59 47 7 44 52 58 43 4 37 41 40 45 37 36 46 33 61 57 7 58 7 34 25 45 55 15 61 6 53 62 3 43 23 62 13 96 42 98 5 50 61 13 7 50 37 80 86 85 7 8 43 33 34 7 61 32 43 A2 55 33 50 4 55 62 63 60 47 7 63 6 96 9 6 6 27 30 2 18 25 39 64 78 64 7 24 7 23 7 45 62 27 4 85 27 7 Annex 2: Country progress indicators and data.

Islamic Republic of Jamaica Japan Kazakhstan Kenya Kyrgyzstan Lao People’s Democratic Republic Latvia Lebanon Lithuania Luxembourg Madagascar Malawi Malaysia Maldives Mali Mauritania Mauritius Mexico Moldova Mongolia Montenegro Morocco Myanmar Nepal Nicaragua Niger Nigeria Norway Pakistan Panama Papua New Guinea Paraguay Peru Philippines Poland Portugal Romania Russian Federation Rwanda Saint Lucia Sao Tome and Principe Senegal Serbia Sierra Leone Singapore 36 77 67 9 43 15 All 64 71 71 5 Male Female 64 71 34 All 88 71 7 76 32 33 7 20 7 73 81 42 14 Male Female 88 76 32 31 20 5 43 5 52 25 20 43 70 53 57 28 20 73 81 92 42 14 69 53 70 5 12 2 53 5 24 4 50 5 49 5 69 5 100 3. 4 7 100 4. 5 51 5 40 38 5 38 5 4 55 47 5 100 5 12 5 11 4 25 4 50 49 69 7 53 20 14 91 7 100 4 63 76 31 53 73 4 51 52 37 91 38 38 4 59 100 5 52 47 100 54 4 12 45 38 7 14 55 7 56 100 20 19 6 13 59 47 45 38 15 52 60 100 55 19 23 52 83 7 51 7 71 65 51 71 32 23 52 69 7 14 91 69 35 5 61 5 65 5 35 61 65 29 39 7 29 39 65 72 4. 5 70 5 72 4 70 75 100 31 7 70 45 35 48 7 100 31 70 52 48 100 79 356 Annex 2: Country progress indicators and data.PERCENTAGE OF SEX WORKERS. INJECTING DRUG USERS. 5 30 2 72 31 5 53 5 73 4. 2004 to 2010 | 2010 GLOBAL REPORT . AND MEN WHO HAVE SEX WITH MEN THAT HAVE RECEIVED AN HIV TEST IN THE LAST 12 MONTHS AND WHO KNOW THEIR RESULTS SEX WORKERS 2005 20071 2009 All Guyana Haiti Honduras Hungary India Indonesia Iran.

INJECTING DRUG USERS 2005 2007 1 MEN WHO HAVE SEX WITH MEN 2009 2005 20071 2009 All All Male Female All Male Female All All 44 48 40 All 87 71 7 29 7 100 17 8 18 9 36 23 36 23 42 16 100 21 44 7 23 7 100 9 43 23 100 36 61 16 38 15 32 34 7 11 7 53 7 32 60 42 34 41 32 49 43 56 40 56 39 56 45 38 40 70 5 14 26 30 41 61 44 64 62 24 60 60 50 4 81 63 7 73 7 65 7 60 73 70 14 4 72 28 100 4 33 17 15 67 100 10 15 4 20 2 31 2 34 24 2 28 2 33 02 48 2 38 75 32 48 29 49 49 41 23 16 2 54 38 60 81 4 78 50 13 13 21 6 13 21 11 13 7 27 22 13 27 22 10 48 30 42 23 23 44 33 23 7 12 23 12 32 30 30 7 56 7 A2 45 100 4 <1 36 7 36 16 4 46 100 4 17 4 44 100 4 10 4 50 100 4 19 26 17 35 18 23 16 41 20 33 23 100 4 100 15 1 2 0 76 42 100 21 16 <1 76 7 67 100 6 7 27 7 47 32 75 61 47 100 11 32 30 39 53 47 34 7 31 43 Annex 2: Country progress indicators and data. 2004 to 2010 | 2010 GLOBAL REPORT 357 .

5 43 5 67 7 43 75 100 38 4 43 7 7 64 78 7 43 7 62 94 4. Data collection started before 2005. 4. 2004 to 2010 | 2010 GLOBAL REPORT . but data collection can vary from 2005-2007.PERCENTAGE OF SEX WORKERS. 4 Methodology not harmonized with UNGASS 2008 guidelines. AND MEN WHO HAVE SEX WITH MEN THAT HAVE RECEIVED AN HIV TEST IN THE LAST 12 MONTHS AND WHO KNOW THEIR RESULTS SEX WORKERS 2005 20071 2009 All Slovenia Somalia South Africa Spain Sri Lanka Sudan Suriname Swaziland Sweden Switzerland Tajikistan Thailand The former Yugoslav Republic of Macedonia Timor-Leste Togo Tonga Tunisia Turkey Ukraine United Kingdom of Great Britain and Northern Ireland Uruguay Uzbekistan Vanuatu Viet Nam Zambia 26 32 All Male Female All Male Female 5 67 2. 358 Annex 2: Country progress indicators and data. INJECTING DRUG USERS. 5 Females only. 3 Data collection period not defined. 5 34 4 59 94 4 33 4 29 70 38 100 42 29 5 53 54 42 36 35 52 36 67 47 40 87 22 39 89 100 4 47 7 58 14 59 87 43 39 53 59 14 97 46 5 100 97 46 26 19 5 15 5 17 14 19 15 23 35 12 7 35 26 35 12 35 1 2 Report date 2007. 6 Males only. 7 Data collection started before 2008.

INJECTING DRUG USERS 2005 2007 1 MEN WHO HAVE SEX WITH MEN 2009 2005 20071 2009 All All Male Female All Male Female All All All 33 27 68 2. 4 67 2. 4 76 7 49 3 14 87 7 14 7 59 84 4 60 24 83 4 59 23 86 4 61 30 82 60 7 36 62 82 59 37 61 81 61 30 71 41 31 35 39 31 7 21 32 44 42 53 44 7 42 53 7 56 56 7 26 53 21 8 27 29 11 29 0 30 26 22 25 13 29 25 35 3 31 27 18 43 70 18 11 6 18 11 18 34 18 33 18 37 17 2 25 16 31 7 26 44 19 A2 Annex 2: Country progress indicators and data. 2004 to 2010 | 2010 GLOBAL REPORT 359 . 4 72 2.

.

.

org unaids.org .20 Avenue Appia CH-1211 Geneva 27 Switzerland +41 22 791 3666 distribution@unaids.

Sign up to vote on this title
UsefulNot useful